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Abstract 
Vaginal microbicides are pharmaceutical products in development that are designed to 
reduce the sexual transmission of HIV in women. They are commonly known as a 
`woman-controlled technology' and tool for women's empowerment, and form part of a 
burgeoning field of clinical research into new biotechnologies for HIV prevention. 
Little work has critically examined how such research and new technologies are 
produced, and how they in turn contribute to the construction, maintenance or 
deconstruction of gender relations. 
Adopting a Foucauldian understanding of power and discourse, and using theoretical 
insights from science and technology studies (STS), this research explores the co- 
production of gender and technology through the case study of vaginal microbicides. 
'T'his account of the relations between science, society and technology draws on 
empirical research conducted in the UK and Zambia with the pharmaceutical industry, 
trialists, trial participants and trial communities. It interrogates the techniques of power 
through which transnational scientific networks are mobilised to test new products, such 
as microbicides, and how these affect scientific practices, knowledges and identities 
across socio-geographic boundaries. It attends to the potential multiplicity of 
interventions in diverse contexts, calling into question the presumed stability and 
singularity of both the randomized controlled trial and vaginal microbicides. 
This research makes an empirical contribution to knowledge about new biomedical 
technologies for HIV prevention, detailing the transformation that may occur when 
technologies travel from their site of development to their site of use. It provides a 
detailed analysis of the interaction between gender performativity and science in action, 
challenging the sense of `gendered' technologies for a `feminized' epidemic. 
Theoretically, it contributes to debates about the role of social theory in public health 
research and reconstructivist agendas in STS, concluding with a model for greater 
collaboration between health technology designers, evaluators, critics, and users. 
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Chapter One 
Introduction: Demystifying HIV Prevention Science 
A quarter of a century of AIDS responses has created a huge body of knowledge 
about HIV transmission and how to prevent it, yet every day, around the world, 
nearly 7,000 people become infected with the virus. Although HIV prevention 
is complex, it ought not to be mystifying. (Piot et al. 2008: 845) 
This thesis seeks to demystify; not HIV, or its prevention, but how knowledge about 
HIV prevention comes into being. Collins once wrote, "Knowledge is like a ship 
because once it is in the bottle of truth, it looks as though it must always have been there 
and it looks as though it could never get out again" (Collins 1985: vii). In this research, 
I have been present as one particular ship was built and erected in its bottle. Between 
2004 and 2009, I worked for the Microbicides Development Programme on a clinical 
trial of the candidate microbicide PRO 2000. This innovative research programme 
provided an ideal location within which to examine HIV prevention science as a cultural 
activity rather than a source of certain knowledge. The current case study explores how 
science and society emerge as the joint achievements of human activity and, in the case 
of the HIV epidemic, what this means for prevention. 
In the chapters that follow, I describe the process of defining my topic and research 
questions, before presenting my empirical findings. In this chapter, I will give a brief 
overview of the broader context in which this research took place, starting with the HIV 
epidemic and current prevention approaches. The aim here is not to provide a 
comprehensive review of the HIV literature, but merely to outline the scale of the 
problem and the field in which this case study is situated. In the same way, since this 
thesis is based on a case study of the Microbicides Development Programme (MDP), I 
will provide some background information on microbicides and the MDP. I conclude 
this chapter with a summary of the thesis. 
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HIV, AIDS and HIV prevention 
At the end of 2008, an estimated 2.7 million people became newly infected with HIV, 
joining the 33.4 million already living with the disease. Of these new infections, 71% 
occurred in sub-Saharan Africa (UNAIDS 2009). Although important gains have been 
made in terms of treatment, with a tenfold increase in the number of people receiving 
antiretrovirals in low and middle-income countries over the past five years (UNAIDS 
2009: 7), these gains are not matched by prevention. In fact, for every new person 
starting antiretroviral treatment, many more become infected (UNAIDS 2007c)'. In 
2008, Horton and Das observed: 
From the very beginning of the global response to the AIDS pandemic, 
prevention has been marginalised. Treatment has dominated. This systematic 
imbalance is largely responsible for the fact that around 2.5 million people 
become newly infected with HIV each year. (Horton and Das 2008: 421) 
Whilst the failure to prevent new infections has been attributed to lack of financial 
commitment2, this simplifies a more complex picture in which the most trusted 
prevention interventions are at best unproven, and at worst disproven, for reducing HIV 
incidence (Wilson and Halperin 2008: 424); proven interventions reach only a fraction 
of those who need them (UNAIDS 2008c: 127); and the epidemic repeatedly defies 
predictions derived from epidemiological modelling (UNAIDS 2008c: 16). Three 
decades into the epidemic, much remains mystifying in and about HIV prevention 
science. 
Gender and HIV in sub-Saharan Africa 
One of the most striking features of the AIDS epidemic is what is referred to as its 
"feminization". Whereas in 1985, thirty-five percent of infected people were women, 
1 According to Merson et al, for every two patients who started antiretroviral therapy in 2007, five new 
HIV infections occurred (Merson et al. 2008: 485). 
2 In 2007, approximately 40% of the USS10 billion spent on HIV/AIDS in low-and middle-income 
countries went to prevention; in the same year, UNAIDS estimated that HIV prevention would cost US$11.6 billion by 2010 (UNAIDS 2007a). 
12 
the figure has now risen to approximately fifty percent (Quinn and Overbaugh 2005). 
In the most severely affected countries in sub-Saharan Africa3, prevalence is on average 
three times higher in young women than in young men aged 15-24 years (Gouws et al. 
2008). In sub-Saharan Africa as a whole, women account for approximately 60% of all 
HIV infections (Garcia-Calleja et al. 2006; UNAIDS 2008c). Women's higher 
vulnerability to HIV infection has been well-documented, and is attributed to both 
biomedical and socio-economic determinants. In terms of the former, efficiency of 
transmission is generally believed to be greater in women than in men (European Study 
Group on Heterosexual Transmission of HIV 1992; Nicolosi et at. 1994; O'Brien et at. 
1994), and this may be partly due to the larger surface area of the female genital tract 
and higher viral load in semen than vaginal fluids (Chersich and Rees 2008). However, 
as Chersich and Rees note, "the biomedical vulnerability that most interventions seek to 
target is an outward manifestation of an underlying gendered social and economic 
vulnerability, which takes expression in behavioural risks" (Chersich and Rees 2008: 
S35). Social and economic factors that have been reported to increase women's 
vulnerability to HIV include inequitable access to education and labour markets 
(Hallman 2004; Jukesa et al. 2008; Ehrhardt et al. 2009); lack of power within 
relationships (Blanc 2001; Dunkle et al. 2004; Pettifor et al. 2004); and gender-based 
violence (GBV) (Andersson et at. 2008). It is widely acknowledged that the pathways 
through which such determinants operate are complex and multi-faceted. 
Heterosexual sexual intercourse is the primary mode of transmission in sub-Saharan 
Africa and, ironically, "models suggest that the proportion of new infections among 
people in stable, so-called `low-risk' partnerships is often high" (UNAIDS 2009: 29). 
In spite of the dyadic context of HIV infection between sexual partners, HIV prevention 
programmes and evaluation have focused almost exclusively on individuals rather than 
couples (Painter 2001). Furthermore, the needs and vulnerabilities of heterosexual men 
have been relatively ignored in the development of HIV prevention models; where men 
are included, this is often in an instrumentalist way, relating solely to their impact on 
women (Peacock et al. 2009). In a new recognition of the importance of partnerships, 
UNAIDS declared in 2008 that, `By specifically tailoring programmes to reach people 
3 Gouws et al analysed data from countries where national adult HIV prevalence was more than 10%. In 
2007, these were Botswana, Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Zambia 
and Zimbabwe (Gouws et al. 2008). 
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in different kinds of partnerships, HIV prevention efforts may achieve greater impact 
than programmes that solely aim to affect the behaviours of a single individual" 
(UNAIDS 2008c: 117). This follows findings from observational studies suggesting 
that Voluntary Counselling and Testing (VCT) with serodiscordant couples is effective 
as an HIV prevention tool (Kamenga et al. 1991; Allen et al. 1992; Padian et al. 1993; 
Skurnick et al. 1998; Roth et al. 2001; Allen et al. 2003) and that in terms of prevention 
of mother-to-child transmission (PMTCT), male involvement is associated with 
women's acceptance of counselling, receipt of HIV test results, uptake of antiretroviral 
medication, and modification of infant feeding practices (Farquhar et al. 2001; Kiarie et 
al. 2003; Farquhar et al. 2004; Msuya et at. 2006; Homsy et al. 2007; Kakimoto et at. 
2007; Traore et at. 2009). It is clear that gender relations play an important role in both 
perpetuating and mitigating the virus, and that simplistic assumptions about gender and 
HIV prevention need to be problematised. 
Advent of the `NPTs': New Prevention Technologies 
In the 2000s, as polarized debate and fatigue set in with ABC ('Abstain, Be faithful, 
Condomise') behaviour change programmes (Collins et al. 2008), a wave of research on 
new prevention technologies buoyed hope of curbing the epidemic. Amongst the 
proposed technological fixes were diaphragms, microbicides, vaccines, pre-exposure 
prophylaxis (PrEP), post-exposure prophylaxis (PEP), male circumcision, and Herpes 
Simplex Virus 2 (HSV-2) suppressive therapy. These biomedical innovations were 
loosely grouped together under the term `New Prevention Technologies' - or 'NPTs'. 
According to Imrie et al, "the euphoria about biomedical interventions to prevent 
HIV... ignited the 2006 International AIDS Conference" (Imrie et al. 2007: 10). Since 
this early excitement, however, the prevention field has had to deal with the 
complexities of clinical trials to test the NPTs; finding populations with adequate HIV 
incidence, choice of control group, accurately measuring adherence and sexual 
behaviour (Tolley et al. 2009), and identifying surrogate markers for HIV infection 
(Gurunathan et al. 2009) are just some of the key issues that have preoccupied 
prevention scientists (Lagakos and Gable 2008). Apart from male circumcision 
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(Auvert et al. 2005; Bailey et al. 2007; Gray et al. 2007), none of these `magic bullets' 
has yet been shown to reduce the risk of HIV infection. 
Background to the case study 
This research is a case study of one clinical trial of one candidate microbicide. The 
microbicide in question is PRO 2000, which was tested through the Microbicides 
Development Programme. As mentioned above, I worked on the trial for five years, 
coordinating the socio-behavioural component of the research. My PhD aimed to step 
back from this work and examine the co-production of gender and technology in the 
scientific process. Specifically, I was interested in the circuit of knowledge-power 
relations in which gender identities are produced, how ideas and technologies travel, 
and how scientific knowledge and its products bridge different geographic and social 
locations. The literature review in chapter two lays out in detail the conceptual framing 
of my research questions; below, I set the empirical scene. 
Microbicides 
Microbicides are a class of substances under development that could reduce the sexual 
transmission of HIV and other sexually transmitted diseases, when applied locally to 
genital mucosal surfaces. Various mechanisms of action are being investigated, as well 
as different product formulations, including gels, films, creams, rings and suppositories 
(for an overview, see Cutler and Justman 2008). At the end of 2009, four compounds 
were in phase I/II clinical trials4 (Dapivarine, VivaGel, Acidform, UC-781) and one was 
in phase 1113 (Tenofovir) (Alliance for Microbicide Development 2009). To date, five 
' There are several phases of clinical trials. Phase I trials test the safety of the product in small numbers 
of healthy volunteers, identify side effects and determine a safe dosage range. Phase 11 trials test the 
safety and efficacy of the drug in larger numbers of volunteers over a longer time period. Phase III trials 
take place in large groups of people to confirm the drug's effectiveness, monitor side effects, and 
compare it to the best available alternative. Phase IV studies may be conducted after the drug or 
treatment has been marketed to collect additional information on the drug's effect in different populations 
and any side effects associated with long-term use (for further information, see 
httr): //www. nlm. nih, izov/serviccslc! phases. htmi). 
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products have entered phase III clinical trials, but no product has been found to be safe 
and effective. 
PRO 2000 was one of four `second generation' microbicides that entered the final 
stages of clinical testing, the others being Carraguard, Cellulose Sulafate and 
BufferGel5. These polyanionic compounds are commonly referred to as `entry 
inhibitors' and work by blocking HIV binding (McClure et al. 1992). This is very much 
an evolving field; during the course of this PhD research, the last of the second 
generation microbicides completed phase III clinical testing, and six `third generation' 
products entered clinical trials (Alliance for Microbicide Development 2009)6. `Third 
generation' microbicides, which contain antiretroviral compounds, are said to present a 
more `tailored' approach to HIV prevention and are likely to be more effective than 
previous generations (Cutler and Justman 2008; Garg et al. 2009). 
The Microbicides Development Programme (MDP) 
The Microbicides Development Programme is a large, not-for-profit, African-European 
partnership, which was established in 2000 to develop vaginal microbicides to reduce 
the risk of HIV infection in women. It aims to do this through the evaluation of 
potential microbicides in vitro; clinical safety studies in the UK and Africa; clinical 
efficacy trials; social science research on acceptability and barriers to adherence; and 
facilitation of marketing and access to a successful product. The partnership is 
coordinated in the UK by Imperial College London and the Clinical Trials Unit of the 
Medical Research Council (MRC) (http: //www. mdr). mrc. ac. u k/). It is funded by the 
UK government through the Department for International Development (DFID) and the 
Medical Research Council; following an initial grant of £16 million, it subsequently 
received £24 million in 2005 to conduct the largest phase III trial of a microbicide 
candidate to date (see below) (Department for International Development 2010). MDP 
consists of 16 collaborating partners in Africa and Europe, including institutions in the 
UK, Spain, South Africa, Zambia, Tanzania, Uganda and Mozambique. 
First generation microbicides included the surfactants Nonoxynol-9 (N9) and Savvy. 6 Third generation microbicides include Tenofovir, a nucleotide analogue reverse transcriptase inhibitor 
antiretroviral drug, UC781 and TMC120 non-nucleoside reverse transcriptase inhibitors (NNRTD). 
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The MDP301 trial 
MDP301 was an international, multi-centre, randomised, double-blind, placebo- 
controlled trial to evaluate the efficacy and safety of the candidate microbicide PRO 
2000. for the prevention of vaginally acquired HIV infection. The trial started in 
October 2005 and recruited a total of 9,404 women. It was conducted at six sites in 
Africa: three in South Africa, and one each in Zambia, Uganda and Tanzania. In South 
Africa and Zambia, women were recruited from the general community; in Tanzania, a 
sample of women working in bars, hotels, guesthouses and other food or recreational 
facilities was recruited; and in Uganda, women in HIV sero-discordant relationships 
were recruited through sero-survey. At each site a community mobilisation team led 
recruitment strategies, variously involving public meetings, newsletters, posters, 
community roadshows, sponsored sports and social events, peer-led education, door-to- 
door campaigns and presentations in clinic waiting rooms. To participate, women had 
to be 16 years or over in the Tanzanian and Ugandan sites, or 18 and over in the others, 
sexually active, HIV negative and not pregnant (Nunn et al. 2009). 
Trial participants received pre-filled vaginal applicators containing either a placebo gel 
or PRO 2000 gel and were asked to insert one dose intravaginally within one hour 
before each vaginal sex act during the follow up period. Every four weeks, they were 
given an appointment to come to the clinic to collect further gel supplies and to return 
their used and unused applicators. These were counted to ensure all gel was accounted 
for and to allow gel exposure estimates. At every other follow up visit, they had to 
provide urine for a pregnancy test; if pregnant, they were required to discontinue gel 
use. At weeks 0,4,12,24,40 and 52 they underwent additional procedures, including a 
clinical evaluation, genital examination, and specimen collection for STI and HIV 
testing. All participants received HIV testing and counselling, promotion of safer sex 
practices, free condoms, and diagnosis and treatment of sexually transmitted infections 
(Nunn et al. 2009). 
Each woman was followed up for 12 months, or up to 24 months in Uganda. The 
primary outcome measures were acquisition of HIV infection at or before 9 months 
(efficacy), and grade 3 or 4 clinical events (safety). Secondary outcome measures 
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included HIV infection at or before 6 and 12 months, acquisition of HSV-2 in women 
uninfected at enrolment, and point prevalence of Neisseria gonorrhoeae or Chlamydii 
trachomatis after 24 weeks of follow up. 
In addition to undergoing clinical procedures, a sub-sample of women (approximately 
100 at each site) were randomized to take part in a parallel social science component. 
The aims of this integrated work were to assess the reliability and validity of sexual 
behaviour data collected in the clinic; understand acceptability of the trial procedures 
and reasons for withdrawal; understand acceptability of the study product, including 
barriers to gel adherence; and assess the informed consent procedure. Women who 
participated in the social science study were followed up at three time points during the 
trial and asked both to complete a coital diary and take part in an in-depth interview. A 
smaller number of male partners were also asked to take part in an in-depth interview. 
In addition, the views of both men and women were sought at a community level 
through ongoing focus group discussions. 
Follow-up was completed in August 2009 and the results of the trial were made public 
on 14th December 2009. The press release stated that, "the risk of HIV infection in 
women who were supplied with PRO 2000 gel was not significantly different than in 
women supplied with placebo gel. Although ineffective in providing protection, PRO 
2000 gel itself was safe to use" (Microbicides Development Programme 2009). 
Study settings: United Kingdom and Zambia 
This research was conducted in two MDP `sites': the coordinating site in the UK and 
one of the six clinical trial sites in Africa, in Zambia. Studies in public health research 
typically describe the study setting, and this is presumed to be the location where the 
intervention takes place, often an exotic-sounding `Other'. However, if research itself 
(including its socio-political antecedents) is taken as "a constituent part of any 
intervention, then the description of the study setting should rightfully include all of the 
sites where research is practised. In this case, that includes the UK. A few brief details 
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serve to highlight the disparities - not merely geographical, but social, economic and 
health-related - that provide a backdrop to the current research. 
The United Kingdom is an island country located off the north-western coast of 
continental Europe, with an estimated population of 61.4 million in 2008 (Office for 
National Statistics 2009). It is the world's sixth largest economy, based predominantly 
on the service sector, which is dominated by financial services. Per capita income in 
2008 was estimated at $36,1307 and life expectancy at birth was 79.3 years (World 
Bank 2010). The UK is ranked 17/155 in the 2009 Gender-related Development Index 
(GDI) (United Nations Development Programme (UNDP) 2009). The GDI is a measure 
of human development originally formulated by the UNDP that accounts for inequality 
between men and women (see Charmes and Wieringa 2003; Shiva Kumar and Fukuda 
Parr 2009). In 2007, adult HIV prevalence was estimated to be 0.2% and there were an 
estimated 500 deaths due to AIDS (UNAIDS 2008a). 
Zambia, by contrast, is a landlocked country in Southern Africa and in 2000 had an 
estimated population of 9.9 million (Central Statistical Office Zambia 2003). Per capita 
income in 2008 was estimated at $1,230 (World Bank 2010) and the 2006 Living 
Conditions Monitoring Survey estimated the incidence of poverty at 64% (Central 
Statistical Office (CSO) Zambia 2006). Life expectancy at birth is 45.9 years (World 
Bank 2010). The economy is based largely on copper and cobalt mining, whilst the 
majority of people (72% in 2000) are employed in agriculture (Central Statistical 
Office Zambia 2003). In terms of the status of women, the 2009 Human Development 
Report ranked Zambia 136/155 in the Gender-related Development Index (United 
Nations Development Programme (UNDP) 2009). The 2007 Zambia Demographic and 
Health Survey reports that although women have some decision-making power within 
the home, they are relatively disempowered in relation to men, being less likely to 
receive secondary education, less likely to be employed or earn their own money, and 
more likely to be the victims of violence (Central Statistical Office (CSO) [Zambia] and 
Macro International Inc. 2009). In 2007, adult HIV prevalence was estimated at 15.2% 
and there were an estimated 56,000 deaths due to AIDS (UNAIDS 2008b). 
7GNI per capita based on purchasing power parity (PPP). 
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Summary of the thesis 
In this thesis I explore the co-production of gender and technology through a case study 
of the Microbicides Development Programme. In the seven chapters that follow, I 
review approaches to the study of science, technology and gender in HIV prevention 
research; detail my methodology; present empirical findings from fieldwork in the UK 
and Zambia; and reflect on the relevance of my research for future HIV prevention 
efforts. 
Chapter two presents a review of the empirical and theoretical literature which has 
framed the current study. Starting with the topic of new pharmaceutical prevention 
technologies, I explore pertinent bodies of work from the sociology of pharmaceuticals 
and the anthropology of biosciences. I go on to consider approaches from the Science 
and Technology Studies (STS) literature, counterpoising debates between feminist 
technoscience and radical constructivism. I discuss the relevance of Foucauldian theory 
on power, discourse and the subject to studying clinical trials, and end the chapter by 
defining my research agenda. 
In chapter three, I lay out the methodological issues negotiated in the study, situating 
these within the salient debates at the intersections of public health research and STS. 
This chapter explicitly frames methodological choices in terms of a tension between 
social science and social contingency, acknowledging that `mess' in the social world 
does not stop at the door of research (Law 2004). In addition to discussing theoretical 
underpinnings and assumptions, I also present and justify my methods, detailing sites 
and informants, sampling, interviewing and ethical considerations. 
The four empirical chapters that follow present a sociological analysis of the 
Microbicides Development Programme and the MDP 301 trial. The analysis follows a 
temporal and spatial evolution, from the historical development of the microbicides 
research agenda in the UK in the late 1990s to the contemporary testing and use of the 
candidate product, PRO 2000, in Zambia between 2006 and 2009. 
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Chapter four, therefore, places PRO 2000 in historical context. Using the idiom of co- 
production, I analyse the social, scientific and political discourses that led to the 
stabilisation of the product as a tool for women's empowerment in the West, and the 
simultaneous production of gendered identities in the HIV prevention field. This 
chapter is based on interviews conducted with senior research scientists in the UK and 
the US who were pivotal in the product's development and testing. 
Chapter five moves on from the processes of technological production to focus on how 
PRO 2000 was brought into a phase III clinical trial in Africa. Using interviews with 
UK and Zambian researchers, I explore how the Microbicides Development Programme 
established itself as a cohesive scientific enterprise across diverse geographic and 
institutional settings. The discursive production of participatory democracy, 
partnership, and gendered capacity building, I argue, was fundamental to establishing an 
effective collaboration, and played an important role in the production of both scientific 
and gendered identities. I chart the mobilisation of these discourses through the creation 
of the MDP network and phase III protocol. 
In chapter six, the focus shifts from the site of central coordination in the UK to the 
establishment of the MDP clinical trial site in Zambia. This chapter uses interview data 
with Zambian researchers, and focus group data with community members, to explore 
the creation of a new trial site as a site of knowledge production. Specifically, I look at 
the discursive metamorphosis and ongoing construction of microbicides in the context 
of their actual use in an African setting. I discuss how the research produced particular 
kinds of subjects as an effect of discursive and power relations, and the appropriation of 
and resistance to techniques of power by the community, men and women. 
In chapter seven, I explore how ideas and technologies travel, how scientific knowledge 
and its products bridge different geographic and social locations, and how scientific and 
social intelligibility are produced in a Zambian trial community. Interview and focus 
group data from the MDP trial site in Zambia form the basis for this discussion, with the 
focus on trial participants and their male partners. The analysis starts with a description 
of how gender is produced through existing institutions in the trial community. I then 
go on to discuss a crisis in masculinity, particularly in relation to HIV, and the role the 
21 
research played in re-producing negative male representations. I explore women's 
participation in the trial as a `technology of the self' nd their enrolment of the trial into 
their own strategies to negotiate power with their partners. 
The final chapter of this thesis, chapter eight, returns to the questions that emerged from 
the literature review and considers the empirical and theoretical contributions this 
research makes to the fields of public health and STS. I discuss the role of research in 
constructing gendered identities, and the importance of this to HIV prevention. On a 
more theoretical level, I demonstrate how Foucauldian concepts of governmentality, 
disciplinary power and technologies of the self have been used to understand the 
processes of clinical trials research into microbicides. The thesis concludes by posing a 
challenge for future work on health technology development, suggesting greater 
collaboration between different epistemic communities. 
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Chapter Two 
Science, Technology and Gender in HIV Prevention Research: 
Empirico-Theoretical Approaches 
Introduction 
... the contributions of early theoretically rich cultural and social research on 
HIV have been largely eclipsed by the yearning for evidence; the value of deep 
social science inquiry of HIV is no longer well recognized or well understood. 
(Mykhalovskiy and Rosengarten 2009: 190) 
In 2009, Mykhalovskiy and Rosengarten drew attention to the waning of theoretically- 
engaged critical social research on HIV and AIDS. In contrast to the innovative 
scholarship that marked the early years of the epidemic (for example Treichler 1988; 
Patton 1990; 'Martin 1994; Patton 1994; Epstein 1996), there has been a dearth of 
interest in theory and socio-cultural critique, due in part, they argue, to the ascending 
hegemony of evidence-based medicine. The latter has privileged positivist social 
science and applied knowledge outputs as part of the project of governing healthcare: 
"This is an organization of research in which health, illness and disease are constituted 
as governmental problems to be ameliorated by research considered to generate 
evidence-based solutions and formulated within the established terms of health policy, 
managerial and professional discourses" (Mykhalovskiy and Rosengarten 2009: 189). 
The effect has been to foreclose thought and stifle critical inquiry into the current field 
of HIV and biomedical attempts to control it. As they note, dishearteningly, "increasing 
biomedicalization does not necessarily mean that the epidemic itself has subsided 
or... become more manageable" (Mykhalovskiy and Rosengarten 2009: 193). 
The 2000s have been marked by developments in biomedical technologies to prevent 
HIV, such as vaccines, pre-and Post-exposure prophylaxis (PrEP and PEP), 
microbicides, cervical barriers, HSV-2 suppressive therapy and male circumcision. All 
of these technologies currently follow a trajectory from Northern lab benches to 
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Southern population testing, with scientific and media attention focused on the outcome 
of large-scale efficacy trials. Almost no attention is paid to the processes through which 
new technologies for HIV prevention emerge into the testing arena and how scientific 
knowledge is subsequently generated within so-called `trial communities'. Various 
disciplines contribute to the possibility of framing research questions around new 
prevention technologies; anthropology, sociology, science and technology studies 
(STS), and cultural studies have all broached aspects of this topic, tackling ontological 
and epistemological questions about human subjects, diseases and their remedies, and 
science. Below I explore empirical and theoretical pathways into the topic of new 
pharmaceutical prevention technologies, seeking to elucidate how these - might 
contribute to the critical social study of microbicides as a case study. 
Clinical trials and medical research as the subject of research 
Medical technologies, including both drugs and devices, have been studied extensively 
in anthropology, sociology and science-studies. Of particular relevance are the rich 
bodies of literature that have evolved in the sociology of pharmaceuticals and the 
anthropology of biosciences. Williams et al recently provided a concise review of 
progress and prospects in the sociology of pharmaceuticals, listing the major themes in 
the field as biomedicalisation, regulation, consumption and expectations/innovation 
(Williams et al. 2008). Several of these concerns overlap with work being undertaken 
in the anthropology of bioscience, in particular a focus on bioethics and the political 
economy of clinical trials. Studies of the evidence-making process and its biases have 
proliferated over the past decade at these disciplinary intersections (Moynihan and 
Cassels 2005; Petryna et al. 2006; Abraham 2008). Ethical concerns surrounding 
medical research in resource-poor settings, including the 'pharming' out of clinical 
trials8, and how these relate to the economic, historical and political dimensions of the 
global scientific field are a recurrent theme (Geissler 2004; Petryna 2005; Fairhead et al. 
2006; Geissler and Pool 2006). 
`Pharming out' is a play on words used by some researchers to insinuate that pharmaceutical companies 
irresponsibly shift the dirty work of experimentation onto poorer and more vulnerable populations 
in 
developing countries. 
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Although ethics is obviously an important aspect of clinical research (and one which has 
been studied extensively), more relevant for my own work are studies which focus on 
trials more holistically; for example, adopting a political economy approach, Petryna 
and Fisher interrogate the global and local politics of industry-led pharmaceutical trials, 
both in the US and `off-shore' clinical sites (Fisher 2009; Petryna 2009). Both of these 
insightful ethnographic texts shed light on the organizational culture of commercial 
clinical trials and situate detailed local accounts within broader debates about neoliberal 
governance and the concept of experimentality. Inherent to both is a critique of 
neoliberalisation and the enrolment of vulnerable populations into potentially 
exploitative regimes of commercial experimentation. 
Both Petryna and Fisher focus on industry-led pharmaceutical research and do not 
explore the distinct field of academic-led clinical trials. The latter represents an under- 
researched area within science studies, although one which is now being investigated by 
various European groups9. Again, the primary debates emerging from these studies 
concern bioethics and the political economy of trans-national biomedical research, with 
developing countries and their citizens implicitly positioned as the victims of 
globalization10. Whilst it is clearly important to study the political and ethical 
dimensions of trans-national research, and to highlight the disparities in wealth and 
power that collaborative overseas research may engender, we should not neglect the 
social study of science itself in these configurations. 
Indeed, rather than taking trials as the locus of `science in action', researchers have 
predominantly analysed them in terms of broader debates about ethics, governance, 
medicalisation and consumerism. Until recently, there has been a persistent neglect of 
the social and scientific co-production that occurs through product development and use 
in human experimentation. Rosengarten and colleagues have now begun to address this 
gap, interrogating the clinical testing of pre-exposure prophylaxis (PrEP) for HIV 
prevention (Rosengarten and Michael 2009a; Rosengarten and Michael 2009b). 
9 For example, the Martin Okonji Research Group on the Anthropologies of African Bioscience at the 
London School of Hygiene & Tropical Medicine, and LOST (Law, Organisation, Science and 
Technology) at the Max Planck Institute. 
10 See, for example, the syllabus of the Oslo Summer School in Comparative Social Science Studies 2008, 
on "The Ethics and Political Economy of Medical Research - Anthropological 
Perspectives": 
http: //www. sv, uio. no/ossfMuseum/2008/jzeissfer., htmi accessed 17/10/09. 
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Drawing on Mol's concept of ontological multiplicity (Mol 2003), Rosengarten and 
Michael problematise the notion of PrEP as a stable and singular pharmaceutical 
product. By analysing scientific discourse around the development and expectations of 
PrEP, they draw attention to the technology's simultaneous nature as performative and 
processual, in spite of its manifestation as a non-relational entity (Rosengarten and 
Michael 2009a). The question this raises is the extent to which clinical testing 
designed around the notion of a singular and stable object can account for, and therefore 
prepare the way for, the multiple contingencies of a technology which is in fact 
complex, heterogeneous and in flux. They call for "the multiplicity of PrEPs" to be 
recognised and expectations of this new prevention technology adjusted accordingly 
(Rosengarten and Michael 2009a: 1054). 
Multiplicity is again fore-grounded in their discussion of the bioethics of using 
antiretroviral therapy as a technology for prevention. In this instance, trials themselves 
are taken as technologies that are heterogeneous, processual and multiple, not simply 
the drugs that they are designed to test. Rosengarten and Michael discuss RCTs as 
performative and ontologically divergent fields that both shape and are shaped by the 
contexts in which they are enacted (Rosengarten and Michael 2009b). In this analysis, 
bioethics becomes a performative element of trial design and implementation (as 
opposed to an external comment on them), reducing the field to an abstracted 
relationship between researcher and researched. In this conceptualisation, the complex 
dynamics engendered by material and cultural differences between actors and actants in 
PrEP trials are obscured and progress towards an expanded notion of inclusive and 
ethical trial participation forestalled. 
A hallmark of sociological and anthropological research on clinical trials has been their 
critical stance vis-ä-vis the pharmaceutical industry and sponsors of academic trials. 
Whilst this stance has been productive in highlighting the inequalities in global access 
to biomedical treatment and prevention, and the ethical dubiousness of some 
experimental undertakings, we should not be seduced by the easy (yet often futile) 
accomplishment of demonising those we study. Much of the work cited above is 
heavily laden with the rhetoric of victims and exploiters, in such a way that the issue of 
subject-formation through the research process is painted over and disappears. For 
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example, in proposing that "the trial be viewed as composed of multiple relations with 
heterogeneous entities... through which medically drugged bodies emerge" 
(Rosengarten and Michael 2009b: 191), Rosengarten and Michael conjure up an image 
of torpid zombies, devoid of agency and lacking mental faculties. In attending to the 
macro-level processes of clinical trials as they emerge trans-globally, scholars have 
mobilised a normative concept of power, in which `the West' or `the Scientists' exploit 
`the Other'. This approach obscures the micro-level techniques of power that all actors 
negotiate in interaction with each other and through which they, and the technologies 
they test, are co-constituted. 
Beyond medicalisationll: `Living drugs' and `the pharmaceutical 
imagination' 
Underscoring the need to move beyond the critique of drug companies as ruthless 
exploiters of a duped public, Nikolas Rose argues that "medicalisation has become a 
cliche of critical social analysis" (Rose 2007: 700). Taking up his call to see 
medicalisation as "the starting point of an analysis" rather than "the conclusion of an 
analysis" (Rose 2007: 702), a number of authors have adjusted the analytical frame to 
consider the mutual constitution of drugs, bodies, subjectivities and cultures (Biehl and 
Moran-Thomas 2009; Fraser et al. 2009; Marshall 2009). Encapsulating the continuities 
between the social, medical, moral, ethical, political and pharmaceutical domains, 
Fraser et al refer to `living drugs': 
We `live' drugs in the process of making ordinary lives, social relationships and 
political institutions.. . drugs are social and political agents. In a strange way, 
they too have lives - as much as we live through drugs, they live through us. 
The notion of `living drugs' means taking drugs seriously as analytic objects. 
(Fraser et al. 2009: 124) 
" There has been a shift among some sociologists from using the term 'medicalisation' to using the term 
'biomedicalisation'. According to Clarke et al, "Biomedicalization describes the increasingly complex, 
multisited, multidirectional processes of medicalisation, both extended and reconstituted through the new 
social forms of highly technoscientific biomedicine" (Clarke et al. 2003: 161). For more on this transition 
see (Conrad 2005; Conrad 2007). 
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Marshall exemplifies an analysis of living drugs using the example of sexual 
dysfunction, demonstrating "the ongoing co-construction of diseases, the bodies through 
which they are enacted, and the drugs used to treat them" (Marshall 2009: 138). 
Although there is a growing literature on so-called sexuopharmaceuticals 
(pharmaceutical products for sexual dysfunction), what makes Marshall's work notable 
is her invocation of the `pharmaceutical imagination' as a player in the scientific and 
cultural narratives of sexuality and sexual problems: 
... the pharmaceutical imagination assumes that the biological body 
is a realm 
unto itself, neatly separable from its cultural materialisation or subjective 
experience. It circumscribes what is to be considered problematic, valorises 
particular kinds of solutions and accords significance to some agents over others 
in constructing explanatory narratives for the success or failure of those 
solutions. But more so than a `style of thought', the pharmaceutical imagination 
embodies a future-orientation: there is an optimism linking patients, 
practitioners, researchers and industry that, whatever the problem, a better 
chemical solution is on the horizon. (Marshall 2009: 135) 
In contrast to the self-righteous markets-and-profits critique of pharmaceuticals, the 
concept of the pharmaceutical imagination permits an analysis of how knowledge is 
produced in the context of drug-making and -taking. It suggests an analytical space in 
which biotechnology can be seen to materialize not only the social, political and 
economic body, but simultaneously the bodies of individuals. 
From drugs and trials to artefacts and networks 
Pharmaceuticals are but one aspect of the much broader intersecting fields of science 
and medicine. Whereas the recent critique of pharmaceutical trials focuses to a large 
degree on bodies and bioethics, it is nonetheless part of a longer history of the critique 
of science and its paradigms going back to the 1960s. Kuhn's The Structure of 
Scientific Revolutions was a watershed for the sociology of science, opening up not just 
the context surrounding scientific discovery, but the very discipline of science itself, to 
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critical enquiry (Kuhn 1962). Since then, studies of the nature of scientific knowledge 
have abounded; by demonstrating the socially situated nature of scientific vision and 
interpretation, critics have highlighted the constructed nature of scientific facts and thus 
called into question science's status as gatekeeper to an incontrovertible truth. 
Philosophers of science have focused on science as a social and political process, whose 
claims to knowledge are inseparable from the way in which that knowledge is produced. 
Work in the relatively young field of science and technology studies has also sought to 
expose the social nature of scientists' claims to truth and objectivity by "trying to detect 
the real prejudices behind the appearance of objective statements" (Latour 2004). 
Science and Technology Studies (STS) has much to offer the analysis of microbicides 
as a technology. STS focuses on "the nexus of science, technology, culture and power" 
(Jasanoff 2006: 1), exploring the production of knowledge and artefacts in society 
through a critical deconstruction of discursive and material sources. The field is 
characterised by a heterogeneity of approaches and methods taken from across the 
social sciences and humanities, including anthropology, sociology, philosophy, politics, 
history, media and cultural studies. Perhaps because of this confluence of disciplinary 
interests, and the relative youth of the field, STS is typified by highbrow intellectual 
jousting and constant debate on key terms and approaches (see for example Pickering 
1992; de Vries 1995). Whilst these debates are stimulating in and of themselves, I do 
not wish to focus on them here; rather my aim is to elucidate some of the key concepts 
that may be useful to the current thesis within a public health context. 
The social construction of technology (SCOT), championed by Pinch and Bijker in the 
mid-1980s (Pinch and Bijker 1984) has been highly influential in studies of technology. 
Building on the Empirical Programme of Relativism (EPOR), which evolved as a 
method to demonstrate the social construction of scientific knowledge within the 
sociology of scientific knowledge (SSK), SCOT formalises a series of theoretical and 
methodological steps for analysing the development process of technological artefacts 
(see also Bijker et al. 1987). The first stage of both EPOR and SCOT involves 
demonstrating the interpretative flexibility of scientific findings and the design of 
artefacts respectively. Interpretative flexibility refers to the idea that multiple 
competing interpretations of the natural world are available and there are many ways in 
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which artefacts can be designed. In other words, the sociologist must show that there is 
nothing natural or inherent about scientific knowledge or artefacts (and therefore that "it 
could have been otherwise"). In subsequent stages of EPOR and SCOT, the aim is to 
demonstrate how debates about scientific knowledge are closed and consensus 
established, and how artefacts come to be stabilized, typically amongst different social 
groups. A third stage of SCOT involves relating technologies to the wider socio- 
political context, a step that is not expanded on in Pinch and Bijker's original paper. 
EPOR and SCOT are both located within the strong programme of science studies as 
advocated by Bloor (Bloor 1991 [1976]). The main tenet of the strong programme is 
that sociologists should be impartial to the success or failure of scientific theories and 
artefacts, analysing `truths' in the same way as discounted beliefs and `falsehoods'. 
This has been referred to as the principle of symmetry. The original call for symmetry 
was a response to `weak' sociological explanations of science that only explained 
scientific failure, and left unquestioned the `facts' and `truths'. EPOR and SCOT were 
conceived as a response to such scientific and technological determinism. More 
recently, however, these approaches themselves have been criticised for sociological 
reductionism, that is, explaining nature by reference to society and social `facts' 
(Jasanoff 2006)12. `Social Constructionism' arguably infers causal primacy on the 
social, ontologically privileging social over natural reality (Hacking 1999), and as 
Jasanoff notes, "the discourse of social construction tends to inhibit the symmetrical 
probing of the constitutive elements of both society and science" (Jasanoff 2006: 19). 
Extending the notion of symmetry, proponents of Actor-Network Theory (ANT) 
additionally argue that knowledge takes a material as well as a social form, which 
should be taken into account in analyses of scientific process (Callon 1986a; Callon 
1986b; Law 1992; Latour 2005). Under the principle of generalised symmetry, the 
material-semiotic approach controversially attributes agency to both human and 
nonhuman actors ('actants'), and maps the relations between human 
interest/cognition/emotion and the material objects (such as machines and texts) with 
which they interact. ANT has provided some useful analytic concepts for dissecting 
1= SCOT has also been criticised on various other grounds, including its lack of attention to how 
technologies "transform personal experience and social relations" and its inclination to "sidestep 
questions that require moral and political argument" (Winner 1993: 369 & 373). See also (Russell 1986). 
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and explaining the work of science in action, such as the core notion of translation, used 
"to refer to the processes by which entities mutually enrol each other into a combination 
of some type, claiming to speak for each other, interpreting, configuring and 
reconfiguring each other" (Prout 1996: 202). It also champions tenets which are 
relevant beyond the study of networks; for example agnosticism - analytic impartiality 
as to the actors implicated in a controversy - and free association - the rejection of a 
priori dichotomies (for example between the natural and the technological). It is ANT's 
non-dualistic approach that has been seen both as one of its greatest strengths and 
weaknesses. 
In spite of its methodological contributions to the study of technoscience, ANT has 
sustained a number of valid criticisms (predominantly, but not exclusively, around 
generalised symmetry' 3), which I believe limit its utility for my own work. One such 
criticism is that it is `prosaic' and empirically reactionary (Collins and Yearley 1992: 
323); in focusing so doggedly on the minutiae of the network as the object of analysis, 
ANT fails to attend to the values, morals, politics, ideologies etc. which accompany the 
genesis and sustaining of systems of governance (Jasanoff 2006: 23). One of ANT's 
chief proponents, Law, has stated that: 
Sociology is usually interested in the whys of the social. It grounds its 
explanations in somewhat stable agents or frameworks. Actor-network's 
material semiotics explore the hows. In this non-foundational world nothing is 
sacred and nothing is necessarily fixed. But this in turn represents a challenge: 
what might replace the foundations that have been so cheerfully undone? Is it 
possible to say anything about network-stabilising regularities, or are we simply 
left with describing cases, case-by-case? (Law 2007) 
As if pre-empting this, and addressing the aforementioned debate, Jasanoff remarks, 
"the answer is not to substitute for the once unanalyzable category called "science" a 
13 In a well-known and scathing attack on ANT, Collins and Yearley respond to Callon's seminal 
1986 
paper on the scallops of St. Brieuc: "... the creation of symmetry is very much in the hands of the analysts. 
The analysts remain in control the whole time, which makes their imposition of symmetry on the world 
seem something of a conceit. Would not complete symmetry require an account from the point of view of 
the scallops? " (Collins and Yearley 1992: 313). 
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term like "network", whose internal structure and function also resist sociological or 
normative analysis" (Jasanoff 2006: 44). 
Since microbicides are an overtly `gendered' technology, it's worth noting that a 
number of feminist commentators have also criticised ANT and found it unsuitable in 
feminist analyses of science and technology, citing excessive relativism, ahistoricism 
and gender-blindness (Ormrod 1995). For example, Cockburn accuses ANT of being 
gender-blind, since those involved in the design and development stages of an artefact's 
life are predominantly male. Furthermore, "there is a lack of concern with subjectivity, 
which leads to a neglect of the way technology... enters into our gender identity" 
(Cockburn 1992: 39, emphasis in original). Cockburn goes on to criticise the lack of 
attention to historical dimensions of power, which, she argues, dissolves the possibility 
of demonstrating technology's role in perpetuating patriarchy. Wajcman similarly 
observes that ANT ignores gender and has focused on sites of female absence 
(Wajcman 1991: 23-24). The latter criticism is inherent in Star's observation that ANT 
fails to consider the invisible work conducted by marginal or multiply-located members 
of networks such as "secretaries, wives, laboratory technicians and all sorts of 
associates" (Star 1991: 29). Drawing on feminist theory and symbolic interactionism to 
discuss the dimensions of power within (and with-out) networks, she proposes a theory 
14 of multiple membership and heterogeneity that attends to the non-enrolled. 
Not all feminist writers have rejected ANT; for example Singleton has used the 
approach productively to analyse the public/science relationship within the British 
Cervical Screening Programme (Singleton 1995; Singleton 1996). Singleton's accounts 
are interesting, not only for their findings but for the interwoven debate on the tensions 
between feminism and ANT. Whilst proclaiming that she "became enamoured of the 
approach, in particular its non-dualistic nature and its concomitant emphasis on the 
contingent nature of scientific knowledge-claims" (Singleton 1995: 147), she 
nonetheless signals the risks to feminism: 
14 Star has not been alone in critiquing ANT's traditional lack of attention to multiplicity, ambivalence 
and instability in what can be one-dimensional accounts of actor-networkers. For more on this, and on 
the `ecological approach', see (Star and Griesemer 1989; Fujimara 1992). 
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ANT may offer a way for feminists to think about the woman/science 
relationship outside patriarchally determined dichotomies, but this way of 
thinking may be, at best, degendered and politically impotent and, at worst, 
politically potent through (its claim to) being degendered (Singleton 1995: 154- 
155). 
The benefits that Singleton raises of using ANT within a feminist context are not 
limited to ANT as an approach; for example, Foucauldian analyses also provide a way 
of thinking about the self in relation to science outside of patriarchal dualisms. So whilst 
the feminist critique of ANT may be somewhat short-sighted, ANT itself remains 
limited in the ways described above. 
If SCOT is asymmetrical, and ANT overly concerned to describe rather than explain, 
what other approaches are available for studies at the intersection of science, technology 
and gender? Which approaches lend themselves to the study of knowledge as well as 
practice, are concerned with the links between the macro and the micro, attend to social 
theory as well as empirical detail, and are concerned to elucidate the historical, political 
and cultural workings of power? Jasanoff has convincingly proposed the idiom of co- 
production to counter leanings towards either technoscientific or social determinism and 
to bridge the gap between constitutive and interactional strands within STS' 5: 
Briefly stated, co-production is shorthand for the proposition that the ways in 
which we know and represent the world (both nature and society) are 
inseparable from the ways in which we choose to live in it. Knowledge and its 
material embodiments are at once products of social work and constitutive of 
forms of social life; society cannot function without knowledge any more than 
knowledge can exist without appropriate social supports. Scientific knowledge, 
in particular, is not a transcendent mirror of reality. It both embeds and is 
embedded in social practices, identities, norms, conventions, discourses, 
instruments and institutions - in short, in all the building blocks of what we term 
13 The constitutive strand focuses broadly "on the constitution of new technoscientific cultures, often 
around emergent ideas and concepts"; the interactionist strand "on solving problems of disorder within 
established cultures". These two strands capture STS's engagement with the metaphysical and the 
epistemological respectively (Jasanoff 2006: 6). 
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the social. The same can be said even more forcefully of technology (Jasanoff 
2006: 2-3). 
Co-production does not represent a unified theory, nor does it insist on a resolution of 
the controversies that have dominated STS. Rather, it presents an interpretative 
framework for analysing "the relationships between the ordering of nature through 
knowledge and technology and the ordering of society through power and culture" 
(Jasanoff 2006: 14). Within this framework, the interaction between the material, the 
cognitive, the social and the normative is probed to elucidate the making of identities, 
institutions, discourses and representations. 
Feminism and technology 
Since the call for microbicides has been closely linked to the women's health 
movement, and the technology itself has come to be associated with women's 
empowerment, it is appropriate to consider how feminist theory has contributed to 
analyses of technology. Feminist studies of technology have proliferated over the past 
two decades, growing out of the feminist critique of science (Hawkesworth 1989; 
Harding 1991; Rose 1994; Oakley 2000) and science and technology studies. Some of 
the earliest work came from within the eco-feminist school of thought, espousing 
feminist standpoint theory and the centrality of women's biological difference to their 
values, knowledge and experience of the world (see for example Rich 1977; Griffin 
1984). Classic examples of these studies include those focusing on the new 
reproductive technologies (NRTs), such as in vitro fertilization, amniocentesis and 
genetic screening (Arditti et al. 1984; Corea 1987; Spallone and Steinberg 1987; 
Raymond 1993). Corea's analysis of the new reproductive technologies has been 
particularly influential, both in spawning similar analyses and in provoking critique 
(Corea 1985). In The Mother Machine, she argues that technologies such as in-vitro 
fertilization, embryo replacement, artificial wombs and cloning reduce women's bodies 
to their constituent parts and functions - eggs, womb, social mother. She suggests that 
since these technologies emerge from the male-dominated medical and scientific arenas 
(and are therefore inherently patriarchal), women are being divested of agency over 
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their bodies and any power that reproduction has historically accorded them. Along 
with other members of the Feminist International Network on Resistance to 
Reproductive and Genetic Engineering (FINRRAGE), Corea posits that rather than 
providing women with new choices, the NRTs in fact conceal a more sinister process 
through which women's options are increasingly controlled by men' 6. 
The radical feminist critique of technology as patriarchal and detrimental to women's 
interests has been criticised from various sides, but a sustained critique has been 
levelled at its primary assumption of biological determinism (Stanworth 1987; Sawicki 
1991; Grint and Gill 1995). By basing their analyses on the biological dichotomy 
between men and women, radical (or eco-) feminists unquestioningly reproduce 
traditional ideas about masculinity and femininity that have historically been used to 
oppress women. Rather than attending to the multiple sites of potential resistance 
embodied in women's diverse positions vis-a-vis technology, they provide a one- 
dimensional account of female oppression within the prevailing ideology of patriarchy. 
Furthermore, they conflate society with technology in a similarly deterministic way, 
uncritically characterising technology as patriarchal because of the patriarchal nature of 
society (Grint and Gill 1995). This has led Grint and Gill to conclude that the eco- 
feminist account of technology is "flawed as a theoretical perspective and 
disempowering as a political one" (Grint and Gill 1995: 5). 
An alternative approach within liberal feminism has been to regard technology as 
neutral rather than inherently masculine and to focus on the relationship women have to 
technology in comparison to men. These studies have tended away from the biomedical 
sphere and focus more on routine applications of technology in the home and 
workplace, for example information technology (Kreinberg and Stage 1983). Women 
are seen to have a disadvantage in relation to new technologies because of the roles they 
have to take up in society which grant them unequal access to objects like computers. 
Early proponents of this view proposed that women should be given more opportunities 
to engage with technology, for example through the use of specially designed learning 
16 For a flavour of the radical feminist critique of technology, see for example Mies: "Any woman who 
is 
prepared to have a child manufactured for her by a fame- and money-greedy biotechnician must know 
that in this way she is... surrendering yet another part of the autonomy of the female sex over childbearing 
to the technopatriarchs" (Mies 1987: 43). 
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materials and training programmes (Faulkner and Arnold 1985). Critics have 
underscored the subsequent failure of these initiatives and critiqued the way in which 
technology itself remains unanalysed in liberal feminist accounts (Karpf 1987). Others 
have objected to the implication that it is women who must change in order to adjust to 
the technology, while men, masculinity and male relationships to technology are taken 
as the unquestioned norm (Grint and Woolgar 1995). 
Perhaps the most useful feminist studies of technology, as far as my own research is 
concerned, are those which see technologies as gendered, but posit this as a result of the 
culture of their production and use rather than biological or social determinism 
(Wajcman 1991; Cockburn 1992). Although this body of work discusses technology as 
masculine culture, it has important insights for technology as feminine culture or indeed 
any culture at all. In `The Circuit of Technology', Cockburn describes technologies 
both as a sign and source of women's oppression. The implication of this theory is that 
technologies are both constituted by and constitutive of social relations, a notion that 
anticipates Jasanoff s `idiom of co-production', discussed above (Jasanoff 2006). 
Furthermore, as Grint and Gill have noted, the `technology as masculine culture' theory 
foregrounds gender identity by highlighting how technical competence becomes part of 
masculinity and technical incompetence part of feminine gender identity. They go so 
far as to read in these accounts a notion of performativity, since performing particular 
technological tasks can be seen as performing gender. Again, this provides a useful 
conjuncture between Butler's theory of gender performativity (Butler 1990) and science 
and technology studies, which is particularly relevant for the study of how new, so- 
called woman-controlled, HIV prevention technologies come to be `gendered'. 
Tensions between feminism and constructivism 
One of the major tensions at the convergence between feminism and studies of science 
and technology is the ontological nature of both the subject and power. Implicit in 
many feminist analyses of technology is the notion of patriarchy, often mobilised (here 
as in many other areas of feminist writing) to suggest women's universal and 
transhistorical subordination to men (see for example Rowbotham 1981; Segal 1987; 
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Walby 1990). This notion assumes a set of social relations that are stable and 
acontextual; gender is based on the binary categorization of men and women and 
relations between the genders presumed to be fixed and enduring. Constructivism, 
however, does not presume the existence of the subject prior to its discursive formation 
through particular social and historical signifying practices'7. This is as true for gender 
as it is for the artefacts which form the object of analysis in science and technology 
studies. In feminist studies of technology, the problem is how to point to the 
constructed nature of artefacts whilst simultaneously alluding to their construction 
within a set of pre-existing patriarchal relations. As Grint and Gill state: 
There is a problem.. . 
in that if gender is used as an analytical tool, researchers 
run the risk of `black-boxing' it, of treating its meanings as self-evident and 
stable, producing an artificial analytic closure. This is the basis of 
constructivists' attack on feminist research (Grint and Gill 1995: 20). 
Linked to the above is a tension over agency, with feminists applying normative 
theories of subject-as-agent, including the subject's capacity for empowerment, while 
constructivists pursue questions of how the subject is continuously formed through 
competing discursive and power relations. Ormrod has provided a compelling analysis 
of these tensions (Ormrod 1995), and proposed both Foucauldian and Actor Network 
Theory (ANT) approaches as ways to pursue feminist-inflected analyses of technology. 
She concludes: 
... 
feminist sociology on technology must be able to show how relations of 
power are exercised and the processes by which gendered subjectivities are 
achieved. It must therefore attend to the range of discursive practices and the 
associations of (durable) materials, meanings, and subjectivities within which 
gender and technology are defined and differentiated. To do otherwise is to 
reify gender as binarism and technology as `thing', whereas we know that they 
are relational, performative and subject to negotiation (Ormrod 1995: 44-45, 
emphasis in original). 
17 I make this point whilst acknowledging that there are various strands of constructivism, just as there are 
various strands of feminism. 
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She is not alone in advocating this, and indeed there has been lively debate from both 
sides of the feminist/constructivist divide about the best way to reconcile philosophical 
and political differences in practice (for example see Berg and Lie 1995; Hirschauer and 
Mol 1995; Prins 1995)18. 
Power and gender: Foucault and feminisms 
The above tensions between feminism and constructivism in science and technology 
studies mirror the long-standing (and ongoing) philosophical and political debates 
between Foucault and feminisms. These debates provide important analytical insights 
for understanding microbicides as a technology that is both `gendered' and proposed as 
a tool for women's empowerment, since each deals respectively with power and the 
formation of gender identity. 
Foucault on power 
Since the 1970s, Foucault has been one of the most influential theorists in critical 
studies of both biomedicine and science. Through his archaeological and geanealogical 
studies, Foucault aimed to defamiliarize and contest the seemingly natural categories of 
social life by exposing them as historically-contingent, discursive constructs. Although 
Foucault's views evolved during the writing of his oeuvre, and he cannot be said to 
offer a unified theory of power19, the subject or discourse, he nonetheless provides a 
useful conceptual apparatus for the study of medical research. Foucault has admirers 
and detractors in equal measure, and the use of his concepts is fraught with contests not 
only over their meaning, but also over their legitimacy. Below, I discuss some of the 
key concepts of relevance for my own research, acknowledging the debate that has 
18 Even as the tensions between feminism and constructivism move towards resolution, Grint and 
Woolgar highlight the failure of both schools of thought to thoroughly escape essentialism. For a 
discussion of the 'post-essentialist' endeavour, see (Grint and Woolgar 1995). 
"Indeed, Foucault himself was reluctant to be designated a theorist of power, stating, "When I examine 
relationships of power, I create no theory of power. I examine how relationships of power interact...! am 
no theoretician of power" (Foucault 1996: 360). 
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surrounded them. Since a vast amount of scholarship already exists on Foucault, I will 
limit this discussion to those aspects of his work most salient to the current thesis. 
Power, for Foucault was intimately bound up with knowledge because of the way it was 
mobilised to regulate and normalise individuals through institutions such as the prison 
and the clinic. Departing from the conventional view that the acquisition of knowledge 
makes a person more powerful (knowledge=power), Foucault suggested that knowledge 
was something that made people its subject, since people make sense of themselves in 
reference to the various bodies of knowledge that are available to them in a given time 
and place (power/knowledge). Power, then is not something that is possessed but 
something that is exercised in a diffuse and relational way; we have moved from 
sovereign power as the archetypal regime to that of disciplinary power: 
We must escape from the limited field of juridical sovereignty and state 
institutions, and instead base our analysis of power on the study of the 
techniques and tactics of domination. (Foucault 1980e: 102) 
Nor should power be understood solely in a negative sense, as in the Marxist sense of 
repressive hegemonic power, for example as outlined by Gramsci (Gramsci 1971). 
Foucault saw power as a productive force embedded in daily practices and constitutive 
of subjects and subjectivity: 
What makes power hold good ... is simply the fact that it doesn't only weigh on 
us as a force that says no, but that it traverses and produces things, it induces 
pleasure, forms knowledge, produces discourse. (Foucault 1980d: 119) 
Works such as The Birth of the Clinic (Foucault 1975), Discipline and Punish (Foucault 
1977), and The History of Sexuality (Foucault 1980b) are core instances of Foucault's 
project of documenting the constitution of subjects and bodies through the techniques of 
disciplinary power. 
The Birth of the Clinic has been particularly influential in medical sociology, providing 
new ways to frame and explore the origins and nature of medical practice (Armstrong 
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1983; Rose 1990; Armstrong 1994). In particular, Foucault proposed not only that 
diseases were produced (or `fabricated') by medicine, but that the very bodies in which 
the diseases resided were also produced by medicine. Such a claim resonates with the 
strong programme of social constructivism (Bloor 1991 [1976]; Barnes et al. 1996), 
which sees all phenomena - both those which depend on social consensus for their 
existence and those deemed to have a more independent reality - as produced. As 
Armstrong notes, "It is... a radical step - and one that has been challenged - to argue 
that the body is created, or fabricated, or invented" (Armstrong 1994: 23). 
According to Foucault, the way in which bodies are produced is through surveillance, 
objectification and normalisation. In his studies both of the clinic and the prison, he 
drew attention to the techniques of disciplinary power which used surveillance as a 
means to create self-regulating `docile bodies'. The development of the human 
sciences, which focused on the human body as an object of knowledge, spawned 
institutions designed to measure, regulate and control people and their behaviours. The 
monitoring of medical and psychiatric patients by an institutionally validated gaze - the 
medical gaze - was central to such techniques, both in routine questioning and 
observation, and the more intrusive techniques of looking inside the body (for example 
through internal probes). Foucault linked the exercise of these disciplinary techniques 
to the state's ability to bring about production and harness its human resources, a 
concept he designated `biopower'. Foucault's ideas on the creation of subjects through 
the exercise of power ('subjection'), specifically in the context of clinical surveillance 
and scientific discourses, have been taken up in the field of medical sociology, to 
analyse phenomena as diverse as dentistry (Nettleton 1989; Nettleton 1994) and teenage 
pregnancy (Arney and Bergen 1984). 
Subject-production and scientia sexualis 
The project of a science of the subject has gravitated, in ever narrowing circles, 
around the question of sex. Causality in the subject, the unconscious of the 
subject, the truth of the subject in the other who knows, the knowledge he holds 
unbeknown to him, all this found an opportunity to deploy itself in the discourse 
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of sex. Not, however, by reason of some natural property inherent in sex itself, 
but by virtue of the tactics of power immanent in this discourse. (Foucault 
1980b: 70) 
Foucault's first volume of The History of Sexuality, in which he traces the processes of 
subject-production through modern scientific discourses of sex and sexuality, has 
particular relevance for my own research. Using his geneaological method20, Foucault 
analyses the evolution of western sexuality and the historical contingency of the body, 
sex and sexuality. The importance of The History of Sexuality lies not in his exposition 
of the norms of sex and sexuality as socio-cultural constructs, but rather in his analysis 
of the constitution of sexuality as an object of knowledge via relations of power 
operating within a specific historical context. For Foucault, sex was not so much about 
bodies or erotic desire, but rather about technologies of government and technologies of 
the self (Danaher et al. 2000). The creation of the self through discourse is a major 
preoccupation in this work, with Foucault demonstrating the normative regulation of 
`the deep self through practices such as the confessional and psychoanalysis. Foucault 
argues that these historically and culturally contingent discourses on sex - including 
sexual identity, sexual practices, and the body - are important in constituting the ways 
in which societies establish the `truth' of the subject. This gives rise to particular 
subject categories (e. g. normal or deviant) and effectuates the norms for behaviour in 
society. 
Discourse, as used by Foucault, refers to "historically variable was of specifying 
knowledge and truth - what it is possible to speak at a given moment" (Ramazanoglu 
1993: 19). In the History of Sexuality, Foucault attends to the ways in which the 
techniques of confession spread from the religious to the secular domain and how 
nineteenth-century medicine appropriated discourses of sex in pursuit of the truth of the 
subject: "our society has equipped itself with a scientia sexualis... it has pursued the task 
of producing true discourses concerning sex, and this by adapting... the ancient 
procedure of confession to the rules of scientific discourse" (Foucault 1979: 67-68). 
The medicalised study of sex and sexuality is a phenomenon that has recurred with 
20 Foucault used the term `geneaology' to describe his method of analysing the historical relationship 
between knowledge, truth and power through discourse. His aim was to explore not who had power, but 
to analyse discourses to show how the exercise of power created knowledge. 
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force since the advent of the AIDS epidemic (Booth 1989; Vance 1991; Aggleton et al. 
2000). Biomedical, epidemiological and psychosocial surveys of sexual behaviour 
have proliferated, spawning new discourses of sexuality at the nexus of risk, rights and 
national security, to name but a few. Foucault's work prompts us to question the 
circumstances through which these discourses are created, the means and ends to which 
they are mobilised. 
Foucault and feminisms 
During his lifetime, Foucault had little interest in feminism and barely touched on 
gender in his writing. Indeed, Jones and Porter write, "at face value, it would appear 
that women did not exist for Foucault: they are spectacularly absent from almost every 
dimension of his work" (Jones and Porter 1994: 10). This has not stopped a productive 
dialogue evolving between Foucault's oeuvre and feminist theory over the past two 
decades (Diamond and Quinby 1988; Butler 1990; Hekman 1990; Sawicki 1991; 
McNay 1992; Taylor and Vintges 2004; Oksala 2005). Since feminism is a label that 
encompasses a broad spectrum of theories and viewpoints21, it is not surprising that 
there is considerable divergence in the response to Foucault, be it warm and receptive or 
thoroughly dismissive. At one end of the scale, core bodies of feminist theory have 
appropriated Foucault's work as their very foundation; at the other end, there has been 
wholesale rejection of Foucault's philosophical position. Two areas of the debate which 
are relevant for the current thesis are the production of sexual identity and Judith 
Butler's theory of gender performativity; and the subject, power and empowerment. I 
cite these as two areas for ease of discussion, whilst acknowledging that the distinction 
between them is a false one, since, at least in Foucauldian terms, one cannot speak of 
sexual identity without invoking the subject and one cannot speak of the subject without 
invoking power. 
21 Alluding to the "parade of feminist approaches". Sylvester playfully jibes, "Feminists parade the 
geospaces. Liberals, radicals, Marxists, socialists, ecos, empiricists, standpointers, womanists, lesbians, 
postmodernists, poststructuralists, postmodems and queers pass in review. Nationalist and critical Third 
World feminisms join the march. WIDS and WADS GAD about in gorgeous attire. Several melodies 
play simultaneously. Cheers strike up for the favourites" (Sylvester 1995: 942). 
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The antagonism that many feminists have felt towards Foucault is encapsulated in Toril 
Moi's seminal paper of 1985: 
What could be more seductive for feminists than a discourse which, like that of 
Michel Foucault in La Volonte de Savoir (The History of Sexuality), focuses on 
the complex interaction of power and sexuality?... Alluring as they may seem, 
however, the apparent parallels between Foucault's work and feminism ought 
not to deceive us. Feminists ought to resist his seductive ploys since.. . the price 
for giving in to his powerful discourse is nothing less than the depoliticisation of 
feminism. If we capitulate to Foucault's analysis, we will find ourselves caught 
up in a sado-masochistic spiral of power and resistance which, circling endlessly 
in heterogeneous movement, creates a space in which it will be quite impossible 
to argue that women under patriarchy constitute an oppressed group, let alone 
develop a theory of their liberation. (Moi 1985: 95) 
Moi's concerns have been echoed many times since this paper was published, with 
numerous writers contesting Foucault's notions of power and the subject (for example 
Christian 1987; Alcoff 1990; Deveaux 1994). Since power, according to Foucault, 
cannot be possessed by any particular social group, nor is it repressive, the patriarchal 
oppression of women by men is entirely undermined as a concept. Furthermore, if men 
are not in possession of power over women, how can women wrest themselves free of 
their oppression? In other words, women's agency and the struggle for empowerment - 
the touchstone of feminist politics - seemingly become a flawed ambition. 
In spite of this obvious challenge to feminist political practices, numerous writers have 
used Foucault's analysis of power, surveillance, sexuality and the body to interrogate 
contemporary aspects of women's lives. For example, Sandra Bartky uses Foucault's 
docile bodies and Panopticon theses as an explanatory paradigm for women's adoption 
of daily practices, such as diet regimes and the application of make-up, which produce a 
female body dictated by patriarchal notions of femininity (Bartky 1988). Susan Bordo 
likewise uses Foucault's notion of disciplinary power to propose that anorexia and 
bulimia are part of these same normalizing regimes of femininity (Bordo 1988; Bordo 
1989). Many other examples lend support to Jana Sawicki's endorsement of a 
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Foucauldian feminism "that is compatible with feminism as a pluralistic and 
emancipatory radical politics" (Sawicki 1991: 8). These theorists tend to focus on 
Foucault's later works (such as The History of Sexuality and Technologies of the Self), 
in which he brought out issues of resistance and suggested a more agential subject than 
in his earlier work. 
Whereas the above examples all use Foucault to problematise the construction of 
women's bodies and behaviours within a society permeated by forms of patriarchal 
surveillance, an alternative body of literature problematises the very notion of woman 
itself. Judith Butler has been at the fore of a wave of Foucauldian feminist theory that 
deconstructs sex and gender identities, arguing that these are discursively produced and 
performed via the body in compliance with or transgression of social norms. Butler 
started with the premise that sexual practice has the power to destabilize gender, arguing 
that gender is materialized by repeated acts that come to be seen as natural (sex) over 
time: "there is no gender identity behind the expressions of gender; that identity is 
performatively constituted by the very "expressions" that are said to be its results" 
(Butler 1990: 33). Following Foucault's genealogical exposition of sex as an effect, as 
opposed to a cause, of sexuality and sexual experience (Foucault 1979; Foucault 
1980a), Butler goes on to argue that sex does not describe a material given, does not 
precede gender, but rather produces and regulates the way we understand the materiality 
and sexuality of bodies. In other words, the body does not exist prior to signification. 
This vision of gender avoids both biological and social determinism, since identity 
categories are neither stable nor unified, having no fixed referent. On the contrary, they 
are permanently open to resignification. This, according to Butler, is grounds for 
optimism within feminism, since the resignification of the category `women' opens up 
possibilities to expand what it means to be a woman and therefore the potential for an 
enhanced sense of agency (Butler 1992)22. 
22 Butler is critical of feminism's attempt to emancipate women by mobilising politically around 'women' 
as a fixed and natural identity category, arguing that "the feminist subject turns out to be discursively 
constituted by the very political system that is supposed to facilitate its emancipation. This becomes 
politically problematic if that system can be shown to produce gendered subjects along a differential axis 
of domination.... ln such cases, an uncritical appeal to such a system for the emancipation of "women" 
will clearly be self-defeating" (Butler 1990: 4-5). 
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The issues of freedom and agency have been a point of tension in feminist readings of 
Foucault, since he has been read as denying the autonomy of the subject and the body's 
capacity for resistance (Oksala 2005); see also (Diamond and Quinby 1988; Bigwood 
1991; McNay 1991). In The Psychic Life of Power, Butler analyses the notion of 
resistance in Foucault's work, asserting that "resistance appears as the effect of power, 
as part of power, its self-subversion"23 . Resistance is not generated by the body, but 
through the repetitive acts of subjection which allow for the proliferation of "effects 
which undermine the force of normalization" (Butler 1997: 93). Butler's denial of the 
body's capacity for resistance has frustrated some feminist critics; in this and other 
aspects of her work, the "over-textualization of the body" is seen to reify it in a way that 
precludes discussion of the lived body and embodied experience (Diseger 1994; 
Howson 2005), and fails to acknowledge that gender is also located culturally within 
social relations, institutions, structures and practices. By reducing all to text and 
representation, `context' - historical, geographical, economic etc. - is lost. Once the 
material has been reduced to discourse, and language privileged as the very condition 
for knowing the material, then the only legitimate object of analysis becomes language. 
This, as many have objected, forecloses an analysis of the social, economic and political 
inequalities fundamental to women's and men's experience of gender `in the real world' 
(Fraser 1995; McNay 1999; Speer and Potter 2002). 
Butler exemplifies the type of western feminism that more broadly has come under 
criticism from African scholars and activists, who have questioned the relevance of the 
white bourgeois intellectual elite's framing of women to their own experience (Macleod 
2006). Moreover, `First World' feminist writing has been accused of positioning the 
`Third World' as "the suppressed absent trace to the preoccupations of the gender-race- 
class relations of the `First World"' (Macleod 2006: 373); homogenizing `Third World' 
women into a single category (Mohanty 1991); and mining them as a resource for 
`Western' theory (Lai 1999). It. is hardly surprising then for Meena, a prominent 
African feminist, to contend that "feminism is considered by most of our African 
scholars as a foreign importation which has no relevance to the African situation" 
23 Foucault: "Where there is power, there is resistance, and yet, or rather consequently, this existence is 
never in a position of exteriority to power ... there is no single locus of great Refusal, no soul of revolt, 
source of all rebellions, or pure law of the revolutionary. Instead there is a plurality of resistances, each 
of them a special case ... 
by definition they can only exist in the strategic field of power relations" 
(Foucault 1979: 95-96). 
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(Meena 1992: 4). Similarly, Essof writes that "unless feminist theory in Africa registers 
a sensitivity to context and practice, it is likely to remain impoverished, either 
rehearsing jargon emanating from western-centric frameworks or developing facile 
generalisations" (Essof 2001: 125). 
Work in feminist anthropology speaks to these criticisms by focusing on the symbolic 
construction of gender within specific cultural contexts (thus in a sense marrying the 
textual and the material). Biological differences are not seen to provide a universal 
basis for social definitions (Brown and Jordanova 1982)24, but nor is culturally-situated 
embodied experience elided through linguistic deconstruction (MacCormack and 
Strathern 1980; Ortner and Whitehead 1981; Moore 1988; Moore 1994). Furthermore, 
by locating gender differentiation in the broader structure of social and cultural form, 
feminist anthropology is more aptly placed to describe the intersection of gender with 
other forms of difference such as class, race, disability etc. As Moore points out, gender 
difference is experienced simultaneously with, and therefore in relation to, these other 
forms of difference, and as such, requires analysis within specific contexts, rather than 
at the level of abstraction (Moore 1994). 
While feminist anthropology, therefore, can usefully direct us to specific contexts, the 
postcolonial critique of the linguistic turn, to which it is an antidote, should not be taken 
too seriously. Reducing gender to lived, embodied experience foregrounds the 
immutability not only of the female body but of the racialised body and asks us to 
analyse sex and gender only within the terms of epistemological givens. It masks the 
fact that the identity category of `Third World women' is not merely descriptive, but - 
as with all identity categories - normative and hence exclusionary (Butler 1992: 15-16). 
The pertinent task is not to describe the materiality of experience, but rather to enquire 
into how the intelligibility of experience is produced and regulated through discourse. 
This is a task that Foucault equips us to undertake, regardless of location. 
24 "What cultures make of sex differences is almost infinitely variable, so that biology cannot be playing a 
determining role. Women and men are products of social relations, if we change the social relations, we 
change the categories 'woman' and 'man'" (Brown and Jordanova 1982: 393). 
46 
Vaginal microbicides as case study: Defining questions 
From this literature review, it is clear that there is no scarcity of theoretical material 
upon which to draw in the social study of HIV and new prevention technologies. 
Above, I have tried to link eclectic bodies of literatures in a dialogic manner, exploring 
a series of tensions and convergences relevant to the study of knowledge-making and 
social order. Since this is an empirical study, I have not attempted to resolve the 
manifold epistemological and ontological debates, as one might do in a theoretical 
thesis. Instead, I have sought ways to frame the current study, focusing particularly on 
questions about what gender is, how science is made, and the nature of power. In 
elucidating core aspects of Foucauldian, feminist and STS scholarship I have delineated 
paths into the topic of emerging pharmaceutical technologies for HIV prevention that 
can be explored through empirical research. 
My aim in the current study is to explore the co-production of gender and technology 
through the case study of vaginal microbicides. Jasanoff's `idiom of co-production', 
referring to the way in which the social and the natural worlds are produced 
simultaneously (Jasanoff 2006), will provide the analytical backcloth to the research. 
Within this framework, science is neither understood as a simple reflection of the truth, 
nor as a particular configuration of social interests. Rather, science "both embeds and is 
embedded in social practices, identities, norms, conventions, discourses, instruments 
and institutions - in short, all the building blocks of what we term the social' (Jasanoff 
2006: 3). This is equally the case for technologies. Co-production provides useful 
ways to analyse problems of essential and stereotypic reproduction, since it underscores 
how the cultural capacity to construct and validate knowledge and technologies can lead 
to stability, or conversely flexibility and change. In this respect it is apt for the study of 
gendered and technological identity-making. 
Within this overarching pursuit, I will seek to understand how historically, 
geographically and culturally contingent discourses contribute to the production of new 
technologies for HIV prevention. As I have outlined above, Foucault understood 
discourses as ways of specifying knowledge and truth within a given historical context: 
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... basically in any society, there are manifold relations of power which 
permeate, characterise and constitute the social body, and these relations of 
power cannot themselves be established, consolidated nor implemented without 
the production, accumulation, circulation and functioning of a discourse. There 
can be no possible exercise of power without a certain economy of discourses of 
truth which operates through and on the basis of this association. (Foucault 
1980c: 93) 
Through his genealogical excavations, he traced patterns of the exercise of power 
through the interplay of discourses. This understanding of power/knowledge/truth 
provides a fitting analytical framework for exploring the emergence of microbicides in 
both social and scientific domains, and the subjection entailed in their production. 
The techniques of power through which transnational scientific networks are mobilised 
to test new products, such as microbicides, will form a further area for enquiry, and how 
this affects scientific practices, knowledges and identities. Rather than seeing power as 
repressive and possessed by certain individuals or sections of society (as implied, for 
example, in common references to patriarchy as the source of women's oppression, or 
Northern scientists dominating Southern partners), I will use a Foucauldian notion of 
power as productive, diffuse and relational. As noted above, Foucault saw power as 
embedded in daily practices and constitutive of subjects and subjectivity; he linked 
power to knowledge, suggesting that subjection took place through the production and 
exercise of knowledge (Foucault 1980c). Although the participants of clinical trials are 
most often taken as the object of enquiry, I will start by exploring how scientists 
themselves are produced and regulated through the research process. 
From a Foucauldian perspective, clinical trials which test new prevention technologies 
can be seen as a form of disciplinary power, operating through the surveillance and 
objectification of the body, and creating particular types of subject in those whom they 
recruit. The disciplinary management of trial participants is institutionalised through 
daily routines and procedures which function as part of `the clinical gaze'; power is 
exercised through the strategies of observation, measurement, examination and 
comparison of individuals against an established norm. In the trial context, such 
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strategies may include blood testing, genital examinations, and the collection of 
demographic and sexual behaviour data. In this sense, the trial can be taken as an 
extension of the clinic. How power relations are instituted, challenged or re-produced 
across diverse cultural settings through the trans-national scientific testing of 
technologies therefore suggests itself as a further important area of enquiry. 
Closely tied to subjection is the role of scientific framings of new biomedical 
technologies in constructing gendered identities. Rather than seeing gender as 
determined by biological sex and therefore as static and immutable - as does much 
research in the field of HIV prevention -I will follow Connell, amongst others, in 
seeing gender as a process. If we use the word `gender' as a verb (I gender, you gender, 
he/she genders, we gender... ), then the social act of gender-ing can be seen to rest not 
only with the individual, but to operate in interaction with other people, institutions and 
discourses (Connell 1987). As a social act, gendering works within and across cultures, 
in historically contingent ways. The construction of gender within a `Western' 
paradigm may differ significantly from its construction in other cultures; we should not 
assume the universality of the western concept of personhood, the self, and self-identity, 
nor take for granted biomedical models which posit two discrete physiological body 
types as the arbiter of gender. As Moore underscores: "The obvious fact of biological 
differences between women and men tells us nothing about the general social 
significance of those differences; and although human societies all over the world 
recognise biological differences between women and men, what they make of those 
differences is extraordinarily variable" (Moore 1994: 71). 
Finally, it is not only human variability that is at stake, but the variability - or stability - 
of biomedical technologies across cultural contexts. This has been illustrated in 
Akrich's analyses of technology transfer from industrialised to developing countries, in 
which she disentangles "the links between technical choices, users' representations, and 
the actual uses of technologies" (Akrich 1992: 208). Extending this theoretical 
engagement through an analysis of the Zimbabwe bush pump, De Laet and Mol have 
written insightfully on fluid technologies, deepening science studies' hitherto shallow 
engagement with technologies that emerge in or travel to worlds outside `the North' (de 
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Laet and Mol 2000)25. As Hine has suggested, "whilst it was once of a vital strategic 
importance to "go inside the laboratory", it is now often more timely for STS to pursue 
the ways in which science is practiced across sites and the ways in which it practices 
sites" (Hine 2007: 669). In the study of microbicides, as with other biomedical 
technologies for HIV prevention, the potential multiplicity of the intervention across 
cultural locations presents a ripe field of enquiry26. 
Summary 
In the 2000s, evidence-based research into new biotechnologies for HIV prevention 
abounds, with ever increasing funds for technological research and development. The 
scarcity of deep social science inquiry into this evolving sub-field of HIV science 
presents a missed opportunity to further our understanding of the permeable relationship 
between the scientific and the social. Regardless of the success or failure of these 
technologies, the process of their development and testing has important implications 
for the production of `truths' about the epidemic, its `victims' and its would-be 
vanquishers. Using theoretical and empirical insights from anthropology, sociology, 
science and technology studies and cultural studies, I have framed an agenda for 
research that is pursued in the remainder of this thesis. In the following chapter I 
outline the methodological considerations for such an undertaking. 
25 Extending Latour's notion of 'immutable mobiles' (Latour 1987) ("materials that can easily be carried 
about, and tend to retain their shape" (Law 1994: 102)), de Laet, Mol and Law have explored the 
spatiality of technoscience, finding that what facilitates technological travel and transfer is not an 
artefact's rigidity, but its very mutability (de Laet 2000; Law and Mol 2001). 
26 This research will therefore answer Mellström's recent call for more attention to be given to non- 
western gender-technology relations: "addressing the relative absence of gender and technology research 
on non-western contexts should introduce a wider range of cultural perspectives on the gender relations 
embedded in a diverse range of settings" (Mellstrom 2009: 888). 
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Chapter Three 
Social Science and Social Contingency: Methodological Negotiations 
In this chapter I will lay out the methodological issues negotiated in the study, locating 
them within the salient debates at the intersections of public health research and STS. I 
start by discussing the challenges posed by studying a large multi-sited clinic trial, 
including the unboundedness of the field. Whereas STS has traditionally favoured an 
ethnographic approach, I outline my decision to use in-depth interview data, both on 
practical and theoretical grounds. Law has suggested that we "need to think hard about 
our relations with whatever it is we know, and ask how far the process of knowing it 
also brings it into being" (Law 2004: 3); 1 take up this suggestion by paying particular 
attention to the role of my relationship with the MDP trial in constructing the data for 
this study. The identity of the researcher as an insider/outsider is fundamental to this 
discussion and is an issue I reflect upon throughout the chapter. In the-current study, 
this relates not only to my professional role in the MDP trial, but other markers of 
difference between me and my informants such as race and gender. As part of a 
reflexive endeavour, I detail decisions made about the choice of sites and informants, 
my relationship with them and with my research assistant, and how I constructed an 
analysis out of the data. I address the cross-cultural nature of the study, including the 
challenge of working across languages, and conclude by reflecting on the ethical 
landscape in which the study was conducted. 
Studying science in action 
Instead of black boxing the technical aspects of science and then looking for 
social influences and biases, we realised.. . 
how much simpler it was to be there 
before the box Closes and becomes black. With this simple method we merely 
have to follow the best of all guides, scientists themselves, in their efforts to 
close one black box and open another. (Latour 1987: 21) 
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Science and technology studies has traditionally used ethnography as a way to get under 
the skin of science and observe what it is made of. Since the 1970s, laboratory-based 
ethnographies have been particularly important in grounding the theoretical insights of 
the field, with scientists followed in the minutiae of their labours by the visiting 
anthropologist (Knorr-Cetina 1981; Latour and Woolgar 1986; Latour 1987; Knorr- 
Cetina 1996). As the field has evolved, so have inclinations to more comparative 
approaches, and the inclusion of multiple study sites (Collins 1985; Knorr-Cetina 1999). 
In the past decade, the focus has shifted from identifying multiple places in which to 
study science to studying the spatiality of scientific practice itself (de Laet 2000; Law 
and Mol 2001). These studies have moved outside of the laboratory, perhaps - as Hess 
(2001) suggests - as a result of greater interest in issues of culture and power (which 
some previous commentators felt could not adequately be captured by the sole focus on 
laboratory life, see for example Golinsky 1998: 11). In my own study, the starting point 
was an interest precisely in power and cultural multiplicity in HIV prevention research. 
I also arrived at a point when the laboratory work on the technology in question (PRO 
2000 gel) was already accomplished; thus the interesting questions concerned 
technoscientific fluidity (de Laet and Mol 2000) in the testing phase. 
If anywhere could said to be the location of this research, it is the phase III trial of PRO 
2000. This non-geographical designation points to the methodological difficulty of 
capturing `science in action'; the sites where the science of pharmaceutical testing take 
place in the final stages of microbicide development are multiple and diverse. In the 
case of PRO 2000 they range from the offices of the small biotech company that 
developed the drug; to the production line in a US factory in Lexington that 
manufactures individual gel applicators; to the hallowed offices at Whitehall where 
funding was agreed to invest in testing the gel; to the academic spaces where the RCT 
was designed and from which it was coordinated; to the ethics committee meetings (at 
multiple institutions) during which the study protocol was approved; to the regulatory 
authorities (in multiple countries) where import licenses for the gel were authorised; to 
the academic partner institutions in four African countries where trial sites were 
established; to the trial clinics where doctors and nurses and receptionists and drivers 
ran the trial; to the homes of participants - and bars, toilets and bushes - where gel was 
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used; to the community spaces in which it was talked about, illicitly sold and exchanged 
(perhaps). 
The multiple sites I mention are by no means exhaustive, but they demonstrate the, 
enormity and unboundedness of `the field' and the challenge that even a multi-sited 
ethnography would encounter. As Law and Urry have observed, "so-called 
`globalisation' means that the phenomena.. . of the social are less about territorial 
boundaries and states and more about connection and flow" (Law and Urry 2003: 10); 
and in response Law suggests, "many now think that ethnography needs to work 
differently if it is to understand a networked or fluid world" (Law 2004: 3). My 
response in the current study has indeed been to `work differently', choosing to enquire 
not through ethnography, but through in-depth interviews in a networked world of 
which I myself was already an established member. This decision was based both on 
practical and methodological considerations. Whilst ethnography posed methodological 
challenges in terms of location, it was also problematic in terms of my professional 
position within the Microbicides Development Programme; as I undertook the current 
research, I was also employed full time as a social scientist to coordinate the socio- 
behavioural component of the MDP301 trial. Whilst ,I considered participant 
observation as a method, I decided that having a dual day-to-day role would 
compromise the integrity of relationships with colleagues, particularly those over whom 
I had some degree of authority. The decision to use only interviews as data was 
designed to avoid colleagues' suspicion that they were being spied on or scrutinised, 
which would have been detrimental to the running and ethos of the programme27. 
Limiting the study to interview data allowed me to take in the spatial fluidity of the trial 
in a way that a full-blown ethnography may not have; for example, I was able to access 
the worlds of academia, advocacy, politics and trial participation via a carefully 
considered set of key informants. Thanks to my experience of working on the trial, the 
choice of informants was well-informed and based on privileged prior knowledge. 
Access to informants was also facilitated by virtue of being `an insider', as I discuss 
27 Whilst I did not use participant observation as a method in this study, it is impossible not to observe in 
the course of daily life, which for me involved the trial. Therefore the framing of the study and my 
interpretation of respondents' accounts will necessarily have been coloured by my 'insider knowledge' of 
what was going on. 
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below, both in terms of gaining interviews and in terms of the questions I knew to ask 
(and was granted answers to). The obvious drawback to this approach was foregoing 
data about what actually happens and what is actually said in a `natural' setting; 
interview data only provides access to accounts (Silverman 2006). However, in terms 
of my research questions - framed around a Foucauldian understanding of discourse - 
the construction of accounts through interview dialogue is an entirely appropriate source 
of data. As Kitzinger has noted in a discussion of feminist approaches to research: 
Constructionism... disputes the possibility of uncovering `facts', `realities' or 
`truths' behind the talk, and treats as inappropriate any attempt to vet what 
people say for its `accuracy', `reliability', or `validity'... From this perspective, 
what women say should not be taken as evidence of their experience, but only as 
a form of talk -a `discourse', `account' or `repertoire' - which represents a 
culturally available way of packaging experience. (Kitzinger 2004: 128) 
What she describes as `culturally available ways of packaging experience' resonates 
'28 with what Foucault referred to as the discursive production of `regimes of truth. 
In this study, then, I selected interviews as the most appropriate way to gain access to 
the discursive co-production of gender and technology in the context of the MDP 301 
trial. he accounts were generated as the trial was in full swing, and for the most part 
concerned discussion of contemporaneous social and scientific processes. However, 
since I was also interested in the stages of the research immediately preceding the trial - 
such as the development of the phase III protocol -I was reliant to some extent (in 
some interviews) on retrospective accounts. There is an epistemological tension in 
respecting these accounts as indicators of history, whilst simultaneously analysing them 
as indicators of socially constructed realities. Since no written history of the 
programme exists, and other documentary sources, such as minutes of meetings, would 
have suffered from the same problem, this is a tension that remains unresolved. I feel it 
is nonetheless important to signal its presence at the outset. 
2' Foucault: "Truth isn't outside power ... Truth 
is a thing of this world; it is produced only by virtue of 
multiple forms of constraint... And it induces regular effects of power. Each society has its regime of 
truth, its 'general politics' of truth; that is, the types of discourse which it accepts and makes function as 
true" (Foucault 1984: 72-73). 
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An area in which I felt it important to go beyond individual accounts in my data was in 
relation to the discursive production of gendered identities in the Zambian trial 
community. Focus groups have commonly been used in sub-Saharan Africa to collect 
data on normatively prescribed gender roles and sexual identity amongst both men and 
women (recent examples include Brown et al. 2005; Strebet et al. 2006; Mankayi 2008; 
Ragnarsson et al. 2008; Shefer et al. 2008). Although there is a tendency in the 
literature to treat focus group data in the same way as interview data and simply look for 
commonly occurring themes, my aim was to use this format to access the social process 
of gender production itself. The value was in creating a performative space in which to 
observe not only what people said, but how what they said was taken up, reinforced, 
legitimised or contested in a naturalistic setting. The topics covered in these group 
interactions were loosely hung around values, behaviours, and expectations regarding 
men and women in the study community (for example, "what do we admire in a 
woman/man? "). The group setting - in which social interaction can be used as research 
data (Kitzinger 1994) - was ideal for accessing the discursive production of gendered 
identities. 
Field sites and informants 
Where can we start a study of science and technology? The choice of a way in 
crucially depends on good timing. (Latour 1987: 2) 
As indicated above, the research was designed partly around the contingencies of my 
working life. Above all, the timing of this was what gave rise to `a way in' to the study 
of new technologies for HIV prevention; I was employed by the MDP trial in the UK, 
but travelling frequently to the African trial sites. From the outset, I was clear about 
the need to trace the co-production of science and society across cultural boundaries; at 
the outset the most obvious of these seemed to be the boundary between `the scientists' 
in the UK and `the trial participants' in Africa. As with all dichotomies, however, this 
boundary was hard to sustain upon even the most basic of investigations; neither `the 
scientists' nor `the trial participants' were unproblematic entities, since science and 
participation were not mutually-exclusive activities and certainly did not observe 
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`cultural' boundaries. As such, the selection of sites and informants became less about 
a dichotomous set of relations and was instead guided by the multiple intersections of 
activity and location characterising a large transnational clinical trial. My informants 
represented work being carried out on three continents, spanning a diverse array of 
activities, from biochemistry to grass-roots advocacy. 
Because of the size of the trial and the nature of qualitative research (in particular, 
labour-intense and time-consuming data analysis), I limited my sample to one African 
trial site and the key people in the UK/US who I felt were instrumental in bringing the 
trial into being. Out of the six possible phase III trial sites in Africa, I selected the 
Zambian site, based in Mazabuka, Southern Province. This was partly a result of 
practical reasons, such as the fact that the majority of the other sites were already 
supporting PhD researchers, some of whom were also working on microbicides. Whilst 
I considered the benefits of conducting the research in South Africa, where a large 
proportion of microbicide trials have taken place, there was only one site which was not 
already hosting PhDs. When I applied for ethics approval to conduct the study at this 
site, the local ethics committee would not allow me to ask participants about their first- 
hand experience of the trial, proposing instead that "all topics be of a general nature"; 
they also objected that my application for research did not contain a structured 
questionnaire. I felt that such constraints would limit the quality and integrity of my 
research and therefore chose to work elsewhere. 
In addition to these practical considerations, there were reasons for positively choosing 
the Zambian site in its own right. Unlike the other MDP sites, it had been created from 
scratch for the purposes of MDP in a so-called `research-nave' community. Apart from 
being in the MDP trial network, it was not part of any larger institutional structure, such 
as a university or research centre. As such, it presented an opportunity to study 
scientific and social co-production solely as it related to the MDP trial and 
independently of other scientific work that might be going on in other institutions. 
Furthermore, at the time I was planning the study, recruitment and retention at the site 
were waning and there was a strong suggestion that this was as a result of male 
opposition to the trial in the community (Anon. 2007). Since I had an interest in 
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exploring the interaction of scientific testing of microbicides with gendered power 
relations, this provided a relevant context for my research. 
Mazabuka, where MDP Zambia is located, is an industrial town located approximately 
125 km south of the capital, Lusaka, with a population of 203,219 inhabitants (Central 
Statistical Office Zambia 2003). The town has largely grown up around Zambia Sugar, 
the largest sugar producer in the country, which employs over 2,500 full-time 
employees and an additional 4,000 seasonal workers (Zambia Sugar Plc, 2007 Company 
Profile). The latter come predominantly from Western Province during April to 
November to work as cane-cutters on the plantations. Workers are housed on the sugar 
estate in residential compounds, of which there are six. In 2003, the Microbicides 
Development Programme conducted a Feasibility Study to assess the possibility of 
conducting the phase III trial on the Nakambala Sugar Estate. Following successful 
Feasibility and Pilot Studies, the trial started enrolling in July 2006 and shortly 
afterwards opened up a sister site in the urban townships of Mazabuka. This clinic 
recruited women from compounds in and around the commercial heart of the town and 
along the main road between Lusaka and Livingstone, drawing participants from a 
population of around 43,000. 
Figure 1: Map of Zambia 
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Before committing myself to research at the site, I conducted a 3-week visit in July 
2006 to assess suitability, spending time shadowing the staff and exploring the 
community with a local guide, Benson. On the basis of this visit and the fact the site 
was receptive to me doing the research with them, I felt confident to proceed as 
planned. Since the paragraph above gives a `factual' but sense-less picture of the study 
area, I include an extract below from field notes written at the time of my 2006 visit. 
Because this was my first outing into the town compounds, it gives the first impressions 
of a complete outsider. 
Benson, a community worker, took me around Ndeke compound. It has around 
15,000 people crammed into it, starting from what is known as `Compound Z' 
and streaming out into 'Overspill' and various other subdivisions. I think it's 
one of the most extreme cases of poverty I've seen, and it seems all the worse 
because it is urban poverty, with people packed on top of each other with no 
space. There's a dirty, sweet smell as you walk around that comes both from 
local brew - which seems to be drunk in abundance - and the molasses, which 
has been used to make the streets (it was brought in as a waste product from 
Zambia Sugar across the fields). In fact, there's really only one main street and 
it is lined with taverns and small stalls. There's a market with everything you'd 
want - fish, meat, vegetables... Most people in the compound make a living by 
selling. And then there are the houses, which are so small and higgledy- 
piggledy that you wonder how they stay up with so many people inside. 
Water is an issue. There are several bore holes from which water is pumped to 
stands, but the supply system is precarious with pumps prone to breaking. They 
were all put in by Irish Aid and Plan International, both of which seem to have a 
big presence in the community. There's a community centre, which is a hive of 
activity. It houses a school teaching basic skills (such as woodwork and 
metalwork) to 600 students; the Plan office; a grocery; a women's centre; and 
the Resident Development Committee Secretariat. Plan is doing a mass of 
activities, mainly around training: peer educators, traditional birth attendants, 
widows, community workers ... they have nutrition programmes, so many 
programmes I can't think of them all. The compound is bordered by the sugar 
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fields at the back. You wonder how much of the profits are returned to the land 
and the people from which they came... 
We walked and walked. We came to what is called the `airstrip' but could 
hardly be more unlike one -a large wasteland covered in scrub and small 
bushes, with mounds of earth, craters where people have been digging for clay 
to make bricks, miscellaneous rubbish and all sorts of hazards. No planes land 
there anymore. It is likely this land will shortly turn into another 
compound... We arrived back at Ndeke clinic where we had started. Benson 
showed me the Nutrition Garden, another community initiative. They grow 
vegetables - tomatoes, onions, cabbage, ochre, bananas - which they sell in 
order to get money to buy nourishing food for underweight infants. (Field notes 
10 July 2006) 
Sampling 
Fieldwork took place between October 2007 and June 2009 in the UK, Zambia, and at 
an MDP Investigators Meeting in Mozambique. The relatively protracted time over 
which the interviews took place was partly a result of cyclical data collection and 
analysis, as described by Glaser and Strauss (Glaser and Strauss 1967). Although I 
started off with a provisional list of key informants, I sampled theoretically, seeking to 
saturate categories in my data as I built up my analysis. In the UK, I initially selected 
informants I knew to be key players in the development and running of microbicides 
research relating to MDP, purposively sampling from the different disciplinary domains 
such as social science, community liaison and clinical coordination. I also sought 
advice from colleagues and supervisors as to who they considered to be central actors in 
the field, particularly when it came to those not employed by the trial itself. 
In Zambia, I likewise sought informants from among the different disciplines and 
grades of staff, selecting those whom I felt would be able to contribute rich accounts. In 
terms of trial participants, male partners and key community stakeholders, I consulted 
with the senior social scientist, community liaison officer and my research assistant 
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(discussed below) in order to locate suitable informants. Amongst trial participants and 
their partners, I considered suitable those who were currently enrolled in the trial or who 
had exited within the past 3 months, and who were not shy and retiring. The social 
science team had already built up good rapport with a subsample of approximately 60 
women in the trial who had been randomly assigned to the social science substudy at the 
town site. Given that there were existing good relations with these women and that I 
could consult their previous interviews, I decided this was an appropriate group from 
which to sample. I relied on the community liaison officer to advise on other key 
informants, selecting those who had some prior knowledge of or involvement with the 
trial in their varying capacities in the community (e. g. as members of the Community 
Advisory Board (CAB), or through HIV prevention networks). Table I below details 
the final sample of key informants interviewed in both Zambia and the UK. 
Finally, it was necessary to select women, men and CAB members to take part in a 
series of five focus groups. Members of the CAB were selected by the community 
liaison officer to be as representative as possible of the overall composition of the 
group. Women trial participants were randomly selected from the trial database 
according to age, one group aged 18-30, the other over 30. They encompassed a range 
of educational and employment characteristics. In order to invite men from the general 
community (likewise split into younger and older groups), we approached the chairs of 
10 local Resident Development Committees (RDCs, which form part of local 
government structures) and asked them to invite two men in their area to participate. A 
good range of men of different ages and from different compounds attended, from the 
unemployed to skilled white collar workers. 
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Table 1: Key InR rmants 
Location Type of informant Main role Identifier" 
US Ke stakeholder Biomechist. pharmaceutical partner Neil 
Clinical principal investigator Kate 
Clinical principal investigator Chris 
Community liaison coordinator Patrick 
MDP trial staff Social science coordinator Dylan 
Statistician Dominic 
UK Representative 
. 
MDP Programme Management Board (PIVIB) Harry 
Consultant, marketing and communications Gill 
Re resentati\. e. International Working Group for Microbicides Adrian 
k h ld r K t 
Re resentatiýeUK-based microbicides advocacy Alyshia ey s a e o e s Citil servant, broker in the funding for the trial James 
Re resenatiee. international microbicides advocacy Ellen 
Clinician & project coordinator Susan 
Clinical officer Edward 
Counsellor Eleanor 
Counsellor Mary 
Nurse Gertrude 
Nurse banne 
l taff MDP tri 
Community liaison officer John a s 
Community mobiliser C stal 
Community mobiliser Colin 
ZAMBIA 
Community mobiliser Rachel 
Senior social scientist Marle 
Research assistant Michael 
Research assistant Ben 
Research assistant Margaret 
Traditional marriage counsellor Isobel 
Traditional marriage counsellor Lillian 
k h ld K t 
Church leader Pastor 
ers a ey s e o Church leader Pastor 
NGO leader & CAB' member Frank 
Local HIV/AIDS coordinator Joshua 
*Pseudonvms have been used to conceal the identity of informants. I have used first 
names in all cases, as I was on first-name terms with all of my informants, apart from 
the church leaders. +ho I have designated simply as 'pastor'. 
The things we carry: Cross-cultural fieldwork in Zambia and the UK 
Our ýkciJhty hackpack>... bulge with necessities: computers and field notes. 
cameras and tape recorders, Cipro and toothpaste, pocket dictionaries.. More 
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important, however, are those things that cannot be measured in pounds, namely 
the theoretical paradigms currently in favour, the social prejudices and political 
predilections of the times, and, of course, our personal past. All of these things, 
too, we carry with us. They simultaneously sustain and demoralize, illuminate 
and deceive, focus our attention on some phenomena, and blind us to others. 
(Brandes 2008: 145) 
In the section that follows, I provide some discussion of the relationships I brought to 
the fieldwork and how these shaped the data I produced with my study participants. I 
was keenly aware of the `baggage' I brought with me to the research; although Brandes 
alludes above to what we carry with us when travelling to foreign cultures, it is equally 
important to recognise what we carry with us in our own. With many of my informants I 
not only had a shared language and culture, but a long-standing relationship by virtue of 
my role in the trial. All of my informants who worked on the trial knew me as an 
insider and someone whom they could safely and legitimately discuss the trial with. By 
the time I started interviewing, I had been a `member of the team' for three years, 
travelling extensively with colleagues from across the trial network and building up 
strong professional (and in some cases social) rapport with them. This relationship gave 
me unprecedented access, both in terms of being granted interviews and in terms of 
being able to ask questions that might have been considered sensitive or impertinent if 
posed by an outsider. The following exchange with a high-ranking scientist exemplifies 
this: 
Harry: Internally, when we considered (microbicides), it was to ask the question 
'did they work? '... 
CM: And have you ever utilised the women's empowerment line to obtain 
funding [Harry laughs] or popular opinion? 
Harry: [Laughing] What a question! Um... [pause] I think one would have been 
pretty stupid not to use all, um, potential levers available to you. So I mean, I'm 
sure you've read the first grant application that was written, indeed back in '94, 
when we were first writing the very first grants, I'm sure the first line was about 
empowerment of women. 
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My question as to whether popularist tactics had been used to gain funding for the 
science was really a question about spin and public relations. Harry rightfully balks at it 
("What a question! "), but nonetheless, because he knows me and presumes me to have 
the answer anyway ("I'm sure you've read the first grant application"), decides to 
answer the question. 
Although I believe my insider status gave me better access, it is possible that because of 
my role within the organisation, people were more careful with what they told me about 
the programme, applying a filter to their responses. Whilst I was comfortable to ask all 
of the questions I felt needed to be asked, it's not unreasonable to suppose that an 
outsider could have framed these more critically, being less dependent on their 
relationship with the interviewees. There is no way to know what difference this made 
to the accounts we produced during the interviews, since no comparable work was 
undertaken by a third party. I have raised the issue here, and included myself in the 
extracts presented in the thesis where possible, so that the reader can judge the context 
of production for themselves. 
Given the richness of the accounts I was able to generate, I would argue that 
communality was, to a large extent, an advantage in my interviews, since it was the 
basis of trust and rapport which led informants to `speak easy'. Aware of the risk of 
taking too much for granted in our shared knowledge and understanding of the trial, I 
had to negotiate an awkward balance of presenting myself as an insider, whilst 
questioning `the obvious'. At times, this clearly confused or confounded my 
informants, breaking the spell of complicity and highlighting altered dynamics in the 
researcher-researched relationship. The following extract from an interview with 
Dylan illustrates this tension: 
CM: So why do you think everyone was so focused on the fact that women were 
going to use this (microbicide) covertly? 
Dylan:... just think about Gill's little leaflet for the journalists in which she had 
a statement that there's no woman who can force her partner to use a condom. 
Those sort of assumptions, you know, women are absolutely powerless, there's 
not a single woman in the world who can force her partner to use a 
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condom... and Gill thinks that's a perfectly legitimate statement. And I said, 
'you can't put that in 'cause it's not true "... 
CM: And what was the aim of her putting in that sentence, what was she...! 
don't know the, I don't know this document you're talking about. 
Dylan: No? Didn't she circulate it to you? It's a sort of advisory thing for 
journalists, so that they know what microbicides are, what MDP's doing... that's 
what she wanted the quotes from NVivo for [that I, CM, gave her] you know... 
"I love the gel and it's improved my marriage " and all that sort of thing. And, 
so she's explaining in simple lay terms what microbicides are and why they're 
needed and one of her statements is that they're needed because there isn't a 
woman in the world who... can force her partner to use a condom. And... coming 
back to your question, I mean that's why people are surprised, because there're 
a lot of people who do assume those sort of things. 
CM: So you think those assumptions are flawed? 
Dylan: Well they are flawed, you know that. 
CM: It doesn't matter what I know... 
Dylan: Yah... 
Dylan assumes that we both know about Gill's leaflet for journalists and that we both 
share an opinion on it. Although I had contributed some quotations to the leaflet as part 
of my job, I had not in fact seen the document itself and so did not know what Dylan 
was referring to. Once he has explained about the leaflet, he again presumes that we 
share an opinion as to the legitimacy of its assumptions. His response - "Well they are 
flawed, you know that" - effectively closes down discussion of his views; he refuses the 
social roles of interviewer and interviewee that normally operate in this context, 
upholding our collegial relationship. On occasions such as this, communality was a 
disadvantage that may have limited the analytical depth of accounts (Green and 
Thorogood 2009). 
The extent of communality - and what was shared - obviously varied according to who 
I was interviewing. In this respect, my position in the trial hierarchy worked to my 
advantage. Senior scientists in the UK knew we shared the same language, so that they 
could talk in their own terms about the trial, and at the same time did not feel threatened 
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by my questions because I was a junior, relatively powerless actor. This very lack of 
position was what enabled me to speak freely with other junior researchers at the 
Zambian site, with whom I did not share a linguistic or socio-cultural background. 
Even where I was perceived as having some authority over them, this was mitigated by 
my age and gender (young female) and by the fact that I did not display the 
accoutrements associated with someone in a position of power and authority. For 
example, whilst living and working at the Zambian site I used a bicycle rather than a car 
to get around -a source of much mirth amongst all whom I encountered, not least the 
trial staff themselves. I lived with one of the staff members and his family, cooking and 
eating with them. 
During an interview with Colin, a community mobiliser, he commented to me: 
Colin:... some of the educated women here, they are not as simple as you are. 
You really amazed me. 1'm proud of you. 
CM: What do you mean? 
Colin: You really... you don't stop amazing me every day. You know, you are my 
boss; you are a friend, despite your status and ... you are exposed, of course 
(to 
education), and... you can't wait to prepare food for me, I eat. You give me 
water, and you are this simple. 
The simple acts of providing him with a glass of water during the interview, and 
cooking a meal that he had been invited by my hosts to share with us, disrupted 
expectations about our social roles. Although Colin only refers explicitly to education, 
his remarks occur in a racialized context in which education can be seen as a proxy for 
wealth, privilege and a particular constellation of cultural markers. His sentiment - 
which occurred at the end of our interview - underscored the fact that my 
insider/outsider identity not only affected access and rapport, but was pervasive in 
shaping the production of dialogue between us. DeVault has suggested that qualitative 
researchers engage in a "sustained analysis of the structured organizing effects of 
ethnicity and gender in the stories we are told" (DeVault 1995: 628). The performance 
of stories about the MDP trial were no doubt tailored for me as a young, unmarried, 
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white, British, female researcher who partially represented the organisation, as I discuss 
further below. 
Interviewing at the intersections of difference 
In order to conduct interviews with trial participants and their partners in Zambia, I 
needed to work with someone who was fluent not only in the local languages (Nyanja, 
Tonga, Bemba and Lozi), but also in the language of the trial. The need for this dual 
competency, as well as a propensity for appropriate interview technique, suggested that 
someone who already worked locally on the trial social science team would be most 
appropriate. Although I considered the advantages of working with someone not 
associated with the trial - in particular, their greater neutrality towards the research 
topic - the need to maintain confidentiality about trial participants' identity and contact 
details meant that I opted for an existing team member. The choice of team member 
was largely dictated by the senior social scientist at the site, in consultation with the 
project manager and was based on staffing requirements during the period of my stay. 
Whilst this was not an ideal way to select a research assistant, it was part of the 
contingencies involved in working within the trial site. 
My research assistant, Michael, had been working for MDP Zambia for five years as a 
social science fieldworker29. He had been trained (partly by me) in social science 
research methods and had been conducting interviews with trial participants for a 
number of years. I was initially concerned about having a male research assistant given 
the nature of my enquiry into various aspects of gender relations, including power in 
sexual relationships. Two issues concerned me: firstly, the acceptability to respondents 
and the broader community of a man interviewing women on this sensitive subject; and 
secondly, the more fundamental issue of how accounts are produced within gendered 
relationships. 
29 Michael is a pseudonym, which I have used so preserve the anonymity of my research assistant, who 
was also a participant in this study. 
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On the first point, my concerns were allayed by talking to female staff at the site, who 
told me that women had had no problem being interviewed by a man, even when it 
came to sensitive topics such as sexual behaviour. Furthermore, in 2006, the social 
science team had conducted a feasibility study to assess how acceptable it was for 
women to be interviewed by men, concluding there were no barriers to this being 
instituted in their setting (Kalumbilo et al. 2006). 
On the second point, it is commonly assumed to be best practice for interviewers to be 
gender-matched, since rapport is deemed to be more easily created between members of 
the same sex. The issue of mixed-sex interviewing was important to consider, not only 
when it came to interviewing women, but also men and couples; how would the 
dynamics work? Would men feel comfortable talking to me as a woman? Williams and 
Heikes have challenged the assumption that gender-matching in interviews is the ideal, 
arguing instead that interviewers analyse how, not whether, gender makes a difference: 
Clearly, all interviews are gendered contexts, whether they are single-or mixed- 
sex. No Archimedean point exists outside the sex/gender system where 
"unbiased" interviews can be conducted; every understanding about the social 
word and social identity is necessarily and inevitably partial. (Williams and 
Heikes 1993: 290) 
In the end, I felt that having a male research assistant was no bad thing; with all of my 
Zambian informants - both male and female - the greatest marker of difference was not 
simply gender, but gender intersecting with "racial, class, ethnic, sexual and regional 
modalities of discursively constituted identities" (Butler 1990: 3). As I suggested above 
in relation to race and ethnicity, there were various markers of difference that were 
likely to frame the production of accounts in this study, and I did not presume that 
gender was the only or even most significant of these. Indeed, cultural theorists and 
anthropologists of gender have long exposed the fallacy of gender as a simple defining 
category (Moore 1988; Butler 1990; Ortner 1996); the presumption of separate 
gendered worlds that can only be accessed by same-sex interviewers essentializes 
`male' and `female' identities and masks a continuum of difference along multiple axes. 
As Falen notes, "the study of gender need not be a see-saw between male and female 
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emphasis, but must be an integrated approach to incorporating male, female (and 
perhaps additional) gendered perspectives" (Falen 2008: 167). A growing body of 
literature attests not only to the legitimacy but also the productivity of cross-gender 
research (see for example McKegany and Bloor 1991; Trevino 1992; Presser 2005; 
Berliner and Falen 2008). 
Schilt and Williams have suggested that reflexive dialogue between researchers about 
their positionality can strengthen enquiry within collaborative cross-gender research 
(Schilt and Williams 2008: 223). More broadly, Temple has also argued for the 
importance of debriefing sessions between researchers and interpreters to ascertain how 
their "intellectual biographies" are reflected in the data (Temple 2002). During the 
fieldwork, Michael and I had regular de-briefings to discuss how the interviews and 
focus groups had gone and whether and how gender dynamics had influenced the 
discussion. In some cases, this was obvious, for example when a female respondent 
would directly address Michael as a (male) gendered person, as in the following 
exchange: 
Respondent: When I say that, "this year there is no giving birth to a child' - 
even when you don't know that your wife got the (contraceptive) pill -I will be 
taking that pill until the year finishes. 
Michael: In secrecy? 
Respondent: Yes, because I can be taking it nicely in the kitchen. How are you 
going to know that I have taken a pill? Do you touch the mealie-meal [she 
mentioned earlier on that women hide their pills in the mealie-meal]? Okay let 
me ask you, do you like touching the mealie-meal bag? 
Michael: No 
Respondent: There is no difference which is there. With the pill, maybe you can 
say that when cooking you can take it; it is the same with gel. You caress and 
then you leave him in the mood and say, "I will be coming". "Where are you 
going? " "You just wait I will be coming, " then you go that side. 
Michael: You use? 
Respondent: Yes. Let me give you an example. Gel, I was inserting it in the 
toilet. He found me when I was just withdrawing the applicator. I just hid it in 
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my skirts and I came out and he asked me, "What are you holding? "I said, 
"Sweetie, I am holding my skirt, do you want it to drop? There are children 
here "... Wouldn't you believe me? 
Michael: Yes 
Respondent: You will believe, not so? 
In this exchange, the woman makes her point about gender relations with her husband 
by enacting the scenario with Michael. She directly confronts him on the topic of a 
woman's ability to act secretly around her husband, invoking norms of gendered space 
and the gendered division of labour (the discussion of mealie-meal pointing to women's 
ownership of food preparation and the spaces in which it is done). In this 
confrontation, Michael is put onto the back foot as a man, as the respondent inverts the 
interrogatory roles. 
On other occasions, the way in which our positionality affected the interview - and the 
way the interview affected us as gendered researchers - was less overt. For example, 
Michael confided to me, both informally and when I asked him subsequently in an 
interview, that hearing women talk about men as `difficult' had made him question his 
own male identity and behaviour: 
So I was asking myself questions - what else (in what other ways) do I think I'm 
not like these men (that women talk about in our interviews), but I am 
them?... You know, I was asking myself, and it's because of the same term, 'men 
are difficult, men are difficult. 'I said, "O1, I'm also being difficult [chuckling], 
I'm also being difficult ".... 
I kept a daily and weekly fieldwork diary in which I also reflected on these issues, as 
well as cogitating more critically on my own position in memos when I went back to the 
data. Through discussing these issues regularly during the fieldwork, it was possible to 
incorporate gender into the fabric of the interviews; had it not been acknowledged, or 
had we tried to erase the `bias', this additional layer of analytical depth would have been 
lost. 
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Focus group discussions presented similar issues, except that through them, in 
particular, I wished to access the normative production of gender identities in 
commonly occurring social groupings. In many cases, such groupings were all-male or 
all-female, reflecting the gendered division of labour in the community30. In the focus 
groups with men, then, I had to debate whether or not to be present if I wanted to mimic 
the social construct of male-only talk. Since I was reluctant to relinquish input into the 
discussion, I decided that the benefits of being able to observe the group and direct the 
discussion outweighed any loss of `naturalism' that might occur. As with all the data, I 
recognised my role in co-producing men's accounts in this set-up, and have reflected 
upon this in the findings. 
For the female focus groups, I decided to facilitate with two female research assistants 
(one older, one younger), who, like Michael, had been working on the project for a 
number of years. Of course, the identities of the female research assistants remained 
important in producing the type of discussion that was had; the younger of the two, who 
facilitated the focus group with women under 30, was heavily pregnant. Early on in the 
discussion, as the talk turned to marriage, this - and the fact that neither of us was 
married - became a pivotal interactional moment, as the following brief extract 
illustrates: 
CM. - Are they all married? 
Research assistant: Are you all married? You, you, you and you, are you 
married? 
All: [Laughter] Yes, we are all married. 
Research Assistant: [To CM] They are all married, that only leaves you and me. 
[To the group] Catherine and 1 are single. 
Participant: What about this [pointing to research assistant's pregnant belly]?! 
Research assistant: Me? 1 am engaged. 
All: [Laughter] 
Research assistant: You try this and that. 
30 For example, it was common to find women talking together in groups and attending women-only 
events, such as kitchen parties, while men went off to seek paid labour. A kitchen party is an event 
thrown for a bride-to-be shortly before she gets married. It is attended by women only and consists of 
pre-marital rites of passage, as well'as eating, drinking, singing, dancing, and the giving of kitchenware 
utensils. For a full discussion of the social and symbolic function of kitchen parties, see (Rasing 2001). 
70 
All: [Laughter] 
This exchange not only indicated normative views about pregnancy outside marriage, 
but made evident the fact that even amongst an all-female group from the same 
community, multiple axes of difference shaped the production of the data. Although I 
cannot know how accounts would have been forged with a different set of facilitators, I 
have analysed the data with an awareness of the positions from which we all spoke as 
participants in the research (DeVault 1995). 
Working across languages 
Fortunately, the majority of my interviews were with English speakers, enabling me to 
conduct the interviews myself, as well as transcribe them. Interviews and focus groups 
in Zambia with trial participants, their partners, and local community men could not be 
conducted in English, and required someone to interpret. There are various models for 
collecting data through the use of interpreters (Pool 1994; Esposito 2001; Adamson and 
Donovan 2002; Temple 2002); Michael, my research assistant, was involved in multiple 
aspects of the study, including arranging interviews, helping to decide on the suitability 
of questions and interpreting respondents' accounts. Working together involved a two- 
way exchange of knowledge, skills and competencies, as described by Maynard-Tucker 
(2000); I worked to develop his research skills and knowledge of the research area, 
whilst he worked to develop my understanding of local language and culture. Rather 
than seeing his work as neutrally conveying informants' accounts through the exchange 
of words between languages, I proceeded on the assumption that both of us were active 
producers in the research process (Pool 1994). We spent a lot of time discussing the 
meaning of key terms and concepts, and how they might be translated and interpreted in 
different contexts. 
Following training on the goals of the research and research methods, I initially decided 
that Michael should conduct the interviews himself, with me sitting in and observing. I 
made this decision on the basis of previous experience in Mozambique, when 
conducting interviews through real-time interpretation had led to disastrous interview 
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data. However, after reading the first couple of transcripts of Michael's interviews, I 
felt equally frustrated at my inability to direct the process of data collection and follow 
up on interesting leads. As Esposito notes, "optimally during the data collection 
process, the researcher processes the meaning of the participant's comments and is able 
to adjust questions and comments in response to unanticipated answers" (Esposito 2001: 
573). As such, we agreed on a third way -a hybrid form of interpretation that allowed 
both of us some flexibility to direct the course of the interview with the participant. 
This involved me asking the questions, Michael interpreting into the participant's 
language, letting the conversation evolve to a `natural' break, and then him interpreting 
back into English. If he felt it appropriate to probe and ask follow-up questions, he 
could so; what I got back in English was not a nuanced word-for-word translation, but 
more of a summary covering the main points and meaning of what the participant had 
said. This allowed me to pursue interesting leads and get clarification on any issues that 
weren't fully explored or developed. The natural rhythm of the interview was 
maintained as far as possible and I could also judge the content of the interpretation to 
some extent based on the non-verbal responses of the participant. 
All of the interviews and focus groups were digitally recorded. Michael transcribed the 
interviews directly into English on an ongoing basis and we discussed each one together 
to clarify the meaning of the interpretation. The transcriptions consisted of translated 
questions and answers that had taken part in the vernacular, my English questions, his 
English interpretations, any discussion between us in English, and any discussion that 
he had with the participants in the vernacular. This made some of the indeterminacies 
and the evolution of the interpretative process evident; as Pool notes in his reflexive 
examination of ethnographic meaning-making, the researcher can never attain the final 
interpretation of what his or her informants `really' mean, "because there is no final 
interpretation. Meaning in texts (and in the events which generate them) is recursive; it 
depends on the meaning of what has preceded it and it may lead to a revision of earlier 
interpretations" (Pool 1994: 52). 
Where there was significant ambiguity over key terms - such as `power', `control', or 
different types of relationships -I asked for sections to be transcribed into the 
vernacular. This then provided the basis for further interrogation of the terms, and 
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comparison of use and meaning across different respondents. We frequently went back 
and listened to the audio recordings to tease out the way in which participants had used 
particular terms or turns of phrase. Because of the language barrier, I was not able to 
access participants' own words, an impediment that necessarily limited the depth of 
analysis; as Esposito has observed with translated interview data, "analysis and 
interpretation are accomplished as one would analyze and interpret a silhouette" 
(Esposito 2001: 576). Nonetheless, through the steps described above, I tried to ensure 
the rigour of the interpretative process and to access as much meaning - verbal, non- 
verbal and textual - as possible. 
Analysis 
Following the Foucauldian concepts outlined in the previous chapter, my analysis 
focused on the production and regulation of identities through discourse, as well as the 
discursive production of power/knowledge. Various methods have been suggested for 
such an analytical concern, including narrative analysis, content analysis and grounded 
theory (Clarke 2005: 155). Since I was not interested theoretically in the `stories' in my 
data (indeed, I did not use life stories or oral history in this study), I did not feel that 
narrative analysis was appropriate. Nor was I primarily interested in producing 
summaries and typologies of recurring themes in respondents' accounts; a thematic 
content analysis would not have answered questions about the circulation of power 
through discourse. Although grounded theory has been criticised for not taking power 
into account at the micro and macro levels, Charmaz has convincingly argued that "the 
method does not preclude attending to power... Merely because earlier authors did not 
address power or macro forces does not mean that grounded theory methods cannot" 
(Charmaz 2006: 134). 
Although grounded theory, as outlined by its originators, provides some useful 
techniques for qualitative data analysis, its positivist assumptions - for example that 
social theory can be `discovered' from the data, `uncontaminated' by the analyst - make 
it problematic for this research. Various writers have suggested how grounded theory 
can be used in ways that dislodge it from its positivist roots (for example Hall and 
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Callery 2001; Clarke 2003; Clarke 2005; Charmaz 2006). Aligning grounded theory 
with the constructivist paradigm, Charmaz has proposed that "we are part of the world 
we study and the data we collect. We construct our grounded theories through our past 
and present involvements and interactions with people, perspectives, and research 
practices" (Charmaz 2006: 10). In this study, I tried to follow her vision of a reflexive, 
constructivist grounded theory that digs deep into the empirical while building "analytic 
structures that reach up to the hypothetical" (Charmaz 2006: 151). 
In order to help manage my textual data, I used the qualitative data analysis software 
(QDAS) Nvivo version 2.0. The use of QDAS has become ubiquitous in qualitative 
research and its advantages well documented (see for example Richards and Richards 
1994; Bazeley 2007; di Gregorio and Davidson 2008). However, methodological 
concerns have also been raised about the use of such software, for example that it might 
alienate the researcher from their data and that the computer might `take over the 
analysis' (Seidel 1991; Kelle and Laurie 1995). Kelle has provided a useful and critical 
analysis of some of these issues, particularly as they relate to theory building, 
concluding that "we should address these programs as software for `data administration 
and archiving' rather than as tools for `data analysis"' (Kelle and Laurie 1995: 14). 
This is the approach I have taken in the current study, drawing most benefit from the 
ability to code, index, and retrieve textual data systematically whilst travelling across 
multiple locations (the analytic process spanned work spaces from my flat in London, to 
guest houses, conference rooms and offices across several African countries). 
As should be clear from the description of the interview processes above, analysis ran 
parallel to data collection, in the manner suggested by Glaser and Strauss (Glaser and 
Strauss 1967). Glaser and Strauss describe a method of moving backwards and 
forwards between emerging theory and data collection, and constant comparison across 
codes and cases in the data. In this study, I started coding as soon as I had conducted 
the first interviews, transcribed them and imported them into Nvivo. I followed an 
initial process of line by line coding within individual interviews, `fracturing' the data - 
that is, opening them up analytically and developing provisional categories. I also 
started writing memos at this early stage, cycling memo-writing with coding to maintain 
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what Charmaz refers to as `analytic momentum' (Charmaz 2006). The memos fell 
broadly into four types (in practice, there was overlap between these areas): 
 A coding journal, kept continuously, detailing initial impressions and insights 
into the data 
  Methodological memos, describing key decisions taken about theoretical 
sampling, the coding scheme, etc 
  Thematic memos, describing phenomena participants referred to in their 
accounts, for example, rumour typologies 
  Conceptual memos, exploring the dimensions of different categories, their 
analytic properties, and their occurrence across cases. 
On the basis of detailed line by line coding in the early interviews, I developed a coding 
scheme which I used to undertake focused coding of subsequent data. This iterative 
process involved testing the adequacy of categories against the data (constantly turning 
between codes and data) and then of moving between cases (comparing data to data). 
This was a particularly important part of the analysis given the multi-sited nature of my 
data and the range of participants included in the study. 
Although grounded theory also describes the use of axial coding to relate categories to 
subcategories, I did not feel that applying a detailed scheme in the manner suggested by 
Strauss and Corbin would add to the analysis (Strauss and Corbin 1998). As Charmaz 
has suggested, "students who prefer to work with a preset structure will welcome 
having a frame. Those who prefer simple, flexible guidelines - and can tolerate 
ambiguity - do not need to do axial coding" (Charmaz 2006: 61)31. I used memos and 
diagrams to explore the relationships between categories and to interrogate the context, 
conditions and consequences of their occurrence. Through theoretical sampling, I was 
able to take these categories out into the field to collect additional data that would 
elaborate and refine them, checking my `grounded theories' as I went. For example, 
some way into the research, one of my key informants recounted how PRO 2000 was 
31 Charmaz goes further to cast doubt on the utility of axial coding, suggesting that the overlay of an 
analytic scheme on the data may limit the analysis: "... relying on axial coding may limit what and how 
researchers lean about their studied worlds and, thus, restricts the codes they construct" (Charmaz 2006: 
62). 
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just as likely to prevent HIV infection in men as in women. He identified the silencing 
of bidirectional protection as a political device to further investment in the development 
of microbicides. At this point, I was able both to go back to previous data and explore 
rhetorical strategies for investment, and probe subsequent informants about the 
silencing of bidirectional protection. Referring to Foucault's work on the incitement to 
discourse and discursive absences, I was able to see how this might fit into a broader 
theoretical scheme of knowledge/power relations. 
Green has argued that "the key to developing rigorous and valid theory using the 
constant comparative method is the search for deviant cases" (Green 1998: 1065). 
Whilst remaining vigilant to `deviant cases' in my data, I also purposively sampled key 
informants beyond those who worked on the MDP trial, including others who worked in 
advocacy, pharmaceuticals and government. The goal of doing this was to see whether 
the theory I had constructed about microbicides development in the UK stood up in the 
light of non-MDP accounts. I also used public forums and information in the public 
domain to `sound out' hypotheses; for example, on a public advocates' teleconference 
entitled "Microbicides: the Herstory of a Movement"32, I asked the speakers about the 
potential for bidirectional protection. This context allowed me to stage a `live 
experiment' to see a) whether the silencing of bi-directionality was enacted in practice 
(as put forward by one of my scientist key informants, see above) and b) whether it was 
a category with analytical purchase beyond the scientific community. This approach 
was in keeping both with Glaser & Strauss's call to `verify' emerging theory and with 
constructivist emphases on the role of the researcher in constructing both data and 
theory. 
From principlism to performativity: Ethics and method 
Law and Urry have compellingly argued that research methods are performative in that 
"they have effects; they make differences; they enact realities; and they can help to 
32 This was a public teleconference organised jointly by the International Rectal Microbicides Advocates 
(IRMA) and the Global Campaign for Microbicides (GCM), "Microbicides: The Herstory of a 
Movement". The teleconference was held on 11/06/09 and was open for anyone to join around the globe. 
A recording of the teleconference was made publicly available shortly after the call at 
http"//www rectalmicrobicides. ora/teleconf. aha. 
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bring into being what they also discover" (Law and Urry 2003: 3). As such, research 
methods are not innocent, but political, since "they help to make realities" (Law and 
Urry 2003: 10). This so-called `ontological politics' demands that we think about 
which realities we want to make more real and how we interfere as we do our research 
(since interference is inevitable). There is an obvious ethical dimension to these 
questions, a dimension of research ethics that has been debated in the academic 
literature (see for example Parker 2007), but has not come to concern research ethics 
committees. The latter - at least within the institutional bounds of biomedicine - are 
primarily concerned with applying universal principles of autonomy, non-maleficence, 
beneficence and justice, which were formalised following the Nuremberg Code and the 
Declaration of Helsinki (see Beauchamp and Childress 1994). As a purely non-medical 
piece of social research institutionally based in a school of public health and conducted 
across territorial boundaries, this study traversed multiple ethical landscapes. Below I 
describe the journey through principlism and performativity33. 
Interviews with MDP staff members and key stakeholders in the UK all took place in a 
work setting, usually the respondent's own. In Zambia, I had wanted to interview 
participants (non-staff members) in their own homes or at a place of their choosing (e. g. 
a neighbour or relative's house). This was partly to dissociate myself from the medical 
and institutional setting of the trial and partly so that participants might feel more 
empowered by being in their own environment (Green and Hart 1999). According to 
the reimbursement structure of the trial, which I was obliged to follow on ethical 
grounds, participants only received money for coming to the trial site and not for 
appointments in their own homes. This was because the money had been designated as 
reimbursement for travel expenses and was not to be (or be seen to be) an enticement to 
participate. As a result, many of those I invited for interview insisted on coming to the 
trial site, usually under the pretext that they had other business nearby or would be 
passing anyway. From their experience of participating in the trial, the reimbursement 
system was well known to them, and the way for them to exercise power in the research 
encounter was in collecting money for their participation. Whereas textbook ethics 
guidance both limits the terms of reimbursement and posits research participants as 
33 This research was approved in the UK by the London School of Hygiene & Tropical Medicine Ethics 
Committee. In Zambia, it was approved by the University of Zambia Biomedical Research Ethics 
Committee. 
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disempowered altruists, respondents in my study were frustrated by these assumptions, 
which they readily overturned. The ethical landscape in this instance meant that much 
of the data was collected in a sterile office environment with a desk and office 
paraphernalia separating myself and my research assistant from the participants. This 
context doubtless affected the creation of respondents' accounts, particularly since 
many of the questions concerned their relationship to the trial. 
Written informed consent was obtained from all participants prior to interviews and 
focus groups, as well as verbal consent as the digital recording started. Whilst there is 
almost universal agreement in health research of the need for informed consent, the 
nature of the process has been criticised in various ways. For example, Corrigan has 
referred to the implementation of informed consent within a bioethical framework as 
"empty ethics" and an ethical panacea (Corrigan 2003), a position echoed by numerous 
others (Wolpe 1998; Strathern 2000; Fisher 2007). The critique of informed consent 
within the social sciences has emerged on several fronts. Some authors have suggested 
that informed consent overplays the risks involved in qualitative studies and 
unnecessarily subjects social research to biomedical review (Kent et al. 2002). Others 
object to `anticipatory' informed consent on the basis that it is often not possible in 
social research to predict at the outset what the questions and outcomes will be 
(Strathem 2000; Miller and Bell 2002)34. In the current study, a two-page information 
sheet was required to communicate all of the information deemed necessary for 
prospective participants to make an informed decision to take part. Although I made 
every effort to deliver this information in the most appropriate way possible for all 
participants35, almost all participants seemed to find it a more burdensome part of the 
research process than the interview itself. 
In the UK, leading scientists didn't want to be bothered with informed consent, because 
they didn't have time and seemed confident that they were the ones in a position of 
power over me and not vice versa. In Zambia, women and men from the compounds 
were troubled by the fact that they had to sign and verbally agree to the interview when 
34 For an overview of these and other critiques, see Moulton and Parker 2007). 
" For example, in the UK, I emailed the information sheet to prospective key informants and tried to 
summarise it succinctly when we met in person; in Zambia, information sheets were translated into both 
Nyanja and Tonga and the information relayed orally. Again, participants were given the information in 
advance to take home and read, and were encouraged to ask questions when they came for the interview. 
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all I was interested in doing was talking to them for an hour or so about their 
experiences of taking part in the microbicide trial and analysing this for a scientific 
study. Furthermore, having agreed to participate, and ticked and signed that they were 
happy to do an interview, be quoted etc. they were then presented with a box asking 
them to tick if they did not want to be included in any of the analyses (see Appendix 2). 
This box had been specified by the ethics committee in the UK as an extra safeguard for 
participants. What it did in practice was confuse participants, substantially lengthen the 
explanations required, and ultimately lead them to ridicule the consent process once it 
had been clarified. 
I was aware that the enactment of research ethics though these principle-led formalities 
was at once creating a reality that I did not wish to authorise and simultaneously 
diverting my attention from more salient ethical concerns. These, for me, included 
reproducing potentially exploitative power relations through the research with 
informants in Zambia, and negotiating potential conflicts of interest with `elite' 
informants in the UK. On the first point, I introduced myself as a student to my 
informants, indicating that whilst I had a professional role on the trial, it was not within 
this capacity that I was interviewing them. In addition to foregrounding my own status 
as a learner, I actively approached my informants as experts, indicating to them that 
their participation in the trial and use of the gel gave them fluency in a particular 
knowledge system that I could only access through their accounts. This is a position 
adopted by numerous researchers working with disenfranchised groups, for example 
Moore in her research on the technologies of safer sex amongst sex workers (Moore 
1997) and Salmon in her work amongst young Aboriginal mothers (Salmon 2007). The 
interviews were very much geared around their responses to open questions, such that 
their constructions of the research enterprise were privileged over my own. Although I 
initially came with an interest in women's `empowerment', I did not presume that 
women were powerless victims and did not treat them as such. Likewise, in interviews 
with male partners, I was careful not to reproduce prevailing assumptions about men 
and masculinity, which may have reinforced negative stereotypes of men as sexual 
predators or breadwinners. 
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In the UK, my main concern was a potential conflict of interest between my allegiance 
to the trial and my colleagues, and producing a critical piece of research guided by 
sound data. Being a part of the phenomenon I was studying in this way presented one 
of the greatest ethical challenges, and one that has arisen for others in similar settings; 
for example, May, in a study of the politics of evidence-making in health technology 
assessment writes, "there can be no pretence of my being present in any of these 
contexts as a neutral observer. Instead, I was (and continue to be) embedded in the 
institutional trajectories discussed in this paper, sometimes in contradictory ways" (May 
2006: 518). Throughout the research process - from interviews to analysis and writing 
-I have been mindful of my position within the trial and, appropriating Collins, have 
used "philosophical scepticism, which is safe, legal and inexpensive, to loosen the 
trammels of commonsense perception" (Collins 1985: 6). That I attempted an 
`ecological' analysis of the trial, interviewing not only colleagues from my own social 
world, but actors from the diverse worlds of advocacy, politics, pharmaceuticals and 
`the lay public', has both contributed to and necessarily drawn upon this scepticism. 
Nonetheless, my research remains a constructed and partial account - to paraphrase 
Latour and Woolgar -a constructed fiction about fiction construction (Latour and 
Woolgar 1986: 282). 
Summary 
In this chapter I have outlined some of the methodological issues I negotiated in 
studying the co-production of gender and technology through the case study of the 
Microbicides Development Programme. Following Law (2004) and others, I have 
argued that methods are constitutive of, rather than simply reflective of, social reality, 
and that I, my research assistants and participants actively co-produced the accounts and 
analysis in this study. By providing an explicit discussion of `the things we carried 
with us' and the decisions taken about sampling, translation, ethics and analysis, I have 
aimed to make visible the "sticks and strings and glue from which the ships of 
knowledge are built" in this thesis (Collins 1985: 6). In the past decade, science and 
technology studies has begun to focus on the fluidity of technological objects and the 
spatiality of technoscience across geographical and cultural locations. In this chapter I 
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have discussed the need - both theoretically and practically - to follow science across 
its sites of practice. Multi-sited clinical trials are confined neither within geographic 
nor within disciplinary boundaries, traversing countries, institutions, and ('lay' and 
`professional') communities. As such, this study of (only aspects) of (only one) multi- 
sited clinical trial is also not confined within geographic and disciplinary boundaries. 
Whilst adopting the normative style of social research in public health, I have also 
suggested the limitations to this approach, using insights from STS as a foil to 
methodological givens. 
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Chapter Four 
Microbicides: The Co-production of Gender and Technology 
It is at the point of emergence, before things are completely stabilized or black- 
boxed, that one most easily observes the mutual uptake of the social and the 
natural... Important normative choices get made during the phase of emergence; 
in the resolution of conflicts; the classification of scientific and social objects; 
the standardization of technological practices; and the uptake of knowledge in 
different cultural contexts. (Jasanoff 2006: 278) 
In this chapter I will use the idiom of co-production36 (Jasanoff 2006) to examine the 
construction of microbicides as an empowering `woman-controlled technology', and the 
simultaneous production of gender in the social, scientific and political arenas. To do 
this, I will take the example of one specific candidate product, PRO 2000, and explore 
how it came to be developed by networks of actors from diverse social worlds working 
in a specific historical context. Following work in science and technology studies 
which has challenged the assumption that science operates independently of other forms 
of social activity (Collins 1985; Bijker et al. 1987; Clarke and Fujimara 1992; Gieryn 
1999), 1 will discuss how scientific practice is intimately bound up with prevailing 
social norms and political agendas, or as Jasanoff puts it, how "the realities of human 
experience emerge as the joint achievements of scientific, technical and social 
enterprise: science and society, in a word, are co-produced, each underwriting the 
other's existence" (Jasanoff 2006: 17). 
The basis of this chapter is interview data from eleven key informants who have been 
central to the development and testing of PRO 2000, as well as secondary material from 
other sources, such as advocacy materials and minutes from House of Commons 
debates. The key informants include an investigator and two chief investigators of the 
MDP301 trial; coordinators of the various disciplinary groups involved in the trial 
(statistics, social science, community liaison, social marketing, communications); the 
36 In essence, co-production is defined quite simply as "the simultaneous production of knowledge and 
social order" (Jasanoff 1996: 393). For a fuller discussion of the idiom of co-production, see (Jasanoff 2006). 
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pharmaceutical partner; and representatives of government and international advocacy. 
The interviews took place between October 2007 and June 2009 in London and at an 
Investigators Meeting in Mozambique. The majority of the interviews were conducted 
roughly in the middle of the phase III clinical trial of PRO 2000, which started enrolling 
in October 2005 and completed follow up in August 2009. During the interviews, I 
asked both about the historical development of PRO 2000 and the current research 
which aimed to bring PRO 2000 to licensure. Therefore, although the technology had 
already been produced to some extent, it was by no means fixed or stable, and my aim 
was to interrogate the ongoing stabilisation of PRO 2000, in line with Latour's first rule 
of method: "We study science in action and not ready made science or technology; to do 
so, we either arrive before the facts and machines are blackboxed or we follow the 
controversies that reopen them" (Latour 1987: 258). 
Microbicides in historical context 
So it was a particular window, we were there at a particular time, with a clear 
vision of where we would go and with products to test that looked plausible. And 
so, you know, the whole thing was of a time. (Harry, clinical professor and 
MDP investigator) 
In the field of HIV prevention, microbicides are now a given. However, it is only in the 
past two decades that the 'NPTs' - `New Prevention Technologies', such as 
microbicides, pre- and post-exposure prophylaxis and vaccines - have emerged as 
objects of enquiry. Posited as a woman-controlled or initiated form of HIV prevention, 
microbicides are also commonly referred to as a tool for women's empowerment. On its 
website, the Microbicides Development Programme provides the following definition: 
"A microbicide is an HIV-prevention method specifically for women"37 , and typifying 
the discourse on microbicides, the World Health Organization (WHO) focuses on three 
key facets of this new technology: power, protection, and women's independence: 
37 fittl2: //www, md2, mrc, ac. uk/what. html , accessed 18/03/2009. 
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The availability of microbicides would greatly empower women to protect 
themselves and their partners. Unlike male or female condoms, microbicides are 
a potential preventive option that women can easily control and do not require 
the cooperation, consent or even knowledge of the partner. (World Health 
Organization 2009b) 
So pervasive is discussion of women's empowerment from all quarters - not only 
advocates, but also scientists, government and the media, to name but a few - that the 
fact that this is a pharmaceutical product almost gets overlooked. 
The idea that a pharmaceutical product could not only address physical and biological 
problems but also confront social ailments is not new; however, the social remedies of 
pharmaceutical products tend to be seen as secondary or collateral benefits, and have 
not usually been proposed as a solution to structural inequalities. With microbicides, 
the social and the biological have been fused, and pre-clinical and clinical development 
have come to depend on the notion of women's empowerment. In some respects this 
may seem unsurprising, given the widely held notion that HIV is a social disease that 
requires intervention not only at the level of individual behaviour, but also at the 
structural level (Kelly 1999; Parker et al. 2000; Sumartojo et al. 2000; Weismayer et al. 
2003; Fenton 2004; Pronyk et al. 2006; Gillespie et al. 2007). Poverty and inequality in 
various forms, but especially in terms of gender inequality, are recognised as key to the 
spread of HIV (Garcia-Moreno and Watts 2000; Rao Gupta 2002; Pronyk et al. 2006) 
and change at this most fundamental level is seen as a pre-requisite for the long-term 
control of the epidemic. 
Although there is now apparent coherence in the microbicides field about common 
goals and hopes for a product, with these hopes turning around women's protection and 
empowerment, the various actors who brought PRO 2000 to the testing arena initially 
came with a range of agendas and ideas for development. As others have noted, 
scientific production is heterogeneous, but "at the same time, science requires 
cooperation - to create common understandings, to ensure reliability across domains 
and to gather information which retains its integrity across time, space and local 
contingencies" (Star and Griesemer 1989: 387). In 1990 microbicides did not yet exist; 
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by the year 2000 PRO 2000 had entered clinical testing and by 2010, approximately 
10,000 women had used the technology in the MDP 301 trial. As I will describe below, 
the successful development of this new technology was a result of diffuse networks of 
expertise, which created a new knowledge field and garnered political support - both 
ideological and financial - for microbicides. Drawing on a Foucauldian concept of 
power relations, which emphasises the historical specificity of productive forms of 
power, I explore below the conditions of production of new knowledge on microbicides. 
From individual to committee: The composition of expertise in forming a 
new field 
Following the `discovery' of HIV in 1984, hopes were high that a vaccine would be 
found within a couple of years (Hilleman 1995). However, the challenge proved greater 
than anticipated and ambitions to develop a successful vaccine within just a few years 
were dashed by a slew of disappointments in the field. As one senior researcher 
recounts, "I spent the period '91 - '06 really out of vaccine work, working exclusively 
on drug development. And in that time, I'd done some vaccine work which had been 
massively disappointing, and it was pretty bloody clear in the mid '90s that there wasn't 
going to be a vaccine any time soon" (Harry). As such, the search for other means to 
reduce the spread of the epidemic became ever more pressing, with public recognition 
by key players that a vaccine was not imminent (Butler 1995; Horton 2003). Adrian 
told me how in 1990, as head of the Medical Research Council (MRC) AIDS 
Secretariat, he had started to pursue the question of whether Nonyxnol-9 (N-9), a 
licensed spermicide, could protect sex workers from HIV. Following a meeting of the 
Expert Group on AIDS, run by the UK Department of Health, the conclusion was that 
not enough was known about N-9 and Adrian decided more research was needed. At 
this stage, discourse centred on the general reduction of HIV, and focused on women 
only in as much as female sex workers were considered a `core group' spreading 
infection to the general population38. Adrian: `I thought and thought about it and 1 
32 Schiller et al have provided a pertinent critique of the cultural construction of AIDS risk groups, noting how "the study of the transmission of 1-IIV in social behaviour became the study of behaviour of members of 'risk groups'", and thus obscured the complexity of the epidemic (Schiller et al. 1994: 1338). This has 
85 
said, this seems like such an obvious idea, it may be difficult but... it may be difficult, but 
um it may be a lot more easier sooner than we'll have a vaccine and the sooner you get 
something even imperfect to deal with this epidemic, the better the overall impact will 
be. " Disillusionment with vaccine development was also the stimulus for others 
working in HIV prevention to turn their attention to novel applications of newly 
characterised compounds that showed antiretroviral activity. 
Adrian presented himself as instrumental in getting what he first called "virucides" onto 
the scientific research and funding agendas. In 1990 he put a paper in to the MRC 
Directed Programmes Steering Committee, the MRC committee responsible for 
working on HIV vaccines and new therapeutic drugs, which had a ringmarked budget. 
He `felt pretty certain they wouldn't like the idea"; when I asked why he said 
bemusedly "Well because it wasn't scientific, you know, [chuckling] it was, you didn't 
need to know immunology, you didn't need to know anything, you just were looking for 
something which would kill the virus". Virucides, then, were considered something of a 
blunt tool for a sophisticated job, and even `non-science' relative to vaccines. Because 
of this, a lot of boundary work39 was required to move virucides forward in the 
scientific world, and as I discuss below, this arguably contributed to the trajectory of 
their development as a `woman-controlled' technology. 
Ellen, a leading international advocate for women's prevention options, likewise 
recounted a story in which microbicides were seen as the poor cousin of vaccines - in 
her words, as "non-sexy science ": 
I definitely had scientists who said to me, "well, no one's gonna get a Nobel 
Prize by making a... (microbicide) ". Everyone is motivated in science by, you 
know, the aspiration to make this huge contribution.., in the early days, 
especially, the science of microbicides was very pooh-poohed and... people 
called it 'jams and jellies "... it didn't garner the same attraction, it didn't 
garner the same prestige (as vaccines). 
been echoed elsewhere (Ellison et al. 2003), with some feminist critics identifying biomedically-defined 
taxonomies of risk as perpetuating phallocentric interests (Patton 1994; Waldby 1996). 
"1 use boundary work to refer here to the rhetorical and institutional demarcating of science from non- 
science. See (Gieryn 1983; Gieryn 1999). 
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Ellen came from the field of women's health activism and spearheaded microbicides 
advocacy, initially in the United States. Whilst Adrian and the other scientists I 
interviewed were developing microbicides in the UK, parallel work was being 
undertaken in the US. Ellen indicated that the context in which microbicides emerged 
onto political and scientific agendas was likely to have differed between these different 
socio-cultural and political settings; so whilst the response to microbicides in the global 
scientific discourse was similar, the socio-political discourse may not have been. 
In the UK, in spite of what Adrian described as the ambivalence of the Directed 
Programmes Steering Committee towards his virucide strategy, the fact that it got 
minuted in the meeting with them enabled him to set up a committee to explore the 
concept in more detail. Following three meetings of this group, which included 
"British, Belgian and US people who 'd been involved in this field very sporadically; 
they were all little groups working in isolation really, and not getting anywhere ", 
Adrian wrote again to the board recommending the urgent institution of a Virucides 
Steering Committee to develop further programmes. The board agreed; as to why, he 
said, "Well, the fact that we'd had these three meetings of a group of experts and 
basically the consensus was yes, let's do it. So it wasn't just me any longer ". The 
transformation of sporadically-involved, underachieving academics into a network of 
"experts" was key to legitimising microbicides as a field of study, a legitimacy that 
gained further authority through the institution of a committee. 
The Virucide Steering Committee sat between 1993 and 2004. Members of the 
committee came from a wide array of disciplines, with new scientists asked to join on 
an ad hoc basis; as one member of the committee described: 
It had a mixed sort of group of people on it, there were social scientists, there 
were laboratory scientists, there were clinical trial specialists, there were 
people bringing an ethical perspective as well... it expanded over lime with new 
people being brought in. It was finding its way, as it were, because it was a new 
area and it was just, if there was somebody who we thought could contribute, 
then they would be asked to join the committee. So it grew in that way. 
(Dominic, statistician) 
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In spite of the multi-disciplinary composition of the committee, there were reportedly 
significant gaps in certain knowledge areas. Adrian recalled that one particularly 
pertinent omission from the committee's expertise was semen: 
So it struck me that sexual transmission of HIV always occurs in the presence of 
semen. And we had nobody on there - it took me a year to realise this - nobody 
on there knew anything about semen. So I found a very good guy from the MRC 
Reproductive Biology Unit in Edinburgh who came to some of our meetings, he 
gave us lectures on human seminology. And none of us around that table knew 
anything about it. We knew all about HIV; we knew nothing about seminology. 
This moment of realisation is important because it highlights the way in which HIV 
transmission was conceived along biologically sexed lines, removed from the context of 
the sexual relationship, and how, historically, scientific expertise has been highly 
compartmentalised. The juxtaposition "we knew all... we knew nothing" encapsulates 
the nature of expertise on HIV. The history of focusing on subgroups at risk for AIDS 
(as designated by the Centers for Disease Control in the first decade of the epidemic) 
and the ensuing `hierarchy of exposure' led scientists to focus on group characteristics, 
such as sex and sexual orientation, rather than on the fact that it is the exchange of blood 
and semen that transmits the virus. By focusing on women (sex workers, in the first 
instance) as the `risk group', the context of HIV transmission - i. e. the transfer of semen 
between man and woman during intercourse - was overlooked. By his own admission, 
it took Adrian, an expert in his field, many years to grasp the significance of this and a 
year to realise that nobody on the Virucide Steering Committee knew anything about 
semen. 
From national to international: The International 'Working Group on 
Microbicides 
From the word go, political support was sought for microbicide development, and this 
became the linchpin of progress, thanks to the funds it made available. Adrian reported 
that even before the Virucide Steering Committee was set up, he had included a 
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paragraph on virucides in his annual report to government detailing how AIDS money 
was being spent. Although he suspected this would get cut out, "it got laundered 
through the various superior committees" and the Secretary of State for Health 
reportedly responded, "This is a very exciting new idea! I look forward to hearing 
about progress next year". By approaching existing contacts at the Overseas 
Development Administration (ODA)40 and the Department of Health, Adrian secured 
new funds with which to set up three laboratories to screen compounds and host a 
meeting in Geneva aimed at improving international coordination. This, in conjunction 
with a paper published in AIDS, which also called for more coordination, led to another 
committee being set up - the International Working Group on Microbicides. Amongst 
the members of the committee were senior representatives of the MRC, the National 
Institutes of Health (NIH), and the Institute of Tropical Medicine in Antwerp; David 
Fible, then head of antivirals at the FDA in Washington, was the first chairman. 
Between 1994 and 2008, the International Working Group sought to ensure closer 
coordination of microbicide research programs and to establish consensus on pertinent 
issues, such as requirements for pre-clinical and clinical testing and criteria for selecting 
promising leads for evaluation. The Global Campaign for Microbicides (GCM), an 
international coalition of NGOs spearheading microbicides advocacy, reported that "it 
serves as a mechanism for the independent/neutral assessment of significant issues by 
some of the most experienced and knowledgeable individuals in the field" (Global 
Campaign for Microbicides 2007). The endorsement of this high-level scientific 
committee by advocates and activists was mutually beneficial; for the researchers, it 
cemented their public commitment to the cause of women's empowerment and opened 
the door to potential funding opportunities; for advocates, it lent a degree of legitimacy, 
transferred from the ontologically privileged site of scientific knowledge. The fact that 
the Working Group was declared to provide independent and neutral assessment from 
an expert base helped to unify the field and solder cooperation between the social 
worlds of advocacy and science. 
40 The ODA later became the Department for International Development (DFID). 
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The medicalisation of powerlessness and its remedy 
PRO 2000, the candidate microbicide that was taken forward into the MDP phase III 
trial, was initially developed by a company called Procept in the United States. 
Although this company was subsequently taken over by Indevus Pharmaceuticals, and 
Indevus was taken over by Endo Pharmaceuticals in 2009, PRO 2000 bears the 
biographical stamp of the original developers. As Neil, vice-president of pre-clinical 
development at Indevus and responsible for PRO 2000, described: 
The company that developed the molecule initially was called Procept and that's 
where the 'PRO' in PRO 2000 comes from... all of their new compounds got a 
'PRO-' something, and I actually said - we were up to PRO 19-something 
something - and I said, "why don't we call this one PRO 2000, because it's easy 
to remember, the year 2000's coming and, you know, it might be an important 
molecule. 
And so, whilst the name is suggestive of progress and epoch-making (PRO being `for', 
both in the sense of positive and forwards, 2000 being the Millennium year), the 
molecule is also situated historically - towards the end of the second decade of HIV - 
and geographically - in the US. Both of these contextual details constitute not just the 
name but the nature of the microbicide. 
At first, when the molecule was found to have anti-HIV activity, "the initial thought 
was to use it as an intravenous therapy for HIV infection, so they were going to treat 
AIDS patients with it" (Neil). At the time, AZT was the only approved antiretroviral 
and so this application would have had a strong place in the market. However, 
following early clinical trials administering PRO 2000 intravenously to HIV positive 
gay men, it was felt that this application wasn't suitable, given the side effects 
associated with intravenous use41. At this point, PRO 2000 was a molecule looking for 
" Polyanionic agents "had too high a molecular weight to be orally absorbed, and interfered with clotting 
if given parenterally, and hence they were not developed for antiviral therapy" (Weber et al. 2005: 393). 
In the early 1990s, Harry was also interested in a class of compounds - sulphated sugars, such as Dextrin 
Sulphate - which were also initially thought to 
be potential drugs to treat HIV. He says, "it was clear. I 
think by the early '90s that... they weren't going to be usable systemically as drugs in any delivery 
system. And we did wonder what else to do with them", 
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a `technology'; uses and user groups were being constructed and contested. Following 
and contributing to the trajectory of discourses on AIDS, the drug itself was to move 
from the domain of the sick gay male body (HIV-infected gay men as a core group) to 
the unprotected female body (uninfected, vulnerable women as the potential victims of 
generalised epidemics). This move was ostensibly a commercial one; Neil describes the 
point at which women became the new user group for PRO 2000, and the concept of 
women's control imbued into the molecule: 
So the way I, the way we came to microbicides was, you know, essentially we 
were trying to figure out if there was anything we could do with PRO 2000 since 
it wasn't gonna work as an antiretroviral, and the idea of, you know, a female 
controlled prevention method had been kind of kicked around a little bit so I 
kind of looked into it a little further and Lori Heise and Chris Elias had recently 
published a paper, you're probably familiar with it, it's one of the seminal 
papers in the microbicide field you're talking about. And I read their paper and 
I said, "Wow, PRO 2000 would be perfect for this" and so we re focussed the 
whole programme on its development as an intra-vaginal microbicide. 
It's not clear which of the two frequently cited papers by Elias and Heise (one in AIDS, 
the other in Social Science & Medicine) Neil was referring to42. In the former, the 
authors pick up on previous calls for "an HIV prevention technology within the personal 
control of women" and dispassionately outline the issues in terms of biological knowns 
and unknowns, clinical testing, programmatic issues, and public-private partnerships 
(Elias and Heise 1994: 1). The 1995 article is a much more impassioned argument for a 
complete restructuring of AIDS prevention focused on women's vulnerability to HIV 
infection. Whilst the authors reiterate throughout the paper that fundamental change is 
required in terms of gender relations, they nonetheless couple women's empowerment 
with HIV prevention and simultaneously call for women-controlled prevention 
technologies: 
The AIDS epidemic therefore creates two imperatives: to begin in earnest to 
work on changing the underlying causes of women's vulnerability and to pursue 
42 "The Development of Microbicides: A New Method of HIV Prevention for Women" was originally 
written as a working paper. before being adapted for publication in AIDS. 
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vigorously every means possible to strengthen women's immediate ability to 
protect themselves in the face of the economic and cultural forces currently 
allied against them. This, in turn, means placing greater emphasis within 
existing AIDS programmes on empowering women and committing major 
resources to developing new prevention technologies - like vaginal 
suppositories or foams lethal to the virus - that women can use without their 
partner's knowledge or consent. (Heise and Elias 1995: 931) 
Microbicides advocacy such as this initially started in the field of women's health and 
contraceptive research and development. Zena Stein, a South African epidemiologist, 
was one of the first major voices in the field; her article, "HIV Prevention: The Need for 
Methods Women Can Use, " published in the American Journal of Public Health, drew 
widespread public attention to the issue. Stein was unambiguous is linking women's 
empowerment with HIV prevention using women-controlled technologies: 
The proposition of this paper is that the empowerment of women is crucial for 
the prevention of HIV transmission to women. It follows that prophylaxis must 
include procedures that rely on the woman and are under her control. A wider 
range of chemical and physical barriers that block transmission through the 
vaginal route must be developed and tested. (Stein 1990: 460) 
The link made between HIV prevention, empowerment and technology was a fortuitous 
one for Indevus at this point in time, when they had a molecule with anti-HIV activity to 
develop and commercialise. Neil described Indevus as an opportunistic company; its 
portfolio, he said, consisted mainly of urology and endocrinology drugs, but they were 
interested in PRO 2000 as a novel candidate that they could add value to through 
clinical trials and the registration process. Because of the global interest in women- 
controlled technologies and the government funding being made available to test new 
products of this nature, PRO 2000 was a good commercial prospect for the company at 
that time: 
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I think at that particular time they were kind of just being very opportunistic and 
looking for things and they didn't have to pay much for PRO 2000, you know, it 
was just that very small up-front payment and they thought, you know, it's an 
interesting opportunity and it's heavily government funded, if it works there 
could be a big, a big pay-off. (Neil) 
Neil was frank about the fact that women's empowerment was interesting from a 
commercial point of view; unsurprising, perhaps, given that microbicides were forecast 
in 2002 to have a peak market size of US$5 billion (Pharmaco-Economics Working 
Group of the Rockefeller Foundation Microbicide Initiative 2002). In my interview 
with him, he discussed the company's obligation to shareholders to be commercially 
successful and said the way to do this was to identify and meet consumers' needs. This 
discourse of consumerism is not one that readily fits with discourses of empowerment. 
However, where empowerment becomes an `unmet need' in the medical arena, as Neil 
demonstrates below, it becomes possible to meet that need and therefore to 
commercialise the solution: 
Neil: ... when I presented it to the scientific advisory board, you 
know that idea 
of a woman-controlled method really did resonate with them and you know, the 
impression was that this could be commercially, you know, successful. 
CM. " Right. So would you say it was a marketable commodity, in a way, the idea 
of women's empowerment? 
Neil: I think; um,... marketable in the sense that there was an appreciation that it 
was an unmet need and that a vaginal microbicide for women might fill an 
important unmet need, a medical need, and 1 think that there was that 
recognition from the beginning, I think. 
It's important to note here the way in which Neil uses the clinical language of "unmet 
need", commonly associated with family planning, to bring the social into the medical 
domain. First of all, women's empowerment is described as an unmet need and Neil 
then equates this with "a medical need". By medicalising women's lack of power, it 
becomes possible to find a medical solution to empower women -a vaginal 
microbicide. 
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Neil was not alone in translating women's social needs into medical ones. Adrian, often 
identified as one of the first advocates for microbicides, was persuaded of the need to 
give women a product they could control without the consent of their male partners. 
During the 1990s, the discourse on women and HIV took on a new dimension; by 2002, 
when Kofi Annan stated that "AIDS has a woman's face" he hit on a crest of sentiment 
that had grown through repeated discussion of the `feminization' of the epidemic 
(Annan 2002). Although this discourse became so entrenched as to be treated as a self- 
evident fact43, Ellen drew attention to the work that advocates had done to effect this 
discursive shift: "As the power of gay men in HIV was on the descendency, I think you 
started to see the rise of women and HIV and that became... a mantra and became very 
mainstream then... But the microbicide thing was always ahead of that. So we didn't 
actually ride that wave, we were like pushing the wave almost". 
At least in part through women's health advocacy, then, the idea that AIDS was a 
women's disease became common currency, and was an important persuasive device in 
the microbicides field. The fusing of women's biological vulnerability to HIV with 
their social vulnerability to infection seamlessly led to the medicalisation of 
powerlessness and the search for a medical solution to it: 
Jf you go back to my very original paper that 1 produced for the Committee in -I 
think it was December 1990, the. MRC main committee -I said that, you know, 
the reason people aren't using condoms is because the man won't use them, for 
various reasons, and that a point about this: the woman would be able to take 
the initiative herself. In other words, empowerment. So that was a major thing 
and later on - it was mainly the men who were getting infected, I suppose from 
sex workers, I'm not sure - but when it became a woman's disease, you know, 
HIV wears the face of a woman and now more women are being infected than 
men, once that was appreciated, then of course it became not only women's 
empowerment but women were very vulnerable and needed to be... these 
microbicides to be able to protect themselves. (Adrian) 
43 Peter Not, Executive Director of UNAIDS reported in 2004, "Today we can safely say that the face of 
the epidemic is an African woman" (Reaney 2004). 
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In this extract, we again see the shift in discourse from women as a circumscribed core 
group ("it was mainly the men who were getting infected, I suppose from sex workers ") 
to all women as a vulnerable population in need of medical intervention ("it became a 
woman's disease... women were very vulnerable"). The discourse of women's 
vulnerability and powerlessness constructed men as the enemy in the fight against HIV, 
and this engaged some in thinking about microbicides in warfare terms; for example 
Adrian recalled, "We used to call them `stealth virucides' like the stealth bomber". 
Covert use became a presumed feature of microbicidal products and was directly linked 
to the discursive production of gendered subjects by advocates and investigators 
working in this field, as discussed below. 
Of men, women and gels: The discursive production of gendered subjects 
and technology 
Dr Piot: The biggest problem are the men. The driving force in this epidemic is 
male sexual behaviour. As long as that does not change we can empower these 
fifteen year old girls but when they are raped that approach is not very useful... 
Mr Worthington: One of the things which has puzzled me, you referred to the 
behaviour of men, which is appalling probably everywhere all of the time, but 
we put all of the focus on condoms. We know what is wrong with condoms as a 
method and there seems to be extremely little attention paid to the female 
condom and microbicides. Am I right in that? 
Dr Piot: What you are saying is music to my ears. (Extract from: Select 
Committee on International Development Minutes of Evidence, Examination of 
Witnesses (Questions 480 - 499), Tuesday 18 July 2000, Dr Peter Piot) 
The seed had now been sown for a prevention product to empower women in the fight 
or against 
HIV and the concept of female-controlled technologies was rooted. In order for 
work on microbicides to obtain funding and progress, it was imperative that there be a 
coherent subject in need of the technology. It was not enough that this should simply be 
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`women'; as noted above, during the early 1990s women sex workers were seen as a 
core group, the reservoir of infection from which the disease was spreading to the 
general population (Eckholm 1985; Van De Perre et al. 1985; Kreiss et al. 1986; Padian 
1988; Rosenberg and Weiner 1988; Scambler and Paoli 2008). A new type of woman 
was needed, an acceptable face of the epidemic that would garner sympathy and support 
applications for funding to develop microbicides. Regardless of the science, the subject 
of the new technology was to be the victim of social, cultural and economic inequalities, 
the powerless married woman. As Ellen remarked to me on the subject of political 
lobbying, "we had to play up - which I always hate - the kind of vulnerable married 
woman thing". One of the first scientists to develop microbicides in the United 
Kingdom, Harry, was also clear about the need to capitalise on the notion of the 
powerless female user: 
Harry: It's absolutely the case that I and I don't think Celia or probably Kate or 
Dominic, in 2000, when this was first beginning to be articulated, it wasn't seen 
as an issue around women's empowerment. 
CM. - To you or to others? 
Harry: Internally, when we considered it, it was, it was, to ask the question "did 
they work? " or "did this one work? " 
CM. - And have you ever utilised the women's empowerment line to obtain 
funding [Harry laughs] or popular opinion? 
Harry: [Laughing] What a question! Um... [pause] I think one would have been 
pretty stupid not to use all potential levers available to you. So I mean, I'm sure 
you've read the first grant application that was written, indeed back in '94, 
when we were first writing the very first grants, I'm sure the first line was about 
empowerment of women. 
This extract leaves no doubt as to the divergence in priorities between scientists and 
those for whom women's empowerment was the primary issue. Harry was not alone 
amongst my informants in articulating that the development and testing of microbicides 
was first and foremost a scientific question - did they work or not? However, in a clear 
manifestation of social and scientific co-production, the construction of gendered 
subjects became a necessary part of drug development. How the scientific community 
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defined and produced the end user of microbicides is fundamentally intertwined with 
the technology itself and the research designed to test it. Discussions with senior 
investigators showed how through an essentialising discourse of women and men, it was 
possible to produce a subject in need of medicalised empowerment. 
While it would be wrong to suggest that the investigators all shared a common view of 
women and men which they mobilised to further the research agenda, a discourse 
around disempowered women and irresponsible men did form during the development 
of the trial. This was remarked upon by the senior social scientist, Dylan, who 
bemoaned the fact that: 
there's... always such an assumption that, you know, poor old women are always 
the victim and, you know, these guys are dreadful, they won't use condoms and, 
you know... women can't persuade them to use condoms and it's that whole sort 
of... feminist politically correct discourse that makes people think that it's 
essential that women use these things secretly. 
Interestingly, the social scientists in the group tended away from discourses of 
empowerment while their medical counterparts re-produced and perpetuated them as the 
research progressed. Some of the most senior male investigators were core proponents 
of the `victim' women and `dreadful' men discourse. Talk of women and men drew 
heavily on a biologically deterministic view of sexual difference, with women 
frequently referred to in terms of their reproductive capacity and men as promiscuous 
inseminators. As one senior researcher noted, "women are the, you know, repositories 
of the family and the creation of the next generation". The exculpation of women was 
further established by conferring on them `innate' qualities that turned around caring 
and nurturing, sacrifice for the good of the family, communication rather than obstinacy 
and responsibility-bearing. Women's nature could only be elaborated in this way by 
reference to their binary opposite in men, and thus men were typically described as 
irresponsible, uncaring, pleasure-seeking and driven by their sexual urges rather than 
concern for the good of others. Various examples were drawn upon which appeared to 
legitimate these givens, for example "evidence" that men won't use condoms; a 
feasibility study in which men said they would only accept microbicides if the products 
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didn't interfere with their own pleasure; and a study of prevention of AIDS-related 
illnesses in which men had "damaged" the study by protesting when their wives 
enrolled. The following extract is illustrative: 
And they (the women) were post-natal so in fact they were often enrolled just 
soon after they'd delivered their baby in hospital, and many of them hadn't been 
tested up until that point in time. So they were tested, found to be HIV-positive, 
offered the opportunity to join the study. They went back home and, well in 
some cases all hell broke loose because in fact their husband discovered that a) 
his wife's been tested for HIV and of course, like husbands do, he blamed his 
wife for the fact she was positive even though in fact he may be the one, most 
likely was the one who actually infected her in the first place. (Dominic, 
statistician. First emphasis added, second respondent's own) 
Here we see the rehearsing of an old discourse on wicked men and innocent women. 
Women are described in their maternal role as wife and mother and men are generalised 
about using the phrases "of course", "like husbands do", and "most likely" to implicate 
all men in the infection and blaming of innocent women. 
Whilst some of the researchers drew on previous experience and social research 
findings (e. g. about condom use) to paint the need for a product women could use alone, 
others went back to biological basics to argue for this. Describing the conceptual appeal 
of microbicides, Chris, one of the clinical principle investigators said: 
For a heterosexual sexually transmitted disease, you don't have to actually 
prevent both sexes, for example, a single sex vaccine will work in a heterosexual 
sexually transmitted disease. You only need to block one... one partner, so it's 
ok if you have a female-only intervention, it's gonna block the transmission 
cycle. 
As we continued to discuss `women-controlled' prevention methods, Chris went on: 
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... with sexually transmitted diseases it's fairly obvious, for venereologists, that 
you're more likely to get compliance with an intervention in women than with 
men, you know, it's just that... 
CM: Really, with women than with men? 
Chris: Well, yeah, well, yeah, because women are responsible, aren't they? This 
is the sort of Desmond Morris type of theory, that you know, that men are out 
there to... you know, inseminate their genes into as many women as possible and 
women are there to try and maintain the most stable structure in which to bring 
up their children. And that usually translates into having a single partner that 
they then, you know, form a long, a very long-term stable relationship with. So 
men can't help it... I mean, I, I, I'm a bit old-fashioned, but there's a lot of, a lot 
of the old-fashioned things have a very substantial germane truth in them, so, I 
mean, not all men are heterosexually promiscuous and don't care two hoots, but 
there is that trend in men, they... it 's just... it's all that testosterone imprinting in- 
utero, isn't it, I mean, [laughter] you can take the gonads out of a male sheep 
after, you know, one quarter of the in-utero time and they still come out as rams, 
you know the imprinting of the cells is very early in gestation under the 
influence of the testosterone. So, yeah, no, it seemed quite logical you could 
have an intervention that women would be more adherent with. 
In this case, the biological and epidemiological rationale for microbicides takes 
precedence over moral arguments. Epidemiologcially-speaking, you can stop the 
transmission-cycle by intervening in one sex or the other. Biologically-speaking it 
makes more sense to intervene in women than men, because women, by their very 
nature, are more compliant (and men, due to their testosterone levels, can't help being 
uncontrollable). So although the tone and legitimating devices of this rhetoric vary 
from that described above, the discourse nonetheless constructs women as 
monogamous, maternal and passive; and men as promiscuous, uncaring and 
irresponsible. 
Having established women's vulnerability to infection, their biological suitability for 
intervention and the moral need to protect them, it became obvious to develop a 
women-controlled technology. As mentioned above, microbicides were initially 
99 
conceived as "stealth" products that could circumvent men altogether. However, it was 
not only women's use of the product that was proposed to be covert; the fact that the 
technology might also protect men was also `covered' up. As I have been discussing 
and will elaborate on below, there were reasons why it was advantageous to position 
women as the sole beneficiaries of the technology, and to exclude men from 
microbicides discourse except in negative terms. In discussion with Adrian it became 
clear that the absence of men from the microbicides prevention discourse was socially 
rather than scientifically motivated. He admitted: "I would be very surprised, if 
Nonoxynol-9 had worked, for instance, or Savvy more recently, if that had worked and 
protected women ... Ijust wouldn't 
believe it if it didn't protect men. " And reverting to a 
scientific discourse, he described the potential for bi-directional protection in PRO 
2000's mechanism of action: 
We don't know that microbicides will protect a woman, it's never been shown 
yet. But we're assuming that will happen, which it will. So on the same grounds 
it's protecting a woman it should be possible to protect a man, because the 
principle on which these things work - for instance, er, let's take for example 
PRO 2000 gel, which binds to the V3 loop and prevents the virus from attaching. 
I mean that's a crude explanation, but let's say that's how it works. The healthy 
woman inserts this gel and ... she 
has sex with a man that's infected, his semen 
has to mix with that gel or somehow the gel coats every vulnerable surface, and 
it has to attach to the V3 loop of the virus - and the PRO 2000 molecule does 
that - and that will protect the woman. Now how long does it have to attach, 
what's the time window? Not very long. The virus enters the woman, it's going 
to attach to its receptor lymphocytes fairly quickly, so it doesn't have very long. 
So what we're saying is we think that's going to protect the woman. Think of it 
the other way - the man is uninfected, the woman is infected... she inserts the gel, 
she is shedding virus into her fluids, that is going to be around for an hour or 
longer, I don't know, it depends, but it's going to be around for much longer 
than in the case of the man's semen. So the chances of that microbicide 
destroying or attaching to the virus that she herself is shedding is much greater 
than... So in other words, that should really, if it protects the woman, it's jolly 
well going to protect an uninfected man. 
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From this biological point of view, then, men are more or equally likely to be protected 
by PRO 2000 than women and so rather than the technology being a women's product, 
it could also have been a men's product or a product for both sexes. So why has bi- 
directionality been absent in discussions and descriptions of vaginal microbicides? 
Following on from the above quotation Adrian continued: "Now that has never been 
published, it's never, as I say, it's never really discussed unless I raise it and so on. 
Because it's speculative. " He located the failure to publish on bi-directional protection 
in the fact that it was speculative, but as he also noted, protection in women was also 
speculative given that the product had not yet been tested. The sticking point, as he saw 
it, was that you can prove in trials that the product protects women, but you can't prove 
that it protects men. Therefore, on the one hand, the silencing of bi-directionality could 
be seen as an inevitable response to the limits of scientific knowledge production. 
However, if bi-directionality were simply not discussed because it wasn't possible to 
prove it, it's unlikely that the technology would have been framed so completely as a 
woman-controlled product. In fact, I suggest that the silencing of the potential 
protection of men was a political and commercial move, subsequently legitimated by 
the scientific impossibility of proving it. By labelling protection in men as 
"speculative", it is thrust outside the domain of scientific knowledge and is thereby 
ontologically demoted. 
The limits of scientific possibility were not only invoked to legitimate why microbicides 
were only being tested in women, but why PRO 2000 was only being developed as a 
vaginal, as opposed to rectal, microbicide. Several informants raised the fact that it is 
much more challenging, scientifically, to develop a rectal microbicide because of the 
physiology of the rectum and the efficiency of HIV transmission via this route. When 44 
probed, however, it became apparent that whatever the scientific hurdles to developing a 
rectal microbicide, the social conditions and consequences of developing a product for 
rectal use made this still more problematic. Neil, from the pharmaceutical company, 
said they had considered rectal development, but that it was "obviously a little bit more 
of a delicate thing" and that whilst their marketing department thought it could be 
highly successful to pitch it to gay men in industrialised countries, this was "definitely 
not a high priority". Although he was not explicit about the reason why rectal use was 
" Biological challenges to rectal microbicide development have been well-documented in the scientific literature; for a brief overview, see (McGowan 2008). 
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not high on the agenda, showing continuities between the sexual behaviour of the 
mainstream (i. e. heterosexual men and women) and `deviant' risk groups, such as gay 
men, may have been a deterrent. It's worth noting that the US FDA has never approved 
a condom or other device for anal sex and that approval of technologies for rectal use is 
considered a "political minefield" (Scarce 1999)45 
Chris provided additional reasons why the development of a rectal product was not 
gaining much ground. Firstly, he discussed how the available research expertise is in 
the domain of women's reproductive health and not rectal physiology: 
... the number of people that 'ye 
done kind of rectal research is 
very ... traditionally, in medicine, is very small, it's really just the STD 
doctors. 
The surgeons, you know, are mainly... the general surgeons, are. mainly doing 
sigmoidoscopies and going up into the sigmoid colon and then full colonoscopy, 
the whole range of the colon. Very few people actually use protoscopes, it's 
really only STD physicians who use protoscopes. So with HPV research on the 
cervix, there was this huge mass of gynaecologists also driving the research as 
well, but very little knowledge base about rectal... rectal examination, rectal 
physiology um... 
CM. - Why's that? 
Chris: Why? Because... because, it's only really doctors looking after gay men 
who want to come for checkups for STDs that ever look in the rectum... there's 
very few people around who regularly look in the rectum and take swabs from 
the rectum. So there just isn't that sort of knowledge base of people out there. 
He related the popularity of gynaecological research to the social acceptance of 
examining the female reproductive tract, as opposed to the rectum: "a no-go area, the 
bottom really, for heterosexual male conceptions". This is perhaps indicative of the 
long history of the medicalisation of women's bodies (Ehrenreich and English 1979; 
Corea 1985) and the continuing stigma of homosexuality and its practices in some 
's Scarce reports that, "Sodomy laws often provide a rationale for squelching any government act that 
might encourage safer anal sex. Such was the case with the Reality Female Condom. Formerly named 
"Aegis" and pitched as a gender-neutral barrier pouch for rectum and vagina, the device was restricted to 
vaginal use by the FDA, citing sodomy statutes as a deciding factor" (Scarce 1999). 
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spheres of public life46. It is notable that the baseline against which Chris measures 
conceptual deviation is the heterosexual male, hierarchically the most dominant group 
and clearly still powerful in determining the knowledge base from which health research 
proceeds. 
At the time we did the interview, Chris was in fact conducting a phase I rectal safety 
study of PRO 2000, but had said it wasn't possible to do the study in heterosexual 
couples: 
.., consent would 
be an issue... maybe, maybe there are lots of women out there 
who are having consensual anal sex within their heterosexual relationships and 
both partners maybe would be willing to agree to, you know, having consensual 
anal sex within their relationship for a trial. But you know it's difficult, the 
ethics committee... we're getting into quite small print areas here and the ethics 
committee has... it's a bit like the jury, it's got to have normal men in true, you 
know, men and women and you know, the average folk, so you've got a bit of a 
job persuading average folk about consensual anal sex, it's just - it's a bit like 
legalising heroin or something, actually there's a very powerful argument to do 
it, but it's so... it's... it's a difficult area for ordinary people to actually see the 
logic in legalising heroin. It would be very difficult for an ethics committee to 
see that all the people in your trial, there's this notion of rape around 
heterosexual anal sex, that's what comes to people and you know, the 
domination of men over women is subconsciously a more powerful metaphor in 
terms of anal sex than vaginal sex because it's not a... it's not a route that results 
in conception, so... it's just a complex area. 
Chris is clear that the design of the study was directly related to social conceptions of 
appropriate heterosexual behaviour, which does not include consensual anal sex. The 
" Scarce supports this with the assertion that "scientists and public health experts have long approached 
anal sex with a mix of anxiety, scorn and denial". He quotes Dr Kelum, one of the first researchers to test 
rectal microbicides in human subjects, as saying, "Most of the researchers in this field aren't just 
homophobic, they are erotophobic" (Scarce 1999). Dr Carballo-Dibguez, a professor of clinical 
psychology at Columbia University, is reported to have told a meeting of the US Rectal Microbicides 
Campaign that he had had to call one of his rectal microbicide studies 'topical microbicide acceptability in high risk men': `"`We have to play this infantile game, " he commented, "avoiding all mention of works like 'gay', 'MSM' and `rectal'. It gets past people who are hostile to gay men's work" 
(http: //www. aidsman. com/cmSI065822. aspx accessed 17/11/2009). 
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bounds between the social and the scientific are blurred by the institution of the ethics 
committee - composed of "the average folk", but arbitrating on the realm of the 
scientific. In a good example of how the social, the scientific and the technological are 
co-produced, we see how gender is produced by reference to sexual difference and 
reproduction, how compulsory heterosexuality is instituted through denial of anal sex as 
a legitimate heterosexual activity, and how science follows and thereby reproduces 
social prescriptions on gender. Finally, relating this to the development of PRO 2000 
first and foremost as a vaginal microbicide, Chris linked the social to the political: 
To get into specific research to prevent sexual transmission through alternative 
sexual practices, if you like, if that's how you want to describe anal sex, it is a 
bit... a bit challenging for many of the Daily Mail readers, yup. And the 
government, I'm afraid, has to go by the Daily... that's, that's... they're all so 
centrist now, that you know, we're not living in a socialist, progressive... we're 
not living in an era when we can expect any more socialist progressive 
administrations for the foreseeable future. 
Similar apprehensions were raised by advocates in the US around advocating for rectal 
microbicides at a time when to do so might jeopardise funding for microbicides from 
what was then, circa 1999/2000, a highly conservative administration. Ellen shared 
Chris's belief that social apprehensions around homosexuality inhibited the 
development of rectal technologies: 
People don't like to think about that (rectal use), they don't feel comfortable, 
there's been fear that... sort of raising the issue of rectal use could - and it 
could, quite frankly - undermine the vaginal microbicide programme, because of 
the crazies that are in Congress and you know, all of a sudden you get wind that 
NIH is funding rectal microbicide studies and the whole funding for the 
microbicide programme could be cut off tomorrow. 47 
47 Anna Forbes, deputy director of the Global Campaign for Microbicides (GCM) spelled this out in more 
detail during a public teleconference: "... other people who were working on microbicides advocacy 
[were] really discouraging GCM from even mentioning rectal microbicides, even talking about the 
issue.. . 
in 2000 George W. Bush was campaigning for president the first time, there was a very big, ultra- 
right, ultra-conservative political spirit abroad; Newt Gingrich had been Speaker of the House, the US 
House of Representatives ... 
[was] very, very conservative, particularly around sexual politics ... 
he'd just 
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The political discomfort with acknowledging heterosexual anal sex has led to a vicious 
circle of abdication and ignorance48; by letting themselves be led by dominant social 
proscriptions around appropriate heterosexual behaviour, scientists have avoided the 
rectum as an area of research and thus, as Chris originally justifies, there is an extremely 
limited knowledge base in the scientific arena. 
Scientific, political and technological co-production 
I am trying to define in what way, to what extent, to. what level discourses, and 
particularly scientific discourses, can be objects of a political practice, and in 
what system of dependency they can be in relation to it. (Foucault 1978: 23) 
I have outlined above the way in which social and scientific discourses about women, 
men and HIV came together to gender the technology of microbicides. The relationship 
between science and politics, in its most literal sense, should not be overlooked or 
underestimated in terms of the trajectory of this development. This is particularly the 
case because the pharmaceutical industry had shown no interest in microbicides, 
meaning that funding was dependent on the public and charitable sectors. As Weber et 
al noted in 2005, "microbicide research has attracted considerable political attention 
because of the urgency of the HIV epidemic, the plight of vulnerable women in high- 
incidence regions, and the delays in progress towards an HIV vaccine" (Weber et al. 
2005: 395). Political involvement was essential in financial terms, but was not merely 
monetary; the UK political landscape of the late 1990s also contributed to the evolution 
of microbicides as a woman-controlled prevention technology. 
been replaced by Dennis Hastert, who wasn't any better; we had just introduced the Microbicide 
Development Act into Congress in the first time in March of 2000 and so lots of people were saying, "for 
God's sake, shut up! " You know, if you start talking about rectal microbicides, the far right is going to 
jump on that and we will never get any funding for microbicides research" (IRMA/Global Campaign for 
Microbicides joint Teleconference 2009). 
46 I here borrow Rabeharisoa and Callon's phrase, which they use to describe the way in which little- 
known diseases, such as muscular dystrophy, suffer from medical lack of interest: "when a disease is 
unknown the professionals turn away from it because it highlights their powerlessness. This disinterest, 
in turn, maintains the state of ignorance because it paralyses all efforts at carrying out research on these 
diseases" (Rabeharisoa and Callon 2006). 
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The UK government was involved in microbicides development from the early 1990s, 
when it provided money for laboratory screening of compounds and the programme of 
phase I studies conducted at Imperial College, London. Funding for these studies came 
through the concordat between DFID and the MRC, which first came into effect in 
1992, and continues to contribute approximately £4 million annually to health research 
in developing countries. Of this relationship, MRC states: "our partnership with DflD 
strengthens the "research pipeline, " delivering products and informing health policies 
and practice" (Medical Research Council 2009). The elements of "delivering" and 
"informing" are both clearly visible in DFID's support of microbicide development, 
which was cemented under the leadership of Clare Short, Secretary of state for 
international development from 1997 to 2003. 
The role of advocacy in securing government money for HIV prevention research was 
key. Initially, AIDS advocacy had centered on treatment and was driven to a large 
extent by gay men and gay men's organizations in the West, which then developed into 
an advocacy movement around access and distribution. In the early 1990s there was 
little advocacy in the West around prevention for the developing world. However, in 
1996, the International AIDS Vaccine Initiative, IAVI, was set up and drove forward a 
very clear and very aggressive advocacy agenda at government level, targeted mostly at 
European governments49. According to Harry, "Seth Berkley, who set it up, was very 
good in that regard and he went around all the governments and raised this level of 
expectation that European governments should be investing in public private 
partnerships with a view to investing in a science base and then move towards 
prevention technology, new prevention technology in Africa". Through IAVI's 
charismatic approach, `New Prevention Technologies' became the thing to invest in, 
and it is easy to see how the joint concepts of scientific progress and modernity 
appealed to funders. DFID initially invested £25 million in IAVI and senior researchers 
working on microbicides in the UK saw the potential of this precedent. Firstly, DFID 
was persuaded that it was legitimate to spend development money on research if it had a 
clear clinical outcome to it; and secondly, by giving a large sum to one organization, 
" For a detailed analysis of IAVIs advocacy and communication strategy, see Chataway & Smith, who 
note that IAVI "put the possibility of an HIV/AIDS vaccine, and awareness of the need for very 
considerable investment, on the agenda of every development agency in rich countries" (Chataway and 
Smith 2005: 9). 
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they could satisfy their (real or supposed) obligations to AIDS prevention research. As 
Kate, one of the clinical PIs, remarked, "they liked the idea of investing in new 
technology, they liked the idea of giving it all to IA VI in a big sum, it sort of satisfied 
that kind of "we've given X million pounds to AIDS research"". 
The appeal of new technologies and the convenience of large research investments was 
not enough to secure government funding for microbicides. As mentioned above, in 
comparison to vaccines, microbicides were considered unscientific, and their appeal 
therefore had to rest on the additional dimension of women's empowerment' Under the 
first Blair government, with its anti-poverty drive, DFID had benefitted substantially 
from the spending round; the then secretary of state for international development, Clare 
Short, was clear about where the money should be spent: "Women bear the brunt of 
poverty, but they also hold the key to its eradication" (Commons Hansard Written 
Answers, Wednesday 8 Dec 1999, Column: 575W). Senior researchers in the 
Microbicides Development Programme were acutely aware of these women-focused 
interests at government level: 
1 think she was looking for something which pulled together the pro poverty line 
which she was addressing with something that was very clearly for women's 
health, targeted at improving women's health and decreasing women's 
vulnerability and, um, and she wanted DFID to do something. (Harry) 
However, It was not only that DFID was pushing through a pro-poverty agenda linked 
to women's health, but that Clare Short herself was passionate about women's 
empowerment; when I asked Harry how important to DFID the element of advancing 
women's status in Africa was in respect of microbicides, he replied: 
... it absolutely 
fitted in with their agenda about their priorities as of '99/2000 as 
to how to address issues of poverty and, um, so, as I say, because, I think, of the 
personality of Clare Short, it was a very woman focused, um, outlook which 
they took then around women's education and women's health. (Emphasis 
added) 
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This view was reiterated by numerous investigators, for example Chris, "... you know, 
because of the vulnerable nature of women, I mean Clare Short was quite a leftie really, 
so this was all very appealing to her ". The opportunity to appeal to this interest was 
not lost. However, highlighting the specificity of this socio-political context, Ellen 
contrasted the European and American settings in terms of the appeal of microbicides: 
"In Europe... you talk to European donors... and you can use the empowerment 
argument and that resonates fine. You talk to certain people in more conservative 
settings and, you know, they're not so sure they want their women empowered". Within 
the US context, she said, the female-gendered dimension of microbicides had not 
always been to advocates' advantage: "I do think that ... part of the 
lack of support and 
the constant resistance and dismissal of this field is something to do with gender. " In 
the UK, it was precisely the gender element that held appeal. 
As described above, from a biotech perspective, microbicides became commercially 
interesting when powerlessness was transposed into a medicalised need with a 
pharmaceutical solution. In terms of gaining political support and funding, it became 
advantageous to package or commodify women's empowerment in the form of a 
biomedical solution. Minutes from House of Commons debates at this time reveal a 
strong rhetoric amongst politicians and civil servants around women's lack of control 
over their destinies in developing countries and the need to give them power. This ties 
in closely with advocacy materials proclaiming slogans such as "putting power in 
women's hands", words that quickly found their way into media discussions of HIV 
prevention. Researchers took advantage of this favourable political climate; several key 
informants were unabashed in admitting that women's empowerment was a "selling 
point" for the science: 
Chris:... there was a window of opportunity, which we were lucky to.... we were 
in the right place at the right time and we had the right presentation and it all 
went well. 
CM: Did that have anything to do with the growing advocacy movement around 
women-controlled technologies? 
Chris: Yes, it was always... that's right, yeah, that women had lack of 
opportunities to control... that was our selling point from the outset, yeah, that 
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this could be a female-controlled intervention that would challenge the gender 
politics ifyou want to put it that way, yeah. Give women some power over their 
own sexual relationships. 
CM. - So would you say that the concept of a microbicide was seen as 
empowerment per se, or is that a bit too simplistic? 
Chris: Yeah, no, I think that's not too simplistic. (Emphasis added) 
Although many of the senior researchers in MDP had come to microbicides through an 
interest in the scientific problem, and their priority was to show efficacy, the need to 
capitalise on DFID's poverty agenda, spearheaded by Clare Short, led to further 
propagation of the empowerment discourse and further gendering of the technology. 
Summary 
What are microbicides? At the start of this chapter, I referred to microbicides as a given 
and as a tool for women's empowerment; it should now be clear that it is no more 
obvious that they are `an HIV-prevention method specifically for women' than that they 
could have been (and still could be) `an HIV-prevention method specifically for men'. 
Essentialists (and among them many scientists) would view PRO 2000's technical 
attributes as deriving from internal characteristics, themselves resulting from a chain of 
scientific events - either the direct application of scientific method or linear 
extrapolation from previous technologies. However, in line with anti-essentialist 
approaches, I have shown that PRO 2000's `innate' capacities are not merely the result 
of scientific method, but derived from the social circumstances of its production. In 
other words, it is socially constituted, embodying the interests and politics of the parties 
involved in its development. 
PRO 2000 was initially conceived of as a treatment for HIV positive gay men, and it 
was at least partly through the changing global discourse on HIV that it came to be 
developed as a preventive tool for HIV-negative heterosexual women. In spite of the 
stabilisation of the user group, the fact remains that biologically, PRO 2000 has the 
potential to protect men, and it is only by silencing discussion of bi-directionality in 
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scientific publications and meetings that the interpretative flexibility of the artefact has 
been foreclosed. Although microbicides are now synonymous with women's 
empowerment, this too is not a natural function of the technology. I have discussed 
above how a jigsaw of agendas came together to bring PRO 2000 to the point of clinical 
testing. Scientists in the vaccine world had suffered a barrage of disappointments, with 
no discovery in sight; for some of these scientists, microbicides posed an achievable 
alternative, but one that was so technologically simple relative to vaccines that it 
became necessary to promote the concept in ways other than its scientific merits. 
Women's empowerment had been brought centre-stage by the International Conference 
on Population and Development in 1994 and women's health advocates started 
publishing more prolifically on a joint solution to women's powerlessness and HIV in 
the same year. The international attention to women-controlled technologies attracted 
the interest of Procept, a small pharmaceutical company with a molecule to 
commercialise; women's empowerment was not only highly marketable, but also came 
highly subsidised with government funds. For the UK government, PRO 2000 fitted 
their agenda on poverty, and held strong appeal for the secretary of state for 
international development, who had a special interest in advancing women's causes. 
At stake in the development of microbicides is the very production of gender, which 
potentially reinforces women's inequality vis-a-vis men. Previous analyses of 
reproductive technologies have argued that such artefacts are inherently patriarchal 
(Rowland 1984; Corea 1987; Stanworth 1987; Burfoot 1990), and indeed a common 
argument for microbicides is that condoms are a male device, therefore women need 
their own female technology. However, eco-feminist accounts such as these draw on a 
problematic conceptualisation of gender based on the `natural' differences between 
women and men. As Wajcman has rightly criticized: 
The first thing that must be said is that the values being ascribed to women 
originate in the historical subordination of women... it is important to see how 
women came to value nurturance and how nurturance, associated with 
motherhood, came to be culturally defined as feminine within male-dominated 
culture.... Secondly, the idea of "nature" is itself culturally constructed. 
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Conceptions of the "natural" have changed radically throughout human history. 
(Wajcman 1991: 9) 
The ascription of female values to the woman-user of microbicides could not be more 
pertinent, given the widely-stated goal of empowering women. If, following Foucault, 
we understand subjects as produced through discursive and power relations (Foucault 
1980b), then it becomes necessary to analyse how the category `woman' is produced 
and regulated by the very networks of power through which empowerment is sought. 
As presented above, those working not only in the political arena, but within science 
itself, mobilised a discourse of vulnerable, powerless women and powerful, malevolent 
men. Given the number of senior male scientists themselves working on PRO 2000, this 
may seem self-defeating; however, crucially, the user of PRO 2000 was initially 
conceived of as the African woman, in the face of her adversary, the African man. Thus 
the vilification of men did not construct all men as reprobate, but specifically `other' 
men - those men in the `Third World' who refused to use condoms with their partners. 
A highly Westernized concept of oppression was therefore mobilised as part of the 
stabilization of the technology, whilst gender inequality in Africa was attributed to a 
distinctly non-Western form of male behaviour. Thus, while women's experience of 
subjugation was treated wholesale, men could no longer be taken as a unified and 
coherent category, and it is perhaps this fracture which led to the erasure of men from 
microbicides discourse. 
Given that power is exercised discursively through the production of subjects, it is 
ironic that microbicides are often discussed as `giving women power'. As I have 
indicated above, what is important to ask is not who has power and who does not, but 
how is power exercised through the interplay of discourses. Rather than trying to 
understand power as a general concept that can be given by one person to another, as 
advocates and researchers have implied, it is instead instructive to examine the 
techniques which enable the exercise of power and the production of knowledge. 
Foucault: 
Power must be analysed as something which circulates, or rather as something 
which only functions in the form of a chain. It is never localised here or there, 
never in anybody's hands, never appropriated as a commodity or piece of 
wealth. Power is employed and exercised through a net-like organisation. And 
not only do individuals circulate between its threads; they are always in the 
position of simultaneously undergoing and exercising this power. In other 
words, individuals are the vehicles of power, not its point of application. 
(Foucault 1980c: 98) 
The `net-like organisation' through which power is exercised extends through the social 
worlds of science and politics, with no discontinuity between, as Latour and Woolgar 
put it, the "controversies in daily life and those occurring in the laboratory" (Latour and 
Woolgar 1986: 281). Scientists' own discourse around women and men, as analysed 
above, makes this quite clear. 
If we take both technology and gender to be discursively constituted, can we 
legitimately claim that microbicides are a gendered technology, and further still, can we 
claim that this `gendering' is responsible for certain effects of the technology? On the 
first point I would argue that microbicides are indeed gendered, but that since gender 
itself is a discursively produced category open to constant re-contestation, this 
descriptor does not denote a necessarily enduring identity. To date, the gendering of the 
technology has been a scientifically, politically and commercially driven process 
deemed necessary to secure development of the PRO 2000 molecule. The question to 
pursue in the future will be not whether the technology is male, female or neutral, but 
how it comes to be interpreted as such. Secondly, on the issue of effects, women's 
health advocates, like eco-feminists more generally, assume that because microbicides 
are a female technology, the result will be empowerment for women. However, as 
Grint and Woolgar suggest: 
If what counts as feminine and masculine are cultural attributes, subject to 
challenge and change, then replacing masculine technologies with feminine 
technologies begs the question of what precisely (and who decides what 
precisely) is to count as feminine technology. Are all feminists the same? 
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Unless they are, changes to the technology will not resolve the problem of 
asymmetric control over the technology. (Grint and Woolgar 1995: 294) 
Again, what is more significant are the effects of the development process, whereby the 
technology comes to be constituted as a product for the powerless female in the first 
place. 
Ultimately, PRO 2000, the microbicide, exists only in and through our practices and 
discourse. We have seen that its properties do not pre-exist the user, but that through a 
global re-definition of the problem, both user and technology were together constructed. 
In the next chapter, I go on to discuss the planning and implementation of the MDP 301 
trial and the evolving relationship between those defining the research programme and 
those being defined by it. 
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Chapter Five 
Science in Action: The Microbicides Development Programme 
No one, no thing, no class, no gender, can `have power' unless a set of relations 
is constituted and held in place: a set of relations that distinguishes between this 
and that (distribution), and then goes on to regulate the relations between this 
and that.. . power, whatever form it may take, is recursively woven into the 
intricate dance that unites the social and the technical. (Law 1991: 18) 
Law's reference to socio-technical relations as an intricate dance reminds us that neither 
society nor technology are static or given, but are in a constant interactional process of 
becoming. The previous chapter drew attention the co-production of gender and 
technology in the emergence of the microbicide field. Key to the development of this 
field was the institution of clinical trials to test candidate microbicide products, such as 
PRO 2000 gel. Clinical trials - whether seen themselves as a technology, or as science 
in action - are part of the circuit of knowledge-power relations in which gender 
identities are produced. Recognising this, various writers have underscored the ways in 
which research practices can be implicated in reproducing systems of class, race and 
gender inequality, and how resultant knowledge is always discursively situated within 
specific relations of power (Kincheloe and McLaren 1994; Oakley 2000). In this 
chapter, I explore the knowledge-power relations at work in the institution of the 
Microbicides Development Programme (MDP) and its phase III trial to test PRO 2000 
(MDP 301). I focus on two major axes of difference which were pivotal in structuring 
and shaping this trans-national network: firstly, the constitution of Northern versus 
SouthernS° researchers and secondly, gender. 
SOBinka writes, "The term north-south is used to describe a pervasive geographical division whereby the 
north represents the richer countries of North America, Europe, Japan, Australia and New Zealand, and 
the south represents the poorer majority countries in Africa, Asia and Latin America" (Binka 2005: 207). 
As analytical categories, `Northern' and 'Southern', or 'North' and 'South', are problematic, since they 
are commonly used as coherent and unified cultural categories when it is impossible to delineate who, 
what or when Northern and Southern refers to. This is a point that Moore has underscored in her 
discussion of 'the West' as a discursive space and "imagined category" (Moore 1994: 131-132). In the 
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Although a distinction exists between MDP and MDP 301, this distinction proved 
difficult to pin down analytically. At the time of this research, MDP 301 was the only 
major piece of work the programme was funded to undertake; in conversation and in 
some interviews, the two entities - the trial and the programme - were often referred to 
interchangeably, their identities symbiotically linked. Therefore, rather than try to 
analyse the separate production of each of these parts of the research, in the following 
analysis I have treated them together, tracing discursive power relations and subjection 
through the research as a whole. 
Genesis stories 
Harry: I think Adrian representing MRC had gone on a visit somewhere with 
DFID, I can't remember where, it might have been Zambia... there was some 
visit that Clare Short did... and I suspect it's one of these back of the aeroplane 
chats over a gin and tonic where the whole idea of this had come up. 
Chris: From the outset DFID said that we couldn't possibly make decisions on 
our own and it's got to be academic, and we said absolutely, you know we don't 
want, we don't want to get any money without academic credentials, so... Harry 
then got involved and met various people, um, maybe did Harry and Kate go to 
meet Clare Short at one stage? Yah, it gradually sort of... it gathered 
momentum ... 
DFID liked it because it was aimed at sub-Saharan Africa, that 
was what we were selling them. 
Kate:... all the phase III expertise is very much here and Harry realised 
that... And so Dominic and I were pivotal in getting involved in it at that stage 
and saying, `how could we put together this network in Africa, where would we 
go, where were the academics in Africa, who could put together a cohort and we 
would check incidence. ' We had no idea; we knew there was no data... 
context of MDP, 'the North' was used to refer predominantly to the UK and the US, and 'the South' to Africa. 
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These accounts of the early days of the Microbicides Development Programme by UK 
researchers speak of the period before a formal collaboration between Northern and 
Southern scientists was set up. Stories of scientific hob-nobbing with politicians over 
gin and tonics in the back of planes to the tropics may be just that - narratives that 
conveniently package a more complex set of circumstances and events. However, they 
are also redolent of a past era in which the UK decided what was best for Africa. The 
story of MDP's evolution in certain respects mirrors the evolution of international 
development discourse; in the late 1990s, when MDP was being set up, the focus in 
these discourses was on relief; in 2000, it was aid, moving to development in 2001 and 
between 2002 and 2004 to `partnership' (World Bank). In October 2004, the House of 
Commons Select Committee on Science and Technology criticised DFID's lack of 
attention to capacity building in science, technology and innovation. The summary of 
the Thirteenth Report states: 
The frailties in DFID's approach to science, technology and research have had a 
detrimental effect on the support that DFID provides to developing countries. 
There is now an urgent need for DFID to commit significant extra funds to 
capacity building of science and research systems in developing 
countries... (Select Committee on Science and Technology 2004) 
DFID's response was to hire a Chief Scientist (Sir Gordon Conway) and to prepare a 
detailed strategy for supporting science, technology and innovation capacity building. It 
was into this policy environment that MDP 301, funded by DFID, was born. 
Since the mid-1990s, partnership has become the watchword in initiatives for 
development between North and South (Gaillard 1994; Fowler 1998; NEPAD 2001; 
Jentsch and Pilley 2003; Smith 2005). Partnership is espoused not only by DFID but by 
many other international development agencies, and is embedded within the Millennium 
Development Goals5' (Johnson and Wilson 2006). In the protocol that was written for 
the MDP 301 trial, the following definition of the research programme was provided: 
51 The eighth Millennium Development Goal is to "develop a global partnership for development". See http: //www. un. ort! /millenniumizoals/p, lobal. shtmi. 
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The Microbicides Development Programme (MDP) is a partnership set up to 
develop vaginal microbicides for the prevention of HIV transmission, funded by 
the UK Department for International Development through the UK Medical 
Research Council (MRC) and co-ordinated by the MRC Clinical Trials Unit 
(CTU) and Imperial College London. (MDP301 protocol version 1.3: 16; 
emphasis added) 
Subsequently - approximately five years later, and in the advent of the results of the 
trial - the MDP website was updated and provided the following information: 
The programme is in the forefront of north-south research partnerships in terms 
of the capacity it has built in Africa... and the degree to which it is African-led. 
Trial management is collegial52, with significant authority vested in the southern 
partners ... MDP 
has built a vigorous multicultural and multidisciplinary research 
network... Years of working collegially have built cohesiveness, efficiency and 
mutual trust among the scientists, clinical staff, data managers, and other 
professionals and support staff comprising this African-European and pan- 
African clinical trial network ... 
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Whilst this discourse of partnership can be seen cynically as a mere exercise in good 
public relations, I propose that it be analysed as part of the discursive domain of techno- 
scientific and social co-production. Latour has written that "two things are needed in 
order to build a black box: first it is necessary to enrol others so that they believe it, buy 
it and disseminate it across time and space; second, it is necessary to control them so 
that what they borrow and spread remains more or less the same" (Latour 1987: 121). 
Taking the Microbicides Development Programme as just such a black box, I explore 
below how collaborators were enrolled and controlled with a view to understanding not 
only the construction of one particular programme of scientific knowledge production, 
but how forms of difference, and their attendant power relations, intersected and were 
(re-)produced within it. 
52 Collegial is defined as "of or characterized by the collective responsibility shared by each of a group of 
colleagues, with minimal supervision from above. " (Dictionary. com Unabridged, Random House, Inc. 
http: //dictionary, re rence. com/browse/coliezial, accessed 21/11/09). 
33 http: //www. mdo. mrc. ac accessed 21/11/09. The MDP homepage contains 14 mentions of the word `partner' or 'partnership', indicating the centrality of this concept to the institutional discourse. 
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The discursive production of partnership 
In 2004, when the protocol was being written for the MDP 301 phase III trial of PRO 
2000, there was no `proof of concept'54 for microbicides and only a handful of trials had 
been conducted. Propounding a scientific discourse of high risk and uncertainty, senior 
investigators confided that "no one really had a clue how to go about it" (Harry) and "I 
think it was all very vague in the beginning, this was all some crazy idea that nobody 
would do" (Chris). The language of lack and uncertainty suffused accounts of taking 
PRO 2000 forward to clinical testing in Africa: no one knew how much it would cost to 
follow ten thousand women up for three years; there was no fixed answer as to what to 
do with the additional pathology that the trial uncovered in participants; and there were 
additional ethical questions such as what standard of care should be made available to 
those who were found HIV positive. UK scientists presented themselves as pioneers, 
the element of uncertainty dovetailing into that of celebrated scientific risk-taking; as 
Hackett notes, "we celebrate heroic accounts of scientists who take risks pursuing ideas 
that others think unlikely to succeed, and the rhetoric of science funding policy abounds 
with praise for high risk/high reward investments" (Hackett 2005: 805). 
Senior UK researchers created accounts that quasi-mythologized the scale and gravitas 
of the undertaking, making reference to high-level meetings with UK politicians and the 
important work international delegations had conducted across the globe. The 
potentially rather mundane institution of bureaucratic structures to run the trial was 
framed in terms of delivering cutting edge scientific results at the highest national and 
international levels: 
... at the sort of 
highest level, programme level, when we first got the award in 
2001, um, Celia and I had lunch with Clare Short and she said very clearly, 
"you two are responsible for delivering this [chuckles] - go away and make sure 
that it works properly! " And um, so, you know, we took it quite seriously and set 
up the structures to protect us from being criticised. (Harry) 
5' Proof of concept provides clinical confirmation that an investigational product possesses a desired 
pharmacological effect in individuals with the condition of interest. In terms of vaginal microbicides, 
proof of concept studies are designed to ascertain whether the product is effective in preventing HIV 
infection in sero-negative women. 
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Harry and others I spoke to outlined various strategies that were mobilised to legitimate 
the programme and deflect potential problems, such as cementing academic credentials 
in the UK (primarily linking Imperial College with the Medical Research Council) and 
carefully building up a network of trusted partners in Africa. Although governance was 
implied in the exhortation to make sure that the trial `worked properly', the ensuing 
discussion was of `partnership'. 
According to Harry's account, the choice of partners was calculated to offset the 
unknowns of the scientific process. In other words, the deficit in knowledge amongst 
UK researchers as to how to conduct such a large population-based trial in Africa was 
compensated for by choosing well-known Africa-based colleagues as partners. In this 
respect, it can be seen as capacity-building of the Northern partners, although this was 
never suggested by my informants. Harry was, in Latour's terms, the central 
`entrepreneur, ' in that he enlisted allies from a range of locations and aligned agendas to 
meet a common programmatic goal. 
Harry: I knew Site A because 1'd set it up with [funding body], so we knew what 
their capacities were. Um, Jane, I knew, because I'd been at university with her 
many years earlier and so I knew what she was doing, and she was a natural 
person to approach. Dominic knew the Zambian crowd and um, er, he brought 
them on board. And then I think Celia brought Institute Alpha on board through 
Site B because she approached them originally through Phillip. And um, and 
I'd always planned to do vaccine work in Uganda but we'd also started the work 
in [place] with the Uganda group, so they were an obvious group. So that's 
where the groups came from; a mixture of, you know, people you knew... 
CM: So, sort of through existing networks? 
Harry: People you knew or people, you know, friends of friends as it were. It 
was done, it was done like that, yes, it wasn't a call or anything. And um, but 
nobody had done any population-based work, not one of those groups, no one 
really had a clue how logo about it. (Emphasis added) 
As this extract demonstrates, friendship and familiarity compensated for a lack of 
knowledge, experience and expertise in this particular field of scientific development; 
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the extract also points to the continuity of the networks of social relationships within 
science with networks in society as a whole55. By referring to these choices as "natural" 
and "obvious", Harry naturalised and thereby legitimated the process of selection; 
Dominic used a similar mechanism, describing both sites C and D as "a logical group 
to work with" and site B as "a natural, a good partner to work with" (emphasis added). 
In line with Max Weber's types of grounds on which claims to legitimacy can be based 
(rational, traditional, and charismatic grounds) (Weber 1978), senior researchers 
appealed to the (often institutional) logic of particular partners, long-standing pre- 
existing relationships, and the outstanding qualities of individual site leaders. The 
esemplastic banner of the "Microbicides Development Programme" formalised these 
friendships into a scientific network and gave them a corporate identity, obscuring the 
social accomplishment of the scientific programme. 
It was crucial at the outset that the programme's figureheads, to whom DFID had 
entrusted £40 million of tax payers' money, establish the legitimacy of the programme 
and maintain authority over the collaborators. Although MDP was dynamic in 
constitution, for the most part it comprised a stable membership of academic partners 
and clinical sites. These included six phase III sites in four African countries, and a 
feasibility site in a fifth; five UK universities and a sixth in Spain; and numerous 
consultants, research council branches and hospitals. Most of the partner sites and 
institutions themselves consisted of many individuals, from senior academic professors 
to junior operational staff. In 2007, when I started fieldwork for this study, MDP 
comprised over forty staff in Europe and over 350 in Africa, with each clinical trial site 
employing an average of 63 staff (MRC/DFID Microbicides Development Programme, 
Fourth Annual Report). The sheer size and geographic dispersal of the programme's 
members required leadership, unification and governance; as I discuss below, the 
partnership discourse was fundamental to achieving this, both by enrolling the 
collaborators and controlling them. 
351 have paraphrased here from (Collins 1985: 165). 
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From sovereign power to govern mentality: `Partnership governance'56 
"It's a democratic organisation, MDP, and it represents, it arises out of its members " 
(Chris) 
`Partnership governance' has been used to describe a form of governance based on 
networks rather than hierarchies and on participatory democracy (Fairclough 2005). 
This idea builds on Foucault's development, in his later work, beyond technologies of 
domination (as was the focus, for example, in Discipline and Punish) to the concept of 
governmentality, which he used to describe the kinds of power exercised in the 
management of populations or groups of people (Foucault 1991). Foucault suggested 
that within liberal democracies, governance rested not upon quashing subjects' agency 
and forcing them into submission, but upon directing their agency in particular ways. 
Governmentality represented the nexus between technologies of domination and 
technologies of the self (Petersen and Bunton 1997), for, as Burchell observes, 
"government in general is understood as a way of acting to affect the way in which 
individuals conduct themselves" (Burchell 1996: 20)57. Gallagher has argued that this 
notion of governmentality contains an important ambiguity: 
On the one hand, those who exercise such power attempt to make those whom 
they are governing so effective at regulating their own conduct that they will 
ultimately have no need of any external supervising power. Persuading people 
to participate in their own subjection in this way can be seen as the most 
cunningly efficient mechanism of power, enabling those who govern to do so 
with the bare minimum of intervention. Yet equally it can be argued that the 
ability to subject oneself to a set of behavioural principles - in Foucault's terms, 
an ethics of the self - is in fact the very basis of autonomy. In other words, by 
developing human beings' ability to govern themselves, governmental power 
56 1 do not wish to imply a simple chronology here from sovereignty to governmentality, but rather 
movement around systems of power; as Foucault noted, "we need to see things not in terms of the 
replacement of a society of sovereignty by a disciplinary society and the subsequent replacement of a 
disciplinary society by a society of government; in reality one has a triangle, sovereignty-discipline- 
' 
dovemment.. " (Foucault 1991: 102). 
According to Foucault's well known maxim, government is the `conduct of conduct' (Rose 1999: 3). 
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actually ends up equipping those humans to become independent agents, no 
longer beholden to externally imposed systems of rules (Gallagher 2006). 
That subjects are not simply subjected to governance but are required to participate is a 
point that Rose has previously made in his analyses of governmentality (Rose 1992; 
Rose 1999). 
Partnership governance - as an example of Foucault's governmentality - was key in 
creating the cohesive and functional scientific network that came to be the Microbicides 
Development Programme. As Fairclough has noted, partnership governance has a 
significantly discursive character (Fairclough 2005)58; In MDP, discourses of 
democracy and North-South partnership were ubiquitous, as some of the above quotes 
illustrate. In addition to formal contracts, such as the MDP Framework Collaboration 
Agreement, signed in January 2006, these discourses can be seen as a fundamental tool 
of governance, binding disparate international groups together and gaining consensus on 
future scientific protocols. The image below shows the MDP organogram, notable in 
two respects: firstly, in structure - almost entirely flat; and secondly, in name - 
`organogram' from the Greek, literally signifying a drawing of the body59. This 
representation of the disciplinary power structures that composed the programme was 
shared with collaborators and trial staff on a regular basis, for example at training 
workshops and international meetings; it was disseminated by email, used in 
PowerPoint presentations and became a staple point of reference in discussions of 
participation, communication and governance. It was also made public on the MDP 
website (http: //www. md]2. mrc. ac. uk/govern. htmi). 
58 Rose has also argued that "it is possible to govern only within a certain regime of intelligibility - to 
govern is to act under a certain description. Language is not secondary to government; it is constitutive of it. Language not only makes acts of government describable; it also makes them possible" (Rose 1999: 28). 
59 Örganon- implement, tool, bodily organ, musical instrument; grämma - something drawn. 
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Figure 2: Microbicides Development Programme Organogram 
It is difficult to identify any hierarchy in the representation, not least because the 
representation includes a mixture of human and non-human elements, for example 
`Budgets, Workplans, Targets' and `Independent members of ISAG and Investigators 
from PMB'. The symbolic function of the arrow lines is ambiguous: do these refer to 
the direction of reporting and accountability; do they denote group composition; do they 
indicate lines of communication; or a mixture of all of the above? `Scientific 
Disciplines' are given independent status, but it's not clear how they are either linked or 
divorced from every other aspect of the programme. There is no peak or gradient, as 
there would be with a traditional triangular structure; rather, arrow lines coalesce in 
latitudinal hubs to the left and right of the diagram. In short, the image represents 
visually the `collegiality' to which the MDP professedly aspired (see quotation from the 
MDP website above). 
As Fairclough, again, has noted, "there is continuity between partnership as a mode of 
governance and partnership as a way of working" (Fairclough 2005: 7). In accordance 
with this observation, the widely disseminated image above constructed a collective 
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identity that unified the plurality of groups and individuals involved in the programme, 
both for work and governance; in Latour's terms, it both enrolled and controlled them. 
Furthermore, it did so in such a way that existing divisions and hierarchies between 
disciplines and sites were overridden; all those involved became part of the body of 
MDP, all an equal part of the functioning whole. To the person looking at the 
representation, power relations appear diffuse; however, UK scientists' accounts of the 
programme suggested this was not necessarily the case (see below). Thus, the 
representation itself can be seen as a technique of power, designed to create functional 
scientific collaborators. 
The organogram was part of a larger discourse of participatory democracy which 
produced cohesion amongst the scientific partners. Kate liked to refer to the programme 
as "the MDP juggernaut", vividly evoking the size, power and momentum of the 
collaboration. Again, this was an image that was publicly presented several times, 
along with MDP songs, poems and raps that humorously extolled the aims of the 
programme and a shared commitment to making the trial work (for example the MDP 
training video for new staff members contained two raps - one on team roles, and the 
other an "Ode to GCP"). These entertaining devices were mobilised at site training and 
monitoring visits and can be seen as an efficient means to promote `government through 
freedom'60 (songs and raps are not seen as work, supervision or disciplining, but as a 
fun distraction from these). They provided a forum for group participation and 
inclusion of all cadres of staff, without the prospect of debate and conflict (which 
ideally characterise democracy). 
Uniting the partners around a common protocol was essential to moving the programme 
forwards to undertake its first phase III trial. As May has noted, the symbolic capital of 
the clinical trial arises in part from the purity of the design and associated scientific 
rigour; the randomised controlled trial is the touchstone of clinical epidemiology, and 
the standard against which other research and reputations are measured (May 2006)61. 
As such, the design of the trial, codified in the protocol, had both to meet the demands 
60 Rose: "... when it comes to governing human beings, to govern is to presuppose the freedom of the 
governed" (Rose 1990: 4). 
f Or to borrow Collins' terminology (which he uses to describe the work of core-sets), protocols reflect 
the "transubstantiation of social contingency into methodological propriety" (Collins 1985: 145). 
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of scientific peer review and unite the sites around a common methodological 
undertaking. During the Feasibility studies for the trial, the sites were given a relatively 
free reign, provided information on key aspects, such as HIV incidence, was generated. 
The phase III trial itself, however, had to be standardised and attention to local context 
minimised. As Dominic noted, "there's a fairly defined structure, and so it's really 
populating the different sections of that protocol. And protocols... often run into fifty to 
a hundred pages or more, you know, because they've got to deal with all sorts of issues 
of how you handle serious adverse events and so on. So it's very clear to the people 
running the study on the ground just what they've got to do in different circumstances. " 
The elements of central standardisation and defining structures are clear from 
Dominic's remarks. However, many of the UK scientists I interviewed who had led the 
initiative emphasised how democratic the process of protocol development had been. 
The discourse of democracy and partnership in creating the protocol was deeply 
embedded in relations between the centre and the sites and was a commonly noted 
feature of the trial outside the organisation itself. Accounts from my key informants on 
the details of the process revealed a certain tension between democratic participation 
and top-down control. For example, Kate called the development of the 301 protocol "a 
very participatory exercise", but the way she described the process belied the ultimately 
autocratic approach to writing it: 
... so we sent the topic out62, the sites then sent a response 
back, we collated the 
response, sometimes that meant creating a table, sometimes it just meant, you 
know, summarising key points for discussion in an agenda, and then we had a 
conference call, and then we resolved things on the conference call. And some 
conference calls were very non participatory, so for example, topic 2, which 
was the design... it was non participatory, definitely, nobody had an opinion. 
Once Dominic and Phillip had said, what they, you know, I think Dominic 
managed that thing and put that document out and then Phillip must have done 
the next one, 'cause they did 1,2,3, and then I did all the rest of them I think 
after that...! mean there wasn't much anyone really had to say about, about, I 
62 Seven topics were sent out in total and discussed via teleconference. 
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mean, it's a randomised controlled trial [laughs] in women [laughs]! (Emphasis 
added) 
Two points are worth noting in this account. Firstly, Kate describes the mechanisms 
through which controversies were closed and scientific consensus reached: the UK 
scientists sent proposals out to the sites and set the agenda for their discussion on 
teleconferences, acting as the scientific gatekeepers (or in actor-network terms, an 
obligatory point of passage). Secondly, she depicts the conference calls, around the 
design of the trial as non-participatory. Whereas "there was lots to say about" the 
behavioural aspects of the study (i. e. the social science), the design was a foregone 
conclusion. That "nobody had an opinion" about it shows the extent to which the 
randomised controlled trial itself is a stabilised construct and therefore able to act as a 
closure mechanism. Dominic was more explicit about the limitations to participatory 
democracy, underscoring that the key task of writing the scientific protocol was done in 
London. According to his account, the opportunity for the Southern partners to 
comment was constricted both by the foreclosure of controversies in the written 
protocol format, and reticence about `appropriateness': 
... we 
did have a number of discussion groups around topics relevant to the study 
design, where by teleconferencing, we brought people in to address the issues... 
And so it was a democratic process in that sense. When it came to actually the 
writing of it, I think it's probably fair to say however that almost all of it was 
done in London and drafts were sent to Africa for people to comment on. But I 
always think it's harder for them to suddenly receive a fifty to one hundred page 
document to comment on than if they're sort of seeing earlier stages of the 
document and to be able to comment, you know. And there's a sense, too, that if 
they're not too familiar with it, that er, they may be... a little bit shy of making 
comments, in the sense that whether their comments may or may not be 
appropriate, erm. But it was, yes, but there was some democratic element to it, 
but perhaps not as much as there could have been. 
Dominic's enigmatic remark about the appropriateness of comments from the Southern 
sites suggests an unequal knowledge relationship between partners that led to the self- 
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censoring of those in Africa. Nonetheless, through the provision of an opportunity to 
participate, a liberal-democratic' form of governance was established, with the sites 
`participating' in their own subjection. 
Given Dominic's apparent ambivalence about this format of North-South protocol 
development, I asked if the process would be any different next time round. He replied: 
I think it would be very similar, erm, I would like to think there might be one 
way it could be done, would be that you might have a... a week's workshop in an 
African site at which you brought together the potential African people to sort of 
sit and sort of brainstorm over that at an early stage, maybe an earlier stage 
than we've done in the past. Having said that, of course, the germ of the idea of 
quite what your hypothesis is going to be and what, how you're best going to 
test it, that almost certainly has to come - it comes from a small group of people 
in the first place who, er... will often be coming from the same people who 
perhaps designed earlier studies. But there's nothing to say that it couldn't 
come from, that the starting ideas couldn't come from somebody in the South as 
well. 
In this extract, Dominic signals the replication of expertise as a Northern prerogative. 
Whilst he proposes the possibility of shifting the locus of scientific leadership to the 
Southern partners, this suggestion is undercut by hesitancy. His reference to the "small 
group of people" who have "the germ of the idea", who decide the hypothesis and its 
experimental testing, resonates with Collins' concept of the core-set in science (Collins 
1981; Collins 1985). The core-set is the group of scientists who are involved in the 
resolution of scientific controversies and fact-making63. That the process of protocol 
design and decision-making would be "very similar" for future studies and would 
"almost certainly" come from within the same group of Northern scientists suggests the 
way in which scientific expertise can be retained as the preserve of Northern partners 
while discourses of partnership and capacity-building sustain a collegial scientific 
network. 
63 Note: although some of my UK key informants were in the core-set of the microbicides field, I have not 
undertaken a core-set analysis, which would include scientists from a much wider range of countries. 
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A tale of two technologies? The differential use of gender to enrol allies 
Every time an inside/outside division is built, we should follow the two sides 
simultaneously... . (Latour 1987: 176) 
Since I was interested not only in the relationships around the development of the 
protocol, but also the relationships the protocol itself projected into the trial, I asked my 
key informants about how gender had been conceptualised and incorporated into the 
document. At the time I conducted the interviews, I had not made a distinction between 
`the protocol' and `the trial', having been successfully enrolled myself into the MDP 
black box. However, Dominic inadvertently brought this division to my attention: 
CM. - I've been raising the extent to which men are involved or detailed in the 
protocol, but lots of people who I've spoken to say, "well a) what's the point and 
b) it'd be far too costly"... 
Dominic: Do you mean... Oh, you mean involved in the trial, you mean in the 
trial not in the protocol? When you say in the protocol do you mean... ? 
It was only after the interview that I noticed this inside/outside division between the 
two. From a `protocol-perspective', the UK scientists were all uniformly confused 
when asked about how gender had been considered. The bottom line was that it had 
hardly been considered at all during the writing of the protocol, and where it was 
considered, this was in relation to the `soft' side of the science, that is, the social 
science: 
CM: And did gender come up as a topic for discussion during that phase of.. 
Kate: [Interrupting] No. Well, I mean yes and no, but, so,... so um..... errrr, I 
mean obviously we, we um,... errrr, oooh, now I can't remember in that so, at 
what stage we would have.... trying to think where, you know, where, where we 
got, sort of, um, errrr, at what point we decided to develop the social science in 
the way it developed with focus group discussions with men and enrolling a sub- 
group of male partners, um, I mean that was always there. I can't actually 
remember that being discussed but I guess it must have been discussed... um... I 
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mean it must have been there rubbing along in the background of several topics 
I would imagine, but I don't specifically remember. We certainly never made it 
a single topic. 
Kate illuminated why this was the case: 
It's still going to be a randomized controlled trial, with a placebo, there are 
gonna be the same targets you're chasing, it doesn't matter that it's female, 
none of that makes any difference. And the only difference is that you only want 
to recruit women... with some, you know, due diligence to the men. 
Speaking of men enrolled as part of a couple cohort at one of the sites, Harry also 
commented: 
There was no scientific advantage in (recruiting the men)... no, they were just 
another route to getting a population of women at risk of HIV where the risk, 
you know, was substantially great such that you could power a trial... 
The design of the randomised controlled trial was presented as so conclusive in 
providing robust scientific answers about drug effectiveness that gender was irrelevant. 
`Gender relations' were addressed in a token way by including some in-depth 
interviews and focus group discussions with men into the social science part of the 
protocol, but beyond that, the RCT and its de-contextualising logic prevailed. As Mort 
and colleagues have underscored in their work on telemedicine, "local innovations have 
no place in trial methodologies: indeed, they undermine the very notion of a trial" (Mort 
et al. 2004: 120). This is a point that May also makes when he writes that "clinical 
trials are founded on denying interpretative flexibility in practice to those working 
within them because they rely on the imposition of a rigorous trial protocol on everyday 
practice and thus the standardisation of clinical practice" (May 2006: 525). In order for 
the broader scientific community to be enrolled into the science, it had to be seen to be 
pure and divested of social contingencies such as gender. The protocol was the 
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technology through which methodological propriety was established and social 
64 contingencies erased. 
However, as Dominic indicated, the protocol was not the same thing as the trial. It was 
a technology for scientific fact-making and enrolment of members of the core-set, but it 
was not a technology for enrolling other interest groups, such as the funder or the 
extensive cadre of junior researchers required to carry out the work of the trial. For this, 
a different tool was required, addressing a different set of interests; as Latour has noted: 
The first and easiest way to find people who will immediately... invest in the 
project.. . 
is to tailor the object in such a way that it caters to these people's 
explicit interests. As the name `inter-esse' indicates, `interests' are what lie in 
between actors and their goals... (Latour 1987: 108-109) 
The tool in question was `capacity-building', which was high on the agendas of both 
DFID and the Southern partners who would be implementing the protocol. 
Capacity building: Feminizing the science 
"Capacity building of science and research systems in developing countries" was of key 
interest to DFID, and as Harry told me, was in some ways seen as the uppermost 
concern, in contrast to the scientific priority of the programme's initiators: 
I think the idea that this was a trial where you didn't know the answer was not 
originally part of DFID's thinking [chuckles] ... I genuinely think it 
didn't occur 
to them at the outset that this was an unlicensed investigational product. I think 
s' In designating the protocol as a technology in this way, I follow May, who, in a study of protocol 
development for telemedicine proposes that "the protocol itself was a kind of technology: a way of 
constructing design and practice... " (May and Ellis 2001: 1000). Furthermore, the protocol might be 
seen as what Rose has referred to as a 'technology of government': "A technology of government ... 
is an 
assemblage of forms of practical knowledge, with modes of perception, practices of calculation, 
vocabularies, types of authority, forms of judgement... human capacities, non-human objects and devices, 
inscription techniques and so forth, traversed and transacted by aspirations to achieve certain outcomes 
in 
terms of the conduct of the governed" (Rose 1999: 52). 
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they thought of it as an intervention ... It took quite a while for the penny to sink 
in that it might not work. 
While the rationale for microbicide development was predicated on the need for 
women's empowerment, as outlined in the previous chapter, the empowerment 
discourse served additional purposes within the MDP: to enlist the cooperation of the 
partners and to immunise against the possible failure of the pharmaceutical product. In 
other words, even if the `science' failed because the drug was found not to be effective 
in preventing HIV, there would still have been a `social' success in newly empowered 
African scientists. During the course of the trial - and notably, shortly after one arm of 
the intervention had to be stopped prematurely65 - the capacity building discourse 
started to frame the way the UK scientists also described the trial. Harry: 
It would be hard not to see that if you do an intervention of this scale and 
duration in these populations, then, you know, you are quite clearly the 
intervention itself; irrespective of the gel and the compound within the gel. 
We'll change women's lives and the lives of people and of their partners and of 
their communities by, by the premise of being involved in the study. (Emphasis 
respondent's own) 
In a sense the capacity building and empowerment discourses were conflated so that not 
only would the gel empower women (trial participants), but the trial would build 
women (scientists') capacity. As such, even if the gel were not scientifically shown to 
be effective, the money DFID invested in the programme could still be said to have 
been well spent. 
The combined women's empowerment/capacity building discourse permeated the MDP 
and was re-iterated by numerous scientists in both the UK and Zambia. It contributed to 
the ethos of the programme and although the sites had a mixed composition of male and 
female staff, the feeling was that this was a `female' programme. Dylan: 
bs In February 2008, the 2% PRO 2000 arm of the trial was discontinued following recommendations 
from the Independent Data Monitoring Committee (IDMC). This was seen as a major blow to the trial 
and raised the prospect of a negative result for the product. My interview with Harry took place 
in the 
same month, shortly after this announcement. 
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I think the research process has a much more powerful effect than just the 
introduction of some product. And that also applies not only directly to the 
participant women, but to the researchers themselves. I mean, in these sorts of 
studies, most of the research team is women, a lot of the doctors are women, a 
lot of the interviewers are women, they also move up in the status hierarchy 
compared to men... I mean programmes like this get set up like that, you recruit, 
you automatically recruit women because you're gonna be working with women. 
So you end up having a sort of female, female team, which I think then impacts 
on the communities, 'cause they see all these empowered women rushing around 
with stethoscopes and tape recorders and... it's empowering in itself 
Dylan was clearly referring to the African scientists in this extract and not to the UK 
scientists. The construction of scientists along racialised and gendered axes was 
apparent in the discourses mobilised as part of `capacity building'. Within MDP, 
`scientists' and `women' were often discussed as if they were mutually exclusive 
groups, with "women" used to refer either to the African trial participants specifically or 
to all disempowered African women in general. However, at times, the female African 
scientists also became the object of a discourse of empowerment associated with 
capacity building. That this same discourse was not mobilised to talk about the UK 
women working on the trial suggested that the lines of division between `us' and `them' 
ran along different faults: gender, location, discipline, career position, role. These 
translated into dichotomies such as male/female; developing world/industrialised world; 
PI/fieldworker; scientist/trial participant, which shaped interactions within the 
programme. As Winch has noted, "A man's [sic] social relations with his fellows are 
permeated with his ideas about reality. Indeed, `permeated' is hardly a strong enough 
word: social relations are expressions of ideas about reality" (Winch 1958: 23). 
Conforming to the empowerment-capacity building discourse, the staff I interviewed at 
the Zambian site discussed how MDP Zambia had transgressed normal patterns of 
gendered staffing, whereby men occupy the most senior positions and have ultimate 
responsibility for decision-making. In MDP Zambia, the principle investigator, project 
coordinator, project manager, senior clinician (sister site) and senior counsellor were all 
women; many of the other posts were also held by women, thus giving them a critical 
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mass. Crystal, a community mobiliser, encapsulated many of the ideas raised by others 
in the following description of how working on the programme had `changed' her: 
Working on this project has changed the staff members, including myself. 
Because what I have learnt in my past three years I think has really contributed 
to my wellbeing; I've been... there's been a huge capacity building in myself, 
even the day I will leave this project, there are a lot of things I have learnt, not 
only HIV related, but a lot. Yah, this project has taught me how to work, how to 
meet targets, how to associate with fellow staff, how to (not) condone when 
somebody steps on your toe, you know, we are many, we are from different 
backgrounds. The project has taught me a lot... the experience that I've got at 
MDP is awesome and it will make me somebody one day. (Emphasis added) 
The staff re-iterated the discourse of capacity building, as highlighted above, and 
indicated how the governing structures of the programme, such as working to the 
protocol, had made them who they were. Going back to Gallagher's point made earlier, 
in subjecting themselves to partnership governance and working to the programme's set 
of behavioural principles, female staff acquired an ethics of the self and thereby realised 
their own agency. 
Any capacity building that took place did not take place in a value-free context, 
however, and the gendered nature of reported changes apparently created tensions 
amongst the staff. For example, some male employees were resentful about their 
minority position and critical of women occupying senior posts. Michael, one of the 
research assistants, was a case in point, expressing frustration at having to seek 
permission from female heads of section and at working as part of a predominantly 
female team. He was scathing about his female colleagues, claiming they gossiped, 
weren't straightforward, delayed work, were full of empty politics, and were all talk and 
no action. In his opinion, having more men on the team would have improved 
performance: 
CM: So you think perhaps if there was a man in the senior job things would be 
more effective at the site generally? 
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Whereas inside MDP, he could joke around and make light with other staff members, in 
front of his wife he would need to be serious, act the boss, and be in control: 
Last time when you were saying John's wife should apply - is he going to be 
free? Because he's free here to chat, he'll chat with this one and that one, then 
he goes home. But when the wife is around, he has to act like a real boss, 
walking majestically [laughs], not talking rubbish, just keeping himself as a 
married man. (Ben, MDP research assistant) 
It was felt that because of the shift in gender relations amongst staff members, spouses 
would be unable to work at the site: "... here you can't work with your wife. You can't 
work with your husband here ". Comments such as this suggested that a very particular 
set of gendered power relations was instituted at the site, which framed the knowledge- 
making process of the trial. 
Capacity building: The co-production of Northern and Southern scientists 
In addition to transgressing the normal gender hierarchy within the work place, staff in 
Zambia drew attention to ruptures in the hierarchical relationship between North and 
South. This was something that the UK scientists presented as a conscious part of the 
programme - to "empower the sites": 
We did try, as a matter of, of sort of philosophy, to try and make the sites as 
independent as possible within the trial and to empower the sites as it were, um, 
to... to feel that they were taking a role in leading the research rather than just 
being a cog in the wheel. And I think that's been quite successful. I think, so 
you know, if you go and visit any of the sites, you know people do feel ownership 
of it, over and beyond. (Harry, emphasis respondent's own) 
MDP was said by scientists in the UK and Zambia alike to be radical in devolving 
power from the central to the site level, for example in terms of data collection and 
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project management. I asked staff in Zambia how they felt about working at MDP and 
what they thought of its organisation. 
In terms of MDP being a democratic organisation, staff members spoke of how this 
ethos had permeated their working practices, both amongst themselves locally and in 
relation to colleagues in the UK. A key aspect underlying this was the fact that the 
initial training for the study had emphasised the need for all members of staff - from the 
cleaners to the clinicians - to be conversant with the protocol. During initiation training 
visits by the UK researchers, all members of staff had been required to attend and were 
treated with equal respect; as any member of MDP at any site would have told you, the 
clinical PI knew everybody's name, no matter how lowly their position within the team. 
The ongoing working relationship between the coordinating and trial sites continued to 
remain focused on the principle of partnership; the associated values of respect and 
equality were what some respondents alluded to. For example, Ben, a research 
assistant: 
Ben: Sometimes if you compare with what happens in government offices, it's 
not what's happening here. 
CM: It's not? 
Ben: No. In government offices there are really rules, there are real rules, 
whereby somebody who cleans, someone who is a cleaner or a receptionist, is 
supposed to give respect to people like us in the offices. A receptionist cannot 
just come in and (say) [in a silly female voice] "Hi Mr Ben ", chatting, no. 
When she comes here it's real business. Real business. Like you can even say, 
[pointing to the dirty cups] "can you get these, take them into the kitchen" but 
here you can't do that, I have to carry them myself to the kitchen and take them 
back Because we're just open, just free, everyone knows what they're supposed 
to do. (Ben, MDP research assistant) 
Ben's observation about the difference in working style and discipline between MDP 
and government offices points to the programme's effective use of participatory 
democracy as a form of governance. Instead of answering to a sovereign power 
(embodied in "real rules"), the staff became self-regulating - "everyone knows what 
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they're supposed to do ". This reportedly led the staff to feel free, again underscoring 
the freedom or agency of the governed under governmentality as a system of power. 
Although Ben's account of liberatory working practices at the research site refers to 
internal staff relations, we might speculate as to whether the values he alludes to 
contributed to the staff's interactions with women participating in the trial, women's 
experience of participating in the trial and their subsequent relations beyond the trial 
site. 
In addition to within-site interactions, Marley, one of the social scientists, spoke at some 
length as to how the relationship between the trial site and the coordinating sites in the 
UK had impacted on staff members locally: 
Marley: The design is very ... empowering because as a site it gives you room to 
think; to deal with a problem, and then they come in to actually help or steer 
your thinking and then see what solution comes out... I think the design really 
helps with the aspect of devolution, if you like. 
CM: Devolution? 
Marley: Devolution, maybe devolving power. 
CM: Explain what you mean by that. 
Marley: Devolution is where you really give power to a local unit to actually 
make decisions. So in the MDP trial now, where there is - there's quite a lot of 
devolution of power to the sites. The sites, if they have problems - it's 
interesting the way you try to deal with them. You steer. They can say "there is 
this problem and that " and then the site identifies problems and tries to come up 
with an intervention and then see how they work. So there is that feedback and 
that's, I think; empowering, that devolution. And I've seen other designs, they 
are actually very centralised. They just enter everything you send, everything 
you send. And then people remain the way they were even before the trial 
started. And 1 can tell you what you have developed in most of these ladies and 
gentlemen are long time, long time scientists and community members, who 
actually put their skills together to be better trialists. (Marley, MDP social 
scientist) 
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Marley contrasted the design of MDP 301 with other international trials, many 
coordinated by US scientists, in which African trial sites `harvest' data but have no 
ownership of them. Such centralised organizations were felt to be imperialistic and 
disempowering to local staff. In this respect, the collaborative nature of MDP and the 
discourse of partnership rather than central control was presented as a keenly felt and 
appreciated aspect of the programme: 
I'm part of the MDP team and to me, I would say it's a privilege. Zambians, we 
haven't been many other times participating in such kind. Mostly we just enjoy 
things coming from outside without, you know, participating in it, so being 
considered... really to participate in such a kind of trial, you know, I would say 
it's an honour. (Colin, MDP community mobiliser. Emphasis added. ) 
In contrast to many other international (or so-called `offshore'66) HIV prevention trials, 
MDP was felt by several staff members to be creating scientists in situ, building 
expertise at the site of the research rather than annulling the possibility of it. The very 
strength of this was the soldering of social worlds, with those from the trial community 
acquiring the knowledge and skills to study their community themselves: 
But the fact that I'm working in a trial and there is - in me, there are two people; 
there's the scientist, and then there's also a community member, because I grew 
up ftom here. And I think there's nothing better than that, because I have that 
satisfaction of saying, dc as a scientist I'm really seeing how good science can 
be for the community. Then as a community member I can really see how 
science is making me become a better community member. So as an individual 
that has really brought in two dimensions. (Marley, MDP social scientist) 
This trial-created discourse suggests the extent to which MDP successfully enrolled 
young African researchers from within their own (social) communities into the MDP 
(scientific) community. His reference to the double-sided face of the community- 
member/scientist points to the continuities between science and society and the 
"See (Rosengarten and Michael 2009b) 
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constructed nature of the distinction between the two. The two, in a word, are co- 
produced. 
So far it should be clear that both the Northern and Southern partners propounded a 
discourse of Southern capacity building and empowerment. However, there was no talk 
of Northern capacity building and empowerment, a pattern that has been observed in 
prior studies. For example, Jentsch and Pilley have identified "the assumption of 
Northern superiority, especially related to capacity building" as a problem within North- 
South health research partnerships (Jentsch and Pilley 2003: 1958); see also (Lewis 
1998). Although it was only rarely stated that the expertise in MDP was located 
amongst the Northern partners, UK staff's frequent comments about capacity building 
of the Southern partners implied that this was the case. For example, extolling the 
virtues of the programme, Gill, a UK consultant commented: 
... you go to an 
MDP international meeting and you've got a completely different 
sense, you know, it's very Southern ... I wouldn't say Southern-dominated, 
but 
you know, you just see capacity being built and you see these... oh I mean and 
you see how much capacity there already is, you know there are these 
fantastically bright, exciting, idealistic people involved in MDP all round the 
world. 
Even though Gill acknowledges existing Southern capacity, she indicates that MDP is 
special because it is building the capacity of Southern partners. She goes on to say, 
So whether or not PRO 2000 actually works, you know I think we'll have built 
something in Africa that's tremendously important that will cascade outwards... 
The coincidental juxtaposition of `domination' with capacity building in the first extract 
is telling about the role of partnership, and its corollary, capacity building, in the trial's 
mode of governance. 
In spite of the lack of public discourse about Northern capacity building, and in spite of 
the presumption of Northern expertise, there were numerous occasions on which UK 
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scientists indicated that they too had been produced as part of the trial. This related to 
scientific language, symbols and procedures, for example, Dylan: "I was a bit puzzled 
about what a CRF was, I'd never heard about CRFs before and it only gradually 
dawned on me that it was a sort of questionnaire, it just had a fancy name "67. It related 
to the product being tested: 
Patrick: I haven't, you know, I've never even seen gel [laughter]! 
CM: No, I don't think lots of us have seen it; I haven't seen it. 
Patrick: [Laughter] five years down the line [laughter]. 
And it related more fundamentally to the nature of the intervention itself: 
Harry: When we started, my wife was constantly saying to me, "You know, come 
on, you can't just impose your idea of a Western solution on women in rural 
South Africa ", you know, where I had never been, I had no idea, never worked 
in Africa... but I was, you know, I was imposing a view of what a solution was 
completely externally from any appreciation locally. 
Furthermore, whilst the women participating in the trial and the African scientific 
partners were said to be empowered by having to talk openly about sex during the 
research, there was an acknowledgement by Dylan that the same process was at work 
amongst the UK scientists: 
The more you talk about sex the easier it becomes to talk about sex. It's the 
same with the researchers. It's only among people working on these sorts of 
studies that you can sit in the restaurant and have an hour long conversation 
about anal sex without anyone feeling even slightly uncomfortable [laughter]. 
The production of UK scientists occurred not only through internal discourses and 
routines, but took place in concert with the production of scientists in Zambia. A key 
component of this related to the social contingencies, such as gender relations, which 
had successfully enrolled the Southern partners into the programme, but had been 
67 A CRF is a Case Record Form, the standard tool used to collect clinical data in a trial. 
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largely erased from discussion of the scientific protocol itself. By the time I conducted 
my interviews, approximately two years after the trial had been up and running, UK 
scientists said they felt `changed' by what they had seen and experienced. All of the 
senior UK researchers I spoke to visited the African sites during the course of the trial 
and saw the situation first hand. They were also constantly exposed to accounts of 
gendered inequalities at the sites through monthly teleconferences during which African 
researchers brought operational issues to the table. Kate described her own 
transformation in terms of gender awareness: 
I think that's true, that the added value of the gender resonated more for DFID 
than it did for us. But I wouldn't say I feel that now, I don't feel that now, I'm, 
I'm, er, I'm... really... [sighing]... well, myself much more conscious of gender 
issues and you know, it's never been an issue for me, in my personal life, barely, 
um, anyway, um. So I guess I just... wasn't thinking about it. So I think it's quite 
an eye-opener to see how, how, um, disempowered women are in these settings 
by, you know, lack of education, lack of income, lack of independent income and 
just even lack of physical authority, you know, I think that's been an eye-opener 
for me, which sounds a bit ... naive, ridiculous, whatever. I mean, of course, 
if 
I'd stopped to think about it I would have known it was like that, but I'd, I'd not 
stopped to think about it before and I think often you don't take it in until you 
actually see it in operation. 
Although this confessional-style testimony may have been a product of my own interest 
in gender and was given in response to questions on gender considerations in the trial, 
Kate and others were sincere in their depictions of how the research had affected them 
on a personal level. Contrary to the neutral, objective, a-contextual discourse of 
clinical trials, she and others acknowledged the personal and social nature of the 
research, which led not only to the creation of new scientists in Africa, as discussed 
above, but to the recreation of scientists in the UK. Harry poignantly described how he 
felt about the programme - emotional - the antithesis of the rational, of which science is 
said to be made: 
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... it's also 
been a more emotional piece of work than one might have thought, 
um, you know, this is not a dry programme; this is hundreds of people who are 
really sort of quite passionately committed to it, plus the women. And when I go 
to the sites, you know, if you talk to the women in the sites, talk to the 
investigators and so on, I mean there's a real, there's quite a passion, quite a 
belief in all this, which is not like a dispassionate clinical trial, I mean this is... 
[lost for words] ... um ... So it's been interesting for me, 'cause as I say, I 
approached it in quite a dry and rather focused way and it's made, um... it's, 
it's, it's been far from that, it's been a very unusual programme. (Harry, 
emphasis respondent's own) 
Unusual indeed is the reference to emotions and beliefs, which are not the stuff of 
`science'. 
Summary 
In this chapter I have explored the creation of a knowledge-framework which was to 
form the basis of clinical testing of the candidate microbicide PRO 2000. The 
Microbicides Development Programme and its phase III trial, MDP301, provided the 
conditions for assessing the safety and efficacy of this new prevention technology and 
thereby contributing new knowledge in the field of HIV prevention. Returning to 
Law's proposition, "No one, no thing, no class, no gender, can `have power' unless a set 
of relations is constituted and held in place" (Law 1991: 18). By tracing the enrolment 
of actors into MDP and into the MDP 301 protocol, I have shown how a set of relations 
was constituted between Northern and Southern researchers and have suggested the role 
of a gendered capacity-building discourse in holding these relations in place. 
Governance was achieved through the discursive production of participatory democracy 
and partnership, which granted agency to the `partners' whilst maintaining control over 
them. 
Collins has argued that "since order and knowledge are but two sides of the same coin, 
changing knowledge is changing order" (Collins 1985: vii). How large international 
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scientific collaborations are formed and mobilised, and how the trials they run are 
designed, arguably has a direct impact on the knowledge they produce. If order affects 
knowledge, which in turn affects order, then MDP can be said to have produced a 
potentially transformative circuit of gender and technology relations. This potential is 
explored further in the following chapters. Finally, to paraphrase Collins, the aim of 
this chapter has not been to reveal flaws in the MDP research process, but rather the 
artisanship of its construction. In the next chapter, 1 go on to explore the translation of 
the programme across geographic and cultural borders. 
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Chapter Six 
Trial and Transformation: Gender and Technology in Zambia 
Our society is not one of spectacle, but of surveillance; under the surface of 
images, one invests bodies in depth; behind the great abstraction of exchange, 
there continues the meticulous, concrete training of useful forces; the circuits of 
communication are the supports of an accumulation and a centralization of 
knowledge; the play of signs defines the anchorages of power; it is not that the 
beautiful totality of the individual is amputated, repressed, altered by our social 
order, it is rather that the individual is carefully fabricated within it, according to 
a whole technique of forces and bodies. (Foucault 1977: 217) 
In this chapter I will examine the process of implementing the phase III clinical trial 
designed to test PRO 2000 in one of the six African trial sites: MDP Zambia. Precisely 
because MDP Zambia was set up as a new site in a research-naive community, it 
provides the opportunity to explore how the apparatuses of power and knowledge 
relations embodied in the randomized controlled trial were re-produced independently 
of pre-existing research structures68. In chapters four and five, I discussed the 
discursive production of gender-technology relations in the UK and international 
arenas; here, I describe the ongoing construction of both microbicides and gendered 
subjects through the clinical research process. Data for this chapter come primarily 
from fourteen in-depth interviews with MDP Zambia staff, conducted between March 
and June 2008.1 also draw on two focus groups held with local men, as well as 
interviews with men, women and community members conducted in the same period. 
Foucault's writings on power, knowledge and the body provide the analytical backdrop 
to this discussion, in particular the ideas expressed in The Birth of the Clinic (Foucault 
1975) and Discipline and Punish (Foucault 1977). Foucault described power as a 
positive and productive force that is diffused through the social system in everyday 
68 Of the six MDP trial sites, MDP Zambia was the only one not to be instituted at a long-standing 
research centre, where established institutional systems and hierarchies were already deeply entrenched. 
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practices of normalisation. Medical discourse and practice is central to the constitution 
of bodies and subjectivities; the `clinical gaze' of the health professional constructs the 
body and delineates the normal. As Armstrong has argued, "A body analysed for 
humours contains humours; a body analysed for organs and tissues is constituted by 
organs and tissues; a body analysed for psychosocial functioning is a psychosocial 
object" (Armstrong 1994: 25). By taking the clinical trial as an extension of the clinic, 
we can explore not only notions of surveillance and subjection but also acquiescence 
and/or resistance by trial participants and community members to the power of medical 
researchers69. As intermediaries of the trial and the community, local MDP Zambia 
staff were in a pivotal position; below I explore their role in mediating the power 
techniques of both the international researchers and male partners of trial participants. 
In 1986 Latour and Woolgar described scientific activity as "a fierce fight to construct 
reality" (Latour and Woolgar 1986: 243); in the results that follow we can see MDP as 
the battleground for precisely such a fight. 
Constructing the site: Clinical trials in Mazabuka, Zambia 
The clinical trial site in Mazabuka, Zambia, was set up in 2002/3, specifically for the 
purposes of the Microbicides Development Programme. Prior to this time, no research 
site existed in the town or district and clinical trials were largely unheard of. In popular 
accounts of the site's history among UK researchers, the idea of building a site in 
Mazabuka came from an existing collaboration between a senior UK scientist and a 
Zambian doctor working in Lusaka. The rationale given for choosing the town was that 
it was based around a large sugar plantation, which provided a stable population ideal 
for research. Mobility was much lower than in the capital and the population was well- 
documented, with residential areas already mapped out. According to the UK scientist 
in question, "We thought by and large, you know, we couldn't go wrong. It turned out 
it wasn't quite so straightforward as all that". 
69 On clinical trials as an extension of the clinic, it is worth noting Fisher's observation that "within the 
political, economic, and cultural contexts of neoliberalism, the offering of pharmaceutical clinical trials is 
positioned as adding another option for health care consumers. Because the majority of pharmaceutical 
studies are located in familiar context... the process of research is normalized, meaning that clinical trials 
become a routine part of the clinic" (Fisher 2009: 17). 
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Since clinical trials had not been conducted in Mazabuka prior to MDP, this type of 
research was not only new to the local community, but equally to the staff who were 
recruited to the project. My informants reported that even where drug trials were being 
carried out, many lay people `did not understand' the experimental nature of the 
research70. Discursive accounts produced within the trial construed MDP as a novel and 
exciting enterprise that was taking science beyond the hospital laboratory and into the 
community: 
A clinical trial in Zambia was something people had never heard of. Even me, 
as a nurse, I had never heard of a clinical trial being carried out in 
Zambia... Like when government brought Coartem, which was believed to have 
been in phase II or phase III, government brought that Coartem without telling 
the people that in fact this drug is still on trial. And we hear there are even 
other anti-TB drugs, they will just come, they are tested, and shortly they phase 
out. And that's when you hear that, "oh, in fact, this drug was just on trial". 
(Crystal, community mobiliser) 
Many other trials that were being conducted in Zambia mostly were done inside 
hospitals, without even most of the people knowing that some of the drugs were 
being put on a trial. But this time around it has been done outside the hospital, 
independently, such that really people will be free to come and participate in it 
freely. (Colin, community mobiliser) 
Furthermore, because microbicides themselves were a new concept, very few people 
had ever heard of them. Most of the staff I interviewed said they had not known what 
MDP or microbicides were when they came for their job interview, and that they had 
not even known how to pronounce the word. They presented the stabilisation of the 
research site as a steep learning curve, requiring them to get up to speed with research 
principles, such as those enshrined in Good Clinical Practice (GCP), as well as 
understand the protocol that had been sent from the UK. As Crystal describes: 
70 On the construction of experimentality in relation to the therapeutic within pharmaceutical clinical 
trials see (Petryna 2009). 
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Even when they gave us the protocol the first day we reported, we were told, 
"You read and understand the protocol ". A lot of things were not making sense 
and every day [our supervisor] would sit with us, we'd have questions for him 
and he'd answer, until maybe, it took us two, three weeks, to start really getting 
what's the meaning of this study, what is involved, who is involved, and the like. 
(Crystal, community mobiliser. Emphasis respondent's own) 
In the early stages of MDP, visits were made by the UK coordinating team to the 
Zambian site to help with staff training. A large part of this was training on the protocol 
and clinical procedures, ensuring consistency across the programme. Scientific 
discourse relays the need for multi-site clinical trials to be conducted according to strict 
protocols and standardised procedures, designed to guarantee the rigour and validity of 
clinical findings; local context is to be elided as far as possible. For those implementing 
the research on the ground, however, the trial is not conducted in a vacuum but in the 
real world, often the world they themselves have grown up in and are deeply enmeshed 
in. Whereas the protocol quickly became black-boxed in the UK and accorded the 
status of a sacred and immutable set of procedures, a lot of work had to be done at the 
site-level towards its stabilisation. Coordinating staff in Zambia, who were to train their 
staff in `the protocol', described the challenge of being the conduit for new discourses 
that were being channelled in from outside the community. 
John: As I got into the programme, well things became more complex, because I 
had to understand a lot of things from the clinical perspective, which is not my 
background. 
CM. - What sort of things? 
John: Um, things to do with data capturing... the protocol itself, the procedures 
we were going to follow and the type of women we were going to recruit and 
why we're recruiting them. And I was now looking at that in terms of what we 
actually believe in, or the norm of this place. 
CM: Tell me about that. 
John: Basically, before MDP came into place, I mean things to do with HIV 
testing were really not something that you could talk about openly. And then 
when I looked at the CRFs or the Case Record Forms for data capture, they 
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were all issues to do with sex and it was more or less like bringing out the 
bedroom to the open. So those are some of the things that were a bit 
uncomfortable for me as we started the trial, because you really had to talk 
about bedroom issues in the outside world. (John, community mobiliser) 
The joint taboos of HIV testing and talking about sex, which John mentioned, were both 
a pre-requisite for enrolment into the MDP trial. John and others discussed how 
stigmatised HIV testing was before the arrival of MDP in Mazabuka, reflecting a 
situation that has been documented widely in Africa as well as specifically in Zambia 
(Bond et al. 2002). 
The institutional `incitement' to speak about sex, and the power implied in the trial's 
new regime of discourses, was not met with passive adoption. The open discussion of 
sexual matters - or `bedroom issues' - was reported to go against traditional codes of 
decency, adding to the suspicion that AIDS was a result of Western immorality7l. 
Translating the terms of the research not only into the vernacular, but also into 
something acceptable for the local community was key to enrolling actors into `the trial 
community' and thereby establishing MDP in Mazabuka. In the process of trying to 
engage the community, the programme ran into several difficulties, these primarily 
being rumours that the research was Satanic and opposition by men in the community to 
their wives' participation. 
Resistance to techniques of power: Satanism and "male opposition" 
Rumours about Satanism and witchcraft are common in relation to medical research in 
Africa (Geissler 2004; Geissler 2005; Geissler and Pool 2006). Geissler and Pool note 
that "medical research and the `trial communities' it constitutes by linking scientists and 
subjects, institutions and funders... is one of the networks of global connections that has 
been particularly prolific in the generation of rumours" (Geissler and Pool 2006: 975). 
" Gausset records that the AIDS discourse of most rural Tonga in Zambia is the diametric opposite to that 
in the West, the former seeing Western profligacy as the root of disease spread, the latter blaming African 
cultural norms (Gausset 2001). I experienced this first hand when interviewing one key informant, who 
at the end of the interview confided how concerned he had been that (being a Westerner) I might raise 
indecent questions with him. 
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Popular concerns about blood stealing, Satanism and witchcraft have variously been 
interpreted in the historical and anthropological literature as forms of popular resistance; 
ignorance of medico-scientific research; and local responses to research ethics in the 
context of globalisation and unequal access to resources (Atieno Odhiambo 1974; Burke 
1998; Campion-Vincent 2002). 
Rumours that MDP was a Satanist organisation plagued the research from the start and 
were still circulating at the time I conducted my interviews five years after the site 
opened72. Local Zambian staff were the primary target of these rumours, aspects of 
which are consonant with Colson's description of witchcraft amongst the Gwembe 
Tonga: "In the 1990s the most feared witches are usually said to use... resources that 
obliterate the safeguard of distance and are associated with technology brought by 
Europeans... Despite this, the accused witch so far remains someone who operates 
within one's own immediate network" (Colson 2000: 341). Although Colson here 
refers to technology primarily in the sense of engineering or machinery, such as 
aeroplanes and guns, the parallels with new scientific technology, as embodied in the 
clinical trial site (for example microbicide gels and sophisticated laboratory equipment), 
should not be overlooked. 
The most prevalent rumour circulating during the phase III trial was that MDP took 
people's blood and either used it for Satanic rituals or sold it on in South Africa or the 
UK. In other rumours, women who tested HIV negative were reportedly made to sleep 
with HIV-positive men when they came for clinic visits; MDP staff were said to drink 
women's blood; the drinks that MDP gave participants after taking their blood, branded 
with the slogan `YESS', came from a supermarket believed to be Satanic and made 
people say yes, they were HIV-positive (even if they were negative); and the food MDP 
gave participants as they waited in the clinic was made out of chopped up babies it got 
from the Satanic supermarket: 
Margaret: There's this Indian man, he's got shops and whatever, it's like he 
owns Mazabuka, so they said [MDPJ negotiates with [his supermarket]... They 
72 Mazabuka is considered something of a hot-spot for Satanism and witchcraft, as numerous newspaper 
articles attest to (see for example Anon 2005; Anon 2007). 
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bring nshima73 sometimes with chicken. So with chicken, they say [MDPJ 
connives with him, he sells babies to MDP. 
CM. - Babies? 
Margaret: Babies, small, small babies, to MDP, of which those babies are cut 
and cooked and they come in the form of chicken. That's how come the chicken 
is not even tasty, you know? All those rumours. So when people talk about that, 
like especially men in their workplace, when they say, "MDP is Satanism ", 
MDP this, MDP that, and then they will tell their women, "I don't want to see 
you going there, those are Satanists ". Usually that's one thing that will make a 
man refuse. (Margaret, research assistant) 
Whilst Margaret and a number of other respondents linked the rumours of Satanism to 
men's opposition to the programme, this was not universally the case, with some 
suggesting that the rumours came equally from men and women, and particularly from 
women who had been found ineligible to join the study. However, in focus groups with 
men from the community, participants directly confronted me about whether MDP was 
Satanist, questioning the organisation's motives, funding, and what was done with 
participants' blood. Some men admitted preventing their wives from coming to join the 
trial because it was Satanist, while others said they even feared to come to the trial site 
themselves for the focus group. It is therefore worth considering the broader context 
from which this response may have evolved. Common to the rumours was a link with 
money or wealth accumulation, blood, and foreign infiltration (e. g. blood was said to be 
sold in South Africa or the UK, and the `Satanic' supermarket was owned by an Indian 
businessman74). 
In terms of the specific context of MDP, when it first opened on the Nakambala sugar 
estate in Mazabuka in 2003, it did so as a VCT centre. At this time, Zambia Sugar, on 
whose premises the MDP site was based, had recently been taken over by the Illovo 
Group of South Africa. As part of a publicity campaign for MDP, the new manager was 
73 Nshima is a thick porridge made from ground maize flour, which forms the staple food in Zambia. 
74 The association of blood-stealing with Indian businessmen has been a feature of banyama rumours in 
northern and eastern Zambia since the 1920s, however Colson reports that Gwembe villagers in Southern 
Province, where Mazabuka is located, only began to speak of banyama in the 1970s. She describes how 
"in the multi-ethnic towns of Zambia's Southern Province fear of body robbers led to riots and attacks on 
Indian storekeepers in early 1996" (Colson 2000: 340). 
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the first to go and get tested through VCT. However, male workers at Zambia Sugar 
reportedly took this as a sign that testing would be compulsory for employees in order 
to weed out those who were HIV positive from the workforce. As such, they feared for 
their jobs and shunned the programme. One community mobiliser who had gone door 
to door speaking to men told me that when they heard that MDP was primarily targeting 
women, they interpreted this as a strategy to identify them and their HIV status through 
their wives. At the same time, in April 2003 (a month after the MDP Feasibility study 
started in Mazabuka), Illovo was implementing changes to its pension scheme75 and 
men feared that if they were found HIV positive and lost their jobs, they would not be 
able to access their pension money. Even in 2008, when I held focus groups with men, 
some reported the rumour that MDP was Satanist because it was using women as a 
means to undermine the men: 
Facilitator: Did it bother you that MDP is looked at as an organisation for 
women? 
R7: Yah, it bothered me, because how do you only test women when HIV can 
also affect a man? 
RI: And that's one reason many people associated it with Satanism, because 
they know that women are weaker vessels [mumbled agreement from the 
others], it's very easy to convince them. 
Other Rs: To convince them. 
RI: When you convince a woman, it will be very easy for her again to convince 
the husband. So people said, "Oh, these people, they know the gimmick. They 
know that if we enter from a woman, then it will even be easy for the woman to 
convince the husband". 
Several issues combined at this time to produce anxiety amongst men and hostility 
towards MDP: the take-over of Zambia Sugar by foreign investors and reform of the 
pension scheme coincided with the arrival of an overseas-funded clinical trial recruiting 
people for VCT on the sugar estate (MDP). According to the staff members I 
75 In 2002, Zambia Sugar implemented changes to its pension scheme, establishing a defined contribution 
pension scheme. Prior to this, all employees received a Post retirement gratuity paid on retirement. From 
April 2003, this gratuity was only paid to employees over the age of 50 at that date who did not transfer to 
the defined contribution fund (Zambia Sugar 2005). 
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interviewed, not only were clinical trials alien to the community, but HIV was highly 
stigmatised and HIV testing was neither widely available nor widely acceptable. Fear 
of death, loss of income, desertion by one's spouse and community rejection were 
discursively bound up with knowing one's HIV status, and since anti -rqtrovirals 
(ARVs) were not available, people admitted there was little incentive to test. At the 
same time, MDP was drawing what were perceived to be large amounts of blood and 
was giving women money (reimbursement for their participation) when they came to 
get tested. There has been a long-standing association between Satanism or witchcraft 
and sudden or unexplained wealth in this community76; one of the MDP research 
assistants told me: 
Ben: OK I've heard witchcrafts, you know, you've probably heard also that 
witchcrafts, they can move from here to London within seconds and do their 
business then come back the same day, the same evening. What are they using? 
I'm told they're using blood. 
CM: They're using blood? 
Ben: Human blood. As fuel. If it gets finished, that's when they drop, land- 
crashing. You crash somewhere in Zimbabwe or somewhere, you'll be found 
naked there. So people always take it (as true) and mostly blood has been used 
for rituals, people getting rich; they've heard of people getting rich in Mazabuka 
because of blood. They are selling blood. All that kind of stuff So people are 
scared of anyone talking about human blood, they think they're selling it for 
rituals or for getting rich, which is, well I don't know, it's a belief It's a belief. 
It may be true. (Ben, research assistant) 
Since it was not known what MDP did with the blood it drew, nor where it got its 
wealth from in order to be able to pay women, accusations of Satanism were easily 
levelled. Many staff I spoke to attributed the rumours to men's ignorance of the research 
process and procedures. However, some also expressed ambivalence as to the verity of 
the rumours, as Ben does above, switching between discourses of truth and belief. 
These discursive shifts give cause to question the `ignorance hypothesis' used to 
account for rumours in medical research settings such as this. 
76 This association is widespread in Africa (Comaroff and Comaroff 1999; White 2000). 
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Responding to fear, exclusion and the threat of power loss: The contest over 
knowledge 
Whilst some staff proposed that the Satanism rumours were a response to lack of 
familiarity with research trials, they can also be interpreted as "a way of talking that 
encourages a reassessment of everyday experience to address the workings of power 
and knowledge and how regimes use them" (White 2000: 43). Focus group discussions 
with men of all ages were permeated by a discourse of exclusion regarding the trial, and 
a sense of injustice that they had been sidelined by the researchers. The following 
extracts typify the comments that were made: 
You find that here, they very much welcome women (rather) than men and when 
they are doing these researches of theirs, it's just between the MDP and the 
women, but forgetting their husbands. 
When we came, you explained why you have come here. But then the focus is on 
women. Then we have forgotten that those women are not on their own, there 
are people looking after those women, but then those people - you don't want 
them. 
You know what we are saying is that as men, from the beginning, we are not 
directly involved in the programme. Because there has never been a time when 
MDP called men to explain to them about the benefit they would get from gel. 
This (focus group) is maybe the first step you are taking as MDP to involve men. 
That's why we are saying we are not seeing the benefit of our women using gel. 
It's like it's them alone benefiting. Then the concern is that if family planning - 
there are these rumours that they are contaminated with the HIV virus - how 
safe is gel to our women? That is another question. It could be with these other 
contraceptives; maybe it also has some complications of a woman using (it). 
The last of these extracts points to another, less prevalent, rumour that some men voiced 
about gel, namely that it might be contaminated with HIV. Such stories about Western 
researchers deliberately reducing the population through the spread of disease or by 
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limiting fertility are a commonly documented response to medical research in Africa 
(Feldman-Savelsberg et al. 2000; Geissler and Pool 2006). The fact that MDP was 
recruiting women only, without actively seeking to involve men in the trial, seems to 
have exacerbated the suspicions the community had more generally towards this new 
medical research. Specifically, by excluding men from the process, the trial threatened 
established power relations between men and women, whereby decision-making is a 
male prerogative and women must seek permission for their actions. 
In this community, as in Zambia more broadly, women are brought up to be submissive 
to their husbands and to follow rather than initiate (Bond and Dover 1997; Milimo et al. 
2004). Women are not generally regarded as autonomous individuals; customary law 
treats them as dependents, with property and inheritance rights contingent on marriage 
or family ties. Although legally women's rights are determined by both customary and 
statutory law, with the latter prohibiting discrimination against women, in practice, 
customary law undermines this and provides the dominant discourse through which 
women's subordination is secured. Under customary law, women and all that they 
produce are the property of their husbands (Byrne 1994); popular proverbs reinforce 
this, for example `Mwalumi ngo mutwe wa ng'anda' ('A man is the head of the 
household') and `Bakaintu tabajisi mitwe' (`Women do not have brains') (Milimo et al. 
2004)77. Ben, a research assistant at the site, put it very succinctly: "Most women, once 
they get married, they are like a product to a man; it's like the way you buy a chair, the 
way you have a stool, the way you have a shirt - the man controls... the man pays. 
Somehow it's like I have bought that person, it's like she belongs to you. " 
The discourse of male ownership of women played out through the male focus groups 
and in interviews with alangizi, traditional marriage counsellors for women, who 
relayed the techniques through which female subordination is cemented prior to 
marriage. Dual discourses of African tradition and Christian doctrine were used by 
both women and men to legitimise patriarchal control of women, with Biblical 
references to women being the weaker vessel and having a duty to submit to the 
husband common. Consonant with traditional values, Christian discourse emphasises 
71 These are Tonga sayings typically heard in Southern Province, where the trial took place. However, 
such sayings are present across the country; see Milimo et al. for others in Bemba, Lozi, Ngoni and 
Chewa. 
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the importance of motherhood, servitude and `good conduct' (Seidel 1993). In recent 
years there has been an upsurge in Christianity in Zambia (Colson 2004) and in this 
community, the Church can seen as a highly popular and influential institution of 
normative coercion78. Whereas clinical trials are not yet normative, the Church is fully 
established, and provided objectors with a powerful discourse with which to contest 
notions of women's empowerment. Across all groups of participants in my study - 
community men, female trial participants, male and female staff members and other key 
stakeholders - there was an acknowledgement that the man is the head of the household 
and the appropriate behaviour for a woman is to inform her husband and seek his 
permission in all matters. 
By recruiting only women to the research, and gaining only the woman's consent to 
participate and use gel, men saw the trial as disregarding this well-established norm and 
directly challenging their control over their wives. It is in this context that we should 
consider the rumours linking MDP to Satanism - as an expression of mistrust towards 
"formations of knowledge and power that reach deep into their everyday lives, and 
which are set in a world order that provokes their doubts" (Geissler and Pool 2006: 
975). In the first instance, men's doubts related to the fact that women could enrol and 
use gel without their knowledge or consent, as this male focus group participant 
illustrates: 
Now, you find that when she comes here, she comes here on her own... me, 1 
don't know what she comes here to do, I don't know who attends to that person, 
you see. And then she just comes out and gives me orders, "this is what I will be 
doing from now onwards ". You see, as men, we don't accept such orders. OK? 
So, this mistake was made from the word go. Had it been that when they started 
this programme, if my wife was interested in this programme, it was going to be 
better for them to say, "OK, is your husband there? " "Yes" "OK, we want him 
as well, let him also come ". 
78 Foucault referred to religion, law and medicine as `coercive institutions, ' disciplining individuals 
through everyday surveillance such that their actions were both produced and regulated by them (Petersen 
and Bunton 1997). 
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More fundamentally, however, some men were extremely concerned about the shift in 
the locus of control over women: from themselves to the trialists. In more abstract 
terms this can be seen as a shift of patriarchal control from the traditional African 
household head to the Western scientist-come-emancipator. If we see the clinical trial 
as a form of what Foucault calls disciplinary power, controlling women through the 
surveillance of their bodies and other techniques such as regulation of their fertility and 
imposition of conditions on their sexual behaviour79, then it is easy to see how the trial 
subsumes the role of the husband in controlling his wife's sexuality. 
Yamba has suggested that rumours such as those circulating around the trial be 
considered as "expressions of a traditional discourse, as a local protest against the 
hegemony of important local people, who are perceived as allies of local NGOs and the 
government" (Yamba 1997). Given the Zambian staff's pivotal position at the interface 
between UK government-funded scientific research and the local community, this 
explanation is a plausible one. Yamba's interpretation of witchcraft in Chiawa, Lusaka 
Province, relates specifically to HIV prevention discourse; he argues: 
The presence and hegemony of a global knowledge, expressed in the discourse 
of HIV/AIDS prevention, exists and is known even in the remotest of villages. 
The chief propagators of this global discourse and knowledge have their allies in 
local big men. But the incomprehensibility of the discourse generated, and the 
logical inconsistencies, are what have led to the resurgence of the traditional 
discourse (Yamba 1997: 219). 
In the case of MDP, the `logical inconsistencies' can be seen as women taking control 
of the sexual encounter and the notion of female autonomy presumed by the research. 
In addition to critique through rumour, some men responded to the threat of power loss 
in more demonstrative ways, exercising their own authority both through violence and 
surveillance. Whilst violence against women was said to be common in the 
"The trial protocol stipulated that women must be on a form of reliable contraception and not intending 
to get pregnant in order to take part in the study. Sexual behaviour was both monitored and regulated - 
women were required not to have more than fourteen sex acts in a week, were advised not to insert things 
into their vagina, including traditional preparations to enhance sex, not to wash within an hour of sex, and 
not to have anal sex (MDP 301 protocol version 1.3). 
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community80, some men reportedly used violence or the threat of violence to control 
their wives' behaviour specifically in relation to the research. During the three months I 
spent at the site, respondents spoke many times about incidents of violence involving 
men beating their wives and preventing them from attending the research site. There 
was a reluctance to go into specific details or cases, and staff members tended to give 
the following generalized sorts of accounts: 
CM: Have you seen many cases of women whose partners have stopped them 
coming back (to the study)? 
Gertrude: [Affirmative] Mmhmm, we've had some. And some beaten, you know, 
we have had such for sure, we have had. We've had some, they've stopped; 
although there are times they would not give the reason, but the friend would 
say, "Mmm, the husband, what, what ". Some they would come actually beaten; 
you ask them, they say, "no, I fell ". But the friends would say, "Actually, this 
person was beaten" and so on and so forth. For sure, there is big control. For 
sure. (Gertrude, MDP nurse) 
Some women (on the trial) are still being battered by husbands and partners, 
because I think the men never get to learn and see the benefit of their women ... 
participating. (Edward, clinician) 
In focus groups, some men were unambiguous in stating that they would beat their wife 
if she brought gels home without having informed him first. In addition to participants 
being beaten by their husbands, some female staff members were concerned about their 
own safety: 
CM: So you've mentioned that you encourage women to tell their partners, in 
fact you almost require them to disclose to their partners - is that true, you 
require them to disclose first? To be allowed onto the study? 
`OThis is confirmed by the 200112 Zambia Demographic and Health Survey (ZDHS) which reported that 
55.7% of women in Southern Province had ever experienced physical violence. Across the ZDHS, 
almost eight out of ten women in union who experienced physical violence reported their current 
husband/partner as a perpetrator (Central Statistical Office Zambia et al. 2003). 
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Lianne: Yah, that is one of the key things we tell them. We say "you don't want 
to bring confusions, you know. " One day we will find ourselves being beaten 
here at MDPfor no apparent reason. That's why we encourage them to go and 
sit together. 
CM: You mentioned that you fear being beaten here at MDP as a staff member? 
Lianne: [Laughing] Yah, you may find yourself (being beaten), because some 
men have been coming, [in angry voice] "Hey! What is happening? Who told 
you to... ?" and what. (Lianne, MDP nurse) 
Although there were no reports of staff being beaten at the site, the staff's accounts 
indicated that men's threats of violence had succeeded in influencing their behaviour. 
Another way in which men exercised authority over their wives was through 
surveillance. While men were largely absent from the written protocol, and the power 
of surveillance rested essentially with the researchers, some men contested this 
exclusion by re-instating themselves as their wives' guardians at the trial site (guardians 
in the literal sense of guarding and watching over81). The counsellors and nurses related 
how some men escorted or followed their wives to the site, and how some wanted to be 
present during genital examinations: 
Mary: We have had some who even escort their wives for gel collection. And he 
actually wants to be there during the examination. 
CM. - And is he allowed? 
Mary: [Recalling] Mmmm.... 1 remember the other one... we had to explain to 
him, we said, "what we are doing is A, B, C, D" - it was a long visit - he said, 
"no, I want to see what you are examining on my wife. " (Mary, MDP 
counsellor) 
In addition, there were accounts of men completing their wives' coital diaries for the 
study, and engaging directly with the researchers about their wives' sexual behaviour, 
for example to verify whether they were having extra-marital affairs. I interviewed one 
11 Guardian: "one who guards...: one who has the care of the person, property and rights of another" 
(Kirkpatrick 1983). 
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such man, who said he had been counting his wife's applicators to keep tabs on her. 
When he couldn't account for all the used gels, he fought with his wife and sent a letter 
to the clinic, requesting them to inform him when his wife next came in and not to give 
her any more gel. When the wife showed up at the clinic, the researchers called the 
husband, who arrived and demanded to know with whom the wife had been using her 
gel. Following a heated `interrogation' of the wife, and explanations from the trial staff, 
the husband took his wife home and allowed her to continue participating. According to 
Mary, one of the counsellors involved in the case: 
Mary: I remember there was this case where a man followed the wife to MDP, 
he was like suspecting her of cheating on him. So when they came - he did not 
understand much about the gel - him said, "This gel is just making my wife to be 
more promiscuous" ... So when he came, we had to sit him down and we 
had a 
very, very long session with him. So when he understood he said, "Oh, OK. So 
you count ". Because to him, he was thinking when she's given these 
applicators, obviously she uses some on other men. "So if they are counted then 
I will be the one to insert ". So he's the one now who is inserting in the wife and 
making sure that all the applicators are used [laughing]. 
CM: So he's counting her applicators to make sure that she... ? 
Mary: [Still laughing7 ... she uses them on him! And actually he's the one who's 
even inserting in the wife. 
Whilst it is possible that this represents a one-off, husbands following wives to the 
clinic and disputing their sexual behaviour with the researchers was reported to have 
happened on more than the odd occasion. 
The prerogative to control both physically (e. g. by inserting gel) and psychologically 
(by counting applicators) arguably represents a challenge both to the disciplinary power 
of the clinical trial, and also to the notions of respect, autonomy, consent, and 
confidentiality embodied in it. The latter are constructed by research ethics as core 
Western values. The subject who signs the informed consent is construed as an 
autonomous individual, acting rationally and independently in a context of choice. The 
process is largely viewed as countering medical paternalism by investing research 
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subjects with the information (and therefore power) to freely decide their participation. 
However, as Corrigan observes, "the dualistic opposition between liberal concepts of 
freedom and autonomy versus powerful autocratic medical practices fails to recognise 
that power is not just a phenomenon that is exercised as an external constraint, but that 
prevailing cultural norms, values and systems of expertise shape the field of choice" 
(Corrigan 2003: 789)82. In the Zambian context, the prevailing cultural norm was for 
men to be the gate-keepers to women's choices. 
The `world order' of the clinical trial provoked deep cynicism among some men, who 
rejected the values that the gel and the research to test it had brought, amongst these 
women's empowerment and human rights. Indeed, men in the focus groups disputed 
that human rights were present in the Bible, claiming instead that once they married a 
woman and owned her, it was for them to demand sex anytime they wanted it. 
Contesting women's autonomy to take part in the research, one man said, "the woman 
has no longer got powers over her body because it belongs to the man ", and another: 
RS: In actual fact, when you are talking of human rights, these rights just came 
in very recently .... Otherwise traditionally, even if now this time we go and raise 
my dead grandfather and ask him, "how were you staying in your home with 
your wife? " Had she... you told me to say she had some rights to say "No, I'm 
saying no to sex today"; unless if she's on monthly period, then that's the time 
when you cannot meet (have sex with) that woman. OK But otherwise these 
rights you are talking about, these are the things, if anything, they are going to 
destroy our country. 
R8: And these rights which have come, they are the things which I think bring a 
lot of problems. (Emphasis added) 
Human rights, used as a proxy for women's rights, was anathema to many of these men, 
who presented it as a Western concept that had come in from outside and threatened 
their traditional way of life. 
12 For a discussion on the role of autonomy in bioethics, see (Wolpe 1998). On the rise of individualism 
in Western liberalism more broadly, and the relation of this to bioethics, see (Rose 1999). 
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Managing the trial, mediating values: MDP Zambia staff 
The MDP Zambia staff were in a pivotal position at the intersection of two cultures - 
Zambian society and international clinical research. Deeply embedded in their own 
culture, and in some cases born and raised in the very community in which the research 
was being conducted, they were also now members of a new knowledge network 
coordinated from the UK and regulated by US and international guidelines (such as the 
International Conference of Harmonisation Good Clinical Practice (ICH GCP) and the 
US Food and Drug Administration (FDA)). Their role was a translational one: of 
standardised protocols and research procedures into the local setting, and of trial- 
generated knowledge into data sent back to the UK. I have alluded above to the 
discontinuities in world view between those at the forefront of health research in the UK 
and the US and those at the receiving end of the research in an African trial community. 
If we wish to understand not only how knowledge on microbicides has been produced, 
but also how the research itself has constituted the subjects it purports to describe, we 
need to examine the role of the Zambian staff who brokered the knowledge in both 
directions. How was gender handled in the making of microbicides and the re-making 
of local people? Was the research transformative, or conversely, in the trial's focus on 
one sex to the exclusion of the other, were gender norms maintained? I address these 
questions below, dealing first with the preservation and perpetuation of patriarchal 
control and then with MDP Zambia as a transgressive and transformative space. 
Preservation and perpetuation: The discursive maintenance of gender 
norms and patriarchal control 
In chapter four, I outlined the negative discourse about men that characterised the UK 
researchers' position on gender in Africa. By contrast, the MDP Zambia staff had a 
much more positive attitude towards men and male prerogative, frequently highlighting 
the need for men to be involved in the research, the likelihood of them encouraging and 
supporting their wives, of making programmes successful, and of being the friend who 
would remind the wife about family planning or protection. In short, men were 
generally presented as a potential facilitator rather than a potential barrier to the 
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research. Although there was also a popular mantra that "men are difficult", this was 
seen to relate more to men's need to rationalise and understand phenomena before 
getting on board; the staff were quick to suggest that with adequate information, the 
majority of men would, or did, support their wives' participation on the trial, thereby 
improving both adherence and retention. For example, John, one of the community 
mobilisers: 
So they really do play a critical role in terms of actually bringing these women 
here. And even in retention they play a critical role in that at times you'll see 
women staying here during lunch, when they're supposed to be actually 
preparing meals for their husbands, and the husband will have to fend for 
himself. Meaning they support their wives' participation on the study, even if 
it's not very visible, but we do take recognition of that and that's a critical role 
that these men play. 
John was so enthusiastic about men's role in microbicide use that his vision of the 
technology for the future was essentially as a male-controlled device: 
Because what I'm seeing is that in future, if microbicides are made available 
and they're effective, what everyone would want to see is that a man goes into a 
shop, if it will be in shops, gets the gel, and then takes this gel to the woman and 
says, "Today we have to use this. From today onwards, we have to use this. 
Every time before we have sex I will remind this woman to say, 'have you 
applied? "' 
Female staff members were equally enthusiastic about men's role in reminding women 
to use the gel and inserting it for them. 
Beyond the hypothetical question of men's involvement in the trial, the staff indicated 
that they also took measures to ensure that men were involved, essentially adjusting the 
inclusion/exclusion criteria to ensure that only women who had obtained their partner's 
permission enrolled. This is illustrated in the quotation from Lianne, a research nurse, 
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above, and again below, but was also related to me by several other enrolling staff 
members. 
Crystal: There are some cases, they come, "No, me I want to join the study, but 
you know my husband is not agreeing to it". I will tell them, "Go back. You 
know men, you know African men, you know you have to beg and beg. You find 
by the time you do it, the fifth time, he just says, "no, no, no, please, just go, just 
go" and just there you will see the woman running and she says "please, today 
he has allowed me, and if I hesitate he will change his mind". 
CM. - Do you get such cases? 
Crystal: Yes, we get such cases. So we've been encouraging them to just go and 
liaise and liaise and liaise until the man just says, "no, I think just go, since it's 
like this". (Crystal, MDP community mobiliser) 
Lianne: When we recruit those participants, we tell them to go and discuss it 
with their spouses. They must agree. Not that one person alone comes here and 
starts being screened and then is enrolled without the consent of the husband. 
What we encourage is for them to sit down together, the two of them, and agree 
to take part in the study. 
CM: What about women whose partners don't agree? 
Lianne: That one is very difficult. We normally don't allow them, because we 
don't want to bring confusions in the idea. (Lianne, MDP nurse) 
This local re-working of the official inclusion criteria, as stipulated in the protocol, may 
have met with displeasure if it had been known by the coordinating staff in the UK, who 
were focused on meeting enrolment targets. More fundamentally, by insisting on male 
consent to participate, the Zambian researchers were compromising women's own right 
to participate in the trial freely and voluntarily as autonomous agents. Under the 
principle "respect for persons", the Belmont report states: 
An autonomous person is an individual capable of deliberation about personal 
goals and of acting under the direction of such deliberation. To respect 
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autonomy is to give weight to autonomous persons' considered opinions and 
choices while refraining from obstructing their actions unless they are clearly 
detrimental to others. To show lack of respect for an autonomous agent is to 
repudiate that person's considered judgments, to deny an individual the freedom 
to act on those considered judgments... (The National Commission for the 
Protection of Human Subjects of Biomedical and Behavioral Research 1979). 
Underlying this concept of autonomy is a presupposition of the value of individualism, 
which has become the hallmark of Western liberalism, but in this context was 
disconsonant with social relations in the trial community. As Wolpe has noted, the 
principle of autonomy in bioethics is socially constructed and historically situated; not 
all populations "share a fetish for individualized autonomous decision making" (Wolpe 
1998: 55). 
Crystal's words highlight the extent to which the researchers not only upheld existing 
gender norms, but were complicit in reinforcing these: "you know African men, you 
know you have to beg and beg. " From their point of view, however, their actions 
ensured that the research did not challenge the status quo of prevailing power dynamics 
between men and women and thereby cause upset (and potential revolt) in the 
community. Whilst the reasons they gave related to preserving marital harmony 
between couples and avoiding future conflict, it's likely that the normative pressure to 
bow to patriarchal authority played a significant role in their reworking of the enrolment 
process. 
Given what staff members had told me about requiring men to consent to their partners' 
participation in the study, I asked about the notion of a `woman-controlled product' and 
what staff thought about gel empowering women. This discourse has been pervasive 
and inextricably linked to the technology in Western (and I had assumed global) HIV 
prevention circles (indeed, as I argued in chapter four, the discourse of women's 
empowerment was instrumental in producing the technology). While some of the staff 
had heard the expression - predominantly at international conferences or through the 
media - some had not at all, and only one said she thought it was a suitable expression 
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to be used locally. The following responses, from interviews with staff members, in 
English, were typical: 
CM: Have you heard the expression 'woman-controlled' in relation to gel? 
Gertrude: [Blank] what do you mean? 
CM: There's been a lot of talk amongst advocates for microbicides, that they are 
'woman-controlled'. I'm wondering if that expression is common here in 
Zambia? 
Gertrude: [Hesitantly] Well... er, except that when we have almost, like, you 
mean like, because it's in the hands of women... mmmm.... although not so much. 
(Gertrude, MDP nurse) 
CM: Have you heard the expression 'woman-controlled' in relation to gel? 
Crystal: Expression 'women-controlled'... to gel... Maybe you re-phrase it? 
(Crystal, MDP community mobiliser) 
CM. - Have you heard the expression 'woman-controlled' in relation to gel? 
Mary: Controlled how? 
CM: It's like an expression that's commonly used in some of the advocacy 
materials, that gel, that microbicides are a woman-controlled method of HIV 
prevention. 
Mary: [Uncertain] Mmmm... well... mmmm... but, er... I don't know, how can I 
explain this. It doesn't... it doesn't really affect it much... (Mary, MDP 
counsellor) 
Since English was the language used for communication between Zambian and other 
researchers, both within MDP and the broader scientific community, I was surprised 
that this terminology, germane to the microbicides concept at its original sites of 
development, had not been adopted. A number of other staff did relate to the concept 
of a woman-controlled technology, but through discussion, the English word `control' 
was always re-worked as `use'. ' Ultimately, the expression `woman-controlled' did not 
feature in local discourse on microbicides, whereas `a product women use' was 
commonly invoked to explain what microbicides were. 
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Susan: Yes I have (heard that microbicides are a woman-controlled product), 
um, though not in, in, in the way of, I don't think the way people understand is 
that it's purely under the control of women. But I have heard it being phrased in 
that way. 
CM. Is the phrase used in English or local languages? 
Susan: No, in English. 
CM: In English? 
Susan: I've only heard it in English [laughs]. 
CM. - And you said that people wouldn't perceive it as being totally under 
women's control? 
Susan: I don't think they perceive it as that. Because, I don't know, maybe it's 
just because of the way our society is, there's nothing which is totally under the 
woman's control [laughs], so not even this can be totally under her control. So 
I don't think they really perceive it as totally woman-controlled. 
CM: So what might it mean in this context? 
Susan: In this context it means it's the woman who, um, who uses it. (Susan, 
MDP project coordinator) 
CM:: Do you actually use the word control (when discussing microbicides with 
potential participants)? 
Edward: Well, I think so, because [chuckling] ... I think so, but I think that 
is how 
we've explained, I've personally explained it, you know, and... 
CM: Can you tell me that in local language, how you would say that? 
Edward: In Tonga for instance? 
CM: For instance, yes. 
Edward: OK, Ibakaintu benu mbobano belesha musamu pesi ulamugwasya 
nyonse. That is to say the woman will be the one using this medicine but it will 
help both of you, a man and a woman. 
CM. - So it still refers to use rather than control? 
Edward: Yes, yes. 
CM: It's about who uses it, not who controls it? Am I right? 
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Edward. Yah [thinking] Yes, yes. OK, well... yes, you're right, yes. The one 
who uses it, yes. (Edward, MDP clinician) 
The absence of `women's control' from microbicides discourse at the Zambian site can 
be seen as a strategic way of framing the technology in terms of utility rather than 
gendered power relations. In The History of Sexuality, Foucault discusses the silences 
within particular discourses not in absolute terms, as the limits of discourse, but as a 
discretionary and strategic deployment: "There is no binary division to be made 
between what one says and what one does not say; we must try to determine the 
different ways of not saying such things, how those who can and those who cannot 
speak of them are distributed, which type of discourse is authorised, or which form of 
discretion is required in either case.. . [silences} are an integral part of the strategies that 
underlie and permeate discourse" (Foucault 1979: 27). In the local context, while it 
may have been possible to speak about woman's control, it was not advantageous for 
trial staff to mobilise such a discourse around the new product. Threats to the trial's 
success in the form of male opposition may have led staff to resist the Western 
invocation of microbicides as `a woman-controlled technology'. 
Again demonstrating the strategic use of local and external discourses, staff switched 
between accounts of the gel as empowering and the discursive legitimation of men's 
prerogative to control its use. Many staff presented themselves in favour of women's 
empowerment and said they felt, or indeed had seen, that the gel was empowering. 
However, they also said that women needed their partner's permission to enrol in the 
study and use the gel, and that if a man didn't want to use the product, a woman would 
not be able to use it. This play of discourses became problematic for staff when pushed 
about what exactly empowerment might mean within the context of gel use. Pressed on 
the issue, various informants produced hybrid concepts of empowerment by adding 
prefixes and qualifiers, as below (categories of empowerment are respondents' own). 
One informant spoke of `temporary empowerment' to suggest that women were 
empowered by microbicides for the duration of the trial since they might be protected 
from contracting HIV: 
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C: So in your opinion, do you think gel has empowered women? 
Rachel: It has, though it's a temporal one, and despite the messages that this is 
a trial, we don't know whether it is preventing them, for them, as long as they 
used it, behind their mind, they were comfortable to say, "as long as I'm using 
this, I may not contract the HIV". But now that some of them, they have 
graduated (exited the trial), in their mind they feel exposed, yes... They've had a 
temporary empowerment. (Rachel, MDP community mobiliser) 
Another referred to `psychological empowerment': women were said to feel more 
secure in their relationships because their partners liked sex with gel. In this respect, 
they were given the power to retain their sexual partners and therefore also their 
economic security. However, as Marley points out, below, women don't have any 
intrinsic power of their own; it is an illusory form of empowerment: 
They think it increases sexual pleasure and their man will love them more -I 
think it has (empowered them) in that sense. I think basically, psychologically, 
they are empowered. They are more secure. But I think on the other level it just 
shows that they are truly dependent on men. It just shows how unempowered 
they are. (Marley, MDP social scientist) 
'Husband-induced empowerment' or `negotiated empowerment' was used by several 
staff members to suggest that women were empowered if their partners let them 
participate on the trial and use gel: 
Crystal: For the... group who are married, empowerment is there through 
liaising. I can put it that way. Not on their own. It is like, I can say like 
husband-induced empowerment. 
C: Husband-induced empowerment? 
Crystal: Yes. 
C: Explain what you mean by that. 
Crystal: An example, it could be pregnancy-induced hypertension. So husband- 
induced empowerment. How I can put is, even though she knows that this gel is 
meant to empower women, she has to liaise, you know, until when the husband 
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gives her the go-ahead, then the husband has empowered her. Yes, that's what I 
meant. 
C: OK you mean that empowerment comes... 
Crystal: From the husband (Crystal, MDP community mobiliser) 
The staff were keen to say that women were empowered, perhaps because women's 
empowerment is part of the international research discourse on microbicides. 
Ultimately though, they were not able to discuss empowerment without qualifying it, 
the result of which was to render the idea as conceived from a Western viewpoint 
meaningless. The Zambian researchers' discourse - both on the legitimacy of 
patriarchal control and the absence of real empowerment - coupled with their denial of 
women's autonomy in trial procedures, looks like the antithesis of emancipatory 
research. However, as I will describe below, whilst the discourse of empowerment may 
not have been authorised in the local setting, what might be called empowerment from a 
Western perspective was actually occurring on many levels at the site. In the following 
section, I will detail how the research was constitutive of both researchers and 
participants and how, contrary to the apparently reactionary practices above, 
transgressive and transformative processes were simultaneously playing out. 
Transgression and transformation: Challenging discursive norms and 
practice 
As I have been indicating throughout this chapter, MDP staff in Zambia were at the 
crux of a potential change in norms around sexuality and sexual behaviour, one 
foundational element of which is talk about sex. Through the very act of transposing 
Western research on sexual behaviour into the local idiom, and then transferring data 
back again into the international arena, the Zambian staff became experts in discussing 
sex. Given that open talk about sex is culturally taboo in this setting, it's important to 
understand both how this change was achieved amongst staff members, and also the 
impact it had both on them and on those participating in the research as participants. 
Staff members all told me how difficult it had been at the start of the study, particularly, 
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as Crystal said, "mentioning the unmentionables ". John explained how the staff had 
overcome the problem: 
John: Well... partly it was due to the fact that we almost made a joke of sex in all 
the things we talked about, the language was more inclined to sexual issues. For 
example, in local language there are certain terms that you would use and then 
you just connect them to say, if someone will tell you, "I want that big one ", and 
then you say, "Which big one? I only have a small one" and someone will joke 
about it, "You! I didn't mean that! I meant the cup or the coffee mug". 
CM. - What does it otherwise mean? 
John: Otherwise, for example, I have a big penis or, yah, so sometimes someone 
would say, "No, I slept well", but in our local language sometimes you say, 
"No, I enjoyed my time there" say, "How many rounds83? " then someone will 
say, "No, I don't mean that! I mean something else ". So just to make jokes 
about every situation. So that way it helped us overcome the earlier fears and 
doubts we had about talking about sex. 
From my informants' accounts, the ability to break down barriers in talking about sex 
amongst themselves was critical to the staffs ability to communicate about sex with 
trial participants and community members. The practice and performance of sexual 
communication, particularly through word play and jest, was presented as an important 
part of changing the negative discourse around sex and risk in the community. In the 
following account, John demonstrates the continuities between the researchers and those 
in the community they came from. The approach to overcoming silence on sex was the 
same, and in this example involved the transposition of unpopular, potentially de- 
masculating advice into the popular macho idiom of the `Tonga Bulli84: 
I remember in one of the meetings or the workshops we had with Zambia Sugar 
employees, when I asked them how many people used condoms, they were all 
like looking at me strangely and then I thought, "Oh, so it means this thing is a 
bedroom matter and you don't talk about it anyhow. 11 And then during lunch I 
"'Rounds' refers to the number of sex acts. 
µ My research assistant explained that this is an expression used to indicate that someone is a real man in 
terms of having sex. 
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just commented to say, "You know, you have to be prepared", there is a term or 
there is a saying in Tonga which says "Nkondo ngu kavumbu" that literally 
translated means "You don't know when you will go to war so you have to be 
prepared all the time ". And then I changed that and said, "Sex ngu kavumbu" 
meaning you don't know when you're going to have sex, so you should prepare 
yourself all the time, and everyone came out and was laughing. And we started 
making in-roads in the community talking about sex. Initially we were just 
talking about prevention and other things. As time went on we also started 
making jokes about these issues and most of them also responded to the same. 
But it wasn't really an easy thing to do. 
This process was not a one-off, but a continual evolution and sustained practice in 
discussing sexual matters. Several respondents illustrated this when telling me about 
new staff members who came to work at MDP; for example, Michael: 
There are some new members of staff, you know how some people just join along 
the way, you know when they come, they are very uncomfortable. Maybe they're 
quiet, they're very uncomfortable when you're talking about sex, maybe in the 
kitchen there, you're busy talking about sex, you find them quiet. But as you go 
on, they'll be on the forefront talking about sex. And then someone will make a 
comment to say, "Ah, what's wrong with this place? Is it the people they choose 
to come and work here? " Then you slowly realise, you suddenly realise to say, 
no, it's not the people, it's the place itself [chuckling] because of the nature of 
the work, you know. So I think MDP, yes, it does that, it opens up people to talk 
about sex. (Michael, MDP research assistant) 
Edward commented similarly on how MDP had legitimised open talk about sex: "You 
know, we never did before, so it's here, in the MDP interaction [chucking]! " To quote 
Foucault, "a whole machinery of speechifying, analyzing and investigating" sexual 
behaviour as part of the research meant that sex became "what one might call the 
internal discourse of the institution" (Foucault 1979: 32 & 28). Talking openly about 
sex became the norm. 
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An obvious question following on from change in the staffs ability to talk about sex is 
the extent to which this impacted norms in the community. The starting point for this is 
to be found in those whom the researchers had the most direct face-to-fact contact with, 
namely the female trial participants. Michael related to me how surprised he was when 
a woman used very direct language (in the vernacular) during a social science interview 
- words like `horny' that women might use amongst themselves but would not use to a 
man, especially not to a relative stranger. The implication of using such a word to a 
man would be that she is not `taught' - i. e. she has not been appropriately initiated into 
the correct behaviour of a married woman. There are three points worth noting in this 
example; the first is that MDP opened the door for female trial participants to use a 
language normally forbidden to them - in a way it `untaught' them85. The second is that 
the example Michael gives of taboo language relates to female sexual desire - she says 
the gel made her horny; in other words, it is not just sexual terms broadly that he uses to 
make his point, but specifically terms implying women's agency of their bodies, 
expressed through fulfilled desire. Finally, Michael's own response to this woman is 
important: 
Because of my experience here as a research assistant, that's why I didn't look 
at that woman to be funny, for lack of a better term. But if a woman just came 
up to me in the community to say, "You know, this thing does this to me" and 
uses that term... maybe for other men it will be a problem, because they will look 
at that person to be... she's useless, she's worthless, she's not taught. 
This fundamental change in Michael's response, as a man, to the trial participant, a 
woman, suggests that the learning and un-learning of cultural norms took place in both 
directions between the researchers and the participants. Other male staff also spoke of 
"crossing the border" in terms of relating to people in their community and not always 
knowing how freely to speak about sensitive issues. This reported response, or change 
of behaviour, in relation to those outside MDP arguably built on the transgressive 
dynamics between male and female staff members described above. 
es We don't know how far this `un-teaching' reaches; would they use this language with their husband, 
for example? Would the same discourses available to them within the research setting be legitimate 
within their own homes? 
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Contrary to male researchers' apprehensions, female staff members spoke 
enthusiastically about the new confidence they had to speak about sex in the context of 
HIV within their communities. Some went into churches to address women's groups, 
others gave talks at under-5 clinics, women were addressed door-to-door and in the 
market. Crystal relates vividly the sort of response they received: 
We had a mandate to teach the women about the natural defence mechanisms of 
the vagina and at first it was a big challenge. You had to bring those terms in 
local language and the women would go screaming, [with mixed horror and 
delight] "These girls are insulting! " And they started getting excited, you know; 
that is something which is unheard of in our communities. So you find that even 
when she's feeling lazy to go for MCH (Maternal and Child Health clinic), she 
knows there will be a talk, the girls will be there, she just wants to come and 
listen! And they gave us names! Even when you pass in the community they will 
say, [gleefully] "Hah! That one, she says big insults! " And they gave us, you 
know, names. But slowly they adapted, but at first it was really a challenge to 
mention the private names in local language, and I would make sure I would 
ask all the languages which are there and translate the private parts into all the 
local languages so that when we go home, everybody understands what I was 
teaching! And the women would get excited, because you know the way we have 
been... we have been all along, you know, such things are taboo, they are not 
even heard of. But ... the women were happy... they were keen to learn, they 
would ask you this, they would ask you, the, you know, the vaginal anatomy, you 
know, because it's something they've never heard of (Crystal, community 
mobiliser, emphasis respondent's own) 
The fact that MDP staff occupied respectable, well-paid research jobs made them the 
ideal locus of normative change and legitimated the breaching of traditional norms 
around sexual talk and communication. What were formerly considered "insults" 
became part of authoritative health advice. The sense of excitement at this new 
transgression and the potential for overt expression of the previously forbidden is 
tangible in Crystal's account. 
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Implicit in the MDP301 trial, as in other HIV prevention interventions, was the element 
of sexual behaviour change. Some aspects of this were made explicit, such as 
counselling to use condoms and gel, and advice against anal sex; others were merely 
implied through the way data was collected, for example asking women about their 
number of sexual partners. All women in the social science sub-set of the trial were 
provided with pictorial coital diaries depicting a range of sexual behaviours, such as 
vaginal and anal sex, condoms, and douching. Although designed as a form of 
surveillance, there were cases of these diaries being interpreted as a form of instruction 
(as to what to do for the study). Some semi-literate women required intensive follow up 
visits in order to complete these, as Margaret describes below: 
She doesn't know how to mark coital diaries, she can't remember her sexual 
acts... so those weeks that she comes in, it's something that I have to do every 
week Like in a week I have to follow her at least twice, so that I go and ask 
her, "Did you have sex last night? " then I'm going to tick her coital diary and 
leave it. 
Although it's not possible to say with any certainty, it's likely that such frequent 
contact, monitoring and questioning of women's sexual lives in some way impacted on 
women and their behaviour, at the very least promoting a sense of agency in sexual 
relations. 
In addition to addressing sexual behaviour change at the individual level, MDP Zambia 
actively engaged community members at the level of normative change. One example 
of this was a workshop with all the alangizi (traditional marriage counsellors) in the 
district to discuss their role in relation to microbicides. Although the workshop was 
reportedly designed as a forum for dialogue and exchange, the researchers also told me 
they had been keen that the alangizi change their messages about dry sex and the use of 
vaginal inserts to achieve this. John, who had arranged the workshop, related how it 
had been challenging to explain everything to the alangizi, not least because the female 
staff members wouldn't talk to them. As a result, he, a man, was tasked with the job. I 
asked why female staff were reluctant to talk to the alangizi about changing traditional 
instruction on vaginal insertion and sexual practices. He replied: 
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Because most of the women here, even if they're working for the MDP, still 
respect the tradition very much, yah, and they also live in the same culture. It's 
one thing that is common here, the bridal showers, and there's a night before 
the bridal shower, there's everything that is talked about - sex and satisfying a 
man, and in some situations they've talked about dry sex, and all those kind of 
things. So most of these women that we are working with were uncomfortable to 
talk about these things because they know they are also practising the same 
things they are talking against. So it's really a dicey situation for them, it's 
easier for a man to say those things. 
For the female staff to talk to the alangizi would have required them to openly challenge 
norms around women's sexual behaviour that they themselves had been indoctrinated 
into. Whilst they were confident speaking to women participants (as described above), 
this did not entail an open challenge to the very structures of cultural indoctrination, 
embodied in the alangizi. Because men are absent from women's education in sexual 
matters, and according to John do not themselves undergo such pre-marital counselling, 
it was easier for them to broach change at a more structural level in a non- 
confrontational manner. This example shows how MDP staff navigated change by 
bypassing certain forms of confrontation that would have had a negative impact on 
community relationships. Norms are subtly challenged, but the route through which 
this occurs leaves some of the status quo intact. 
Summary 
In this chapter I have used findings on the implementation of MDP 301 in Zambia to 
argue that the clinical trial can be seen as a form of disciplinary power, operating 
through the surveillance and objectification of the body, and creating particular types of 
subject in those whom it recruits. The disciplinary management of trial participants is 
institutionalised through daily routines and procedures which function as part of the 
clinical gaze; power is exercised through the strategies of observation, measurement, 
examination and comparison of individuals against an established norm. In the trial 
context, such strategies include blood testing, genital examinations, and the collection 
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of demographic and sexual behaviour data. The trial could potentially be called an 
`institution of normative coercion, ' in the same way that Foucault referred to religion, 
law and medicine more broadly as `coercive institutions' (Turner 1992; Turner 1997). 
Petersen and Bunton illuminate the sense in which coercive is used here: 
These institutions are coercive in the sense that they discipline individuals and 
exercise forms of surveillance over everyday life in such a way that actions are 
both produced and constrained by them. However, such institutions as the 
medical clinic are not coercive in the violent or authoritarian sense because they 
are readily accepted as normative at the everyday level. These institutions of 
normative coercion exercise a moral authority over the individual by explaining 
individual `problems' and providing solutions for them. In this sense we could 
say that medicine and religion exercise a hegemonic authority because their 
coercive character is often disguised and masked by their normative involvement 
in the troubles and problems of individuals. They are coercive, normative and 
also voluntary (Petersen and Bunton 1997: xiv). 
International clinical trials, such as MDP, constitute a field of power relations in which 
various forms of difference - such as gender, international relations and medical/lay 
expertise - vie for hegemony. The struggle for power, as presented in this chapter, 
occurred largely around women's bodies as a site of control: male control of women's 
physical movements; medical control of the epidemic through experimental 
pharmaceuticals and surveillance. Whereas the liberal Western view of women as 
individual, autonomous agents framed the research and provided a foundation for the 
discourse of women's empowerment, this did not translate unproblematically into the 
Zambian context. The transfer of both science (in the guise of the RCT) and technology 
(the microbicide) exposed their inherent instability. MDP became the battleground on 
which a fight to construct reality was waged between the neophyte servants- of 
neoliberal governance86 and the prevailing embodiment of African rule: the male head 
of the household. 
$6 Fisher has convincingly argued that clinical trials represent a form of neoliberal governance (Fisher 
2009). 1 use the expression 'neophyte servants of neoliberal governance' to refer to the Zambian trialists. 
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The discursive battles that the trial engendered were artfully negotiated by the Zambian 
trial staff, who had a foot on each side of the battle lines. However, had I not been there 
conducting these interviews, it is questionable to what extent this conflict would have 
been evident, and to what extent it would have remained an implicit tension in the 
implementation of trans-national research. The accounts I have presented were 
generated not only in the context of the trial but specifically in interaction with me as a 
Western researcher working on the trial. The deployment and orchestration of various 
discourses was therefore not `naturally occurring': I did not simply observe the way in 
which people spoke about the trial and gender relations. Rather the play of discourses 
was an active product of the interactions between me and my informants: we co- 
produced them and each other. This itself sheds light on the assumptions and divergent 
priorities between those working in global health research and those positioned as the 
recipients of `First World' technology transfer. My interest in microbicides as a 
"woman-controlled" product was not shared by informants. Their mobilisation of 
discourses of utility suggested a more pragmatic interest in maintaining the gender 
status quo in order to achieve the aims of the trial. 
In their research on reproductive health, Mumtaz and Salway have noted that "the 
women's autonomy framework, with its focus on individualism and independence and 
its assumption of universal applicability, tends to over-simplify complex and context- 
dependent dimensions of women's lives" (Mumtaz and Salway 2009: 1352). Because 
my research focused on the context of the trial rather than the broader socio-cultural 
context, some of this complexity remains unearthed by my analysis, as do the emic 
meanings of concepts such as `woman-controlled'. However, in the following chapter, I 
turn to the women and their partners who took part in the trial to explore the discursive 
production of research, technology and gendered subjects from a third angle. This will 
put into context the findings from both Western and African researchers presented thus 
far. 
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Chapter Seven 
In Transit, In Translation, In Transition: Technology, Science & 
Society 
We now need to find out more about how science and technology travel, not 
whether they belong to one culture or another - Stacy Leigh Pigg (cited in 
Anderson 2002: 644) 
It is a curiosity that with the burgeoning of work on gender in Africa, and in 
particular the work on women, the subject of masculinities in Africa remains 
neglected. (Morrell and Ouzgane 2005: 1) 
In the previous three chapters I have explored the co-production of science and society 
by focusing on the development and testing of PRO 2000. I have discussed how the 
initial development of the drug created a new subject of HIV prevention research - the 
powerless African married woman; how an international scientific network was 
achieved through discourses of partnership and participatory democracy; and how 
African researchers played a pivotal role in both upholding and transgressing gendered 
power relations through the institution of the trial. Thus far, the discussion has centred 
primarily on researchers and explored the process of scientific knowledge production 
from their point of view. In this chapter I address the other side of the coin, namely the 
research subjects, who were both the providers of data and the objects of conjectured 
empowerment. 
I have already suggested, in the previous chapters, that while women were posited as the 
sole beneficiaries of PRO 2000 microbicide gel and the sole participants of the trial to 
test it, men were equally present, if tacitly, in both of these domains; men were as likely 
to be protected from HIV as women and the majority of women sought men's consent 
to participate in the research. Over the past few years, vaginal microbicide advocates 
and researchers have begun to address the discursive absence of men in microbicides 
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research by raising discussion of `male involvement' in clinical trials. Within these 
discussions, men have largely been seen as a problem to be overcome on the path to 
women's empowerment rather than as an active half of the solution to HIV prevention. 
For example, in a report on the ethical aspects of clinical testing of microbicides, a 
chapter addressing men is entitled "What to do about male partners? " - as if men were a 
problematic adjunct to health (Global Campaign for Microbicides 2005: 22). Reporting 
on the 2006 Microbicides conference in South Africa, an article in BETA reports that 
"Track C raised some controversial issues in the microbicides field, including such 
topics as male involvement in trials" (Forbes 2006: 40), pointing again towards the 
apprehension around involving men. 
The need for microbicides for HIV prevention, and the related unease around male 
involvement, have been discursively produced within the framework of what Mumtaz 
and Salway. refer to as the `autonomy paradigm', wherein women's limited autonomy is 
understood as the major barrier to improvements in their sexual and reproductive health 
(Mumtaz and Salway 2007; Mumtaz and Salway 2009). They note, "broadly described 
as `control over their lives', women's autonomy has been viewed as a set of multiple 
inter-linked domains including, but not limited to, decision-making authority, economic 
and social autonomy, emotional and physical autonomy" (Mumtaz and Salway 2007: 
20). The paradigm is deeply imbued with the Western valorisation of individual 
autonomy as the universal moral basis of personhood. This has been debated on various 
levels; the universality of these values has been questioned (Triandis 1995), whilst at 
the same time, some work suggests that the distinction between Western and `Other' 
notions of personhood has been over-emphasised (Carsten 2001). Furthermore, the idea 
of individual separateness that autonomy embodies is at odds with an understanding of 
people as socially embedded, that is, as experiencing their lives in relation to others 
(Nedelsky 1989; Mumtaz and Salway 2009). 
In the field of reproductive and sexual health, there has been an emerging re- 
(e)valuation of the autonomy paradigm, both implicit and explicit. For example, 
numerous studies have started to document the benefits of men's active participation in 
family planning (Bawah 2002), pregnancy health (Mullany et al. 2005; Mullany et al. 
2007), and prevention of mother to child transmission (Farquhar et al. 2001; Kiarie et al. 
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2003; Farquhar et al. 2004; Homsy et al. 2007; Kakimoto et al. 2007). Likewise 
undermining the (presumed) link between female autonomy and improved health 
outcomes, Mullaney et al question whether women's autonomy, based on sole decision- 
making power, is at odds with improvements in health outcomes that can be achieved 
when men are involved (Mullany et al. 2005). And in an explicit critique of the 
assumptions underlying much research on women's reproductive health, Mumtaz and 
Salway demonstrate the inadequacies of the autonomy paradigm for understanding the 
determinants of women's reproductive health in Pakistan. Amongst other things, they 
highlight neglect of the socio-cultural construction of men and masculinities, and the 
multi-sited construction of gender relations as weaknesses of this approach (Mumtaz 
and Salway 2009). 
In HIV prevention, the autonomy paradigm has been embodied not only in 
observational research, but in the very interventions and technologies designed to 
overcome the pandemic. For example, studies exploring HIV risk factors, or the 
barriers and facilitators to sexual behaviour change, often frame these in terms of 
women's self-efficacy or relationship power (Bowleg et al. 2000; Jewkes et al. 2002; 
Pulerwitz et al. 2002; Dunkle et al. 2004; Harvey and Bird 2004). Furthermore, 
interventions themselves - such as micro-finance initiatives and microbicides - are 
aimed at increasing women's autonomy in order to effect changes in HIV incidence (see 
for example Pronyk et al. 2006). The vogue for this approach, often related back to the 
1994 International Conference on Population and Development, has led to a pervasive 
discomfort around men's involvement in interventions. In the microbicides field, this 
can be seen in key stakeholders' reticence about engaging men in trials: "engaging men 
too closely in the trial is ethically problematic... the result could be disempowerment of 
women, precisely the opposite aim of microbicide development" (Global Campaign for 
Microbicides 2005: 23). There is an obvious tension here regarding the site of proposed 
empowerment: the trial and the technology. The implication is that the technology can 
empower women but only in isolation from men; after all, if men are involved in the 
trial to test the technology, women might be disempowered. 
The microbicides trial can therefore be seen as a juncture at which power operates to 
form and re-form both the social and the technological. In the line of previous 
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discussion in this thesis, the idiom of co-production can usefully be used to explore not 
only how gender and technology are co-produced, but also how the scientific process - 
in this case the phase III trial - is a part of this production. The focus here is not 
Latour's Northern European laboratories populated by aggressive, competitive 
scientists; nor is it the `living laboratories' of women's bodies, as eco-feminists would 
have it. It is instead the space between scientists, non-scientists and technologies, the 
space where science moves outside of the laboratory and outside of the West, to the 
world beyond what Emily Martin metaphorically refers to as `the citadel' in science 
studies (Martin 1998). In this chapter I explore how ideas and technologies travel, how 
scientific knowledge and its products bridge different geographic and social locations, 
and how scientific and social intelligibility are produced in a Zambian trial community. 
Interview and focus group data from the MDP trial site in Zambia form the basis for this 
discussion. The data consist of twenty-one interviews and five focus groups with trial 
participants, male partners, and key stakeholders in Mazabuka. The analysis starts with 
a description of how gender is produced through existing institutions in the trial 
community. I then go on to discuss a crisis in masculinity, particularly in relation to 
HIV, and the role the research played in re-producing negative male representations. I 
explore women's agency in appropriating the trial to meet their own agenda and how 
local ideologies of gender and social organization were at odds with the autonomy 
paradigm which originally spawned microbicides. 
Discursive production of gender in the MDP301 trial community 
Gender relations in Zambia are characterised by inequity in multiple domains of life, 
including labour, wealth and education. The legal and institutional context reproduces 
such inequalities through customary law, which tends to treat women as dependents, for 
example denying them independent property and inheritance rights (Byrne 1994). The 
2004 Zambia Strategic Country Gender Assessment identified "culture, in this case 
patriarchy, and socialization as key to gender relations" (Milimo et at. 2004: viii), and as 
Dover notes, "If we take gender to be the social construction of masculinity and 
femininity, in which culture elaborates on the sexed body, then socialization and 
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enculturation are the most important formative processes" (Dover 2005: 174). Whilst 
gender is repeatedly constructed and performed through the praxis of daily activities and 
interactions, a conscious set of teachings and practices congeals dichotomous gendered 
identities at the point at which a man and a woman get married. Marriage counselling 
prepares men and women to take up the roles expected of them in their adult life; in 
Zambia, such instruction is provided primarily by two institutions - Alangizi, traditional 
marriage counsellors; and the Church. 
In the MDP trial community in Mazabuka, the majority of women were said to receive 
marriage counselling, and trial staff referred to the re-production of gender norms and 
expectations through this process. In order, therefore, to understand how gender was 
produced in the trial community, I interviewed four key informants who offered pre- 
marriage counselling: two church leaders (one from a large Protestant church and the 
other from a large Pentecostal church), and two traditional marriage counsellors 
(alangizi). In addition, I used focus groups with both men and women to explore the 
discursive production of gender ideals, masculinities, and relationships between men 
and women. Whereas the key informant interviews provided information on the topics 
covered during young men and women's initiation into married life, the focus groups 
gave a window onto the social production and perpetuation of gender identities in 
action. As I discuss below, the differences in discourse between the focus groups and 
the interviews with men, women, and couples, provided important insights into public 
norms and contrasting private accounts. 
Women's subordinate status in relation to their husbands formed the central axis for all 
teaching, whether traditional or religious. Whereas the alangizi focused on techniques 
to guarantee women's submission and thereby ensure their marital and financial 
security, the religious leaders emphasised the reciprocity of love and obedience between 
both men and women, which formed the basis for marital unity. In this respect, the 
religious leaders voiced what might be termed a more progressive discourse on 
87 women's position while the alangizi bought in to the so-called `patriarchal bargain'. 
67 The patriarchal bargain refers to strategies women use to ensure their survival and security within a 
socio-economic context dominated by men. Although by employing such strategies women support 
existing patriarchal structures which disadvantage their own sex, in the short term they may gain 
economic or social rewards for themselves (Kandiyoti 1988). 
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However, the roles the alangizi ascribed to women did not rest on a belief in women's 
innate, or God-given inferiority, as did the discourse of the religious leaders. For 
example, one of the pastors I spoke to was very much wedded to a biologically 
deterministic view of gender, based on his interpretation of the Bible. According to 
him, a man was a head of the house because... 
... when a man catches something, he will run with it longer than a lady. Women 
are naturally emotional. They will get hold of something but easily drop it. 
Man, rationally, is a realistic person. They want to analyse 
something... naturally, a woman is like a kite, they quickly [indicating with his 
hands the motion of a kite flying away]. But the man will be the string to the 
kite, will give the guidance. At the end of the day you will be very successful. 
Many men in the focus groups and interviews' reflected these sentiments and used 
Biblical references to validate male dominance. The idea that men were naturally 
rational (in contrast to women) was pervasive. 
The alangizi, on the other hand, did not express ideas about innate gendered superiority, 
but based their teachings on pragmatics designed to protect a wife in her marriage. 
Whatever a husband's behaviour, a wife should respect him and maintain the integrity 
of the home by listening to him, looking after him, and keeping any misdemeanours, 
such extra-marital affairs or abuse, secret. Marital harmony should be preserved at all 
times through submission (as opposed to the love and obedience advocated by the 
Church); this should permeate all aspects of daily life, no matter how small. For 
example: 
If the husband says "today I want to eat kalembula88, " even if the wife wanted 
chicken she should follow what the husband wants and prepare what he wants to 
eat and that brings harmony in the home, and when there is harmony the man 
will have no reason to have extra marital affairs because the wife is submissive. 
(Lillian, traditional marriage counsellor) 
u Sweet potato leaves 
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Women in the focus groups largely reiterated ideas about appropriate behaviour for 
husbands and wives, as taught by the alangizi. Women should be respectful of others 
and of themselves; should maintain high standards of hygiene; should work hard and 
not be lazy; should take care of the husband and all his needs; should be stable and 
found in the home rather than out and about; should not be talkative or outspoken; 
should not quarrel with the neighbours; should be humble, submissive and 
monogamous. In addition, having the financial means to look good and dress well was 
seen as a sign of a successful wife. A wife who would not be respected was one who 
could not employ appropriate tactics to manage her husband, and would end up being 
beaten by him: 
R: Others beat (their wives) [laughter] 
R: Some they do beat. 
CM: What distinguishes a man who beats and a man who doesn't beat? 
R: The woman's behaviour. 
R: The married woman. 
R: The behaviour of the woman. 
Interpreter: The woman's behaviour? 
R: Yes, the woman's behaviour. She can be talking with the husband inside the 
house but she will come out and start shouting and people will know that her 
husband does not beat her. 
R: Why shouldn't a man beat his wife when he knows that she is misbehaving? 
That women themselves condoned marital beatings was clear in the interviews with 
alangizi, one of whom remarked: 
It doesn't make sense to start exchanging words when the two of you are 
annoyed, because in the end you can just get beaten and your friends will laugh 
at you because you don't have strategies about how to handle your man (Lillian, 
traditional marriage counsellor) 
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As these extracts show, wives who were beaten were the object of scorn and ridicule; 
the same was true of women whose husbands were having extra-marital affairs, since 
this could also be attributed to the wife's shortcomings. As mentioned above, women's 
re-inscription of the prevailing gender discourse can be seen as part of the patriarchal 
bargain, the dynamics of which I discuss in more detail below. 
In spite of instruction to act submissively, women's role was not defined as one of 
passivity. On the contrary, the alangizi provided detailed instruction in the ways of 
managing a husband using various tactics that maintained the cloak of subservience. 
Therefore, although such teaching could be seen to ensnare women in the trap of 
patriarchal dominance, in more subtle ways it taught them how to negotiate the play of 
power with their partners whilst ensuring their own security. In an interview with one 
of the alangizi, she had told me that it was correct for the wife to respect her husband in 
all things. Following this, I asked, "Is the husband always right? " Her reply 
demonstrates how even within the confines of prescribed gendered power relations, the 
woman retains agency: 
Husbands most of the time they don't do right things and they tell lies... but 
being a woman you just ignore and find ways and means of bringing happiness 
to your home ... I tell 
him when we go to sleep, that "big man, your lies are 
getting out of hand. What you did that day did not please me ". However, I do 
not bring it up the same day, I wait until he has cooled down, that is when I 
bring it up that "I was not happy with what you did that day, you really offended 
me in this or that way when you told that lie ". And the man would even laugh 
and apologize there. and then. It does not mean because you are a woman you 
cannot tally no; it is a matter of knowing the correct time to talk. (Lillian, 
traditional marriage counsellor) 
The public discourse on gender constructed men as the legitimate head of the 
household: strong, able to reason, and possessing the financial muscle to provide for the 
family. The man's authority in the home was presented as absolute and God-given; 
accompanying this was the just use of force to discipline other members of the 
household, be it women or children. Whereas both the alangizi and the religious 
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leaders emphasised that men should be faithful to their wives, there was widespread 
acknowledgement and even expectation that men would have multiple sexual partners. 
Such behaviour is encoded in local sayings, for example "Ubuchende bwa mwaume 
tabonaula ing'anda, " meaning "a man's promiscuity does not break a home". Focus 
groups with men were particularly revealing of the social construction of masculinity as 
virile and violent. The extract below provides one typical example of the public 
performance of hegemonic masculinity: 
RI: Customarily, like here in Africa, especially us Zambians, as a man I have 
the right to have intercourse with my wife whether she likes it or not. That is the 
part of abuse we are talking about. You find a woman will have no say, because 
we even say, "I paid lobola, I paid a lot of animals, so why should you refuse? " 
So that is the abuse we are talking about. 
Interpreter: I am a Tonga bull! [Laughter from the group] 
RI: Yes, I'm a Tonga boy, I want to have it now, I want to have sex! So the 
woman will have no option but to just give in because she's married. 
R4: And just to add, yes, I can agree, we do abuse women or ladies. Maybe you 
are just from somewhere, (you go) to a bitch. You do what you want to a bitch, 
as you come back home, you also want to do (have sex). You get HIV there, and 
you come and add to a person who is innocent, which is now part of abusing. [In 
pleading woman's voice] "No, my friend, this is late time, you are from 
somewhere, you left home in the morning and came at 05.00 and you want me to 
have sex with you? No, better we sleep and maybe we do after some time ". 
"No ", you know we do fight sometimes as Africans, "No, I'm not here to sleep, 
I'm here to fuck you. To produce. " [All laugh]. So we do abuse women through 
sex, like us blacks. 
In this focus group with men aged 18-30, `abuse' was used rhetorically as a token of 
masculinity. In part this display was probably for my benefit as a European woman of 
the same age and I contributed to the production of this discourse by asking questions 
about male/female power within sexual relationships. Nonetheless, within this context, 
the discussion of abuse as a man's right was a consciously ironic counter-discourse to 
that of human rights, which was said to have come from the Europeans and had just 
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been raised in relation to why women might need microbicides. Although there were 
mixed feelings amongst other participants as to whether men force their wives to have 
sex, there was agreement that "there's no rape between a married couple" and that in 
some cases, `abuse' was simply down to men's consumption of alcohol. Debating this, 
R4, one of the most vocal participants, continued: 
R4: Me, I drink beer [interpreter and others laughing], what we call Shake- 
Shake89, Lusaka Beer - those things give appetite. 
Interpreter: Appetite? 
R4: Yes, for sex. You knock off, you hammer (drink) one pack, or two packs, 
when you go to bed, Yah! It's like it's a pump [making sexual gestures of 
"pumping" a bicycle/woman; laughter from the rest of the group], I'm just 
pumping, like a bicycle, a woman [laughter]. You start pumping from 24: 00, you 
maybe reach 01: 00, just pumping, or 04: 00! 
RI: So it is like forcing? 
R4: No, it's not abuse, they do agree sometimes. It's the culture. It's the 
culture. 
CM: It's the culture? 
R4: Yah, we are used to that. And so now they say, "yah nda mujana 
musankwa" "yah I have found a man ", this is now a real man! Eh? [Laughing] 
There was little space in this discussion for alternative forms of masculinity to emerge, 
although it was clear that not all of the men felt represented by R4's comments. In 
many of my interviews with men and women, men's relationship to alcohol was seen 
both as a part of their manhood and a contributory factor to their sexual behaviour, be it 
sleeping with prostitutes, having unprotected sex or forcing their wives to have sex with 
them. The ascription of such behaviour to `culture' legitimated this dominant 
stereotype of masculinity90. 
19 An improved version of local brew that is sold in cartons. 
90 Various researchers have discussed men's macho behaviour, including the resort to alcohol, sexual 
promiscuity and abuse, as a response to a crisis in masculinity that has led to the expression of 
disempowerment through violence (Duggan and Hunter 1995; Morrell 1998; Silberschmidt 2005). This 
crisis has arisen through historical and economic developments in East and Southern Africa which saw 
men defined as breadwinners during colonial times and subsequently faced with high levels of 
unemployment in the post-war period (Campbell 1992; Silberschmidt 2005). Low wages, unemployment 
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Masculinity in crisis 
By contrast, in individual interviews, men expressed alternative aspects of their 
masculinity which cast into relief the performance of `the Tonga bull' as a public 
display of male stereotype. Whereas the expectations of men were publicly extolled as 
victories of masculinity, in private, the discourse was of the pressures some of these 
behaviours brought with them. For example, whereas in the focus groups men were 
discussed as the stronger sex because of their financial muscle (amongst other things), 
in the interviews, they discussed the weight of this responsibility and the hardships of 
being the primary provider: 
William: There are times when it is difficult, whereby you don't even know what 
to do and then you find that your partner says that, "Me, what I want... "- 
maybe there is no relish91, no charcoal, no mealie-meal92, no cooking oil, no 
salt; "You, my father, you are the one who got me (married me), everything is in 
your hands. You are the one who is supposed to look for something the children 
will eat. " So it will force you to answer your wife that, "now where can I find 
the money? "... 
Interpreter: What do you think about that issue? How do you feel? 
William: There is nothing that I feel because I know that I am the one who has 
done such a thing, these children are supposed to eat every day. If I don't look 
for money it means this one (partner), I won't stay with her, because she can 
leave, because hunger has come at home and you (the man), you are not looking 
for money; you want the woman to look for money. So if she goes and looks for 
another man, then he gives her the disease; and if it so happens that you have 
the disease - the bad one is me, who is not looking for food to give this person. 
So 1 am supposed to always look for food to give her, that's when we can live 
together. (William, male partner, 35) 
and job insecurity continue to make it difficult for men in this community to live up to the socially 
defined role of man as breadwinner. 
" Relish refers to any accompaniment to nshima, the staple food in Zambia. 
92 Mealie-meal is maize flour used to make nshima. 
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Whilst in groups, men said they were too busy working hard to chat idly about issues 
like HIV, in extracts such as this they indicated that they were keenly concerned about 
HIV in the context of their families and that the constant search for petty labour was a 
source of worry rather than pride. 
Likewise, while still acknowledging sexual promiscuity as a feature of their lives, in 
private accounts, men described their infidelity to their wives in a more conflicted 
manner, highlighting the tensions they perceived between socially sanctioned male 
behaviour and the consequences for themselves and their families. Their discourse was 
one of paternal obligation, as below, with an emphasis on the welfare of their children 
in the event that they contracted HIV: 
With some of us men, we don't hold on (siti zigwila i. e. we are promiscuous). So 
you will find that even if you have a family of children at home, you are even 
doing such things (sleeping with other women). Because where we go in bars, 
for you to realize that "I have done such a thing", it is after the beer has 
finished. Then when you go home, maybe you have gone with diseases, and then 
you start giving them to your partner. Instead of you dying alone, so that your 
partner remains to look after your children that you have left, you find that you 
have infected each other and get sick at the same time. There will be no one to 
look after those children. (Richard, male partner, 29) 
Men showed themselves aware of their risk of contracting HIV through unprotected sex 
and had obviously considered the consequences of this for themselves and their 
families. Some men expressed regret and self-reproach, but in spite of this, presented 
themselves as unable to resist the lure of extra-marital sex. In a society where men's 
social value and esteem is tied both to their role as breadwinner and to their sexual 
control of women, extra-marital sex may provide an expression of success where such 
masculinity is threatened. Silberschmidt has written that "With control over women 
being an important social index for their masculine reputation, many men seem to have 
"chosen the lifestyle"... of (aggressive) sexual behaviour with multiple partners. This 
behaviour seems to have become a tool to acquire self-esteem, a tool of domination and 
control over women as well as a legitimate way of manifesting masculinity" 
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(Silberschmidt 2005: 198). Although this study did not seek to document men's actual 
sexual behaviour, Silberschmidt's explanation relates plausibly to their discourse, in 
which they presented themselves as incurable sexual risk-takers. 
In line with an acute personal sense of vulnerability to HIV, men also described a deep 
and pervasive fear of learning their HIV status and the difficulty the trial presented to 
them in terms of confronting this fear. Debilitating sickness and death were the 
presumed outcome of learning one's status, and with this, the attendant loss of control 
and social status. The image of sero-positivity was directly at odds with the social 
construction of the `big man'93 as strong, hard and resilient. Interview participants 
commonly reported cases of men skirting knowledge about their status and widespread 
avoidance of the subject in male-male communication. The acknowledged norm was 
that women discuss HIV frequently in groups because of their interest in safeguarding 
their family's health and their constant exposure to health services through family 
planning and child health clinics. Men, on the other hand, said they lacked their wives' 
courage in confronting the subject of HIV. 
Within the MDP trial, HIV testing represented a site of confrontation for men, requiring 
them to negotiate multiple and competing representations of masculinity: the Tonga 
Bull who can have as many women as he wants (and may likely be infected with HIV); 
the breadwinner who provides economically for his wife (and may not be able to work 
if he's found to be positive); the paternal role-model responsible for raising his children 
(who will not live to see his children succeed him if he gets a positive result). Some 
men, then, constructed the test as potentially conferring an identity upon them that they 
were not prepared to accept. Several described how difficult it was to engage with the 
trial because of the issue of testing; one said, "It takes a man to have much courage and 
confidence to get involved in a research programme" and likewise another male 
partner: "Us men, it's not easy for us to come for such trials. It takes someone's 
courage to come for it". The implication was that most men did not have this courage. 
"'Big man' was used both as a term of address to men themselves and when talking to women about 
their husbands. This expression alone is a powerful public re-inscription of hegemonic masculinity. 
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Challenging and re-producing gender: The MDP trial 
Men's fear of learning their HIV status had implications not only for their own 
involvement in the trial, but more specifically their partners'. Men implied that their 
exclusion from the study exacerbated their fears around HIV, since they were not 
targeted with information and did not have an opportunity to discuss their concerns 
first-hand with the trial staff. A number of men admitted that fears about learning their 
HIV status led them to propagate rumours that MDP was Satanist. One man confided 
how he had put up obstacles to his wife going to MDP before she had managed to 
convince him to let her go: 
All I wanted was to find means and ways to prevent my wife from going there, 
because one, I was scared. Once she's found out she's positive, then automatically I 
will be also, I will be thinking I'm positive, and maybe that's the end of our 
relationship. (William male partner, 35) 
And similarly another: 
I had no plan to come here until she told me, "let us go and see what is there ". I 
said, "But for what reason? "I didn't even want to come because I thought, now 
when we are found wanting, we are infected, how are we going to go? You know, 
it's always fear. So we didn't want. And this is why men do not want to come here. 
If you just go round, you will find most men will say "no thank you ". (Simon, male 
partner, 53) 
In fact, in the focus groups, men said they were extremely keen to be involved in the 
programme, only that MDP didn't want them and hadn't provided any outreach to men. 
Their discourse was one of exclusion and injustice; men were "difficult", they said, 
because had they had been left out. A comment from one of the pastors depicted how 
the research itself constructed men as difficult by presupposing male opposition to 
microbicides, not least in the suggestion that gel could be used covertly: 
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Anything hidden brings suspicion and it doesn't matter how much she might explain, 
at the end of the day, expect an opposition. And that opposition will be blind 
opposition with no knowledge, but just defending, that as a man, he should have 
been taught this. For her to come in his house with this lack of knowledge of what it 
means to be head of the house, [booming] "I am the head of this house! " And so 
you will create a man, give him crocodile skin for nothing". Because what you 
don't know you are afraid of. And naturally what you are afraid of you want to 
oppose (emphasis added). 
Indeed the creation of men as the enemy was deeply imbued in the very concept of 
microbicides as a woman-controlled product, the genesis of which I discussed in chapter 
four. Men in the focus groups showed an awareness of this ascription and performed to 
the stereotype of male abuse. Whilst the performance of this identity may have 
preceded the programme (as hinted at by the pastor, above), it was an identity that MDP 
authorised and perpetuated. 
If the trial constructed men as both absent and difficult, it constructed women both as 
powerless victims imprisoned in patriarchy and as autonomous individuals capable of 
independent action. Although the trial team was composed of a variety of researchers 
from both Africa and the UK, and from disciplines spanning biomedicine and the social 
sciences, common buy-in to these assumptions was needed for the study to function. 
The rationale for the technology was women's powerlessness, but it embodied the 
potential for women's autonomy, an autonomy implicit in a woman's individual consent 
to enrol. Indeed, the fact that women were able to enrol in the trial is indicative of the 
fact that they were neither powerless victims nor autonomous individuals, but rather that 
the play of power between partners was operating in a much more nuanced way. The 
relationship within which gendered power relations operated was central to women's 
susceptibility to HIV infection - for example in the unequal power relations that make 
94 The pastor uses this metaphor to illustrate how men are unjustly demonised: they are cast in the 
appearance of the crocodile, a vicious - and much feared - animal. He may additionally be drawing on the 
Biblical imagery of the leviathan (often taken to be a crocodile) in the Old Testament Book of Job (41: 1- 
34), for example: "Will he make many supplications to thee? Will he speak soft words to thee? Will 
he 
make a covenant with thee? ... 
Behold the hope of him is in vain, shall not one be cast down even at the 
sight of him? None is so fierce that dare stir him up... Who can open the doors of his face? His teeth are 
terrible round about. His scales are his pride, shut up together as with a close seal... " (The Holy 
Bible 
1999). 
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condom negotiation problematic - and to their participation in the trial - since they 
needed their husband's consent to take part. Yet this very relationship itself was not 
considered by scientists to be germane to the research. 
During marriage instruction women are traditionally taught how to manage their 
relationship with their husband using strategies that retain the cast of submissiveness. 
In addition, the women I spoke to discussed how they appropriated power from various 
sources to circumvent relations of dominance that disadvantaged them. In their 
accounts, they did not try to `control' their husbands themselves, but rather to mobilise 
external authorities to steer their husbands or exert pressure on them, thus preserving 
their own `submissive' status. For example, one woman reported how she had taken her 
husband to the police for having an extra-marital affair and squandering the household 
income on his girlfriend rather than on her and their son. The police advised the 
husband to renounce the girlfriend for his own good, advice which he decided to take. 
Another described recourse to the husband's relatives to seek their intervention in his 
unacceptable behaviour; and both women and men described how wives could go to a 
husband's employer to obtain his salary if he was not providing adequately for the 
family. In each of these reported scenarios, women indicated how they mobilised 
techniques of power through their interactions with traditionally powerful institutions: 
the police, the employer, the in-laws. What they did not claim to do, however, was 
openly divest their husbands of power, nor was their stated intention to disrupt the 
relations of dominance within the household. 
Likewise, women navigated their participation in the trial in a strategic manner, 
accessing a programme that challenged the gender order by appealing to their normative 
identity as dependent subordinates. In other words, to access the gel designed to 
empower them, it was strategic for women to act within their prescribed gender roles. 
For many women, the first such strategy was gaining their partner's consent to 
participate in the trial in the first place. Data from the representative social science sub- 
set of the trial showed that 83% of women disclosed gel use to their partners and a high 
level of male involvement in wives' enrolment was clear in the data for this study. In 
the previous chapter I discussed how the trial staff made male consent an informal 
condition of women's enrolment, however according to women's own accounts, the 
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majority also saw this as a benefit rather than a drawback and a process they would have 
pursued regardless. Within all but one of the women's narratives, the idea that they 
could enrol secretly or use gel without their partner's agreement was presented as alien, 
impractical, undesirable or a combination of these. Only one woman I spoke to was 
hiding gel from her partner and was unabashed about the merits of covert use: "It is 
simple to hide from a man and it is up to you as a woman... to me it is just okay". 
Generally, involving one's partner was presented as part of the dues of married life and 
provided it was done in the right way, said to promise a favourable outcome. It was 
constructed as being constitutive of the very ideal of unity and togetherness which 
characterised a good marriage and furthermore provided women with an opportunity to 
address aspects of their sexual relationship that were wanting. For example, by sharing 
trial information and materials with their husbands, women could raise the topic of HIV 
and discuss risk - not because they were implicating their husbands, but because it was 
part of the trial information: 
I just felt good (about getting his consent), because he is supposed to know, "where 
my wife is going, what she is going to do is this and that ", and he is supposed to be 
fearful to say that HIV is real because when he just stays in the community there 
will be nothing that he will know, so it is supposed to be that when he comes here he 
sees that for real, HIV is real in Zambia. So even him, he is supposed to know how 
to behave, to say "1 am supposed to behave like this. " (Sarah, trial participant, 31) 
Rather than describing the need for their partner's consent as disempowering, some 
women delineated the opportunity inherent in it, as Sarah, above. Other women spoke 
similarly of how they used the trial's surveillance techniques - such as quarterly HIV- 
testing and monthly pregnancy tests - to instil a sense of responsibility in their partners 
in terms of remaining HIV-negative and not getting pregnant. In group discussions, 
women spoke of the difficulty of telling their partners their desire to stop having 
children or space the births; whilst some had become adept at concealing their use of 
family planning methods, for example by hiding pills in the mealie-meal, others took 
advantage of the trial's stipulation that women must not get pregnant in order to 
participate. 
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You know, as far as I am concerned it has brought a lot of change in my home. 
Do you know why I like the trial? I am a mother of two, and every month I am 
made aware of my status, including whether I am pregnant or not. In the 
neighbourhood where I come from it has done us a lot of good, people are 
aware that they should not get pregnant carelessly, because if you become 
pregnant you will have to stop participating on the programme. (Female FGD 
participant in the 18-30 age group) 
They mobilised the trial's power of surveillance to influence their partners' behaviour, 
motivating them to use gel and condoms, cut down on their extra-marital sexual 
relations and accept the need for contraception: 
You know, men are naughty, but even if they involve themselves in extra-marital 
affairs I have something I am using. At the same time he is also going to reduce 
(his affairs) because he knows that 'since my wife goes to the trial, where she 
has tested negative, maybe 1 am also negative'. So even if he was womanizing he 
would reduce. (Female FGD participant in the 18-30 age group) 
Women alluded to the fact that since they had tested negative at study enrolment, if they 
subsequently tested positive, suspicion would fall on their husbands as being the 
culprits, and their extra-marital affairs bring shame on them. For example: 
... my 
husband benefits [from my being on the trial].... because even the way he 
used to move (`moyendela', meaning here `behave'), at the moment he has that 
fear, because when I tested here I was found to be negative... (Stella, trial 
participant, 21) 
Such techniques were consonant with women's existing strategies to appropriate power 
from various sources to circumvent marital relations of dominance that disadvantaged 
them. 
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"They are one body. They are just one person. My husband and I are 
one"95 
In the trial community gender was constructed through the social prescription of 
particular characteristics and roles to men and women, and these were upheld through a 
discourse of togetherness which emphasised mutuality. From the interviews and focus 
groups it appeared that whilst authority was designated a male attribute and men 
exercised power over their wives, women also had agency in the household and 
possessed strategies with which to circumvent, subvert or appropriate their husband's 
power, as above. In a study of East African masculinities and femininities 
Silberschmidt similarly records that "while women would often express self-limiting 
culturally accepted expectations to them as women, in practice, they would be very 
entrepreneurial agents" (Silberschmidt 2005: 194). Women and men appeared to uphold 
prevailing relations of power, because of the social rewards it brought to both sexes in 
terms of meeting gender ideals. Problems between men and women were not attributed 
to the gender hierarchy but rather to a failure by one sex or the other to meet their 
prescribed duties (e. g. male responsibility for breadwinning and female subservience). 
The discourse of togetherness was paramount not only in accounts of the decision to 
enrol, but also in both women's and men's portrayals of gel use. This represented 
nothing more radical than an extension of the prevailing ethic of unity in marital 
relationships, which was repeatedly iterated as an ideal and a practice that informed all 
daily activities96. Whilst gaining male consent to participate was portrayed as a normal 
part of married life and its attendant strategies for success, women and men also 
rationalised this by saying that HIV affects both women and men and that both partners 
would be exposed to the gel; it was almost taken for granted that men were `part and 
parcel' of the research: 
The ones who are supposed to participate in the MDP programme, it is us 
women, including men, we are supposed to unite. Because like these diseases, 
95 This is a quote from a 27 year old trial participant, Veronica, referring to married couples. ' It has been observed elsewhere that collaboration, negotiation and compromise are central features of 
African gendered life (Nnaemeka 1998) and that "this is because African women and men face the 
challenges of daily life together and their unity is their strength" (Morrell and Ouzgane 2005: 6). 
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when they come they are not supposed to come for one person. When they come 
like in this house then both of us will be affected. So even on the programme we 
are supposed to unite the two of us. (Beatrice, trial participant, 39) 
If you agree as husband and wife that we shall be using gel, that automatically 
puts him on the programme. (Female FGD participant in the 30+ age group) 
It is my wife who is using it. So in using it, we are using it together, so it means 
that even me, I am on the programme. (Richard, male partner, 29) 
Women's and men's accounts of using the gel suggested that the autonomy paradigm 
from which it had emerged was deeply at odds with the ideals of marital relationships. 
Women's control as conceived by the Western developers was not a concept with any 
currency; it was neither a presumed feature of the research nor a desired attribute of the 
gel. On the contrary, male control was seen to be deeply implicated in the product's 
effectiveness and the success of the trial. Men were responsible for allowing their 
wives to enrol; for agreeing to gel use and reminding their wives to insert it; for 
facilitating wives' continuing participation throughout the follow-up period (e. g. by 
taking on child care duties); and in some cases for contributing to data collection (e. g. 
by helping wives complete coital diaries or attending in-depth interviews). 
Although the gel was distributed through the trial institution in Zambia, as noted in the 
previous chapter, the trial staff did not conceive of the gel as `woman-controlled' but 
rather as something that women use. I suggested in chapter four that the gel was 
produced and - at least temporarily - stabilised in Europe and the US as a product for 
women, thanks to a rights-based discourse on women's empowerment. However, 
making the gel available to trial participants in Zambia was not simply a case of 
technological diffusion (implying a finished product); rather, the technology's very 
inconstancy became apparent at its point of use. The following anecdote illustrates the 
contingency of PRO 2000's meaning in the Zambian context: 
Okay the issue of gel, when she came I was coming from work and I found an item 
in the house; then I said, "what about this thing, what... ?" At first I was thinking 
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that maybe it is relish which is inside. I asked her "what is this? " "It is gel ". So me, 
I asked that "is it gel for the hair or what? " Then she said "no, it is for women, this 
one. " "So how does it work? " Then she said that, "You just insert it, that's all ". 
Then I said "okay. You know we are used to gel for the hair - that is strange ". So 
that's when she told me that "with gel they have told us that you have to do this and 
that "... Then I said "even me, how am I going to be squeezing on mysetp. " Then she 
said "no, it's just me alone, you will find it in me; that's all. " (William, male 
partner, 35) 
This anecdote points not only to the ongoing interpretative flexibility of the gel when 
transposed to other settings, but also to the process of stabilisation occurring between 
couples. The centrality of dialogue and spousal communication to this process should 
not be underestimated. Whereas the gel was originally posited as a stealth product for 
women and covert use remains an oft-cited advantage of the gel in the West, as I 
described above, the majority of women in the trial used the gel in discussion with their 
partners. Recently, the high level of gel use `disclosure' - or hypothetical desire for this 
- has been presented in the scientific literature as a surprising finding (Coly and 
Gorbach 2008). However, it is only surprising if we accept the framing of the product 
as designed for covert use, bearing in mind that the prevailing norm is for partners to 
discuss things they're going to use together. In this setting, the gel was not `adopted' as 
an object of women's control; on the contrary, it was configured as a product that men 
and women use together. 
Power and change in the knowledge ecology 
If the gel could not be said to `empower' women through the mechanisms envisaged by 
the developers, the trial nonetheless incorporated processes that had a bearing on power 
relations between men and women. The primary conductor of power was knowledge, 
the circulation of which was channelled in distinct, and perhaps novel, ways by the trial. 
Women were the initial and primary receivers of knowledge via the trial staff. Firstly, 
they attained knowledge of their HIV status, which was a pre-requisite for enrolment 
(women must not only be willing to have an HIV test, but to receive their results). Built 
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around this was pre-and post-test counselling, which educated women about HIV, 
including modes of transmission and options for protection. Secondly, they were the 
recipients of knowledge about the gel, receiving information about its development and 
testing, as well as detailed instruction on how to keep it, insert it, negotiate its use, 
document its use, adjust existing practices around it (such as vaginal douching and 
inserting), plus anticipated benefits and side effects. Thirdly, through ongoing clinic 
visits, counselling sessions, physical examinations and educational events, they 
obtained wide-ranging sexual health information and were fed a constant stream of 
knowledge about their bodies in terms of STIs, pregnancies, and other ailments, which 
were under regular surveillance97. 
The surveillance of women's bodies and behaviours produced particular kinds of 
knowledge that have typically been used as disciplinary techniques to monitor and 
control the HIV epidemic. Such monitoring and analysis can be seen as an example of 
what Foucault calls `biopower'. Outside the trial context, the focus has been on 
women's traditionally-defined childbearing role as the locus of these techniques, for 
example routine antenatal HIV screening and prevention of mother to child transmission 
(PMTCT). Biopower requires individualizing knowledge about particular (women's) 
bodies in order to extrapolate to whole populations and identify scientific criteria for 
`the norm'98. According to Foucault, norms play an important role in the 
power/knowledge relation in constituting the subject (Foucault 1979). 
In contrast to the biopower represented by antenatal screening and PMTCT, the 
microbicide gel shifted the techniques of power from the medical domain (such as the 
hospital) to the woman's own intimate environment and ultimately her own body. She 
was the one invested with knowledge of the product, charged with dispensing it to 
herself, identifying potential side effects in her own body and accurately reporting to the 
97 Women were required to come to the clinic every four weeks to have a pregnancy test, answer a short 
clinic questionnaire and collect gel supplies. In addition, every quarter, they were required to undergo a 
long and detailed clinic interview about their sexual behaviour, have a genital examination, and have 
swabs and blood tests for HIV and other STIs. Women at the Zambian trial site were `followed-up' in 
this way for twelve months. 
9E Figures on HIV prevalence in women, collected through routine ante-natal surveillance, are commonly 
used by international agencies such as the World Health Organization (WHO) and UNAIDS to compile 
statistics about a country's HIV prevalence and incidence: "HIV prevalence among pregnant women 
attending antenatal clinics (ANCs) remains the principal data source to inform trends in the epidemic" 
(Ghys et al. 2006: i52). 
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trial staff. Because the trialists relied on women to use the gel as instructed outside the 
direct observation of the study, women were invested with considerable agency, the 
exercising of which was fundamental to the success of the research. Therefore, the 
knowledge the trial generated from women's bodies was not merely an end in itself (in 
terms of answering the research question); rather, it was simultaneously a means to self- 
care and self-surveillance on the part of women, and a tacit promoter of compliance to 
trial-stipulated behaviours by the study. 
In the focus groups, women identified their accumulated knowledge from the trial as 
distinguishing them from other women who had not taken part in the research, as this 
brief extract highlights: 
Interpreter: Is there any difference between you ladies who have been coming to 
MDP and those who have not been coming? 
R: We are different. 
R: Us, we have been enlightened (bama ti punzisa) about these diseases and we 
know how to avoid them since we are taught that "this disease, I am not 
supposed to do this and that ". So we are different from those who have not 
joined the MDP, they don't know anything, they don't care. Here we are being 
taught. (FGD participants in the 30+ age group) 
The three facets of knowledge - for its own sake ('we have been enlightened'), to 
encourage compliance ('we are being taught') and as a route to care of the self (others 
`don't know anything, they don't care') - allow for what Foucault, in his later works, 
referred to as government of the self through `technologies of the self (Foucault 
1997)99. This focus on government of the self was key to Foucault's later thought on 
freedom and his elaboration of resistance (Oksala 2005). 
Women said that the knowledge they gained at MDP not only "enlightened" them but 
also liberated them: "we become free-minded (ku angunuka mu mizeezo) because we 
' "Technologies of the self... permit individuals to effect by their own means or with the help of others a 
certain number of operations on their own bodies and souls, thoughts, conduct, and way of being, so as to 
transform themselves in order to attain a certain state of happiness, purity, wisdom, perfection or 
immortality" (Foucault 1988: 18). 
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know our status, unlike those who do not come here, they are not free (taba 
angunukide) ". Another participant in an individual interview pulled together these 
aspects of enlightening and liberating to suggest that the research awakened women to 
themselves and to the possibilities in their lives: 
Nora: This research is just okay. It will be like, it will be like .... In 
Nyanja I 
would say 'Galamukani' (wake up) women. 
Interpreter: What does 'Galamuka' mean? 
Nora: To get smart. It is like you were asleep, then "hey, wake up! " You see? 
(Nora, trial participant, 37) 
Women's expressions of being enlightened, getting smart and caring for themselves 
resonate with Foucault's technologies of the self; as Oksala observes, Foucault wanted 
to "argue the point that there is no true self that can be deciphered and emancipated, but 
that the self is something that has been - and must be - created" (Oksala 2005: 163). 
In addition to the knowledge-content, the very act of acquiring knowledge in the first 
place was what some women presented as the defining feature of using gel: 
It is us the women who have it (gel). We are the ones who are coming to get it 
and give it to the men and show them that we are supposed to use it like this and 
that, `that's how gel should work. '(Veronica, trial participant, 27) 
Because women were the ones being given the information on how to use the gel, it was 
their prerogative to share that knowledge with their partners. In this sense, women 
acquired power within their relationships; not through withholding knowledge of the gel 
from their partner, or because they tried to use it regardless of their partner's consent, 
but precisely because they shared the knowledge and established gel use within their 
relationships. In effect, by virtue of participating in the trial, women became experts in 
the new prevention technology, an expertise that men could not access directly but only 
through their partners. The following extract highlights this knowledge-power 
relationship: 
201 
Jocelyn: ... you, a woman, you 
know how to use it. That man doesn't know how 
to use gel. So you know that maybe gel, you have to take so many minutes, you 
are the one who knows, because that man doesn't come here at the clinic and he 
cannot know everything. 
Interpreter: Okay, what if you told him that gel works like this and that? 
Jocelyn: ... you are the one who knows, because you are the one who comes 
every day, maybe you just told him once, maybe he made a mistake of the timing 
and you know something. So that man, you cannot follow what he is doing, but 
you can just use gel according to the way you use it every time. 
Interpreter: Or let us just say that... who can have the power between a woman 
and man in terms ofgel use? 
Jocelyn: It's a woman 
Interpreter: Why? 
Jocelyn: Because as a woman you know how to insert gel and the way it works. 
(Jocelyn, trial participant, 20) 
It's important to note here that the deciding factor is knowledge about how the gel 
works, not the fact that it can be used secretly or in the absence of the partner's 
agreement. In the same interview, Jocelyn argued that if you told your partner about the 
gel and he refused to use it, then you would not be able to use it. She also said she felt 
strongly that it would be bad for a woman not to tell her partner at all. Therefore 
women's power lay in the tactics of knowledge-sharing with her partner and, as with 
other'domains of married life, was dependent on her strategies to handle her partner. 
Because of the high value placed on learning within the community, and the biomedical 
authority embodied in the trial, knowledge about the gel had a special status. 
Hierarchical movement within the knowledge ecology could be obtained by women 
who successfully discussed the trial with their partners and involved them in the details 
of gel use. Whereas men were used to being at the top of knowledge chain, the trial 
positioned them at the bottom, or even absent altogether. Where women took part 
without involving their partners, and their partners subsequently found out, the 
prognosis for successful trial participation was poor. 
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Interpreter: Are there men who have refused their partners? 
Grace: They are there, yes. Like I said, that when staring we started five of us, 
but the other three were stopped by their partners. One was beaten to say "you 
want to kill my children, because of where you are going (MDP) "; she is my 
neighbour. He beat up the wife and so the wife stopped, just like that, up to now. 
(Grace, trial participant, 22) 
However, where women involved their partners successfully through knowledge- 
sharing, they achieved the desired ideal of marital unity, thereby cementing their status 
as a good wife whilst simultaneously accessing the gel. 
Pleasure at the consumption junction 
I have suggested above that women became experts in the new technology, fluent in the 
knowledge system of the trial and agential in determining its outcome. I have also 
pointed to the interpretative flexibility of the technology, by describing its re- 
constitution primarily as a device for couples as opposed to being `woman-controlled'. 
Moore has observed that "each material object undergoes many different iterations in 
which meanings about the device are created and re-created.. . The meanings of each 
device are multiple, unanticipated, and performed in social interaction" (Moore 1997: 
443). As Moore also points out, it is only when devices are used - at what Cowan calls 
the "consumption junction" - that the meanings of the artefact coalesce and become 
manifest. From Cowan's point of view, the consumption junction is also "the place 
where technologies begin to reorganize social structures", and so it is a useful 
conceptual device in the examination of gender (Cowan 1987: 263). 
In spite of the medicalisation of women's powerlessness as the lynchpin of microbicides 
development in the UK and the US, one of the most prominent discourses that the gel 
engendered at its point of use was that of sexual pleasure. Although women's bodies 
have been posited as a site of control in terms of the HIV epidemic, and historically in 
terms of fertility, what women themselves talked about most animatedly was the gel as 
a catalyst for desire: 
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People of God, it stimulates someone quickly! Before I started using gel he was 
only able to have just one sex act, that was all, but now we have sex more than 
once. After a sex act he still remains on heat and wants some more. He liked it. 
It makes the vagina warm inside and after he has ejaculated, the woman also 
still insists on some more sex, 'don't come out, please continue'! [Laughter] 
(FGD participant, 30+ age group) 
The pleasure women spoke about occurred on many levels: their own physical pleasure 
from inserting the applicator and using a lubricant during sex; pleasure from being 
sexually-pleasing to their partners; pleasure from the intimacy and trust of introducing 
and talking about a novel sexual accessory; pleasure from the knowledge that they could 
strategically use gel use to negotiate other aspects of their sexual and reproductive lives, 
such as the use of condoms and contraception. 
It was not only amongst women that the pleasure discourse circulated, but also amongst 
men, and amongst men and women together, as the following extract from a mixed 
male/female focus group illustrates: 
R3 (M):... [gel] maintains the vagina to... to put it in a good condition [laughter 
from other group members]. So Instead of using concoctions, different 
medicines100, it builds the vagina into a good... [chuckles] 
R5 (F): It stimulates! [All laugh] 
Interpreter: It stimulates in which way? How does it stimulate? 
R5 (F): They feel good, not so? 
R3 (M): Sweetness! [Laughter] 
Interpreter: No, feel free! 
R5 (F): ... 
Someone was saying that gel feels good when they are having sex 
together with the husband, they feel very good, more than they were feeling in 
the past. That means that it doesn't only prevent HIV, there are other things that 
it does. 
R7 (M): It adds excitation! 
10° `Concoctions' and `medicines' here refers to substances - such as snuff and dried herbs - that women 
may insert into the vagina in advance of sex to create a tight and warm environment said to be pleasing to 
the man. For more on this topic see (Hilber et al. 2010). 
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RS (F): Men become more... [Others join in] More sexy! (Male (M) and female 
(F) Community Advisory Group members, FGD) 
In effect, gel became a sexual signifier, associated at least in part with being `sexually 
active'. The latter was a stated criterion of trial participation, but was construed locally 
to mean someone who is active in sex and, linked to this, enjoys frequent sex (this 
diverging from the biomedical meaning which refers simply to someone who has sex, 
regardless of its quantity or quality). Changes in open communication about sex within 
the trial context (described in the previous chapter) undoubtedly allowed this discourse 
to be voiced, so that the technology and the research can be seen to have mutually 
configured each other. Not only that, but the new technosexual scripts which gel use 
engendered cast women not as victims, as is so often the case in HIV discourse, but as 
desiring sexual subjects in their own right. As Jolly has noted: 
The development industry has emphasized the dangers of sex and sexuality. 
This negative approach to sex has been filtered through a view of gender which 
stereotypes men as predators, women as victims, and fails to recognize the 
existence of transgender people. It is time to go beyond this negative and 
gender-stereotyped view of sexuality, to recognize that pleasure and danger are 
imbricated in the ways people experience sexuality. We need to move to more 
positive framings of sexuality which promote the possibilities of pleasure, as 
well as tackling the dangers at the same time (Jolly 2007: 24). 
Summary 
This chapter has explored how science and technology travel and how both gender and 
technology are co-produced through the practice of clinical research. The title of this 
chapter refers to three main processes that the results of this study have suggested: 
technology in transit, science in translation, and society in transition. The notion of 
flux is an important one; flux is inherent in the interpretative flexibility of artefacts, 
scientific practice and progress, and the construction of gender identities. Work in 
postcolonial technoscience has begun to move these ideas beyond the confines of the 
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Western laboratory and to provide accounts of science in diverse settings, in the belief 
that "all knowledge traditions, including Western technoscience, can be compared as 
forms of local knowledge so that their differential power effects can be compared but 
without privileging any of them epistemologically" (Turnbull 2000: 6). By tracing the 
development and testing of one candidate microbicide through both scientific and lay 
discourses of discovery and use, I have aimed to shed light on the negotiated boundaries 
and content of gender and technology as processes that cross cultural divides. 
Although microbicides are now synonymous with women's empowerment in the West, 
this is not a `natural' function of the technology, nor is the technology stable across 
cultural and geographic divides. The very concept of women's empowerment in the 
microbicides context is dependent on the construction of the powerless African woman 
at risk of HIV infection from her promiscuous and all-powerful husband. This 
construction provides a one-dimensional account of female oppression within the 
prevailing ideology of patriarchy, and fails to attend to the multiple sites of potential 
resistance within the micro-politics of power. The microbicide is positioned as the 
magic medical bullet which will `put power in the hands of women'. Yet, as this 
research has indicated, women are not the weak and powerless vessels that medical 
research has conjured up. In their everyday lives, women are active in negotiating 
micro-level relations of power with men, relations that affect their health, wealth and 
social standing in the community. At the same time that women enrolled into the phase 
III trial, they also enrolled the trial into their own strategies to achieve their desired 
intentions in terms of fertility, fidelity, sexual safety and fulfilment. Women 
constructed themselves not as powerless bodily vessels waiting for medical 
empowerment in gel form, but as entrepreneurs in the successful creation of marital 
unity. Discourses of pleasure and desire - both their own and their partner's - were 
central to their accounts of using the new technology, a notion that public health and 
development agencies have often ignored in the past. Autonomy, and in particular 
women's autonomy, were not valued or aspired to; the prevailing social ethic in the trial 
community was that of togetherness. 
I alluded above to women's trial participation as a 'technology of the self' n terms of 
the self-knowledge and self-care this entailed. For Foucault, technologies of the self 
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were not separate from technologies of domination; he argued that in order to 
understand the creation of the subject in western civilization, it was necessary to analyze 
"the points at which the technologies of domination of individuals over one another 
overlap processes by which the individual acts upon himself [sic]. Conversely, the 
analyses must also take account of the points at which the techniques of the self are 
integrated into structures of coercion or domination" (Oksala 2005: 164). We can see 
the trial and the use of the microbicide gel as simultaneously producing such 
technologies of domination and individual acts of self-mastery. As part of the co- 
production of scientific knowledge, gender and technology, women became both 
objects of disciplinary surveillance and agents of self-transformation. They resisted 
Western discourses of autonomy and rights built in to microbicides whilst subverting 
micro-level power relations with their husbands and partners. 
In spite of the formal absence of men from the trial protocol, men were both present and 
active in the running of the study. At a most fundamental level, they were the 
gatekeepers to women's consent and subsequent participation in the trial. By 
constructing men as the problem - both in the touting of microbicides as a product 
women could use covertly and in the exclusion of men from trial processes - the 
research reinforced a negative model of masculinity. Stereotypes play a powerful role 
in modelling and sustaining gendered behaviour, and the prevailing image of men in 
this community as dominant, problematical, violent and sexually promiscuous was 
rehearsed by the trial and male community members alike. However, in individual 
interviews, the fragility of this representation was made clear, as men exposed the 
difficulties of their role as breadwinners and heads of household. The construction of 
masculinity simply as a problem in relation to femininity ignores the tensions, 
contradictions and subversions that both women and men negotiate in performing 
gender roles. Masculinities are not static and fixed; as Ormrod has observed, "gender 
identities, like technologies, are achieved rather than given" (Ormrod 1994: 43). Men's 
insecurities and fear of the research are an unsurprising response to their exclusion from 
the transformative processes of gender and technology (re)constitution. 
In the field of HIV prevention, scant attention has been paid to women's resistance to 
local relations of power, to women's bodies as a site of desire, or to women's own role 
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in constructing the self. The global discourse on women's empowerment, especially 
when directed at the developing world, black-boxes gender and obscures a fertile 
ground of negotiation and resistance. Feminist analyses that describe the `New 
Prevention Technologies' as either inherently patriarchal or inherently 'woman- 
controlled' foreclose the possibilities of transformation in gendered relations of power. 
From the analysis in this chapter it is clear that the question is not whether the 
microbicide `empowered' women, but what happened to the social relations of 
knowledge during its introduction and testing. As Emily Martin has pertinently noted: 
The walls of the citadel are porous and leaky. Action and initiative go in both 
directions. It is less "science in action" than "knowledge in action" in a 
multitude of contexts, both scientific and non-scientific. (Martin 1998: 30) 
Women's and men's accounts demonstrate the centrality of knowledge in action to the 
processes of social and technological change. Foucault used the expression `subjugated 
knowledges' to refer to forms of experience and knowledge that "have been disqualified 
as inadequate... or insufficiently elaborated: nave knowledges, located low down in the 
hierarchy beneath the required level of cognition or scientificity" (Foucault 1980e: 82). 
In this chapter I have moved beyond the discourses of those who develop and test new 
technologies, to the subjugated knowledges of the women and men who use them. 
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Chapter Eight 
Enlivening AIDS Discourse, Reinvigorating Prevention: 
Empirico-Theoretical Contributions 
25 years after AIDS was first reported, an institutional, commercial, 
professional, and even civil society industry now controls the global response to 
AIDS. Each party, in good faith, has a position to defend, a strategy to advance, 
and probably someone to oppose. It is time for new voices in AIDS to ask 
questions, to disrupt axes of power, and to disturb the air. (Horton and Das 2008: 
422) 
Opening a special series by The Lancet on HIV prevention in 2008, Horton and Das 
berated the failure of public health to put a stop to the flow of new infections occurring 
worldwide. In spite of a huge global industry engaged in halting the epidemic - global 
spending on HIV reached $13.7 billion in 2008 (Kaiser Family Foundation 2009) - 
there were an estimated 2.7 million new infections in the same year (UNAIDS 2009). 
"Part of the difficulty facing any new and upgraded movement for prevention", Horton 
and Das said, "is the way we currently discuss AIDS" (Horton and Das 2008: 421). 
Almost a decade earlier, as if pre-empting this, Treichler pertinently suggested that "the 
apparatus of contemporary critical and cultural theory prepares us to analyze AIDS in 
relation to questions of language, representation, interpretations, narrative, ideology, 
social and intellectual difference, binary division, and contests for meaning.. . the AIDS 
epidemic ... puts theory stringently to the test" (Treichler 1999: 2). However, as 
Mykhalovskiy and Rosengarten remarked in 2009, there has been a retreat from 
theoretical engagement in the battle against HIV, such is the urgent demand for 
`evidence'. 
In this thesis I have explored the co-production of gender and technology through the 
case study of vaginal microbicides for HIV prevention. In combining theory and 
empirical research, I have sought to strengthen our understanding of how science and 
society mutually constitute new technologies for HIV prevention. However, drawing on 
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the deconstructive tendencies of cultural studies and STS presents a tension between 
epistemological relativism on the one hand and a desire to make recommendations for 
public health policy on the other. How tenable is such a thesis within the worlds of 
either public health or STS? Below, I start by outlining the empirical contribution I have 
made to HIV prevention research. I reflect on how various bodies of theoretical 
literature, introduced in chapter two, have informed this research and how this research 
in turn speaks back to them. Finally, I address the core epistemological tension between 
STS and public health approaches, and suggest potential avenues of interaction between 
the two. 
An empirical contribution to IHIV prevention research 
This thesis represents the first account of how microbicides get constituted. It adds to a 
small but growing body of literature that analyses the meanings of prevention 
technologies to both high-level stakeholders and users (Moore 1997; Kaler 2001; 
Rosengarten et al. 2004). Almost two decades ago, Akrich highlighted the need to 
move beyond a focus on the design of technologies in relation to their potential users 
and examine the simultaneous definition of technology and user: 
... if we are 
interested in technical objects and not in chimerae, we cannot be 
satisfied methodologically with the designer's or user's point of view alone. 
Instead we have to go back and forth continually between the designer and the 
user, between the designer's projected user and the real user, between the world 
inscribed in the object and the world described by its displacement. (Akrich 
1992: 208-209) 
In spite of this, there has been a persistent inclination to analyse how technologies are 
constructed in a particular place and time by one interested group or party. In this 
research, I have taken up Akrich's call, and again demonstrated that the constitution of 
both technologies and identities occurs across social and geographical worlds. 
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Although vaginal microbicides are inextricably associated with women's empowerment 
in the West, I showed in chapter four how there was nothing inherently `gendered' 
about the technology. This became ever more apparent as I traced the technology from 
its point of design in the North to its point of use in the South: the instability of PRO 
2000 as a product for women's empowerment was clear. Not only that, but the 
projected user turned out to lack representational tenacity; that is, the disempowered, 
autonomy-seeking, African woman, discursively enacted in the microbicides research 
agenda, disappeared at the site of use. The autonomy paradigm, fundamental to the 
technology's development, was at odds with a social ethic of togetherness in the 
Zambian trial community. Rather than `receive' the technology, trial participants 
actively produced it within their relationships, enrolling the technological testing 
process into their own strategies of power negotiation. 
Although technically the gel and its applicator did not change between locations and 
social worlds, nor were they at their destination what they were at their point of 
departure. To paraphrase de Laet (2000), they unravelled as they travelled. The fluidity 
- or ontological multiplicity - of artefacts has been described in relation to a variety of 
technologies, from patents (de Laet 2000) to bush pumps (de Laet and Mol 2000) to, 
most recently, HIV prevention technologies and trials (Rosengarten and Michael 
2009b). Rosengarten and Michael have analysed clinical trials of PrEP as ontologically 
divergent performances, in which "trial participants are not simply recipients or 
consumers of the object PrEP but are active in its multiple making" (Rosengarten and 
Michael 2009b: 194). This research supports Their observation and suggests that we 
need to move beyond framing solutions to HIV prevention in terms of singular `magic 
bullets'. 
The microbicides literature is awash with discussion of `women's empowerment', a 
phenomenon which has been presumed, advocated for and disputed, but rarely defined 
or studied. In her work on the female condom, Kaler has presented us with "a 
cautionary tale about the dangers of assuming that certain values or key concepts, like 
`empowerment' are universal" (Kaler 2001: 794). Following discussions with key 
stakeholders, in which the meaning of the technology as `empowering' was shown to be 
unstable, she concluded that the female condom would likely remain "an ambiguous 
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and polyvalent technology" (Kaler 2001: 794). Although commentators often draw 
parallels between the female condom and microbicides because they are both vaginally 
inserted and `woman-controlled' (Elias and Coggins 2001; Warren 2001; Mantell et al. 
2005; Mantell et al. 2008), the more salient parallel between them - ironically - is their 
very multiplicity. 
As I have demonstrated, it is no more obvious that microbicides are an HIV-prevention 
method specifically for women than that they could have been (and still could be) an 
HIV-prevention method specifically for men. The presumption of women's 
powerlessness which was incorporated into microbicides during their design in the West 
was inattentive to micro-level power dynamics operating between women and men in 
Zambia. Women using the gel re-produced it as a technology for partners, disrupting 
the notion of microbicides as a `stealth product'. In so doing, they positioned 
themselves as entrepreneurs in the successful creation of marital unity, resisting 
Western discourses of autonomy. Women used the gel to enrol their partners into 
strategies for sexual safety, including HIV testing and partner reduction. Their ability to 
do this rested on the joint facets of pleasure and surveillance which the gel embodied in 
the context of the clinical trial. 
The role of research in constructing gendered identities 
Individual-based models have been the predominant basis of HIV prevention research 
into new technologies. The Western view of bodies as discreet and sexed, and sexual 
transmission occurring in an individual rather than within a relationship, has led to the 
development of technologies conceived as pertaining to either men or women, but rarely 
both. The conceptualisation of risk as residing in the individual goes back to the 
epidemiological focus on counting and classifying cases: men, women, homosexuals, 
heterosexuals, men who have sex with men (MSM), commercial sex workers, injecting 
drug users (IDUs) etc. Accordingly, in cognitive individual-based models, the self, 
governed by agency and intentionality, is both the locus of risk and the site of risk- 
management. Far from recognising the social construction of gender and the relational 
nature of the concepts `man' and `woman', biomedical AIDS paradigms "refigure the 
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social as the sexed anatomical" (Waldby 1996: 142). In so doing, they ignore the power 
dynamics inherent in sexual relations and thus potentially fail to increase women's 
possibilities for practising safer sex. 
In this research, I have shown how scientists strategically used gender representations to 
motivate politically for the scientific development of microbicide products. The 
political milieu was conducive towards `women-controlled' technologies; the 1994 
International Conference on Population and Development (ICPD) in Cairo had actively 
called for the development of such technologies and Clare Short was keen to invest 
money in women and development. Whereas science, and the randomised controlled 
trial in particular, are presented as neutral and objective, I have demonstrated that they 
play a constitutive role in creating the phenomena they purport to describe. This has 
long been recognised within critiques of biomedicine and AIDS; for example, in 1996, 
Waldby cautioned that: 
Despite, or perhaps because of, biomedicine's assertion of its own innocence of 
historical and political meaning, it constantly absorbs, translates and recirculates 
`non-scientific' ideas - ideas about sexuality, about social order, about culture - 
in its technical discourses. (Waldby 1996: 5) 
In the 1990s, the critique of biomedical research into HIV largely came from within the 
feminist movement and was highly critical of representational practices that 
disadvantaged women (Patton 1990; Treichler 1992; Patton 1994; Waldby 1996; 
Treichler 1999). Wilton observed that: 
In the context of sexually transmitted diseases... [there is] a specific discursive 
package `sex', whereby `womansex' coalesces around notions of disease, 
contamination, death, treachery, excess, liquidity and entropy, all representing a 
danger to men. Within this paradigm, `man' is assigned attributes of cleanliness, 
health, patriotism, life, discipline, order and control... (Wilton 1997: 126) 
Two decades later, there are signs of a representational reversal within some areas of 
STI research, such as microbicides development. Men are no longer the 
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unproblematized and invisible producers of HIV prevention discourse - "clean, healthy 
and safe" (Wilton 1997: 67). They are now the `diseased Other', cast as the enemy 
against which women must protect themselves101. 
The discursive production of gender identities through scientific research linked to new 
technologies represents a site of potential oppression for both women - as vulnerable 
vessels in need of medicalised empowerment - and men - as infected aggressors. 
However, as I have shown in this thesis, biomedical discourses can be resisted, 
disrupted and re-produced through the de-scription of emerging technologies. In the 
Zambian site where my fieldwork was conducted, the meaning of the gel as a woman- 
controlled device, with all that that implied, was not stable. Covert use was largely 
rejected by women, who instead sought to use disclosure of gel use and trial 
participation as a means of negotiating power with their partners. Men were involved in 
using the technology; that this was not self-evident from the designers' point of view at 
the outset shows the disjuncture between development ideals of women's empowerment 
and the reality of dyadic sexual relationships. 
In the MDP 301 trial, as in many other health and development projects aimed at 
women, men were posited as a problematic Other. Regressive stereotyping, which 
portrayed men as power-possessing, sexually irresponsible, callous and uncaring was 
used to motivate for women-controlled HIV prevention technologies; at the same time, 
women were portrayed using "victimization rhetoric" (Kapur 2003). This approach is 
part of a wider trend, as identified by Peacock et al: 
Efforts to draw attention to the many ways in which AIDS maps onto and 
reinforces women's subordination have been relatively successful - at least in 
terms of raising awareness of the issues and securing national and international 
commitments. However, too often, to create a sense of urgency, these efforts 
have described men in broad brushstrokes as inevitably violent, irresponsible 
101 See for example the following typical extract on the need for microbicides: "Although the use of 
condoms has slowly increased in countries most severely affected by the HIV epidemic, many vulnerable 
women are unable to ensure they are used. An effective and affordable vaginal microbicide, whose use 
could be controlled by women, would represent an important addition to the armamentarium against HIV 
infection" (McCormack et al. 2001: 410). 
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and uncaring. Messages have often traded on stereotypes common in the global 
north about men and women in the global south. (Peacock et al. 2009: S122) 
Peacock et al argue that such stereotyping ignores the fact that multiple forms of 
masculinity exist at the intersections of class, race, sexuality, disability and nationality. 
The discursive perpetuation of a singular, negative masculinity obscures the existence of 
men who do not fit the `norm' or who are actively working to challenge rigid gender 
roles. Although Peacock et al focus on human rights and other policy interventions to 
involve men, I wish to argue that research (which may precede interventions) plays a 
fundamental role in maintaining, perpetuating or disrupting gender identities. A clear 
example of this was presented in chapters four and seven; in chapter four, the analysis 
showed how men were configured as absent and difficult in the development of 
microbicides and the trial to test them. In chapter seven, I showed how Zambian men 
performed to this stereotype in focus groups and public discussion of the research. 
In a paper on familial relations in South Africa in the context of AIDS morbidity and 
mortality, Montgomery et al drew attention to the disjuncture between fieldworker 
accounts and observation of men's roles regarding `non-traditional' behaviour (such as 
caring and housework). The paper highlighted that "whilst there is a linguistic and 
conceptual locus for the discussion of `deficient' men, no such language appears to exist 
to talk about men who are positively involved with their families" (Montgomery et at. 
2006: 2415). This was as true for the participants in the study as for the researchers, 
and meant that incomplete data on men's involvement with their families was collected. 
The current thesis provides further evidence that research design and practices have a 
direct impact on the knowledge we accrue, disseminate and use to inform interventions. 
Although I have demonstrated the role of the scientific process in constituting gender in 
Zambia, I have left gender relations relatively unproblematised in the UK. At the start 
of this thesis, I pointed towards a desire to be even-handed in the treatment of study 
settings, for, as de Laet has pertinently observed, it is not only what is far away that 
needs to be understood, since what is nearby is equally strange (de Laet 2000: 150). 
This one-sidedness represents a deficit in the current thesis, which future research might 
productively attend to. 
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Biomedical technologies, human technologies and technologies of the self: 
Contemporary operations of power/knowledge in the clinical trial context 
By tracing PRO 2000 across its sites of development and use, I have been able to shed 
light not only on the technology itself, but also on the networks of actors who both 
defined and were defined by its socioscientific trajectory. The organizational structures 
and cultures that constitute a large, trans-national clinical trial present extreme 
variability: spatially, temporally, institutionally. Gaining analytic purchase on such an 
entity is not an obvious undertaking; following a technology through late-stage testing, 
as I have done in this research, presents a viable way to explore trials and research 
partnerships. Instead of focusing on the network qua network - which may result in 
descriptive, structural analysis rather than explanation - tracing the technology through 
social worlds throws into relief the values, morals, politics and ideologies which 
accompany its development. 
Precedents in the field of anthropology have predominantly focused on industry - big 
pharma - which presents a particular set of relationships and working practices that are 
not consistent with public-funded, academic-led trials. For example, Petryna (2009) 
and Fisher (2009) both discuss the inherent manipulation and oppression of vulnerable 
populations by profit-driven pharmaceutical companies102. Relationships between trial 
entrepreneurs and experimental subjects are shown to be driven by medical 
neoliberalism and pharmaceutical profit-mongering. According to such studies, the 
profit-motive is deeply implicated in the negotiation of the experimental landscape, 
including medical, ethical, regulatory, and managerial practices. By contrast, in this 
research, I have shifted the focus away from both the laboratory and the pharmaceutical 
giants to explore what is becoming an increasingly prevalent phenomenon: the product 
development partnership (PDP) in public health (Sorenson 2009). Work on PDPs has 
centred on power and governance to date (Buse 2004; Buse and Harmer 2004; Backup 
2008; Tucker and Makgoba 2008), issues which are germane to this study. However, 
the empirical contribution this work makes is to examine the production of both gender 
102 For example, Fisher. "I am interested in how the system of clinical trials itself .. can 
be exploitative of 
individuals and groups, given the persistence of social, political and economic inequalities in the US" 
(Fisher 2009: 129) 
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and technology at the intersection of social-scientific governance, where financial profit 
is not the primary objective. 
We are obsessed in HIV-prevention research with the power relations between men and 
women in Africa - one of the so-called 'cultural' factors that accounts for high rates of 
HIV transmission on the continent. But not often discussed are the power relations 
between public health interventionists and the men and women we seek to prevent 
acquiring the disease. This is not surprising given the discipline's positivist outlook. 
However, when questions are asked about the failure of the scientific community to 
curb the spread of HIV in Africa, a certain degree of introspection might lead public 
health researchers and interventionists to consider their own role in perpetuating or 
disrupting relations of dominance. Whereas such a critique has been directed at the 
pharmaceutical industry from outside, in this study I have pursued a form of internal 
critique. Using Foucault's work on power has provided a critical yet constructive 
apparatus through which to analyse relations operating at the interlinked planes of 
clinical research into microbicides. Since academic-led trials operate in a knowledge- 
driven landscape (rather than being profit-driven), Foucault's theory on the relationship 
between knowledge and power has been particularly useful. 
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Figure 3: Threads of power linking planes of clinical research into microbicides, as 
analysed in this thesis 
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At each of these planes, there is a web of discourse delimiting regimes of truth, be it the 
scientific hegemony of the RCT or the merits of `Third World' capacity building. 
However, these planes are not discrete and insular but contiguous, joined by threads of 
power; the web of relations extend from plane to plane, such that power/knowledge at 
one level bears on that at others. 
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Each of the empirical chapters in this thesis addresses issues of power in the context of 
clinical research, focusing on one plane at a time. In chapter five, for example, I 
discussed the discourses of democracy and gendered capacity building that united 
disparate groups across Africa around a protocol largely developed by a core group of 
scientists in the UK. The success of this approach rested on the participation of sites in 
their own self-regulation. The form of government that MDP instituted presupposed the 
freedom of the collaborators; rather than denying their capacity to act, MDP harnessed it 
and shaped it to meet programmatic ends. Therefore, whilst the programme could be 
criticised for retaining power at the centre in terms of setting the scientific agenda, in 
comparison to other research models which work by imposing sovereign rule from a 
Northern `centre', MDP created an institutional space of regulated freedom (Rose 
1999). Rose has discussed technologies of government as `human technologies', a 
concept that is useful for understanding the interconnections in a large research 
programme like MDP: 
Technologies of government are those technologies imbued with aspirations for 
the shaping of conduct in the hope of producing certain desired effects and 
averting certain undesired events. I term these `human technologies' in that, 
within these assemblages, it is human capacities that are to be understood and 
acted upon by technical means. (Rose 1999: 52) 
He goes on: 
A technology of government, then, is an assemblage of forms of practical 
knowledge, with modes of perception, practices of calculation, vocabularies, 
types of authority, forms of judgement, architectural forms, human capacities, 
non-human objects and devices, inscription techniques and so forth, traversed 
and transacted by aspirations to achieve certain outcomes in terms of the conduct 
of the governed (which also requires certain forms of conduct on the part of 
those who would govern). (Rose 1999: 52) 
Using this definition, it is possible to see both new biotechnologies for HIV prevention 
and the research designed to test them, as human technologies and technologies of 
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government. Such a designation - underscoring the human and the technological in the 
practice of what is otherwise known simply as `science' - signals the power inherent in 
scientific research. It directs us to the discourses, processes, objects, and knowledge of 
a system that is constitutive as well as reflective. 
The trial as human technology and technology of government is illustrated by the 
findings of chapter six, in which I analysed the institution of the MDP trial site in 
Zambia. If, as Foucault suggested, governmentality is the contact point between 
technologies of domination and technologies of the self (Foucault 1988: 19), the 
Zambian trial site represents the material manifestation of such a contact point. As I 
suggested in chapter six, the clinical trial can be seen as an extension of the clinic, a 
disciplinary institution operating through the surveillance and subjection of trial 
participants. However, the very humanity inherent in the trial opened up fault lines of 
resistance, both on the part of the researchers and on the part of those being researched, 
for example, in both parties' reworking of the informed consent process into a dyadic 
affair involving male partners. Researchers and participants alike resisted Western 
notions of autonomy which were fundamental to the technology's development in the 
UK and US. Science and technology studies speaks of `configuring the user' to 
describe the way in which the future user of a technology is `scripted' into the artefact 
(Akrich 1992; Mort et al. 2009). In MDP, the user was configured as a disempowered 
African woman seeking autonomy to protect herself (secretly) against HIV. At the 
point of use, however, this script was ruptured by women's (and researchers') desire to 
involve their partners in their participation in the trial and the use of the gel. Women 
appropriated the trial's techniques of surveillance to meet their own agenda in terms of 
sexual safety and satisfaction. This process mirrored similar strategies that women used 
in their everyday lives to negotiate relations with their partners. 
In relation to this, I outlined in chapter seven how the microbicide gel functioned as a 
technology of the self, being a stimulus for body-knowledge and self-care in women's 
sexual lives. Some commentators have suggested that it is in Foucault's articulation of 
technologies of the self that resistance to more dominant forms of power can be 
conceptualised (Grimshaw 1993; Hartmann 2003; Oksala 2005). Indeed, this research 
finds that resistance is manifold at the sites where power is usually said to reside: in 
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women's oppression to patriarchy, be it in the domestic sphere or the sphere of medical 
intervention. Victim rhetoric about women in AIDS advocacy and research conceals 
these sites of agency and resistance, particularly in reference to `Third World' women 
and AIDS in Africa. Partly because the subject is conveniently packaged as a singular, 
universal and essentialised being, the locations of agency in social relationships, and the 
micropolitics of power in heterogeneous configurations of experience, are erased. Kapur 
has suggested that: 
Foregrounding the peripheral and resistive subject... scatters hegemonic 
understandings of culture and gender that are reproduced at the international and 
domestic levels. The reproductions are invariably essentialist and invite 
imperialist, conservative, or protective interventions. (Kapur 2003: 33) 
While scientists and advocates seek `protective' interventions against HIV, we should 
be mindful of `protectionist' discourses that may underlie the forms they take. Using 
Foucauldian analytics of power in this thesis, I have propounded a more nuanced 
account of gender politics, situating local negotiations within the global processes of 
transnational clinical research. 
Reconciling utility and epistemic radicalism'03: STS and public health 
In spite of the growth of science and technology in Africa in recent decades, science and 
technology studies has been - and largely remains - rooted in the industrialised world; 
as the editor of Social Studies of Science remarked in 2008: 
... our submissions and published articles continue to come mainly from Western 
Europe and North America, and our editorial board continues to reflect that 
fact... Currently we see very few publishable submissions from Eastern Europe, 
Central and South America, or Africa. (Lynch 2008: 6) 
103 1 borrow this turn of phrase from Woolgar et at (2009: 13). 
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This supports Shrum's earlier observation that mainstream STS scholarship has 
neglected less developed countries (Shrum 2000)104, a neglect that Dritsas also berates: 
The lack of knowledge about the history of science and technology south of the 
Sahara is especially distressing when one considers the amount of effort 
expended by the development community in building up the technological 
infrastructure of the continent. Although it is widely acknowledged that the 
exchange of technology and ideas between southern Africa and the wider world 
has a long and intricate history, nongovernmental organizations and 
government-based development organizations rarely consider this history in any 
but the most cursory way. Exacerbating this state of affairs is the dearth of 
scholarship in this area beyond the hagiographies of Great White Men. (Dristas 
2003: 331) 
A marriage of STS with Public Health - which has a strong developing country focus - 
has the potential to generate fresh insights into old problems and new solutions. 
Biomedical technologies, in particular, represent a fertile ground for sociological 
enquiry. Pointing to STS's lack of engagement with Public Health, and suggesting the 
intersection, raises the question of normativity in social research. It presents a troubled 
confluence of agendas: activist and reconstructivist on the one hand, and 
deconstructivist on the other. A long-running debate within STS highlights the 
epistemological tensions that are likely to arise when philosophical radicalism comes up 
against normative expectations in such a venture, as discussed below. 
Symmetry and reflexivity have been major preoccupations for STS scholars over the 
past three decades, and linked to this, the tension between neutrality and political 
commitment. In the mid-1990s, a special issue of the journal Social Studies of Science 
on `The Politics of SSK: Neutrality, Commitment and Beyond' was devoted to 
thrashing out some of the main arguments105. This debate built on previous exchanges, 
such as those of the `Epistemological Chicken' debate (Callon and Latour 1992; Collins 
10` Shrum remarks, "Research in less-developed countries (LDCs) continues to be neglected by 
mainstream science and technology studies... In the past ten years, only three of 366 published articles in 
Social Studies of Science and in Science, Technology & Human Values ... have 
dealt with agriculture in 
LDCs" (Shrum 2000: 119). 
ios Social Studies of Science, vol. 26, No. 2 (May 1996), 219-468. 
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and Yearley 1992; Woolgar 1992); those of the `Capturing' debate (Scott et al. 1990; 
Collins 1991; Martin et al. 1991); and those between Winner, Pinch and Woolgar, over 
whether the field was, could be or should be political (see Pinch 1993; Winner 1993; 
Woolgar 1993). In brief, the debate has turned around how far certain principles of 
Bloor's Strong Programme - specifically impartiality, symmetry and reflexivity - 
should be taken in social studies of science and technology. If extended indefinitely, 
what value does radical epistemological relativism hold, since it precludes any 
commitment to normative belief and action? So, for example, Winner objected that the 
SCOT approach, as exemplified by Pinch and Bijker (with its insistence on symmetry) 
was "sanitized of any critical standpoint" and therefore morally and politically impotent 
(Winner 1993: 375). Woolgar, STS's reflexivist par excellence, has consistently argued 
for extensions of symmetry and found that essentialist weaknesses in constructivist 
analyses from within partisan camps such feminism "[preclude] a coherent basis for 
political action" (Grint and Woolgar 1995: 304). 
Pels has argued that symmetry and impartiality are illusory and that STS scholars, as 
much as the scientists and technologists they study, are engaged in knowledge-politics. 
By reshuffling the dualities in scientific controversies - right and wrong, winner and 
loser - analysts necessarily involve themselves in the controversy, subverting the 
dominant view and elevating that of the underdog. He suggests that epistemological 
neutrality "is a misconceived methodological cloak for... the situated distance and 
interested autonomy of third positions" (Pels 1996: 282, emphasis in original). The 
third positions he advocates are characterised not only by distance and autonomy, but 
by `weak asymmetry', in which the boundary between `the true' and `the false' is not 
entirely abolished, but seen to be negotiated and constructed: 
Seeing it [the boundary between true and false] as the outcome of `boundary 
work' denaturalizes and destabilizes it, but does not rob it of all cultural 
footing ... This notion of 
`weak boundaries' also constitutes our model for the 
intricate relationship between science and politics... (Pels 1996: 296) 
Pels' argument is compelling, and provides a useful middle path for those avowedly 
working within, and simultaneously critical of, science itself. Like Jasanoff s call for 
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co-productionist accounts (Jasanoff 1996), it suggests a re-conceptualisation of the 
symmetry principle that retains a commitment to deconstruction while admitting 
normative positions. Jasanoff goes further to posit the choices that taking such a line 
demands of STS scholars: selecting sites of research and analysis; selecting styles of 
explanation; and deciding upon prescription. Each of these choices bears importantly 
on any relationship between STS and public health in developing countries. 
Third wave science studies and reconstructivist STS 
In 2002, Collins and Evans introduced the idea of Third Wave Science Studies, or 
Studies of Expertise and Experience (SEE) (Collins and Evans 2002). The first wave of 
science studies, they argued, consisted of the positivist, pre-Kuhnian explications of 
scientific success of the 1950s and '60s. The second wave, which started in the 1970s 
and is still going strong, is characterised by social constructivism - science is 
reconceptualised as a social activity and the boundary between scientific expertise and 
other forms of knowledge deconstructed. The third wave of science studies, as they 
propose it, is a way to reconstruct knowledge through a normative theory of 
expertise1°6. They propose a new classification of expertise into `interactive expertise' 
("enough expertise to interact interestingly with participants and carry out a sociological 
analysis") and `contributory expertise' ("enough expertise to contribute to the science of 
the field being analysed") (Collins and Evans 2002: 254). The agenda, they argue, 
should be to "think about how different kinds of expertise should be combined to make 
decisions in different kinds of science and in different kinds of cultural enterprise" 
(Collins and Evans 2002: 271). This brings STS firmly into the upstream work of 
technoscientific development and normative proscriptions about public engagement in 
scientific decision-making. 
A pertinent example that Collins and Evans refer to is Epstein's work on the AIDS 
treatment controversy in San Francisco (Epstein 1995; Epstein 1996). They re-frame 
106 The phrase `normative theory of expertise' is Collins' and Evans' own and is introduced as followed: 
"... we will have to treat expertise in the same way as truth was once treated - as something more than 
the 
judgement of history, or the outcome of the play of competing attributions. We will have to treat 
expertise as `real', and develop a `normative theory of expertise"' (Collins and Evans 2002: 237). 
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Epstein's analysis of the triumph of lay expertise in gaining entry to the scientific core 
in terms of interactional expertise; that is, the treatment activists who sought input into 
the design and conduct of clinical trials that affected them and the gay community first 
had to learn the language of the science before succeeding in making a contribution. 
Parallels can be drawn in the field of HIV prevention research, and specifically 
microbicides advocacy, where campaigners have sought to influence the funding, 
selection, and trial conditions of new pharmaceutical products (see for example Mias 
and Webb 2006; UNAIDS 2007b). Campaigners largely advocate, or translate, on 
behalf of experienced-based experts' 07, such as women who take part in vaginal 
microbicide trials; in some cases they are themselves experience-based experts. 
In chapter seven of this thesis, I drew attention to the expertise which trial participants 
in MDP acquired by virtue of extensive interaction with the pharmaceutical product and 
its scientific testing. Collins and Evans encourage the involvement of experience-based 
experts earlier in scientific decision-making - "possibly by encouraging such groups to 
look for spokespersons with interactional expertise in the science in question, or to 
encourage the growth of intermediary groups to speak for the scientific knowledge of 
the uncertified, not as campaigners, nor as experts themselves, but as translators" 
(Collins and Evans 2002: 262). Their sentiment chimes with that of Woodhouse et al 
(2002), who, rather than focusing on activists within the field of study, suggest science 
studies scholars themselves adopt a more normative stance in relation to their own 
academic enquiry. "It is reasonable to suppose, " they suggest, "that sufficiently skilled 
and otherwise `appropriate' advocacy may fit into STS, along with less avowedly 
partisan approaches that begin with symmetry and impartiality as methodological 
heuristics" (Woodhouse et al. 2002: 309). The application of STS to questions 
concerning health and illness in developing countries undoubtedly presents a radical 
intellectual challenge that simultaneously opens up both fields to thoughtful 
partisanship and social activism. 
107 Collins and Evans replace the oxymoronic term 'lay expert' with 'experience-based expert' to refer to 
"members of the public who have special technical expertise in virtue of experience that is not recognized 
by degrees or other certificates" (Collins and Evans 2002: 238). 
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Communication between different epistemic communities 
If a rapprochement of STS with public is embarked upon, the challenge of 
communication across epistemological boundaries needs to be tackled. Writing of 
future intersections between business and STS, Woolgar et al invoke the possibility of a 
trading zone, embodied in the social science `studio', as a forum for dialogue between 
different parties (Woolgar et al. 2009). Galison first used the trading zone metaphor to 
explain how physicists working within divergent paradigms went about collaborating 
with each other and with engineers to develop particle detectors and radar: 
Two groups can agree on rules of exchange even if they ascribe utterly different 
significance to the objects being exchanged; they may even disagree on the 
meaning of the exchange process itself. Nonetheless, the trading partners can 
hammer out a local coordination, despite vast global differences. In an even 
more sophisticated way, cultures in interaction frequently establish contact 
languages, systems of discourse that can vary from the most function-specific 
jargons, through semispecific pidgins, to full-fledged creoles rich enough to 
support activities as complex as poetry and metalinguistic reflection. (Galison 
1997: 783)108 
The studio approach to social science can be seen to function as a trading zone - an 
institutional space in which those who produce new technologies and those who analyse 
them can collaborate in new and experimental ways. INCITE (the Incubator for the 
Critical Inquiry into Technology and Ethnography) is one example of the studio 
approach, bringing together traditional academic modes of production and the practices 
of designers, engineers and artists (Wakeford 2003)109 
One of the ways in which researchers at INCITE have sought connection with each 
other is by "working with an artefact or an idea as an `interprofessional hyperlink"' 
(Wakeford 2003: 235). In other words, building links and collaborative discussion 
around an object (the examples Wakeford gives are all mobile objects). Following an 
ioa For an extended analysis of trading zones in interdisciplinary collaboration see (Collins et al. 2007). 109 For a complete overview of INCITE's work, see htti): //www. studioincite. com. For further examples of 
the studio approach in social science, see (Jankowski 2007; Wouters and Beaulieu 2007). 
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object as it travels, and tracing the web of socio-scientific relations it navigates, 
resonates with the work I have conducted on microbicides in this thesis. The 
technology provides a starting point from which to explore complex networks and 
diverse cultures which may span multiple geographic locations. Work on health 
problems in the developing world increasingly seeks solutions in technological terms, 
be it vaccines, pharmaceuticals and medical devices for treatment and prevention; 
pandemic preparedness software for modelling and planning; or information technology 
such as GPS and Blackberries for data collection and analysis' 10. Work is characterised 
by travel across countries, continents and collaborating institutions. However, the 
technologies themselves tend to be seen as singular and stable objects that are either 
"acceptable" to users or not, with primarily evaluative research centring on cost- 
effectiveness, acceptability, access and uptake of new interventions. Adopting STS 
sensibilities through the studio approach - and thereby turning innovation itself into a 
critical project (Webster 2002; Mort et al. 2009) - has the possibility to reinvigorate 
approaches to public health research in developing countries; combined with links to 
business and industry, it could also radically improve technological solutions to 
problems such as HIV prevention. 
110 For example, in September 2009, the WHO launched a call for innovative technologies that address 
global health concerns. The aim of the call was to identify and evaluate "innovative medical 
devices... which address global health concerns and which are likely to be available, appropriate and 
affordable for use in low- and middle-income countries" (World Health Organization 2009a). The list of 
health problems to be addressed covered everything from lower respiratory infections to malaria, 
HIV/AIDS, TB and cancer. 
227 
Figure 4: Proposed Studio Approach for the Development of New Technologies for 
Health amongst Interactional and Contributory Experts 
Public Health Research 
(applied, university-based) 
Technology Designers 
(business & industry-based) 
New 
Technologies 
fo r 
Health 
Technology Users/Consumers 
(experience-&-'field'-based) 
Science and Technology Studies 
(theoretical, university-based) 
Dialogue between these actors is already occurring in some cases: public-private 
partnerships already couple industry with academics; users' perspectives are sought 
through market research, community advisory boards and acceptability studies; and 
some STS scholars take new health technologies as their object of study. The problem 
with the existing set-up is twofold: firstly, any such interactions occur once the 
technology is deemed to be `finished' so that users and critics are presented with a fait 
accompli. Community advisory boards then become the handmaiden to the trialists 
(achieving high recruitment and retention in the product's testing), `acceptability' is 
often a question of `tolerability' and STS studies are almost bound to be deconstructive 
rather than reconstructive. The second problem, linked to the first, is that during the 
development stage of the artefact, legitimacy is granted only to a small group of 
professionals whose expertise is limited. Sociologists of knowledge, experts in their 
own right (Collins and Evans 2002: 239-240), do not have a seat at the table; nor, very 
often, do experience-based experts. 
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Whilst the suggestion here is not to deem everyone an expert and so to render the 
demarcation meaningless, it is to suggest that there are circumscribed groups of experts 
who are not currently involved in health technology design who profitably could be. 
For example, in the case of vaginal microbicides, plans are underway to develop a 
"smart" applicator that could register time, date and ambient temperature when used, 
thus providing some verification of product use in clinical trials (Tolley et al. 2009); 
likewise a `sexometer': "a vaginal ring containing electronic devices capable of 
registering when sex takes place" (Van der Wijgert and Shattock 2007: 2374). These 
devices are premised on the conviction that trial participants do not report honestly 
when enrolled to test the products. They are also designed by people who may 
approach the context of use as a quite alien and `Other' world; note, for example, the 
following, written by the Director of Product Development at CONRAD": "These 
products are principally designed for use in the developing world and must therefore 
address cultural and societal issues generally unknown in the developed world' (Friend 
2009: emphasis added). If and when such technologies reach their destination (and 
come to the attention of the curious STS scholar), the developing world user will 
already have been configured as a mendacious experimental vessel. We need to ask 
whether this trajectory is a positive one for HIV prevention or whether admitting 
previous trial participants as experts in microbicide testing and use might better inform 
future developments. 
The literature on technomethodology112 (broadly, the use of ethnomethodology in the 
design of technology) (Button and Dourish 1996) also suggests how science and 
technology scholars from within anthropology and sociology might practically engage 
in upstream work. Ethnomethodology has been used productively by the HCI (human- 
computer interaction) and CSCW (Computer Supported Cooperative Work) 
communities to design technologies around the work situations of users (for example 
Hughes et al. 1993; Anderson 1994). For example, conversation analysis, a branch of 
ethnomethodology, has been used to study the ways in which people interact with one 
111 CONRAD is a US-based research organization that has been at the forefront of microbicides research. 
It has been involved in the development of several candidate products, including PRO 2000, BufferGel, 
Tenofovir and UC781. See httn: //www. conrad. ore/about. html. 
"2 Button and Dourish use technomethodology to refer to "the contributions that have been made for 
technological support for socially-organised activity which have come from an ethnomethodological 
perspective" (Button and Dourish 1996: 2). 
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another through or around technology (Button and Dourish 1996). Button and Dourish 
note that "the thrust of this work is to furnish descriptions of the ways in which persons 
normally organise their actions and interactions and then compare this to what is 
possible or not possible using the technology" (Button and Dourish 1996: 2). In the 
case of microbicides, anthropological work has suggested the importance of the 
technology in reconfiguring patterns of communication and negotiation between sexual 
partners (Montgomery et al. 2008). The organisations and interactions between people 
around new prevention technologies - not just sexual partners, but the broader social 
group, including friends, family and peers - represent an area of enquiry and critique 
that could be incorporated into design. The approach, however, would need to move 
from a `tagging on' of the social science acceptability study in late stage clinical trials to 
a design process that incorporates STS sensibilities from the outset. This is already 
happening in some industries, where ethnographic accounts of technology-in-use 
('technographies') are integral to the design process (Fitzgerald 2005; Suchman 2007; 
Cefkin 2009). 
Configuring the collaborators 
The diagram above provides a simple schematic of the intellectual space in which 
collaboration around new technologies could occur. Whilst the contributions of the four 
parties are not likely to be symmetrical in the way the diagram suggests, the implication 
is that there are pockets of expertise amongst them that is legitimate within the sphere of 
technoscientific development in public health. Whereas public health specialists and 
industry developers can be designated contributory experts, STS analysts should be seen 
as knowledge experts, and users as experience-based experts (the latter two potentially 
representing interactional expertise). However, the diagram is problematic in that it has 
the potential to characterize each of these areas of expertise as unified fields with 
transcendental, essential properties. As Woolgar et at point out, "what is precisely 
interesting about the relation between them is how these identities are locally 
constituted, accomplished, made to collide or empathize" (Woolgar et at. 2009: 16). In 
the same vein, it is important to consider how each of these constituent parties is 
configured through the process of collaboration and engagement; how does a 4-way 
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conversation between public health, industry, STS and users in developing countries 
enact particular identities and arguments? What is at stake in the field of enquiry (what 
questions get asked), methods, and political commitments? What mechanisms of 
accountability govern the direction and forms of engagement between developers, 
implementers, users and critics? 
There are no simple answers to these questions. Indeed, writing of corporate 
anthropology, Suchman concludes that: 
Our work as anthropologists sits uncomfortably inside the close-knit 
interweaving of consumer experience understood as something prior, discovered 
through anthropological investigation and then addressed by design and 
marketing, and consumer experience understood as constituted through activities 
of design and marketing, in their contributions to the creation of desire and the 
crafting of cultural imaginaries. I do not believe that we can resolve this 
tension. (Suchman 2007: 13) 
In spite of such unresolved tensions, as debates about interactional social science, Third 
Wave STS, and the links between business, e-research and intellectual radicalism 
develop, the field of public health would do well to engage. To appropriate Collins and 
Evans, "there is, of course, a certain naivete about this suggestion, but unless all hope of 
unbiased action is to be abandoned (and why then, are we academics? ) it is our duty to 
be naive from time to time" (Collins and Evans 2002: 262-263). 
Conclusion 
How, precisely, do linguistic, social and cultural constructions shape research 
investigations or treatment interventions, how do they interact with the 
phenomena that we call data, facts, and even experience, and how, in a given 
historical context as well as in the intellectual and emotional existence of 
institutions, communities, and individuals, do they come to perform unique 
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cultural work? The AIDS epidemic has furnished many case studies for 
exploring these questions... (Treichler 1999: 327) 
The Microbicides Development Programme has provided a timely case study through 
which to explore the questions raised by Treichler, above. However, as HIV prevention 
moves into the era of `combination prevention' (Piot et al. 2008), and increasingly 
complex forms of scientific investigation (such as public-private partnerships) 
proliferate, individual case studies will cease to be adequate. Multi-scale ethnographies 
and critical qualitative studies will need to investigate the intersections between 
research consortia, technology `packages' and multi-sectoral involvement in control 
programmes. Whilst these networked and fluid worlds pose a challenge for social 
science researchers, I have suggested that greater collaboration between different 
epistemic communities may provide a way forwards. As noted at the start of this 
discussion, in 2008, Horton and Das observed that "part of the difficulty facing any new 
and upgraded movement for prevention is the way we currently discuss AIDS" (Horton 
and Das 2008: 421). The task now is to enliven AIDS prevention discourse with 
theoretical insights from social theory, recognising that "the seemingly distinct 
biological, social, and technological are tightly intertwined and affective" (Rosengarten 
et al. 2008: 358). In so doing, we can not only address the complexity of HIV 
prevention, but also demystify the science behind it. 
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Mkrnhlcdes Development Programme 
English Information & Consent Sheets 
Participant Information Sheet: Existing MDP 301 participants 
Sub-study title: The gendering of HIV research and prevention technologies: 
The example of MDP 
Investigator: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)7866 899 485; Fax: +44 (0)207 637 5391 
It is important for you to understand why this research is being done and what it will 
involve. If you decide to take part in the study, you will be free to stop at any time. 
Please ask if there is anything that is not clear or if you would like more information. 
Why is this study being done? 
Throughout the world the most common way in which the Human Immunodeficiency 
Virus (HIV) is spread is through sexual contact between men and women. Although 
condoms are a very effective form of prevention, it is not always possible for a woman 
to get her partner to agree to use them. You are currently involved in the MDP 301 
microbicide trial which is trying to find other methods of protection that can be used by 
women. 
In this sub-study, we want to find out about the interaction of both women and men with 
the MDP301 trial. We are interested in the way the relationships between men and 
women might affect the results of this and other trials, as well as their impact on the 
potential introduction of a future microbicide. Your views and experiences are 
important in helping to improve the design of future HIV prevention research, which is 
why this study is being done. 
What does participation in the study involve? 
Participation involves taking part in either a face to face interview with a member of the 
study team, or a focus group discussion with other participants, facilitated by a member 
of the study team. The interview or focus group will last between approximately 60 and 
90 minutes. The topics that will be discussed relate to your participation in the 
MDP301 trial, the role of men in HIV prevention research, and partnership dynamics 
between men and women. A digital recorder will be used to record the discussion so 
that an accurate record of what you say can be made for analysis purposes. The 
recording will only be listened to by members of the study team and will remain entirely 
confidential. 
You will receive compensation for any costs involved with coming to the clinic 
and this will be xxxx. 
Do I have to take part? 
No. It is up to you to decide whether you would like to take part. This will not affect your 
participation in the MDP301 trial or any care you receive now or in the future 
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Can I stop taking part? 
Yes, you can decide to stop taking part whenever you choose. You do not need to 
explain why you want to stop taking part to anyone, just that you want to stop. 
What are the risks and benefits? 
There are no risks associated with this study, although you may find some of the topics 
discussed embarrassing or difficult to talk about. 
The benefit of taking part in this study is that you can contribute to improving future HIV 
prevention research, helping to find methods that women and men can use 
successfully to protect themselves. 
Will the information from the study be confidential? 
Yes. Your contact details will only be available to the staff that run the study. All the 
other information that is collected will not be identified by your name, only by your trial 
number. You will be asked if you agree to have the interview recorded and your 
consent will be sought to use the information in the analysis and results. You will have 
the option of not being quoted at all, anonymously or otherwise, or included in any of 
the analyses. 
What will happen to the results? 
After the study has been completed the results will be analysed. This can take up to 12 
months, and after this you will be told the results of the study. The results of the study 
will be written up and submitted for review by a public health journal. They may also be 
presented at scientific conferences. 
This study has been approved in the United Kingdom by the London School of Hygiene 
& Tropical Medicine Ethics Committee. In your country it has been approved by: 
Mfft PM 9w kml@g gb@ Im h Md &M 
If you have questions about this study you should discuss them with a 
member of the study team (contact details as provided at the top of this 
form), or the ethics committee (contact details provided above). 
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Participant Information Sheet: MDP 301 Non-enrollers 
Sub-study title: The gendering of HIV research and prevention technologies: 
The example of MDP 
Investigator: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)7866 899 485; Fax: +44 (0)207 637 5391 
It is important for you to understand why this research is being done and what it will 
involve. If you decide to take part in the study, you will be free to stop at any time. 
Please ask if there is anything that is not clear or if you would like more information. 
Why is this study being done? 
Throughout the world the most common way in which the Human Immunodeficiency 
Virus (HIV) is spread is through sexual contact between men and women. Although 
condoms are a very effective form of prevention, it is not always possible for a woman 
to get her partner to agree to use them. The MDP 301 microbicide trial is trying to find 
other methods of protection that can be used by women. 
This is a sub-study of the main microbicide trial, which you have chosen not to enrol in. 
We are interested to find out the reasons why people choose not to take part in the trial 
in order to design better research programmes in the future. Your views and 
experiences are important in helping to improve the design of future HIV prevention 
research, which is why this study is being done. 
What does participation in the study involve? 
Participation involves taking part in an interview with a member of the study team. The 
interview will last between approximately 30 and 60 minutes. The topics that will be 
discussed relate to the MDP301 trial, the role of men in HIV prevention research, and 
partnership dynamics between men and women. A digital recorder will be used to 
record the discussion so that an accurate record of what you say can be made for 
analysis purposes. The recording will only be listened to by members of the study 
team and will remain entirely confidential. 
Do I have to take part? 
No. It is up to you to decide whether you would like to take part. This will not affect any 
future participation in the MDP301 trial or any care you receive now or in the future. 
Can I stop taking part? 
Yes, you can decide to stop taking part whenever you choose. You do not need to 
explain why you want to stop taking part to anyone, just that you want to stop. 
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What are the risks and benefits? 
There are no risks associated with this study, although you may find some of the topics 
discussed embarrassing or difficult to talk about. 
The benefit of taking part in this study is that you can contribute to improving future HIV 
prevention research, helping to find methods that women and men can use 
successfully to protect themselves. 
Will the information from the study be confidential? 
Yes. Your contact details will only be available to the staff that run the study. All the 
other information that is collected will not be identified by your name, only by a number. 
You will be asked if you agree to have the interview recorded and your consent will be 
sought to use the information in the analysis and results. You will have the option of 
not being quoted at all, anonymously or otherwise, or included in any of the analyses. 
What will happen to the results? 
After the study has been completed the results will be analysed. This can take up to 12 
months, and after this the results of the study will be written up and submitted for 
review by a public health journal. They may also be presented at scientific conferences. 
This study has been approved in the United Kingdom by the London School of Hygiene 
& Tropical Medicine Ethics Committee. In your country it has been approved by: 
vmmý pm ft h2mg a@ flu@ ft md &M 
If you have questions about this study you should discuss them with a 
member of the study team (contact details as provided at the top of this 
form), or the ethics committee (contact details provided above). 
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Microbicides Development Programme Trial 301 (MDP 301) 
Existing MDP Participants and Non-enrollers Informed Consent 
Sub-study title: The gendering of HIV research and prevention technologies: 
The example of MDP 
Investigator: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)7866 899 485; Fax: +44 (0)207 637 5391 
PLEASE CIRCLE THE CORRECT ANSWER 
Have you read or had read to you the Participant Information sheet relating to 
this study? YES / NO 
Have you received enough information about the study? YES / NO 
Have any questions you have about the study been answered? YES / NO 
Do you understand that you are free to withdraw from the study: 
- at any time 
- without having to give a reason for withdrawing 
- without affecting future medical care 
- and without affecting your participation in the trial? YES / NO 
Do you agree to take part in this study? YES / NO 
If 'NO' to any of the above the volunteer is ineligible for the study 
Signature/Thumbprint of volunteer 
Signature Date of 
or thumb- signature 
print 
Si nature of witness 
Signature Date of 
si nature 
Signature of study staff taking consent 
Signature Date of 
si nature 
Print 
name 
If you do not wish to be quoted at all, even anonymously, or included in the analyses in 
any way, please check this box L 
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Participant Information Sheet: MDP Staff and Key Stakeholders 
Sub-study title: The gendering of HIV research and prevention technologies: 
The example of MDP 
Investigator: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)7866 899 485; Fax: +44 (0)207 637 5391 
It is important for you to understand why this research is being done and what it will 
involve. If you decide to take part in the study, you will be free to stop at any time. 
Please ask if there is anything that is not clear or if you would like more information. 
Why is this study being done? 
Throughout the world the most common way in which the Human Immunodeficiency 
Virus (HIV) is spread is through sexual contact between men and women. Although 
condoms are a very effective form of prevention, it is not always possible for a woman 
to get her partner to agree to use them. The MDP 301 microbicide trial is trying to find 
other methods of protection that can be used by women. 
In this sub-study, we want to find out about the interaction of both women and men with 
the MDP301 trial. We are interested in the way gender dynamics (the relationships 
between men and women) might affect the results of this and other trials, as well as 
their impact on the potential introduction of a future microbicide. Your views and 
experiences are important in helping to improve the design of future HIV prevention 
research, which is why this study is being done. 
What does participation in the study involve? 
Participation involves taking part in an interview, which will last between 60 and 90 
minutes. The topics that will be discussed relate to your involvement in the MDP301 
trial and/or other HIV prevention research, the role of men in HIV prevention research, 
and partnership dynamics between men and women. If you agree, a digital recorder 
will be used to record the discussion so that an accurate record of what you say can be 
made for analysis purposes. The recording will only be listened to by members of this 
sub- study team. 
Do I have to take part? 
No. It is up to you to decide whether you would like to take part. This will not affect your 
involvement in the MDP301 trial. 
Can I stop taking part? 
Yes, you can decide to stop the interview whenever you choose. You do not need to 
explain why you want to stop taking part to anyone, just that you want to stop. 
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What are the risks and benefits? 
There are no risks associated with this study, although you may find some of the topics 
discussed embarrassing or difficult to talk about. 
The benefit of taking part in this study is that you can contribute to improving future HIV 
prevention research, helping to find methods that women and men can use 
successfully to protect themselves. 
Will the information from the study be confidential? 
All data will be stored securely and only be available to the staff that run the study. 
Due to the small numbers involved in this study, it is possible that others might be able 
to identify you and your comments in the analysis and disseminated results. You will 
be asked if you agree to have the interview recorded and your consent will be sought to 
use the information in the analysis and results. You will have the option of not being 
quoted at all, anonymously or otherwise, or included in any of the analyses. 
What will happen to the results? 
After the study has been completed the results will be analysed. This can take up to 12 
months, and after this you will be told the results of the study. The results of the study 
will be written up and submitted for review by a public health journal. They may also be 
presented at scientific conferences. 
This study has been approved in the United Kingdom by the London School of Hygiene 
& Tropical Medicine Ethics Committee. In your country it has been approved by: 
1Cmk pm fT mn° I° b &M 
If you have questions about this study you should discuss them with the 
investigator or a member of the study team (contact details as provided at 
the top of this form), or the ethics committee. 
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Microbicides Development Programme Trial 301 (MDP 301) 
MDP Staff & Key Informant Informed Consent 
Sub-study title: The gendering of HIV research and prevention technologies: 
The example of MDP 
Investigator: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)7866 899 485; Fax: +44 (0)207 637 5391 
PART I 
PLEASE CIRCLE THE CORRECT ANSWER 
Have you read the Participant Information sheet relating to this study? YES / NO 
Have you received enough information about the study? YES / NO 
Have any questions you have about the study been answered? YES / NO 
Do you understand that you are free to withdraw from the study: 
- at any time 
- without having to give a reason for withdrawing 
- without affecting future medical care 
- and without affecting your participation in the trial? YES / NO 
Do you agree to take part in this study? YES / NO 
If 'NO' to any of the above the volunteer is ineligible for the study 
Sianature/Thumbprint of volunteer 
Signature Date of 
or thumb signature 
print 
Print 
name 
Si nature of witness 
Signature Date of 
signature 
Sianature of study staff taking consent 
Signature Date of 
signature 
Print 
name 
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PART II: COMPLETE IF CONSENT TO PART I OBTAINED 
You have agreed to participate in an interview as part of the MDP Gender Sub- 
Study. 
Please circle the appropriate answer: 
I agree that the interview may be digitally recorded YES / NO 
I understand that due to the small numbers involved 
in this study, it is possible that others might be able to 
identify me and my comments in the analysis and 
disseminated results. YES / NO 
I agree that text from the interview may be used in reports 
and publications WITHOUT my name YES / NO 
If you do not wish to be quoted at all, even anonymously, or included in the 
analyses in any way, please check this box C 
Signature/Thumbprint of volunteer 
Signature Date of 
or thumb signature 
print 
Print 
name 
Signature of witness 
Signature Date of 
signature 
nature of study staff taking consent 
Signature Date of 
signature 
Print 
name 
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Nyanja Information Sheet & Consent Form 
Pepela la mau lawotengako mbali: MDP 301 Participants 
Kamutu: Kugwirizana kwa Adzimai ndi adzibambo mu kufufza kwa matenda 
akaliyonde-yonde ndi njila zochingiliza: chisanzo cha MDP 
Mfufuzi: Catherine Montgomery, Health Policy Unit, London School of Hygiene 
& Tropical Medicine, London, UK. Tel.: +44(0) 2079272931; Fax: +44 (0) 207 
637 5392 
Ndi chofunika kuti munvetsetse chifukwa chomwe kufufuza uk kuchitita ndi 
zochichitika zamukati. Ngati muzaganiza kutengako mbali mumaphunzilowo 
muzakhala ndi danga loleka panthawi iliyonse. Chonde funsani ngati kuli 
chilichonse chomwe simuna nvetsetse kapena mufuna kupandululidwa. 
Ndi chifukwa chiyani maphunzilo akuchitika? 
Mudziko lonse njila ikulu yomwe kadoyo kakaliyonde-yonde kamatengedwa ndi 
logonana pakati pa mwamuna ndi mukadzi. Ngakhale kuti makondomu alindi 
mphamvu lo chingilila, nthawi zambiri sichotheka kuli mudzimai kupanga 
mwamuna wake kubvomela kuyagwiritsa nchito. Pakalipano muli mu MDP 301 
Microbicides trial yomwe ikuyetsa njila ina yo chingilila yomwe ingagwiritsidwe 
nchito ndo adzimai. 
Muka kaphunzilo aka tifuna kudziwa momwe adzimai ndi adzibambo mu MDP 
301 trial agwirizana. Tifunitsitsa kudziwa ngati chigwirizano cha adzimai ndi 
adzimai chizakhuza kuzotulukamo zakufufuza uku ndi ena ndi momwe 
kuzakhuzila ma micribicides yamusogolo Mau anu ndi zomwe mwapitamo 
ndizofunika kwambiri pakuthandiza kutukula kapangidwe yamaphunzilo yo 
fufuza kadoyo kakaliyonde-yonde yamusogolo, ichi ndi chomwe maphunzilowa 
akuchitika. 
Kodi kutengamo mabli mumaphunzilo kuphatikizapo chiyani? 
Kutengamo mbali kuphatikizapo kufunsidwa ndi wanchito wama phunzilo 
kapena kupezeka mukagulu kokambitsana ndi ena otengako mbali, 
koyanganidwa ndi wanchito wama phunzilo. Kufunsidwa kapena ka gulu ko 
kambitsana kazakhala pafupi-fupi 60 kapena 90 minutes. Zomwe zizakambigwa 
zilola pakutengako mbali kwanu, mbali ya azibambo muma phunzilo loteteza 
matenda yakaliyonde yonde, ndi kusiyan kwakunvana pakati pa adzimai ndi 
adzibambo. Ka wailesi kojambula kazagwiritsidwa nchito kunjambula 
zokambitsana kotelo kuti zomwe muzakambitsana ziza sungidwa kuti 
ziyanganidwe. Zomwe zizalembedwa zizanveledwa chabe ndi anchito 
amaphunzilo ndiponso zizakhala zachisinsi. 
Muza landila malipilo yaliyonse yama yendedwe yanu kulingana na malamulo 
ya MDP yalipo manje. 
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Kodi ndifunika kutengako mbali? 
Ai. Chili kuli inu ngati mufuna kutengako mbali. Ichi sichizakhuza ku kutengako 
mbali kwanu kwa kufufuza kwa MDP 301 kapena zaumoyo zomwe mulandila 
tsopano kapena mutsogolo. 
Kodi ndi kaleke kutengako mbali? 
Inde. Mungathe kuleka pomwe mwafunila. Simuzafunika kufotokas kuli aliyense 
zifukwa zomwe mwalekela, ndi chakuti mufuna kuleka. 
Kodi ndi zotani zowopsya ndi zabwino? 
Zowopsya mumaphunzilo awa kulibe, ngakhale kuti mungapeze zokambitsana 
zina kukhala zonvetsa nsoni kapena zolema kukamba. 
Zabwino zotengako mbali ndizakuti mzathilako ndemanga yothukula 
maphunzilo yotetsza matenda yakaliyone-yonde yamusogolo, kuthandiza 
kupeza njila yomwe adzimai ndi adzibambo angagwiritse nchito kuzichingilila. 
Kodi mau amumaphunzilowa azakhala azhinsinsi? 
Inde. Mau yakomwe mukhala ndi anchito oyanganila maphunzilowa. Yonse 
mau yanu ena yomwe azatengedwa siyaza ziwidwa ndi zinc lanu koma ndi 
nambala yakufufuza. Muzafunsidwa ngati muvomela kuti mafunso yani 
ajambulidwe ndi chibvolezo chanu kugwirista nchito mau mu analysis ndi mu 
ma results. Muzakhala ndi chosankha chosafuna kuchulidwa, kwakabisila, 
kapena mwina mwache, kapena kupezeka mulimonse mu analysis. 
Ndi chiyani chizachitika kuzotulukamo? 
Pachimalizilo chamaphunzilowa zotulukamo ziyanganidwa. Ichi chingakhale 
pafupi -fupi miyezi ili 12, pachimalizilo chache muza uzidwa zotulukamo 
mumaphunzilo. Zotulukamo zamaphunzilo zizalembedwa ndi kuyanganidwa ndi 
ba public health journal. Yangakambidwenso mumisonkhano ya science. 
Ili phunzilo ndiloleledwa mu United Kingdom ndi ba London School of Hygiene 
and Tropical Medicine Ethics Committee. Mu dziko lanu ndilo loledwa ndi: 
University of Zambia research ethics committee 
ýýý 
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Ngati mull ndi mafunso pall maphunzilo munga kambitsane ndi wanchito 
wamamphunzilo (Kwamene bapezaka; balemba pamwamba pacipepala ici) 
kapena ba Ethics Committee. 
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Microbicides Development Programme Trial 301 (MDP 301) 
Pepala yo vomekeza kuli botengamo mbali ku MDP na bamene sibantenge 
mbali 
Kamutu: Kugwirizana kwa Adzimai ndi adzibambo mu kufufza kwa matenda 
akaliyonde-yonde ndi njila zochingiliza.: chisanzo cha MDP 
Mfufuzi: Catherine Montgomery, Health Policy Unit, London School of Hygiene 
& Tropical Medicine, London, UK. Tel.: +44 (0)207 927 2931; Fax: +44 (0)207 
637 5391 
NDIPEMPA MU CONGE YANKO LO LUNGAMA 
Kodi mwawelenga kapena akuwelengelani pepala yotengako mbali ya maphunzilo awa? 
Inde / ai 
Kodi mwalandila mau yokwana yama phunzilo? Inde / ai 
Kodi mafunso anu pamaphunzilowa yankhidwa? Inde / ai 
Kodi mudziwa kuti muli ndi ufulu wo leka maphunzilo: 
- panthawi ili yonse 
- kopanda kupasa zifukwa 
- kosakhuza khuza umoyo zomwe mulandila 
- ndi kusakhuza ku kutengako mbali mukufufuza Inde / ai 
Mubvomela kutengako mbali mu maphunzilo awa? Inde / ai 
Ngati 'Al' kuli chilli chonse pamwamba apa, ozipeleka afeluka kutenga mbali 
ndipo SAFUNIKA ku saina cipepala ici 
Kusaina/cidido ca cikumo ca wotenga mbali 
Kusaina/cid Stiku lo saina 
ido ca 
chala 
Kusaina kwa kamboni 
Kusaina Stiku lo saina 
Ku saina kwa anchito 
lo 
Lembani 
Dzina 
Ngati SIMUFUNA ku ku kambani olo kuzibik munjila iliyonse mull iyi nkhani, tipempa 
mu chonge muka mbokosi 
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Tonga Information Sheet & Consent Form 
Chipepala casikutola lubazu: Basikutola lubazu bajanika mu MDP 301 
Mutwe wabumvuntauzi busyoonto: Kwelanya kwakusola sola HIV abukwabilizi 
bwabusyabupampu: Mukohanyo wa MDP: 
Mumvuntauzi: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)207 927 2931; Fax: +44 (0)207 637 5391 
Cilayandika kapati uti umvwisye bu vuntaunsyi oobu ncebucitilwa a zyintu zyiya 
kucitwa. Kuti walisalila kubweza lubazu, ulaangulukide ciindi cili coonse 
kucileka. Twalomba kuti abuse cili coonse ncoota salalilwa nokuba kuti uyanda 
kuzyiba tumbi twaambo. 
Ino nkaambonzi eeci ciiyo ncecicitilwa? 
Nike yoonse nzila iizyizyilwe kapati mbuli mbobuyambukila buiwazi 
bwasikalileke (HIV) nja koonana akati ka basankwa a bamakaintu. Nokuba kuti 
tupila tuli kabotu kapati kubelesya mukukwabilila, takuli kuti lyoonse 
cilakonzyeka kuti mukaintu ulakonzya kucita kuti mwanakasuwa wakwe 
azumine kutubelesya. Kwaciindi cino ulinjide mu MDP 301 microbicide trial yalo 
isola kujana zyimbi nzila zyikozya kubelesya bamakaintu mukulikwabilila. 
Muciiyo eeci cisyoonto ca ciiyo cipati, tuyanda kujana kwaabana twaambo tuliko 
akati kabamakaintu a basankwa boonse mu MDP 301 trial. Tuyanda kuzyiba 
mbuli zyilongwe akati kabasankwa a ba makaintu mbozyikozya kuyambukizya 
mamanino a ciiyo eeci naanka ma trials aambi antoomwe antalisyo 
yakubelesya microbicide iciboola. Imizeezo a luzyibo Iwako zyintu zyipati 
zyikozya kagwasyilizya kubambulula bubambe bwa buvuntausyi 
bwakulikwabilila kazunda kasikalileke kuciindi ciboola, elyo nkekaambo kaako 
eeci ciiyo ncecicitilwa. 
Hena ku tola lubazu mu ciiyo eci camba nzi? 
ikubweza lubazu kujatikizya mbuli kubuzyigwa buzyigwa busyu a busyu a umwi 
uujanwa munkamu ya ciiyo eeci, naanka kabunga kalanganya mibandi a bamwi 
wa basikubweza lubazu, kayendelezegwa a umwi wankamu ya ciiyo eeci. 
Kubuzyigwa buzyigwa nakuba nkamu ilanganya mibandi iyakutola ciindi 
cilampa akati ka 60 a 90 tunzunzumina. Twaambo tuya kubandikwa tujatikizya 
mbuli mbobweza lubazu mu MDP 301 trial, lubazu Iwa basankwa 
mubuvuntausyi bwakulikwabilila kazunda kasikalileke, akati kabasankwa a 
bamakaintu. Ka muncini ka kubweza majwi nomubandika kaya kubelesyegwa 
kubweza mubandi kutegwa kuti kukabe buyobozi bubotu bwa zyoyakwaamba 
zyiya kubelesyegwa mukulangalanga ciiyo ku mamanino. Mubandi ooyu uya 
kuswililwa biyo a bantu bamumbunga ya ciiyo eeci kwamana, ani kuli maseseke 
ciindi coonse. Uyakupegwa bulumbu bull boonse mbotikabelesye ciindi ncoya 
kuboola kucibbadela bwalo oobu buni kuli mbuli kweendelanya a malailile a 
MDP a sunu. 
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Hena ndileelede kubweza lubazu? 
Peepe. Aawa ciyakuba kuli ndiwe naa usala kubweza lubazu naa peepe. Ooku 
kusala kwako kunyina mbokuva kukulesya kubweza lubazu ciindi ciboola mu 
MDP 301 trial nokuba lugwasyo ndopegwa ono naanka ciindi ciboola. 
Hena inga ndaleka kubweza lubazu? 
Eeye, inga waleka kubweza lubazu kufumbwa mpooyandila. Toyelede 
kupandulula kumuntu uli oonse ncoyanda kucilekela kubweza lubazu, 
nkwaamba biyo kuti wacileka. 
Hena mbubi nzi alimwi mbubotu nzi buliko? 
Kunyina bubi buliko muciiyo eeci nokuba kuti uyakujana tumwi twaambo tujazya 
nsoni ku twaamba naanka kukatazya ku twaamba. 
Bulumbu bwakubweza lubazu mu ciiyo eeci mbwakuti inga wayungizya 
kubambulula buvuntauzi bwakulikwabilila kazunda kasikalileke ciindi ciboola, 
kugwasyilizya kujana nzila bamakaintu a basankwa nzyobakozya kubelesya kuli 
kwabilila cakabotu kapati. 
Hena twaambo twa ciiyo eeci tuni kuli maseseke? 
Eeye. Mbotukozya kukubona kuya kuzyibwa biyo aba yendelezi bapati pati 
bendelezya ciiyo. Toonse tumwi twaambo tuyakubwezelelwa tatutikazibwe a 
zyina lyako, pele biyo a nambala. Uyakubuzyigwa kuti naa ulazumina kuti 
kubuzyigwa buzyigwa ulazumina kuti kubuzyigwa busyigwa ooku kuka bikkwe 
mu ka munchini alimwi tuya ku kubuzya kuti naa wazumina kuti tukabelesye 
twaambo ootu mukulanga-langa ciiyo a mamanino a ncinco. Unikuli a kusala 
kuti toyandi kubwezyelwa twaambo, kuti toyandi kuzyibwa naanka kuli koonse, 
naanka kasanganizyigwa kuli koonse mukulanga-langa ciiyo. 
Hena mamanino a ciiyo aya kubelesyegwa kucita nzi? 
Eeci ciiyo caakumana mamanino a ncico aya kulangwa-langwa. Eeci cilakozya 
kutola myezi iili kkumi a yobilo, kwamana twaambo tuyakujanwa twa ciiyo 
tuyakulembwa a kupegwa kuli ba Public Health Journal kuti bakatusepesepe. 
Alimwi twaabo ootu inga twatolegwa ku mbungano zyipati zyaba syaabupampu 
bapati-pati ba lwiiyo. 
Eeci ciiyo cakazumizyigwa mu United Kingdom a baku London School of 
Hygiene and Tropical Medicine Ethics Committee. Elyo mucisi canu caka 
zumizyigwa aba University of Zambia Research Ethics Committee. 
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Kuti kojisi mibuzyo kujatikizya ciiyo eeci weelede kubandika a bamwi 
bankamu ba ciiyo (nkobajanwa kulilembedwe atalaa cipepa eeci), naanka ba Ethics Committee. 
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Microbicides Development Programme Trial 301 (MDP 301) 
Basikutola lubazu bajanika mu MDP abatajaniki mu cipepala cakuzuminizya 
Mutwe wabumvuntauzi busyoonto: Kwelanya kwakusola sola HIV abukwabilizi 
bwabusyabupampu: Mukohanyo wa 
Mumvuntauzi: Catherine Montgomery, Health Policy Unit, London School of Hygiene & 
Tropical Medicine, London, UK. Tel.: +44 (0)207 927 2931; Fax: +44 (0)207 637 5391 
NDALOMBA KUZINGULUSYA MWEENGO KUMWIINGUZI NGOOSALA 
Hena wabala naa wakabalilwa cipepa ca sikubweza ubazu kujatikizya EEYE / PEEPE 
ciiyo eeci? 
Hena wakapegwa twaambo tunji kujatikizya ciiyo eeci? EEYE / PEEPE 
Hena mibuzyo yoonse njowajisi kujatikizya ciiyo eeci yayingulwa? EEYE / PEEPE 
Hena ulizyi kuti uli angulukide kucileka ciiyo eeci: 
- Kufumbwa ciindi 
- Kakunyina kupa kaambo kalikoonse ncoocilekela 
- Kakunyina kunyonganya busilisi mboyakupegwa ciindi ciboola 
- Alimwi kakunyina kunyonganya mbobweza lubazu mu trial 
EEYE/PEEPE 
Hena ulazumina kubweza lubazu mu ciiyo eeci? EEYE / PEEPE 
Kuti WAKAKA kuli koonse kwaabwa atala awa sikulwaaba tayelede ku bam u 
ciiyo eeci alimwi TAYELEDE kusiba a cipapa cakuzumina. 
KUSIMBA/KUDINTA CINWE N'GANDA CA SIKULYAABA 
KUSIMBA NAANKA BUZUBA 
KUDINTA CINWE MUMWEZI BWA 
N'GANDA KUSIMBA 
Kusimba kwa kamboni 
Kusimba Buzuba mumwezi 
bwa kusimba 
Kusimba kwa muntu waci ati ati wendelezya kuzumina 
Kusimba Buzuba mumwezi 
bwa kusimba 
Lemba Z ina 
Ikuti kotayandi kubwezelwa twaambo toonse, nakuba kutayanda kuzyibwa zina, 
naanka kusanganyizyigwa mukulangwalangwa kwa ciiyo munzila ili yoonse, twalomba 
ko kwenyuna mucibbokesi 
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